name	mechanism_of_action	target_moa	target_chembl_id	indication_efo_term	efo_id	max_phase_for_ind	action_type
CETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	urticaria	EFO:0005531	4	ANTAGONIST
CETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	4	ANTAGONIST
PENTAZOCINE	Sigma opioid receptor modulator	SIGMAR1	CHEMBL287	pain	EFO:0003843	4	MODULATOR
LEVOSALBUTAMOL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	3	AGONIST
DOXYLAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	1	ANTAGONIST
DOXYLAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	infection	EFO:0000544	1	ANTAGONIST
DOXYLAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Nausea and vomiting	HP:0002017	3	ANTAGONIST
AFIMOXIFENE	Estrogen-related receptor gamma antagonist	ESRRG	CHEMBL4245	ductal adenocarcinoma	EFO:0000430	2	ANTAGONIST
AFIMOXIFENE	Estrogen-related receptor gamma antagonist	ESRRG	CHEMBL4245	breast carcinoma	EFO:0000305	2	ANTAGONIST
GONADORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	3	AGONIST
GONADORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	infertility	EFO:0000545	3	AGONIST
GONADORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	AGONIST
GONADORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast carcinoma	EFO:0000305	3	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	pain	EFO:0003843	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Retinitis pigmentosa	Orphanet:791	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	asthma	EFO:0000270	1	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Oculocutaneous albinism	Orphanet:55	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Tourette syndrome	EFO:0004895	1	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	stroke	EFO:0000712	3	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Spinal cord injury	EFO:1001919	1	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	orthostatic hypotension	EFO:0005252	1	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	age-related macular degeneration	EFO:0001365	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Angelman syndrome	Orphanet:72	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	cocaine dependence	EFO:0002610	2	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	restless legs syndrome	EFO:0004270	3	AGONIST
LEVODOPA	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Parkinson's disease	EFO:0002508	4	AGONIST
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	age-related macular degeneration	EFO:0001365	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal carcinoma	EFO:0002890	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	sarcoma	EFO:0000691	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast neoplasm	EFO:0003869	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	mesothelioma	EFO:0000588	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	multiple myeloma	EFO:0001378	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	age-related macular degeneration	EFO:0001365	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate carcinoma	EFO:0001663	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	central nervous system cancer	EFO:0000326	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	renal carcinoma	EFO:0002890	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	primary myelofibrosis	EFO:0002430	1	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	melanoma	EFO:0000756	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	cutaneous melanoma	EFO:0000389	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	2	INHIBITOR
VATALANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	central nervous system cancer	EFO:0000326	1	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
VATALANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	primary myelofibrosis	EFO:0002430	1	INHIBITOR
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	pain	EFO:0003843	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hepatitis C infection	EFO:0003047	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Barrett's esophagus	EFO:0000280	0	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	migraine without aura	EFO:0005296	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	type II diabetes mellitus	EFO:0001360	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	metamphetamine dependence	EFO:0004701	1	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	breast carcinoma	EFO:0000305	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	type I diabetes mellitus	EFO:0001359	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Hepatitis, Alcoholic	EFO:1001345	1	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	congestive heart failure	EFO:0000373	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	stroke	EFO:0000712	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	4	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart failure	EFO:0003144	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	congestive heart failure	EFO:0000373	4	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart disease	EFO:0003777	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Proteinuria	HP:0000093	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertrophic cardiomyopathy	EFO:0000538	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	migraine with aura	EFO:0005295	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetes mellitus	EFO:0000400	2	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	atrial fibrillation	EFO:0000275	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	aortic stenosis	EFO:0000266	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart failure	EFO:0003144	4	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	type I diabetes mellitus	EFO:0001359	3	ANTAGONIST
CANDESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	cocaine dependence	EFO:0002610	2	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	metabolic syndrome	EFO:0000195	3	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Alzheimers disease	EFO:0000249	1	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart disease	EFO:0003777	3	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	HIV infection	EFO:0000764	2	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetic nephropathy	EFO:0000401	3	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
TELMISARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	HIV-1 infection	EFO:0000180	2	ANTAGONIST
DIENESTROL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Dengue Hemorrhagic Fever	EFO:0004227	1	AGONIST
TALNETANT	Neurokinin 3 receptor antagonist	TACR3	CHEMBL4429	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
ISOFLUROPHATE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	glaucoma	EFO:0000516	4	INHIBITOR
MIGLUSTAT	Ceramide glucosyltransferase inhibitor	UGCG	CHEMBL2063	Gaucher disease	Orphanet:355	3	INHIBITOR
MIGLUSTAT	Ceramide glucosyltransferase inhibitor	UGCG	CHEMBL2063	Cystic fibrosis	Orphanet:586	2	INHIBITOR
MIGLUSTAT	Ceramide glucosyltransferase inhibitor	UGCG	CHEMBL2063	Sandhoff disease	Orphanet:796	3	INHIBITOR
MIGLUSTAT	Ceramide glucosyltransferase inhibitor	UGCG	CHEMBL2063	Niemann-Pick disease type C	Orphanet:646	3	INHIBITOR
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	migraine disorder	EFO:0003821	1	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	Alzheimers disease	EFO:0000249	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	coronary artery disease	EFO:0000378	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	atherosclerosis	EFO:0003914	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	breast neoplasm	EFO:0003869	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	breast carcinoma	EFO:0000305	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	infertility	EFO:0000545	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	epilepsy	EFO:0000474	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	polycystic ovary syndrome	EFO:0000660	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	HIV-1 infection	EFO:0000180	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	Ovarian hyperstimulation syndrome	Orphanet:64739	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	Vulvar Lichen Sclerosus	EFO:1000623	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	cocaine dependence	EFO:0002610	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	premature birth	EFO:0003917	3	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	marijuana dependence	EFO:0004218	0	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	nicotine dependence	EFO:0003768	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	dysplasia of cervix	EFO:1000910	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	type I diabetes mellitus	EFO:0001359	1	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	preeclampsia	EFO:0000668	2	AGONIST
PROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	AGONIST
DORAMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	psoriasis	EFO:0000676	2	INHIBITOR
DORAMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
CALCIFEDIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	myocardial infarction	EFO:0000612	3	AGONIST
CALCIFEDIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	vitamin D deficiency	EFO:0003762	0	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	multiple sclerosis	EFO:0003885	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	bone fracture	EFO:0003931	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	tibia fracture	EFO:0003944	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	allergy	EFO:0003785	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	inflammation	MP:0001845	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	X-linked adrenoleukodystrophy	Orphanet:43	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	polyp	EFO:0000662	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	abnormal glucose tolerance	EFO:0002546	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	type I diabetes mellitus	EFO:0001359	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	optic neuritis	EFO:0007405	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	systemic lupus erythematosus	EFO:0002690	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	X-linked hypophosphatemia	Orphanet:89936	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	gestational diabetes	EFO:0004593	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	pneumonia	EFO:0003106	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoarthritis	EFO:0002506	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	colorectal adenoma	EFO:0005406	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	male infertility	EFO:0004248	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	diabetes mellitus	EFO:0000400	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	postmenopausal osteoporosis	EFO:0003854	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteopenia	HP:0000938	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate carcinoma	EFO:0001663	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	HIV-1 infection	EFO:0000180	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	skin disease	EFO:0000701	0	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	heart failure	EFO:0003144	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	atopic eczema	EFO:0000274	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic lymphocytic leukemia	EFO:0000095	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteitis deformans	EFO:0004261	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	melanoma	EFO:0000756	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Tuberculosis	Orphanet:3389	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hepatitis C infection	EFO:0003047	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Crohn's disease	EFO:0000384	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	metabolic syndrome	EFO:0000195	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic childhood arthritis	EFO:0002609	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	glioblastoma multiforme	EFO:0000519	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	obesity	EFO:0001073	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	vitamin D deficiency	EFO:0003762	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	ovarian carcinoma	EFO:0001075	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast carcinoma	EFO:0000305	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic kidney disease	EFO:0003884	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	HIV infection	EFO:0000764	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	AIDS	EFO:0000765	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	allergic conjunctivitis	EFO:0007141	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	urticaria	EFO:0005531	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	polycystic ovary syndrome	EFO:0000660	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	pulmonary tuberculosis	EFO:1000049	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hyperlipidemia	EFO:0003774	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prediabetes syndrome	EFO:1001121	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate adenocarcinoma	EFO:0000673	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	lymphoid neoplasm	EFO:0001642	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	influenza infection	EFO:0001669	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	type II diabetes mellitus	EFO:0001360	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Parkinson's disease	EFO:0002508	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	acute myeloid leukemia	EFO:0000222	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	vitamin deficiency	EFO:0005878	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoporosis	EFO:0003882	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	skin neoplasm	EFO:0004198	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	colorectal carcinoma	EFO:1001951	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	irritable bowel syndrome	EFO:0000555	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	asthma	EFO:0000270	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	infection	EFO:0000544	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Staphylococcus aureus infection	EFO:0005681	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	relapsing-remitting multiple sclerosis	EFO:0003929	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Neurofibromatosis type 1	Orphanet:636	2	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Sickle cell anemia	Orphanet:232	1	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	ulcerative colitis	EFO:0000729	3	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Barrett's esophagus	EFO:0000280	0	AGONIST
CHOLECALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hip fracture	EFO:0003964	3	AGONIST
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	rosacea	EFO:1000760	0	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	aortic disease	EFO:0005775	0	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Craniosynostosis	Orphanet:1531	2	INHIBITOR
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	inflammation	MP:0001845	2	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	hemorrhage	MP:0001914	4	INHIBITOR
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	hemorrhage	MP:0001914	4	INHIBITOR
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	Craniosynostosis	Orphanet:1531	2	INHIBITOR
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	aortic disease	EFO:0005775	0	INHIBITOR
AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	PLAT	CHEMBL1873	intracerebral hemorrhage	EFO:0005669	1	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	intracerebral hemorrhage	EFO:0005669	1	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	inflammation	MP:0001845	2	INHIBITOR
AMINOCAPROIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	rosacea	EFO:1000760	0	INHIBITOR
LATANOPROST ACID	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	glaucoma	EFO:0000516	4	AGONIST
LATANOPROST ACID	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	open-angle glaucoma	EFO:0004190	3	AGONIST
LATANOPROST ACID	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	ocular hypertension	EFO:1001069	3	AGONIST
LATANOPROST ACID	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	Meniere disease	EFO:0006862	2	AGONIST
DNK333	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
DNK333	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	atopic eczema	EFO:0000274	2	ANTAGONIST
DNK333	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal neoplasm	EFO:0004142	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast neoplasm	EFO:0003869	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast carcinoma	EFO:0000305	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	lung carcinoma	EFO:0001071	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast neoplasm	EFO:0003869	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	lung carcinoma	EFO:0001071	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast carcinoma	EFO:0000305	2	INHIBITOR
CI-1040	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal neoplasm	EFO:0004142	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	alopecia areata	EFO:0004192	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	inflammation	MP:0001845	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	pneumonia	EFO:0003106	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hepatitis B infection	EFO:0004197	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	colorectal carcinoma	EFO:1001951	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	atherosclerosis	EFO:0003914	0	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	aortic stenosis	EFO:0000266	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	multiple myeloma	EFO:0001378	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Cystic fibrosis	Orphanet:586	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	myocardial infarction	EFO:0000612	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	rectum cancer	EFO:1000657	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	sinusitis	EFO:0007486	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	heart failure	EFO:0003144	0	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	migraine disorder	EFO:0003821	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	intracerebral hemorrhage	EFO:0005669	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Combined hyperlipidemia	Orphanet:79211	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	uveitis	EFO:1001231	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	subarachnoid hemorrhage	EFO:0000713	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	septic shock	EFO:0006834	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	macroglobulinemia	EFO:0002616	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Noonan syndrome	Orphanet:648	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	prostate carcinoma	EFO:0001663	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypertension	EFO:0000537	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	mucositis	EFO:1001898	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	epilepsy	EFO:0000474	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	acute coronary syndrome	EFO:0005672	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	intestinal cancer	EFO:0007330	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	asthma	EFO:0000270	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Graves ophthalmopathy	EFO:1001466	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	relapsing-remitting multiple sclerosis	EFO:0003929	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hyperlipidemia	EFO:0003774	4	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Choroideremia	Orphanet:180	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Hemangioma, Cavernous, Central Nervous System	EFO:1001343	0	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	4	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	systemic lupus erythematosus	EFO:0002690	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	pain	EFO:0003843	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	insomnia	EFO:0004698	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	familial hypercholesterolemia	EFO:0004911	4	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	sepsis	HP:0100806	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	carotid artery disease	EFO:0003781	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	breast carcinoma	EFO:0000305	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Myocardial Ischemia	EFO:1001375	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	lung carcinoma	EFO:0001071	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	periodontitis	EFO:0000649	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	cirrhosis of liver	EFO:0001422	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic progressive multiple sclerosis	EFO:0003840	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	gastric carcinoma	EFO:0000178	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	atrial fibrillation	EFO:0000275	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	intermittent vascular claudication	EFO:0003876	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Abnormality of lipid metabolism	HP:0003119	4	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Smith-Lemli-Opitz syndrome	Orphanet:818	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Hypertriglyceridemia	EFO:0004211	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	vascular disease	EFO:0004264	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	diabetic retinopathy	EFO:0003770	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	bladder carcinoma	EFO:0000292	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV infection	EFO:0000764	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	stomach neoplasm	EFO:0003897	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Parkinson's disease	EFO:0002508	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic kidney disease	EFO:0003884	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Vitiligo	EFO:0004208	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	coronary artery disease	EFO:0000378	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	prediabetes syndrome	EFO:1001121	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	pulmonary hypertension	EFO:0001361	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	uterine fibroid	EFO:0000731	2	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Alzheimers disease	EFO:0000249	3	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Sickle cell anemia	Orphanet:232	1	INHIBITOR
SIMVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	congestive heart failure	EFO:0000373	4	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Alport syndrome	Orphanet:63	2	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertrophic cardiomyopathy	EFO:0000538	2	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	type II diabetes mellitus	EFO:0001360	3	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	4	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetes mellitus	EFO:0000400	3	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	atrial fibrillation	EFO:0000275	3	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	chronic kidney disease	EFO:0003884	2	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart failure	EFO:0003144	4	ANTAGONIST
VALSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	myocardial infarction	EFO:0000612	4	ANTAGONIST
NABUMETONE	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
FARGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	cirrhosis of liver	EFO:0001422	2	AGONIST
NRX195183	Retinoic acid receptor alpha agonist	RARA	CHEMBL2055	acute promyelocytic leukemia	EFO:0000224	2	AGONIST
MOMELOTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	essential thrombocythemia	EFO:0000479	2	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	pancreatic ductal adenocarcinoma	EFO:0002517	3	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	3	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	essential thrombocythemia	EFO:0000479	2	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	pancreatic ductal adenocarcinoma	EFO:0002517	3	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	polycythemia vera	EFO:0002429	2	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	primary myelofibrosis	EFO:0002430	3	INHIBITOR
MOMELOTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	polycythemia vera	EFO:0002429	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	stomach neoplasm	EFO:0003897	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	Meningioma	Orphanet:2495	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	adenocarcinoma	EFO:0000228	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial carcinoma	EFO:1001512	1	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AZD-2014	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	1	INHIBITOR
VS-5584	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	1	INHIBITOR
VS-5584	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	mesothelioma	EFO:0000588	1	INHIBITOR
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	bladder carcinoma	EFO:0000292	2	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	4	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	4	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	hepatocellular carcinoma	EFO:0000182	2	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	kidney disease	EFO:0003086	1	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	endometrial neoplasm	EFO:0004230	2	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	salivary gland neoplasm	EFO:0003826	2	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	breast neoplasm	EFO:0003869	3	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	carcinoma	EFO:0000313	2	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	liver disease	EFO:0001421	1	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	clear cell renal carcinoma	EFO:0000349	0	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	pancreatic carcinoma	EFO:0002618	1	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	breast carcinoma	EFO:0000305	3	ANTAGONIST
ENZALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	4	ANTAGONIST
INTEPIRDINE	Serotonin 6 (5-HT6) receptor antagonist	HTR6	CHEMBL3371	dementia	HP:0000726	2	ANTAGONIST
INTEPIRDINE	Serotonin 6 (5-HT6) receptor antagonist	HTR6	CHEMBL3371	Alzheimers disease	EFO:0000249	3	ANTAGONIST
TEMANOGREL	Serotonin 2a (5-HT2a) receptor inverse agonist	HTR2A	CHEMBL224	acute coronary syndrome	EFO:0005672	1	INVERSE AGONIST
AGOMELATINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
ARRY-797	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	osteoarthritis, knee	EFO:0004616	2	INHIBITOR
ARRY-797	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	ankylosing spondylitis	EFO:0003898	2	INHIBITOR
ARRY-797	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
ARRY-797	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	dilated cardiomyopathy	EFO:0000407	3	INHIBITOR
ARRY-797	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	pain	EFO:0003843	2	INHIBITOR
PH-797804	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	osteoarthritis	EFO:0002506	2	INHIBITOR
PH-797804	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
PH-797804	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	geniculate herpes zoster	EFO:0007281	2	INHIBITOR
PH-797804	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	atherosclerosis	EFO:0003914	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	Disorder of lipid metabolism	Orphanet:309005	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	neuropathic pain	EFO:0005762	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	focal segmental glomerulosclerosis	EFO:0004236	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	atherosclerosis	EFO:0003914	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	acute coronary syndrome	EFO:0005672	3	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	neuropathic pain	EFO:0005762	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	focal segmental glomerulosclerosis	EFO:0004236	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	acute coronary syndrome	EFO:0005672	3	INHIBITOR
LOSMAPIMOD	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	Disorder of lipid metabolism	Orphanet:309005	2	INHIBITOR
BENDAZAC	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	arthralgia	HP:0002829	4	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	migraine disorder	EFO:0003821	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	complex partial epilepsy	EFO:1000877	4	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	neuropathic pain	EFO:0005762	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Alzheimers disease	EFO:0000249	0	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	systemic scleroderma	EFO:0000717	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	breast carcinoma	EFO:0000305	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	neuropathic pain	EFO:0005762	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	leukemia	EFO:0000565	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	lymphoma	EFO:0000574	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	epilepsy	EFO:0000474	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	sarcoma	EFO:0000691	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	dementia	HP:0000726	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Proximal spinal muscular atrophy type 3	Orphanet:83419	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	melanoma	EFO:0000756	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Huntington disease	Orphanet:399	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	lung carcinoma	EFO:0001071	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Alzheimers disease	EFO:0000249	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Glycogen storage disease due to muscle glycogen phosphorylase deficiency	Orphanet:368	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	androgenetic alopecia	EFO:0004191	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	thyroid neoplasm	EFO:0003841	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Seizures	HP:0001250	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	medulloblastoma	EFO:0002939	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	colorectal carcinoma	EFO:1001951	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	HIV infection	EFO:0000764	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Retinitis pigmentosa	Orphanet:791	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	epilepsy	EFO:0000474	4	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	prostate carcinoma	EFO:0001663	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	bladder carcinoma	EFO:0000292	0	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	epilepsy	EFO:0000474	4	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Seizures	HP:0001250	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Alzheimers disease	EFO:0000249	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	tropical spastic paraparesis	EFO:0007527	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Progressive supranuclear palsy	Orphanet:683	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	ependymoma	EFO:1000028	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	complex partial epilepsy	EFO:1000877	4	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	central nervous system cancer	EFO:0000326	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	dementia	HP:0000726	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	chronic lymphocytic leukemia	EFO:0000095	0	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	ovarian carcinoma	EFO:0001075	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	migraine disorder	EFO:0003821	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	Rubinstein-Taybi syndrome	Orphanet:783	2	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	amyotrophic lateral sclerosis	EFO:0000253	3	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
VALPROIC ACID	Succinate semialdehyde dehydrogenase inhibitor	ALDH5A1	CHEMBL1911	alcohol dependence	EFO:0003829	3	INHIBITOR
VX-702	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
PF-00446687	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	sexual dysfunction	EFO:0004714	2	AGONIST
PF-00446687	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	erectile dysfunction	EFO:0004234	2	AGONIST
HYDROCORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
HYDROCORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Vitiligo	EFO:0004208	1	AGONIST
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	ovarian carcinoma	EFO:0001075	1	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	colorectal carcinoma	EFO:1001951	1	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	adrenocortical carcinoma	EFO:0003093	3	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	breast carcinoma	EFO:0000305	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	adrenocortical carcinoma	EFO:0003093	3	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	Ewing sarcoma	EFO:0000174	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	Ewing sarcoma	EFO:0000174	2	INHIBITOR
LINSITINIB	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	colorectal carcinoma	EFO:1001951	1	INHIBITOR
LINSITINIB	Insulin receptor inhibitor	INSR	CHEMBL1981	ovarian carcinoma	EFO:0001075	1	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	ovarian carcinoma	EFO:0001075	3	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	breast carcinoma	EFO:0000305	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	breast carcinoma	EFO:0000305	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	endometrial neoplasm	EFO:0004230	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	Ewing sarcoma	EFO:0000174	1	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	ovarian carcinoma	EFO:0001075	3	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	urogenital neoplasm	EFO:0003863	1	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	lymphoma	EFO:0000574	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	lung carcinoma	EFO:0001071	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	metastatic prostate cancer	EFO:0000196	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	urogenital neoplasm	EFO:0003863	1	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	Ewing sarcoma	EFO:0000174	1	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	metastatic prostate cancer	EFO:0000196	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	lymphoma	EFO:0000574	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	lung carcinoma	EFO:0001071	2	INHIBITOR
NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	endometrial neoplasm	EFO:0004230	2	INHIBITOR
CARMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
PIRBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
LETAXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	venous thromboembolism	EFO:0004286	2	INHIBITOR
LETAXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	acute coronary syndrome	EFO:0005672	2	INHIBITOR
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	retinopathy	EFO:0003839	2	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	cardiomyopathy	EFO:0000318	3	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	atrial fibrillation	EFO:0000275	2	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	type II diabetes mellitus	EFO:0001360	1	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	chronic kidney disease	EFO:0003884	3	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	hypertension	EFO:0000537	3	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	heart failure	EFO:0003144	3	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	Duchenne muscular dystrophy	Orphanet:98896	3	ANTAGONIST
EPLERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	breast carcinoma	EFO:0000305	2	ANTAGONIST
INDACATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
INDACATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	4	AGONIST
INDACATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic bronchitis	EFO:0006505	4	AGONIST
INDACATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	2	AGONIST
PONESIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	multiple sclerosis	EFO:0003885	2	AGONIST
PONESIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	psoriasis	EFO:0000676	2	AGONIST
CLAZOSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	subarachnoid hemorrhage	EFO:0000713	3	ANTAGONIST
VALRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	carcinoma	EFO:0000313	1	INHIBITOR
VALRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	bladder carcinoma	EFO:0000292	3	INHIBITOR
UK432097	Adenosine A2a receptor agonist	ADORA2A	CHEMBL251	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
E-6201	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	psoriasis	EFO:0000676	2	INHIBITOR
E-6201	Mitogen-activated protein kinase kinase kinase 1 inhibitor	MAP3K1	CHEMBL3956	psoriasis	EFO:0000676	2	INHIBITOR
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	brain neoplasm	EFO:0003833	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	osteoarthritis, hip	EFO:1000786	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Dupuytren Contracture	EFO:0004229	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Aortic Coarctation	EFO:1001267	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	pancreatic carcinoma	EFO:0002618	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Inguinal hernia	HP:0000023	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	chronic pancreatitis	EFO:0000342	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	pain	EFO:0003843	4	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	hemorrhage	MP:0001914	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	osteoarthritis	EFO:0002506	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	peritoneal neoplasm	EFO:1001100	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	HIV infection	EFO:0000764	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	osteoarthritis	EFO:0002506	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	hip fracture	EFO:0003964	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	cleft palate	HP:0000175	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	prostate carcinoma	EFO:0001663	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	abdominal pain	HP:0002027	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	migraine disorder	EFO:0003821	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Plantar Fasciitis	EFO:1001909	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	pain	EFO:0003843	4	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Headache	HP:0002315	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	appendicitis	EFO:0007149	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	hypotension	EFO:0005251	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	peritoneal neoplasm	EFO:1001100	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	intracranial vasospasm	EFO:1000994	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	post operative nausea and vomiting	EFO:0004888	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	lung carcinoma	EFO:0001071	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	neuropathic pain	EFO:0005762	0	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	bone fracture	EFO:0003931	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	HIV infection	EFO:0000764	1	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Inguinal hernia	HP:0000023	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	mucositis	EFO:1001898	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	breast neoplasm	EFO:0003869	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	breast carcinoma	EFO:0000305	3	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	hypospadias	EFO:0004209	2	BLOCKER
BUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	femoral neck fracture	EFO:1001792	2	BLOCKER
MIGALASTAT	Alpha-galactosidase A stabiliser	GLA	CHEMBL2524	Fabry disease	Orphanet:324	3	STABILISER
DROPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	pain	EFO:0003843	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	obesity	EFO:0001073	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	Hepatic steatosis	HP:0001397	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	marijuana dependence	EFO:0004218	1	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	Prader-Willi syndrome	Orphanet:739	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	type II diabetes mellitus	EFO:0001360	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	pain	EFO:0003843	1	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	Disorder of lipid metabolism	Orphanet:309005	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	prediabetes syndrome	EFO:1001121	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	coronary artery disease	EFO:0000378	3	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	nicotine dependence	EFO:0003768	2	ANTAGONIST
RIMONABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	metabolic syndrome	EFO:0000195	3	ANTAGONIST
ALOSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	irritable bowel syndrome	EFO:0000555	4	ANTAGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	diabetes mellitus	EFO:0000400	2	PARTIAL AGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	alcohol dependence	EFO:0003829	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	cocaine dependence	EFO:0002610	2	ANTAGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Alzheimers disease	EFO:0000249	3	ANTAGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Fragile X syndrome	Orphanet:908	2	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	alcohol dependence	EFO:0003829	3	ANTAGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	Alzheimers disease	EFO:0000249	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	cocaine dependence	EFO:0002610	2	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Fragile X syndrome	Orphanet:908	2	ANTAGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	Fragile X syndrome	Orphanet:908	2	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	postpartum depression	EFO:0007453	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	postpartum depression	EFO:0007453	3	ANTAGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	cocaine dependence	EFO:0002610	2	PARTIAL AGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	dementia	HP:0000726	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	diabetes mellitus	EFO:0000400	2	ANTAGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Tourette syndrome	EFO:0004895	3	PARTIAL AGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	postpartum depression	EFO:0007453	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	Tourette syndrome	EFO:0004895	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Tourette syndrome	EFO:0004895	3	ANTAGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	dementia	HP:0000726	3	PARTIAL AGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	diabetes mellitus	EFO:0000400	2	PARTIAL AGONIST
ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Alzheimers disease	EFO:0000249	3	PARTIAL AGONIST
ARIPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	alcohol dependence	EFO:0003829	3	PARTIAL AGONIST
PYRIDOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	orthostatic hypotension	EFO:0005252	2	INHIBITOR
PYRIDOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	0	INHIBITOR
PYRIDOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	hypotension	EFO:0005251	2	INHIBITOR
PYRIDOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Parkinson's disease	EFO:0002508	2	INHIBITOR
PYRIDOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	heart failure	EFO:0003144	2	INHIBITOR
IDARUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
IDARUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	2	INHIBITOR
DESVENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Chronic Hepatitis C infection	EFO:0004220	2	INHIBITOR
DESVENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	fibromyalgia	EFO:0005687	2	INHIBITOR
DESVENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Chronic Hepatitis C infection	EFO:0004220	2	INHIBITOR
DESVENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	diabetic neuropathy	EFO:1000783	3	INHIBITOR
DESVENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	diabetic neuropathy	EFO:1000783	3	INHIBITOR
DESVENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	fibromyalgia	EFO:0005687	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	pemphigus vulgaris	EFO:0004719	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	skin neoplasm	EFO:0004198	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Extramammary Paget Disease	EFO:1000249	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	Myopia	HP:0000545	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pain	EFO:0003843	4	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Parkinson's disease	EFO:0002508	1	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	cleft palate	HP:0000175	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	1	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	type II diabetes mellitus	EFO:0001360	1	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	infection	EFO:0000544	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	tooth disease	EFO:1001216	0	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	fever	HP:0001945	4	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	mucositis	EFO:1001898	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Myopia	HP:0000545	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	lymphoma	EFO:0000574	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	common cold	EFO:0007214	4	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	neoplasm of mature B-cells	EFO:0000096	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	neuropathic pain	EFO:0005762	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	infection	EFO:0000544	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	lupus nephritis	EFO:0005761	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	brain disease	EFO:0005774	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	HIV infection	EFO:0000764	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	diabetic neuropathy	EFO:1000783	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	Headache	HP:0002315	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	kidney disease	EFO:0003086	1	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	lupus nephritis	EFO:0005761	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	migraine disorder	EFO:0003821	4	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	systemic lupus erythematosus	EFO:0002690	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	tooth disease	EFO:1001216	0	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	influenza infection	EFO:0001669	4	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	HIV infection	EFO:0000764	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	streptococcal infection	EFO:1001476	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	obesity	EFO:0001073	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	Extramammary Paget Disease	EFO:1000249	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pulpitis	EFO:1001139	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	cleft palate	HP:0000175	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	opioid dependence	EFO:0005611	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Headache	HP:0002315	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	breast carcinoma	EFO:0000305	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	fever	HP:0001945	4	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	sinusitis	EFO:0007486	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	post operative nausea and vomiting	EFO:0004888	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	morbid obesity	EFO:0001074	1	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	hemorrhage	MP:0001914	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	sepsis	HP:0100806	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	breast carcinoma	EFO:0000305	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	mucositis	EFO:1001898	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	multiple sclerosis	EFO:0003885	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	migraine disorder	EFO:0003821	4	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	osteoarthritis	EFO:0002506	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	neuropathic pain	EFO:0005762	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	multiple myeloma	EFO:0001378	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	bone fracture	EFO:0003931	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	malaria	EFO:0001068	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	pain	EFO:0003843	4	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	osteoarthritis, knee	EFO:0004616	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	abdominal pain	HP:0002027	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	mast-cell leukemia	EFO:0007359	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	common cold	EFO:0007214	4	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	systemic lupus erythematosus	EFO:0002690	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	opioid dependence	EFO:0005611	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	multiple myeloma	EFO:0001378	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	influenza infection	EFO:0001669	4	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	hemorrhage	MP:0001914	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	acute graft vs. host disease	EFO:0004599	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	skin neoplasm	EFO:0004198	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	cardiac arrhythmia	EFO:0004269	1	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	chronic myelogenous leukemia	EFO:0000339	1	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	osteoarthritis, hip	EFO:1000786	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	arthritis	EFO:0005856	4	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	lymphoma	EFO:0000574	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	abdominal pain	HP:0002027	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pemphigus vulgaris	EFO:0004719	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	post operative nausea and vomiting	EFO:0004888	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	brain disease	EFO:0005774	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	non-Hodgkins lymphoma	EFO:0005952	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	pulpitis	EFO:1001139	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	type II diabetes mellitus	EFO:0001360	1	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	hypertension	EFO:0000537	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	kidney disease	EFO:0003086	1	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	Parkinson's disease	EFO:0002508	1	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	multiple sclerosis	EFO:0003885	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	cutaneous melanoma	EFO:0000389	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	1	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	mast-cell leukemia	EFO:0007359	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	sinusitis	EFO:0007486	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	arthritis	EFO:0005856	4	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	glaucoma	EFO:0000516	0	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	rheumatoid arthritis	EFO:0000685	2	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	diabetic neuropathy	EFO:1000783	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	cardiac arrhythmia	EFO:0004269	1	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	osteoarthritis, knee	EFO:0004616	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	sepsis	HP:0100806	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	bacterial meningitis	EFO:1000831	3	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	malaria	EFO:0001068	3	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	osteoarthritis	EFO:0002506	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	obesity	EFO:0001073	3	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	glaucoma	EFO:0000516	0	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	hypertension	EFO:0000537	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	morbid obesity	EFO:0001074	1	OPENER
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	bacterial meningitis	EFO:1000831	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	bone fracture	EFO:0003931	2	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	streptococcal infection	EFO:1001476	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
ACETAMINOPHEN	Anandamide amidohydrolase inhibitor	FAAH	CHEMBL2243	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	lymphoid leukemia	EFO:0004289	2	OPENER
ACETAMINOPHEN	Vanilloid receptor opener	TRPV1	CHEMBL4794	type I diabetes mellitus	EFO:0001359	2	OPENER
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	hypertension	EFO:0000537	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	metabolic syndrome	EFO:0000195	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	atherosclerosis	EFO:0003914	0	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	HIV infection	EFO:0000764	1	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	prostate carcinoma	EFO:0001663	0	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	coronary artery disease	EFO:0000378	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	hepatitis D	EFO:0007304	2	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	hypercholesterolemia	HP:0003124	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	aortic stenosis	EFO:0000266	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	hyperlipidemia	EFO:0003774	3	INHIBITOR
EZETIMIBE	Niemann-Pick C1-like protein 1 inhibitor	NPC1L1	CHEMBL2027	Chronic Hepatitis C infection	EFO:0004220	2	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV infection	EFO:0000764	2	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	leukemia	EFO:0000565	2	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	3	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV-1 infection	EFO:0000180	2	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Combined hyperlipidemia	Orphanet:79211	3	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
PRAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	lung carcinoma	EFO:0001071	3	INHIBITOR
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	2	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sciatica	HP:0011868	3	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior uveitis	EFO:1000811	3	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	3	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	3	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	2	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	infectious disease	EFO:0005741	3	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinal vein occlusion	EFO:1001157	2	AGONIST
PREDNISOLONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	uveitis	EFO:1001231	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	toxic epidermal necrolysis	EFO:0004775	1	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen disease	EFO:1000724	2	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	alopecia areata	EFO:0004192	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	2	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	scleroderma	EFO:1001993	1	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	1	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bullous pemphigoid	EFO:0007187	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	1	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Herpes Labialis	EFO:1001347	2	AGONIST
CLOBETASOL PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Vulvar Lichen Sclerosus	EFO:1000623	3	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	ischemia reperfusion injury	EFO:0002687	2	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	rheumatoid arthritis	EFO:0000685	1	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	sexual dysfunction	EFO:0004714	3	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	hepatitis C infection	EFO:0003047	1	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	hyperplasia	EFO:0000536	2	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	lymphoma	EFO:0000574	2	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	relapsing-remitting multiple sclerosis	EFO:0003929	2	AGONIST
NORETHINDRONE	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	3	AGONIST
REGRELOR	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	coronary artery disease	EFO:0000378	2	ANTAGONIST
FEBUXOSTAT	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	hypertension	EFO:0000537	2	INHIBITOR
FEBUXOSTAT	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	Tumor Lysis Syndrome	EFO:1001479	3	INHIBITOR
FEBUXOSTAT	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	gout	EFO:0004274	4	INHIBITOR
FEBUXOSTAT	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	kidney stone	EFO:0003845	2	INHIBITOR
ARGATROBAN	Thrombin inhibitor	F2	CHEMBL204	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
ARGATROBAN	Thrombin inhibitor	F2	CHEMBL204	intermediate coronary syndrome	EFO:1000985	2	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	diabetic nephropathy	EFO:0000401	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	heart failure	EFO:0003144	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	chronic kidney disease	EFO:0003884	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	kidney disease	EFO:0003086	2	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypercholesterolemia	HP:0003124	2	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	atrial flutter	EFO:0003911	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	heart disease	EFO:0003777	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	myocardial infarction	EFO:0000612	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	atrial fibrillation	EFO:0000275	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	Myocardial Ischemia	EFO:1001375	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	metabolic syndrome	EFO:0000195	0	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	3	INHIBITOR
RAMIPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	diabetes mellitus	EFO:0000400	2	INHIBITOR
PONATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	liver neoplasm	EFO:1001513	2	INHIBITOR
PONATINIB	Breakpoint cluster region protein inhibitor	BCR	CHEMBL5146	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
PONATINIB	Breakpoint cluster region protein inhibitor	BCR	CHEMBL5146	liver neoplasm	EFO:1001513	2	INHIBITOR
PONATINIB	Breakpoint cluster region protein inhibitor	BCR	CHEMBL5146	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
PONATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
PONATINIB	Breakpoint cluster region protein inhibitor	BCR	CHEMBL5146	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
PONATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
PONATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	common cold	EFO:0007214	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	atopic eczema	EFO:0000274	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Eczema	HP:0000964	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	3	ANTAGONIST
DESLORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	urticaria	EFO:0005531	3	ANTAGONIST
PRUCALOPRIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	Dysphagia	HP:0002015	2	AGONIST
PRUCALOPRIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	liver disease	EFO:0001421	1	AGONIST
PRUCALOPRIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	constipation	HP:0002019	3	AGONIST
AFATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
AFATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
AFATINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
DULOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	diabetic neuropathy	EFO:1000783	3	INHIBITOR
DULOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	3	INHIBITOR
DULOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	pain	EFO:0003843	3	INHIBITOR
DULOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Urinary incontinence	HP:0000020	3	INHIBITOR
DULOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	multiple sclerosis	EFO:0003885	3	INHIBITOR
DULOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	osteoarthritis	EFO:0002506	1	INHIBITOR
DULOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	diabetic neuropathy	EFO:1000783	3	INHIBITOR
DULOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	osteoarthritis	EFO:0002506	1	INHIBITOR
DULOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Urinary incontinence	HP:0000020	3	INHIBITOR
DULOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	multiple sclerosis	EFO:0003885	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	age-related macular degeneration	EFO:0001365	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	orthostatic hypotension	EFO:0005252	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	hypertension	EFO:0000537	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	gout	EFO:0004274	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rectum cancer	EFO:1000657	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal carcinoma	EFO:1001951	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	inflammation	MP:0001845	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	ovarian neoplasm	EFO:0003893	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	sarcoma	EFO:0000691	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Familial adenomatous polyposis	Orphanet:733	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	oral mucositis	EFO:1001904	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	preeclampsia	EFO:0000668	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	cervical carcinoma	EFO:0001061	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	ankylosing spondylitis	EFO:0003898	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal neoplasm	EFO:0004142	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	obesity	EFO:0001073	0	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	amyotrophic lateral sclerosis	EFO:0000253	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Graves ophthalmopathy	EFO:1001466	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colonic neoplasm	EFO:0004288	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	benign prostatic hyperplasia	EFO:0000284	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	chronic childhood arthritis	EFO:0002609	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	influenza infection	EFO:0001669	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	migraine disorder	EFO:0003821	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	human papilloma virus infection	EFO:0001668	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	prostate carcinoma	EFO:0001663	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	breast carcinoma	EFO:0000305	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	skin neoplasm	EFO:0004198	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	mouth neoplasm	EFO:0003868	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	cervical adenocarcinoma	EFO:0001416	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, knee	EFO:0004616	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Alzheimers disease	EFO:0000249	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Tuberculosis	Orphanet:3389	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	nicotine dependence	EFO:0003768	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	uterine neoplasm	EFO:0003859	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	neuropathic pain	EFO:0005762	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	esophageal carcinoma	EFO:0002916	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	postpartum depression	EFO:0007453	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	neuroblastoma	EFO:0000621	1	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	memory impairment	EFO:0001072	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	temporomandibular joint disorder	EFO:0005279	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	breast neoplasm	EFO:0003869	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	bladder carcinoma	EFO:0000292	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	glioma	EFO:0005543	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	multiple myeloma	EFO:0001378	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal adenoma	EFO:0005406	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colon carcinoma	EFO:1001950	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	central nervous system cancer	EFO:0000326	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	4	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	nasopharyngeal neoplasm	EFO:0004252	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	medulloblastoma	EFO:0002939	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	monoclonal gammopathy	EFO:0000203	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	lung carcinoma	EFO:0001071	3	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Lymphangioleiomyomatosis	Orphanet:538	2	INHIBITOR
CELECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PROPANTHELINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	1	ANTAGONIST
PROPANTHELINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	1	ANTAGONIST
PROPANTHELINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	overactive bladder	EFO:1000781	1	ANTAGONIST
TEGLARINAD	Nicotinamide phosphoribosyltransferase inhibitor	NAMPT	CHEMBL1744525	lymphoma	EFO:0000574	1	INHIBITOR
ZOLMITRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	4	AGONIST
ZOLMITRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	4	AGONIST
METHYLNALTREXONE	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	4	ANTAGONIST
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lung carcinoma	EFO:0001071	3	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	multiple myeloma	EFO:0001378	1	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast carcinoma	EFO:0000305	2	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	bladder carcinoma	EFO:0000292	2	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
AMRUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lung carcinoma	EFO:0001071	3	INHIBITOR
UMECLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic bronchitis	EFO:0006505	4	ANTAGONIST
UMECLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	3	ANTAGONIST
UMECLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	4	ANTAGONIST
UMECLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive lung disease	HP:0006536	4	ANTAGONIST
UMECLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	emphysema	EFO:0000464	4	ANTAGONIST
SCOPOLAMINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Nausea	HP:0002018	4	ANTAGONIST
SCOPOLAMINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	motion sickness	EFO:0006928	2	ANTAGONIST
SCOPOLAMINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Alzheimers disease	EFO:0000249	1	ANTAGONIST
SCOPOLAMINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	dementia	HP:0000726	1	ANTAGONIST
OLOPATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	4	ANTAGONIST
OLOPATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	4	ANTAGONIST
OLOPATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
OLOPATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	3	ANTAGONIST
PALONOSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
PALONOSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
PALONOSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Nausea	HP:0002018	3	ANTAGONIST
PALONOSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	breast carcinoma	EFO:0000305	3	ANTAGONIST
PHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	influenza infection	EFO:0001669	3	ANTAGONIST
PHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	common cold	EFO:0007214	3	ANTAGONIST
NEFLAMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	Alzheimers disease	EFO:0000249	2	INHIBITOR
ACLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	4	ANTAGONIST
ACLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	emphysema	EFO:0000464	4	ANTAGONIST
ACLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic bronchitis	EFO:0006505	4	ANTAGONIST
ACLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive lung disease	HP:0006536	4	ANTAGONIST
ACLIDINIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	nicotine dependence	EFO:0003768	3	ANTAGONIST
RONACALERET	Calcium sensing receptor antagonist	CASR	CHEMBL1878	bone fracture	EFO:0003931	2	ANTAGONIST
RONACALERET	Calcium sensing receptor antagonist	CASR	CHEMBL1878	osteoporosis	EFO:0003882	2	ANTAGONIST
VILANTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
VILANTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic bronchitis	EFO:0006505	4	AGONIST
VILANTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	4	AGONIST
VILANTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
BRETYLIUM	Norepinephrine transporter substrate	SLC6A2	CHEMBL222	cardiac arrhythmia	EFO:0004269	4	SUBSTRATE
FOSAPREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
FOSAPREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
FOSAPREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometrial neoplasm	EFO:0004230	2	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	prostate carcinoma	EFO:0001663	2	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	ovarian carcinoma	EFO:0001075	2	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast carcinoma	EFO:0000305	3	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	male breast carcinoma	EFO:0006861	3	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast neoplasm	EFO:0003869	3	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
EXEMESTANE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	lymphoma	EFO:0000574	1	INHIBITOR
BETAMETHASONE BENZOATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE BENZOATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
DIMENHYDRINATE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	post operative nausea and vomiting	EFO:0004888	2	ANTAGONIST
OXANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	nutritional disorder	EFO:0001069	1	AGONIST
OXANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	Klinefelter's syndrome	EFO:1001006	2	AGONIST
OXANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	Turner syndrome	Orphanet:881	3	AGONIST
OXANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	Fanconi anemia	Orphanet:84	1	AGONIST
OXANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	decubitus ulcer	EFO:0007067	3	AGONIST
CETRORELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	infertility	EFO:0000545	2	ANTAGONIST
CETRORELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	polycystic ovary syndrome	EFO:0000660	3	ANTAGONIST
FLUOROMETHOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
FLUOROMETHOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	3	AGONIST
FLUOROMETHOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
TROPICAMIDE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Parkinson's disease	EFO:0002508	2	ANTAGONIST
RIMEXOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	secondary hyperparathyroidism	EFO:1001173	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	albuminuria	EFO:0004285	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	pancreatic ductal adenocarcinoma	EFO:0002517	2	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic kidney disease	EFO:0003884	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate carcinoma	EFO:0001663	2	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	multiple myeloma	EFO:0001378	1	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	Hypocalcemia	HP:0002901	2	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	IGA glomerulonephritis	EFO:0004194	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	rectum cancer	EFO:1000657	1	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast carcinoma	EFO:0000305	1	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	kidney disease	EFO:0003086	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	type II diabetes mellitus	EFO:0001360	2	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	Proteinuria	HP:0000093	3	AGONIST
PARICALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	pancreatic carcinoma	EFO:0002618	1	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	scleroderma	EFO:1001993	1	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	4	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	Eczema	HP:0000964	2	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	skin disease	EFO:0000701	2	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	Vitiligo	EFO:0004208	1	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	acne	EFO:0003894	2	AGONIST
CALCIPOTRIENE	Vitamin D receptor agonist	VDR	CHEMBL1977	atopic eczema	EFO:0000274	2	AGONIST
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Eczema	HP:0000964	4	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Dermatitis, Perioral	EFO:1001305	3	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lichen planus	EFO:1000726	3	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	seborrheic dermatitis	EFO:1000764	2	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lichen disease	EFO:1000724	2	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Vitiligo	EFO:0004208	2	INHIBITOR
PIMECROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	atopic eczema	EFO:0000274	4	INHIBITOR
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	opioid dependence	EFO:0005611	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	heart disease	EFO:0003777	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	Inguinal hernia	HP:0000023	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	coronary artery disease	EFO:0000378	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	fluoride poisoning	EFO:1001328	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	lung carcinoma	EFO:0001071	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	inflammation	MP:0001845	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	pain	EFO:0003843	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	myocardial infarction	EFO:0000612	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	subarachnoid hemorrhage	EFO:0000713	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	morbid obesity	EFO:0001074	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	colorectal adenocarcinoma	EFO:0000365	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	breast carcinoma	EFO:0000305	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	morbid obesity	EFO:0001074	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	obesity	EFO:0001073	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	post-operative sign or symptom	EFO:0005323	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	obesity	EFO:0001073	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	pain	EFO:0003843	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	alcohol dependence	EFO:0003829	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	colorectal adenocarcinoma	EFO:0000365	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	Inguinal hernia	HP:0000023	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	breast carcinoma	EFO:0000305	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	heart disease	EFO:0003777	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	post-operative sign or symptom	EFO:0005323	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	coronary artery disease	EFO:0000378	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	breast carcinoma	EFO:0000305	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	fluoride poisoning	EFO:1001328	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	pain	EFO:0003843	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	morbid obesity	EFO:0001074	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	subarachnoid hemorrhage	EFO:0000713	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	alcohol dependence	EFO:0003829	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	opioid dependence	EFO:0005611	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	myocardial infarction	EFO:0000612	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	alcohol dependence	EFO:0003829	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	opioid dependence	EFO:0005611	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	inflammation	MP:0001845	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	lung carcinoma	EFO:0001071	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	heart disease	EFO:0003777	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	colorectal adenocarcinoma	EFO:0000365	0	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	Inguinal hernia	HP:0000023	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	inflammation	MP:0001845	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	myocardial infarction	EFO:0000612	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	subarachnoid hemorrhage	EFO:0000713	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	post-operative sign or symptom	EFO:0005323	1	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	coronary artery disease	EFO:0000378	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	lung carcinoma	EFO:0001071	2	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	fluoride poisoning	EFO:1001328	3	OPENER
SEVOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	obesity	EFO:0001073	2	OPENER
DESFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	post-operative sign or symptom	EFO:0005323	1	OPENER
DESFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	post-operative sign or symptom	EFO:0005323	1	OPENER
DESFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	post-operative sign or symptom	EFO:0005323	1	OPENER
DOXERCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate carcinoma	EFO:0001663	2	AGONIST
DOXERCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	2	AGONIST
HYDROXYPROGESTERONE CAPROATE	Progesterone receptor agonist	PGR	CHEMBL208	premature birth	EFO:0003917	3	AGONIST
DYDROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	habitual abortion	EFO:1000954	3	AGONIST
DYDROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	infertility	EFO:0000545	3	AGONIST
DYDROGESTERONE	Progesterone receptor agonist	PGR	CHEMBL208	premature birth	EFO:0003917	3	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	Hypotrichosis simplex	Orphanet:55654	4	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	open-angle glaucoma	EFO:0004190	4	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	androgenetic alopecia	EFO:0004191	2	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	Alopecia	Orphanet:79364	2	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	Graves ophthalmopathy	EFO:1001466	3	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	glaucoma	EFO:0000516	4	AGONIST
BIMATOPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	ocular hypertension	EFO:1001069	4	AGONIST
FLURANDRENOLIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic kidney disease	EFO:0003884	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	Pituitary Gland Adenoma	EFO:1000478	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	reproductive system disease	EFO:0000512	2	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	infertility	EFO:0000545	2	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	endometriosis	EFO:0001065	2	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	breast carcinoma	EFO:0000305	0	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	cocaine dependence	EFO:0002610	2	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	Parkinson's disease	EFO:0002508	4	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	acromegaly	EFO:1001485	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	Ovarian hyperstimulation syndrome	Orphanet:64739	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	obesity	EFO:0001073	1	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	restless legs syndrome	EFO:0004270	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	diabetes mellitus	EFO:0000400	3	AGONIST
CABERGOLINE	Dopamine D2 receptor agonist	DRD2	CHEMBL217	pituitary-dependent Cushing's disease	EFO:1001110	2	AGONIST
METHOCARBAMOL	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	pain	EFO:0003843	3	INHIBITOR
METHOCARBAMOL	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	cirrhosis of liver	EFO:0001422	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	melanoma	EFO:0000756	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	autoimmune thrombocytopenic purpura	EFO:0007160	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	refractory anemia with excess blasts	EFO:0003811	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	thrombocytopenia	HP:0001873	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	myelodysplastic syndrome	EFO:0000198	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	breast carcinoma	EFO:0000305	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	renal cell carcinoma	EFO:0000681	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	multiple myeloma	EFO:0001378	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	neuroblastoma	EFO:0000621	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	thrombocytopenia	HP:0001873	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	ovarian carcinoma	EFO:0001075	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	melanoma	EFO:0000756	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	non-Hodgkins lymphoma	EFO:0005952	0	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	myelodysplastic syndrome	EFO:0000198	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Thalassemia	EFO:1001996	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	metastatic melanoma	EFO:0002617	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	refractory anemia with excess blasts	EFO:0003811	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	breast neoplasm	EFO:0003869	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	leukemia	EFO:0000565	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Sickle cell anemia	Orphanet:232	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	neuroblastoma	EFO:0000621	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	medulloblastoma	EFO:0002939	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	lymphoma	EFO:0000574	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	chronic myelomonocytic leukemia	EFO:1001779	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	non-Hodgkins lymphoma	EFO:0005952	0	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	neoplasm of mature B-cells	EFO:0000096	0	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	medulloblastoma	EFO:0002939	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Sickle cell anemia	Orphanet:232	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	breast neoplasm	EFO:0003869	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	metastatic melanoma	EFO:0002617	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	multiple myeloma	EFO:0001378	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	lymphoma	EFO:0000574	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	leukemia	EFO:0000565	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	chronic myelomonocytic leukemia	EFO:1001779	4	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Thalassemia	EFO:1001996	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	autoimmune thrombocytopenic purpura	EFO:0007160	3	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	ovarian carcinoma	EFO:0001075	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	breast carcinoma	EFO:0000305	2	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	neoplasm of mature B-cells	EFO:0000096	0	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DECITABINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	renal cell carcinoma	EFO:0000681	2	INHIBITOR
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	endometrial carcinoma	EFO:1001512	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	hepatocellular carcinoma	EFO:0000182	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	dementia	HP:0000726	2	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	head and neck malignant neoplasia	EFO:0006859	2	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	breast neoplasm	EFO:0003869	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	HIV wasting syndrome	EFO:0007312	2	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	uterine neoplasm	EFO:0003859	2	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	nutritional disorder	EFO:0001069	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	cachexia	HP:0004326	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	breast carcinoma	EFO:0000305	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	squamous cell carcinoma	EFO:0000707	3	AGONIST
MEGESTROL ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	hyperplasia	EFO:0000536	2	AGONIST
MEPREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	renal carcinoma	EFO:0002890	4	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lymphoma	EFO:0000574	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	neuroblastoma	EFO:0000621	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	embryonal rhabdomyosarcoma	EFO:0000437	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	renal cell carcinoma	EFO:0000681	4	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	bladder carcinoma	EFO:0000292	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	colorectal carcinoma	EFO:1001951	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	adenocarcinoma	EFO:0000228	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	sarcoma	EFO:0000691	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	urethral neoplasm	EFO:0003846	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Hepatoblastoma	EFO:1000292	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	breast neoplasm	EFO:0003869	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	relapsing-remitting multiple sclerosis	EFO:0003929	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	carcinoma	EFO:0000313	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	endometrial carcinoma	EFO:1001512	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	breast carcinoma	EFO:0000305	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	melanoma	EFO:0000756	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	ischemia	EFO:0000556	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	brain neoplasm	EFO:0003833	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Mantle cell lymphoma	EFO:1001469	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	thyroid carcinoma	EFO:0002892	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	leukemia	EFO:0000565	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	oligoastrocytoma	EFO:0000630	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	gliosarcoma	EFO:1001465	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	alveolar rhabdomyosarcoma	EFO:0000248	3	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	male breast carcinoma	EFO:0006861	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	cutaneous melanoma	EFO:0000389	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	multiple myeloma	EFO:0001378	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	osteosarcoma	EFO:0000637	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	ovarian carcinoma	EFO:0001075	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	prostate carcinoma	EFO:0001663	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	central nervous system cancer	EFO:0000326	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	endometrial neoplasm	EFO:0004230	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	endometrioid carcinoma	EFO:0000466	2	INHIBITOR
TEMSIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Genital neoplasm, female	EFO:1001331	1	INHIBITOR
LANREOTIDE	Somatostatin receptor 5 agonist	SSTR5	CHEMBL1792	acromegaly	EFO:1001485	4	AGONIST
LANREOTIDE	Somatostatin receptor 2 agonist	SSTR2	CHEMBL1804	acromegaly	EFO:1001485	4	AGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	acute graft vs. host disease	EFO:0004599	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	diffuse large B-cell lymphoma	EFO:0000403	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	chronic lymphocytic leukemia	EFO:0000095	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	AIDS dementia	EFO:0002608	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV-1 infection	EFO:0000180	3	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	Hodgkins lymphoma	EFO:0000183	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	AIDS	EFO:0000765	3	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	stroke	EFO:0000712	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	myelodysplastic syndrome	EFO:0000198	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV infection	EFO:0000764	3	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	chronic myelogenous leukemia	EFO:0000339	2	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	Hypertriglyceridemia	EFO:0004211	1	ANTAGONIST
MARAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	infection	EFO:0000544	3	ANTAGONIST
LEVOCETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	urticaria	EFO:0005531	4	ANTAGONIST
LEVOCETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Cough	HP:0012735	2	ANTAGONIST
LEVOCETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
LEVOCETIRIZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	narcolepsy with cataplexy	EFO:0000614	4	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	insomnia	EFO:0004698	2	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	multiple sclerosis	EFO:0003885	2	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	obesity	EFO:0001073	3	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	stroke	EFO:0000712	2	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	hypersomnia	EFO:0005246	3	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	central nervous system cancer	EFO:0000326	2	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ARMODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	obstructive sleep apnea	EFO:0003918	3	INHIBITOR
LEVOBUPIVACAINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	pain	EFO:0003843	3	BLOCKER
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	Hodgkins lymphoma	EFO:0000183	2	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast carcinoma	EFO:0000305	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast neoplasm	EFO:0003869	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	endometriosis	EFO:0001065	2	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	multiple myeloma	EFO:0001378	2	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	uterine fibroid	EFO:0000731	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	hypertension	EFO:0000537	0	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	Alzheimers disease	EFO:0000249	2	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	obesity	EFO:0001073	3	AGONIST
LEUPROLIDE	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	Mantle cell lymphoma	EFO:1001469	2	AGONIST
BENZTROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Parkinson's disease	EFO:0002508	4	ANTAGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tendinopathy	EFO:1001434	3	AGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	1	AGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
LISDEXAMFETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	insomnia	EFO:0004698	2	RELEASING AGENT
LISDEXAMFETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	insomnia	EFO:0004698	2	RELEASING AGENT
PREDNISOLONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
PREDNISOLONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	idiopathic pulmonary fibrosis	EFO:0000768	4	AGONIST
PREDNISOLONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
PREDNISOLONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	relapsing-remitting multiple sclerosis	EFO:0003929	2	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	metabolic syndrome	EFO:0000195	1	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	3	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	infertility	EFO:0000545	3	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	male breast carcinoma	EFO:0006861	1	AGONIST
GOSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast carcinoma	EFO:0000305	3	AGONIST
HISTRELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic progressive multiple sclerosis	EFO:0003840	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic lymphocytic leukemia	EFO:0000095	2	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myelodysplastic syndrome	EFO:0000198	1	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	2	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute myeloid leukemia	EFO:0000222	1	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vestibular neuronitis	EFO:0007537	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-Hodgkins lymphoma	EFO:0005952	2	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mast-cell leukemia	EFO:0007359	2	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	IGA glomerulonephritis	EFO:0004194	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	deafness	EFO:0001063	3	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	2	AGONIST
METHYLPREDNISOLONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
LEVOBETAXOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	glaucoma	EFO:0000516	3	ANTAGONIST
LEVOBETAXOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	ocular hypertension	EFO:1001069	3	ANTAGONIST
CINACALCET	Calcium sensing receptor positive allosteric modulator	CASR	CHEMBL1878	prostate adenocarcinoma	EFO:0000673	2	POSITIVE ALLOSTERIC MODULATOR
DIPHENOXYLATE	Mu opioid receptor agonist	OPRM1	CHEMBL233	post operative nausea and vomiting	EFO:0004888	3	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary tuberculosis	EFO:1000049	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	brain edema	EFO:1000845	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pemphigus vulgaris	EFO:0004719	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriatic arthritis	EFO:0003778	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	eosinophilic pneumonia	EFO:0007257	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Peptic ulcer	HP:0004398	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	optic neuritis	EFO:0007405	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic childhood arthritis	EFO:0002609	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	trichinosis	EFO:0007520	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ankylosing spondylitis	EFO:0003898	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tenosynovitis	EFO:1001435	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Mantle cell lymphoma	EFO:1001469	2	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	subacute thyroiditis	EFO:1001194	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sympathetic ophthalmia	EFO:1001205	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ischemia	EFO:0000556	2	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemolytic anemia	EFO:0005558	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Stevens-Johnson syndrome	EFO:0004276	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	erythema multiforme	EFO:1000694	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mycosis fungoides	EFO:1001051	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sarcoidosis	Orphanet:797	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nephrotic syndrome	EFO:0004255	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior uveitis	EFO:1000811	1	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypercalcemia	HP:0003072	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	meningeal tuberculosis	EFO:1000039	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	contact dermatitis	EFO:0005319	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	4	AGONIST
DEXAMETHASONE PHOSPHORIC ACID	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatitis herpetiformis	EFO:1000684	4	AGONIST
TRIPTORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	endometriosis	EFO:0001065	3	AGONIST
TRIPTORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	3	AGONIST
TRIPTORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	AGONIST
TRIPTORELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast carcinoma	EFO:0000305	2	AGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive lung disease	HP:0006536	4	ANTAGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	3	ANTAGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	2	ANTAGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	asthma	EFO:0000270	2	ANTAGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	obstructive lung disease	HP:0006536	4	ANTAGONIST
GLYCOPYRRONIUM	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	chronic obstructive pulmonary disease	EFO:0000341	3	ANTAGONIST
ECHOTHIOPHATE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	glaucoma	EFO:0000516	4	INHIBITOR
BALSALAZIDE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	ulcerative colitis	EFO:0000729	3	AGONIST
BALSALAZIDE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	ulcerative colitis	EFO:0000729	3	INHIBITOR
DEXCHLORPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	multiple sclerosis	EFO:0003885	3	ANTAGONIST
DEXCHLORPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	3	ANTAGONIST
DEXCHLORPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	3	ANTAGONIST
HALOBETASOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
HALOBETASOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	2	AGONIST
ALCLOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-small cell lung carcinoma	EFO:0003060	2	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	gastroesophageal reflux disease	EFO:0003948	4	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	osteoarthritis	EFO:0002506	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	rheumatoid arthritis	EFO:0000685	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	infection	EFO:0000544	0	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	cytomegalovirus infection	EFO:0001062	2	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	ankylosing spondylitis	EFO:0003898	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	Peptic ulcer	HP:0004398	4	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	Menorrhagia	HP:0000132	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	hemorrhage	MP:0001914	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	premature birth	EFO:0003917	2	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	pain	EFO:0003843	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	uterine fibroid	EFO:0000731	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	preeclampsia	EFO:0000668	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	obesity	EFO:0001073	3	AGONIST
MISOPROSTOLIC ACID	Prostanoid EP3 receptor agonist	PTGER3	CHEMBL3710	incomplete abortion	EFO:1001799	1	AGONIST
FLUPROSTENOL	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	glaucoma	EFO:0000516	4	AGONIST
FLUPROSTENOL	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	ocular hypertension	EFO:1001069	4	AGONIST
FLUPROSTENOL	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	open-angle glaucoma	EFO:0004190	4	AGONIST
TRANDOLAPRILAT	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	heart failure	EFO:0003144	3	INHIBITOR
FLUDROCORTISONE	Mineralocorticoid receptor agonist	NR3C2	CHEMBL1994	Parkinson's disease	EFO:0002508	2	AGONIST
FLUDROCORTISONE	Mineralocorticoid receptor agonist	NR3C2	CHEMBL1994	melanoma	EFO:0000756	2	AGONIST
FLUDROCORTISONE	Mineralocorticoid receptor agonist	NR3C2	CHEMBL1994	septic shock	EFO:0006834	3	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	keratoconjunctivitis sicca	EFO:1001001	2	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	3	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	1	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	3	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	3	AGONIST
LOTEPREDNOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	2	AGONIST
DESMETHYLCHLOROTRIANISENE	Estrogen receptor beta modulator	ESR2	CHEMBL242	hepatocellular carcinoma	EFO:0000182	3	MODULATOR
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	4	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hypertrophy	EFO:0002460	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sinusitis	EFO:0007486	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	2	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sickle cell anemia	Orphanet:232	2	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polyp	EFO:0000662	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive sleep apnea	EFO:0003918	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	3	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Spinal cord injury	EFO:1001919	1	AGONIST
MOMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	otitis media with effusion	EFO:0007415	3	AGONIST
LUTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	infertility	EFO:0000545	3	AGONIST
UROKINASE	Plasminogen activator	PLG	CHEMBL1801	infection	EFO:0000544	3	ACTIVATOR
UROKINASE	Plasminogen activator	PLG	CHEMBL1801	pulmonary embolism	EFO:0003827	2	ACTIVATOR
UROKINASE	Plasminogen activator	PLG	CHEMBL1801	empyema	EFO:0003097	3	ACTIVATOR
UROKINASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
UROKINASE	Plasminogen activator	PLG	CHEMBL1801	myocardial infarction	EFO:0000612	2	ACTIVATOR
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	retinal vein occlusion	EFO:1001157	2	ANTAGONIST
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	ocular vascular disease	EFO:0005753	4	ANTAGONIST
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	3	ANTAGONIST
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	diabetic retinopathy	EFO:0003770	3	ANTAGONIST
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	diabetes mellitus	EFO:0000400	2	ANTAGONIST
PEGAPTANIB SODIUM	Vascular endothelial growth factor A antagonist	VEGFA	CHEMBL1783	Von Hippel-Lindau disease	Orphanet:892	1	ANTAGONIST
CALCITONIN SALMON	Calcitonin receptor agonist	CALCR	CHEMBL1832	osteitis deformans	EFO:0004261	4	AGONIST
CALCITONIN SALMON	Calcitonin receptor agonist	CALCR	CHEMBL1832	postmenopausal osteoporosis	EFO:0003854	4	AGONIST
CALCITONIN SALMON	Calcitonin receptor agonist	CALCR	CHEMBL1832	Hypercalcemia	HP:0003072	4	AGONIST
CHORIOGONADOTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	Ovarian hyperstimulation syndrome	Orphanet:64739	3	AGONIST
CHORIOGONADOTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	infertility	EFO:0000545	3	AGONIST
CHORIOGONADOTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	polycystic ovary syndrome	EFO:0000660	2	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	lymphoma	EFO:0000574	3	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	Cystic fibrosis	Orphanet:586	2	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	leukemia	EFO:0000565	3	AGONIST
INSULIN ASPART	Insulin receptor agonist	INSR	CHEMBL1981	Alzheimers disease	EFO:0000249	1	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	lymphoma	EFO:0000574	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	Cystic fibrosis	Orphanet:586	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	diabetic retinopathy	EFO:0003770	0	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	4	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	leukemia	EFO:0000565	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	prediabetes syndrome	EFO:1001121	3	AGONIST
INSULIN GLARGINE	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	4	AGONIST
GLUCAGON HYDROCHLORIDE RECOMBINANT	Glucagon receptor agonist	GCGR	CHEMBL1985	Hypoglycemia	HP:0001943	2	AGONIST
GLUCAGON HYDROCHLORIDE RECOMBINANT	Glucagon receptor agonist	GCGR	CHEMBL1985	type I diabetes mellitus	EFO:0001359	1	AGONIST
GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	azoospermia	EFO:0000279	2	AGONIST
GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	breast carcinoma	EFO:0000305	3	AGONIST
GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	polycystic ovary syndrome	EFO:0000660	3	AGONIST
GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	acute graft vs. host disease	EFO:0004599	1	AGONIST
GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	infertility	EFO:0000545	3	AGONIST
UROFOLLITROPIN	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	male infertility	EFO:0004248	3	AGONIST
UROFOLLITROPIN	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	azoospermia	EFO:0000279	3	AGONIST
UROFOLLITROPIN	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
THYROTROPIN	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	follicular thyroid carcinoma	EFO:0000501	2	AGONIST
THYROTROPIN	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	papillary thyroid carcinoma	EFO:0000641	2	AGONIST
THYROTROPIN	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	head and neck malignant neoplasia	EFO:0006859	3	AGONIST
THYROTROPIN	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	acute respiratory distress syndrome	EFO:1000637	3	AGONIST
THYROTROPIN ALFA	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	thyroid carcinoma	EFO:0002892	3	AGONIST
THYROTROPIN ALFA	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	thyroid neoplasm	EFO:0003841	3	AGONIST
THYROTROPIN ALFA	Thyroid stimulating hormone receptor agonist	TSHR	CHEMBL1963	nodular goiter	EFO:1001062	2	AGONIST
INSULIN LISPRO	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN LISPRO	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN LISPRO	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN LISPRO	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN PORK	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN PORK	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN PORK	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN SUSP ISOPHANE BEEF	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN SUSP ISOPHANE BEEF	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN SUSP ISOPHANE BEEF	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
TERIPARATIDE ACETATE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoporosis	EFO:0003882	1	AGONIST
TERIPARATIDE ACETATE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	postmenopausal osteoporosis	EFO:0003854	2	AGONIST
ANTITHROMBIN ALFA	Thrombin inhibitor	F2	CHEMBL204	preeclampsia	EFO:0000668	3	INHIBITOR
ANTITHROMBIN ALFA	Thrombin inhibitor	F2	CHEMBL204	disseminated intravascular coagulation	HP:0005521	2	INHIBITOR
ANTITHROMBIN ALFA	Coagulation factor X inhibitor	F10	CHEMBL244	disseminated intravascular coagulation	HP:0005521	2	INHIBITOR
ANTITHROMBIN ALFA	Coagulation factor X inhibitor	F10	CHEMBL244	preeclampsia	EFO:0000668	3	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	psoriatic arthritis	EFO:0003778	2	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	aplastic anemia	HP:0001915	1	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	lymphoma	EFO:0000574	1	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	lichen planus	EFO:1000726	2	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	Pustulosis palmaris et plantaris	Orphanet:163927	3	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
ALEFACEPT	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	psoriasis	EFO:0000676	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Sjogren syndrome	EFO:0000699	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	subarachnoid hemorrhage	EFO:0000713	1	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	mucocutaneous lymph node syndrome	EFO:0004246	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	dermatomyositis	EFO:0000398	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	asthma	EFO:0000270	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	leukemia	EFO:0000565	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	lupus nephritis	EFO:0005761	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	pneumonia	EFO:0003106	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	inclusion body myositis	EFO:0007323	0	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	hidradenitis suppurativa	EFO:1000710	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Primary systemic amyloidosis	Orphanet:314701	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriasis	EFO:0000676	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Stevens-Johnson syndrome	EFO:0004276	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic kidney disease	EFO:0003884	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	pemphigus vulgaris	EFO:0004719	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	ischemia reperfusion injury	EFO:0002687	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	HIV infection	EFO:0000764	1	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Wegener's granulomatosis	EFO:0005297	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Sciatica	HP:0011868	1	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	ankylosing spondylitis	EFO:0003898	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	metabolic syndrome	EFO:0000195	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Histiocytosis	HP:0100727	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	urticaria	EFO:0005531	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	lichen planus	EFO:1000726	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Vitiligo	EFO:0004208	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	Alzheimers disease	EFO:0000249	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	temporomandibular joint disorder	EFO:0005279	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	inflammation	MP:0001845	2	INHIBITOR
ETANERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	oral mucositis	EFO:1001904	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate carcinoma	EFO:0001663	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal squamous cell carcinoma	EFO:0005922	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal cancer	EFO:0005842	4	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	mouth neoplasm	EFO:0003868	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	sarcoma	EFO:0000691	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	stomach neoplasm	EFO:0003897	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	ovarian carcinoma	EFO:0001075	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	anal neoplasm	EFO:0003835	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cervical carcinoma	EFO:0001061	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	tongue neoplasm	EFO:0003871	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	upper aerodigestive tract neoplasm	EFO:0004284	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	rectum cancer	EFO:1000657	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	4	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	laryngeal neoplasm	EFO:0003817	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	endometrial neoplasm	EFO:0004230	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal neoplasm	EFO:0004142	4	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colon carcinoma	EFO:1001950	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal carcinoma	EFO:0002916	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	carcinoma	EFO:0000313	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	oropharynx cancer	EFO:1001931	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	nasopharyngeal neoplasm	EFO:0004252	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	adenocarcinoma	EFO:0000228	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	multiple myeloma	EFO:0001378	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	brain neoplasm	EFO:0003833	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	verrucous carcinoma	EFO:0007535	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bladder carcinoma	EFO:0000292	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	2	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	adenoid cystic carcinoma	EFO:0000231	1	INHIBITOR
CETUXIMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic interstitial cystitis	EFO:1000869	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Crohn's disease	EFO:0000384	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriasis	EFO:0000676	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	uveitis	EFO:1001231	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Sciatica	HP:0011868	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	hidradenitis suppurativa	EFO:1000710	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Dupuytren Contracture	EFO:0004229	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	thyroid carcinoma	EFO:0002892	1	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	focal segmental glomerulosclerosis	EFO:0004236	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Mucopolysaccharidosis	Orphanet:79213	1	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	colitis	EFO:0003872	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	pyoderma	HP:0000999	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Behcet's syndrome	EFO:0003780	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	temporal arteritis	EFO:1001209	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Sarcoidosis	Orphanet:797	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ankylosing spondylitis	EFO:0003898	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	asthma	EFO:0000270	2	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ulcerative colitis	EFO:0000729	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	osteoarthritis	EFO:0002506	3	INHIBITOR
ADALIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Sarcoidosis	Orphanet:797	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	pemphigus vulgaris	EFO:0004719	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ankylosing spondylitis	EFO:0003898	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Chronic Hepatitis C infection	EFO:0004220	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Wegener's granulomatosis	EFO:0005297	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	tropical spastic paraparesis	EFO:0007527	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ulcerative colitis	EFO:0000729	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Crohn's disease	EFO:0000384	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	endometriosis	EFO:0001065	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	hidradenitis suppurativa	EFO:1000710	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	colitis	EFO:0003872	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	toxic epidermal necrolysis	EFO:0004775	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	reactive arthritis	EFO:0007460	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	temporal arteritis	EFO:1001209	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	melanoma	EFO:0000756	1	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ischemia reperfusion injury	EFO:0002687	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	hepatitis C infection	EFO:0003047	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriasis	EFO:0000676	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	berylliosis	EFO:0007168	1	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	dermatomyositis	EFO:0000398	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	osteoarthritis	EFO:0002506	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	4	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	inflammatory bowel disease	EFO:0003767	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Behcet's syndrome	EFO:0003780	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	parapsoriasis	EFO:1000747	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	diabetic retinopathy	EFO:0003770	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	polymyositis	EFO:0003063	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	myositis	EFO:0000783	2	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	mucocutaneous lymph node syndrome	EFO:0004246	3	INHIBITOR
INFLIXIMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	spondyloarthropathy	EFO:0000706	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetic retinopathy	EFO:0003770	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal neoplasm	EFO:0004142	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	sarcoma	EFO:0000691	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	primary myelofibrosis	EFO:0002430	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Lymphedema	Orphanet:79383	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lymphoma	EFO:0000574	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	multiple myeloma	EFO:0001378	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	rhabdomyosarcoma	EFO:0002918	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	glioblastoma multiforme	EFO:0000519	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pancreatic ductal adenocarcinoma	EFO:0002517	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Ewing sarcoma	EFO:0000174	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	breast carcinoma	EFO:0000305	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	synovial sarcoma	EFO:0001376	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Merkel cell skin cancer	EFO:1001471	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	prostate carcinoma	EFO:0001663	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	vascular disease	EFO:0004264	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	chronic kidney disease	EFO:0003884	0	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	inflammation	MP:0001845	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	uveitis	EFO:1001231	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pterygium	EFO:0000678	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colon carcinoma	EFO:1001950	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ovarian carcinoma	EFO:0001075	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	astrocytoma	EFO:0000272	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	metastatic melanoma	EFO:0002617	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Von Hippel-Lindau disease	Orphanet:892	0	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal carcinoma	EFO:1001951	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	neuromyelitis optica	EFO:0004256	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	medulloblastoma	EFO:0002939	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	cutaneous melanoma	EFO:0000389	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	central nervous system cancer	EFO:0000326	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	carcinoid tumor	EFO:0004243	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	bladder carcinoma	EFO:0000292	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	alveolar rhabdomyosarcoma	EFO:0000248	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	choriocarcinoma	EFO:0002893	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	oligoastrocytoma	EFO:0000630	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	peritoneal neoplasm	EFO:1001100	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	leiomyosarcoma	EFO:0000564	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	breast neoplasm	EFO:0003869	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Pulmonary venoocclusive disease	Orphanet:31837	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	corneal neovascularization	EFO:1000880	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	germ cell tumor	EFO:0000514	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	brain neoplasm	EFO:0003833	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anterior ischemic optic neuropathy	EFO:1000809	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Genital neoplasm, female	EFO:1001331	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	cervical carcinoma	EFO:0001061	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	gastric carcinoma	EFO:0000178	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	mesothelioma	EFO:0000588	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Hereditary hemorrhagic telangiectasia	Orphanet:774	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinopathy of prematurity	EFO:1001158	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Vogt-Koyanagi-Harada disease	Orphanet:3437	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	male breast carcinoma	EFO:0006861	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Meningioma	Orphanet:2495	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	renal carcinoma	EFO:0002890	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	endometriosis	EFO:0001065	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	neuroblastoma	EFO:0000621	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Pineoblastoma	EFO:1000475	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinopathy	EFO:0003839	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	fibrosarcoma	EFO:0002087	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal cancer	EFO:0005842	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	rectum cancer	EFO:1000657	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	leukemia	EFO:0000565	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	carcinoma	EFO:0000313	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	adenocarcinoma	EFO:0000228	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	melanoma	EFO:0000756	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	thyroid carcinoma	EFO:0002892	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	endometrial carcinoma	EFO:1001512	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	esophageal carcinoma	EFO:0002916	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	spinal cord neoplasm	EFO:0003828	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	primitive neuroectodermal tumor	EFO:0005235	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ovarian neoplasm	EFO:0003893	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	schwannoma	EFO:0000693	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Thymoma	EFO:1000581	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Malignant epithelial tumor of ovary	Orphanet:398934	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ependymoma	EFO:1000028	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Ascites	HP:0001541	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal detachment	EFO:0005773	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	angiosarcoma	EFO:0003968	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	liposarcoma	EFO:0000569	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Keloid	EFO:0004212	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	glaucoma	EFO:0000516	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lung carcinoma	EFO:0001071	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	sex cord-gonadal stromal tumor	EFO:0007483	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pancreatic neoplasm	EFO:0003860	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	renal cell carcinoma	EFO:0000681	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lymphoid leukemia	EFO:0004289	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Myopia	HP:0000545	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	oligodendroglioma	EFO:0000632	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetic neuropathy	EFO:1000783	1	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	endometrial neoplasm	EFO:0004230	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	large cell lung carcinoma	EFO:0003050	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	gliosarcoma	EFO:1001465	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	hemorrhage	MP:0001914	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	adrenocortical carcinoma	EFO:0003093	2	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal vein occlusion	EFO:1001157	3	INHIBITOR
BEVACIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	male breast carcinoma	EFO:0006861	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	anal neoplasm	EFO:0003835	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	rectum cancer	EFO:1000657	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	adenocarcinoma	EFO:0000228	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	somatostatinoma	EFO:1001187	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	bile duct carcinoma	EFO:0005540	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	hemopericardium	EFO:0007298	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	brain disease	EFO:0005774	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	vulvar carcinoma	EFO:0002921	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	reproductive system disease	EFO:0000512	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	ovarian carcinoma	EFO:0001075	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	testicular neoplasm	EFO:0004281	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	ependymoma	EFO:1000028	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	endometrial neoplasm	EFO:0004230	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	Vaginal neoplasm	EFO:1001447	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	colorectal carcinoma	EFO:1001951	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	adrenocortical carcinoma	EFO:0003093	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	prostate carcinoma	EFO:0001663	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	renal cell carcinoma	EFO:0000681	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	stomach neoplasm	EFO:0003897	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	sarcoma	EFO:0000691	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	4	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	carcinoma	EFO:0000313	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	urogenital neoplasm	EFO:0003863	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	leukemia	EFO:0000565	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	esophageal carcinoma	EFO:0002916	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	4	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	Fallopian Tube Carcinoma	EFO:1000251	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	ureteral neoplasm	EFO:0003844	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	ductal adenocarcinoma	EFO:0000430	3	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	Parathyroid Gland Carcinoma	EFO:1000456	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	urethral neoplasm	EFO:0003846	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	lung carcinoma	EFO:0001071	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	insulinoma	EFO:0000549	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	skin disease	EFO:0000701	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	peritoneal neoplasm	EFO:1001100	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	bladder carcinoma	EFO:0000292	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	endometrial carcinoma	EFO:1001512	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	osteosarcoma	EFO:0000637	2	INHIBITOR
TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	cervical carcinoma	EFO:0001061	1	INHIBITOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	intracerebral hemorrhage	EFO:0005669	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	congestive heart failure	EFO:0000373	4	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	retinal vein occlusion	EFO:1001157	1	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	subarachnoid hemorrhage	EFO:0000713	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	pulmonary embolism	EFO:0003827	4	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Thrombophlebitis	HP:0004418	1	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	abdominal abscess	EFO:1001753	2	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	stroke	EFO:0000712	4	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	myocardial infarction	EFO:0000612	4	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	empyema	EFO:0003097	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	abscess	EFO:0003030	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	retinal artery occlusion	EFO:1001154	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	deep vein thrombosis	EFO:0003907	2	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	hemopericardium	EFO:0007298	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	hemorrhage	MP:0001914	3	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Venous thrombosis	HP:0004936	2	ACTIVATOR
ALTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Urinary retention	HP:0000016	2	ACTIVATOR
INSULIN LISPRO PROTAMINE RECOMBINANT	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	1	AGONIST
INSULIN LISPRO PROTAMINE RECOMBINANT	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	1	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	Alzheimers disease	EFO:0000249	2	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	Down syndrome	EFO:0001064	1	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN GLULISINE	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	GCGR	CHEMBL1985	Hypoglycemia	HP:0001943	3	AGONIST
GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	GCGR	CHEMBL1985	obesity	EFO:0001073	3	AGONIST
GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	GCGR	CHEMBL1985	type I diabetes mellitus	EFO:0001359	3	AGONIST
GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	GCGR	CHEMBL1985	diabetes mellitus	EFO:0000400	3	AGONIST
GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	1	AGONIST
APROTININ	Plasminogen inhibitor	PLG	CHEMBL1801	hemorrhage	MP:0001914	4	INHIBITOR
APROTININ	Plasminogen inhibitor	PLG	CHEMBL1801	pancreatitis	EFO:0000278	1	INHIBITOR
APROTININ	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	pancreatitis	EFO:0000278	1	INHIBITOR
APROTININ	Plasminogen inhibitor	PLG	CHEMBL1801	breast carcinoma	EFO:0000305	1	INHIBITOR
APROTININ	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	hemorrhage	MP:0001914	4	INHIBITOR
APROTININ	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	breast carcinoma	EFO:0000305	1	INHIBITOR
INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	2	AGONIST
INSULIN PURIFIED BEEF	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN PURIFIED PORK	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	intermediate coronary syndrome	EFO:1000985	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hyperglycemia	HP:0003074	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	4	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	4	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	hyperlipidemia	EFO:0003774	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetic neuropathy	EFO:1000783	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	myocardial infarction	EFO:0000612	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	relapsing-remitting multiple sclerosis	EFO:0003929	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	gestational diabetes	EFO:0004593	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic progressive multiple sclerosis	EFO:0003840	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	insulin resistance	EFO:0002614	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	nicotine dependence	EFO:0003768	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	congestive heart failure	EFO:0000373	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	obesity	EFO:0001073	1	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	septic shock	EFO:0006834	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	premature birth	EFO:0003917	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	persian gulf syndrome	EFO:0007430	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	pain	EFO:0003843	2	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	acute coronary syndrome	EFO:0005672	3	AGONIST
INSULIN HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	Hypoglycemia	HP:0001943	1	AGONIST
INSULIN ZINC SUSP RECOMBINANT HUMAN	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	3	AGONIST
CALCITONIN SALMON RECOMBINANT	Calcitonin receptor agonist	CALCR	CHEMBL1832	osteoporosis	EFO:0003882	2	AGONIST
CALCITONIN SALMON RECOMBINANT	Calcitonin receptor agonist	CALCR	CHEMBL1832	osteopenia	HP:0000938	2	AGONIST
CALCITONIN SALMON RECOMBINANT	Calcitonin receptor agonist	CALCR	CHEMBL1832	postmenopausal osteoporosis	EFO:0003854	4	AGONIST
DESIRUDIN	Thrombin inhibitor	F2	CHEMBL204	deep vein thrombosis	EFO:0003907	4	INHIBITOR
DESIRUDIN	Thrombin inhibitor	F2	CHEMBL204	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
LEPIRUDIN	Thrombin inhibitor	F2	CHEMBL204	Venous thrombosis	HP:0004936	2	INHIBITOR
LEPIRUDIN	Thrombin inhibitor	F2	CHEMBL204	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
LEPIRUDIN	Thrombin inhibitor	F2	CHEMBL204	lung carcinoma	EFO:0001071	1	INHIBITOR
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	heart failure	EFO:0003144	3	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	melanoma	EFO:0000756	1	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	obesity	EFO:0001073	0	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	myocardial infarction	EFO:0000612	2	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	congestive heart failure	EFO:0000373	3	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	hypertension	EFO:0000537	1	AGONIST
NESIRITIDE	Atrial natriuretic peptide receptor A agonist	NPR1	CHEMBL1988	diabetes mellitus	EFO:0000400	1	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	2	AGONIST
HUMAN FSH	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
LH (MENOTROPINS)	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	infertility	EFO:0000545	3	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	amyotrophic lateral sclerosis	EFO:0000253	3	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	HIV-Associated Lipodystrophy Syndrome	EFO:1001348	1	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Growth hormone insensitivity syndrome	Orphanet:181393	2	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	bone disease	EFO:0004260	2	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Rett syndrome	Orphanet:778	2	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Crohn's disease	EFO:0000384	2	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	diabetes mellitus	EFO:0000400	3	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	growth delay	HP:0001510	1	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	multiple sclerosis	EFO:0003885	2	AGONIST
MECASERMIN	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Noonan syndrome	Orphanet:648	2	AGONIST
MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	retinopathy of prematurity	EFO:1001158	2	AGONIST
MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Myotonic dystrophy	Orphanet:206647	2	AGONIST
MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Laron syndrome	Orphanet:633	2	AGONIST
MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	IGF1R	CHEMBL1957	Steinert myotonic dystrophy	Orphanet:273	2	AGONIST
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	lung carcinoma	EFO:0001071	2	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	lymphoma	EFO:0000574	3	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	unspecified peripheral T-cell lymphoma	EFO:0000211	4	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	multiple myeloma	EFO:0001378	1	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	T-cell acute lymphoblastic leukemia	EFO:0000209	2	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	mycosis fungoides	EFO:1001051	1	INHIBITOR
PRALATREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Sezary's disease	EFO:1000785	1	INHIBITOR
ALCAFTADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	4	ANTAGONIST
DIFLUPREDNATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	2	AGONIST
DIFLUPREDNATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior uveitis	EFO:1000811	4	AGONIST
DIFLUPREDNATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	3	AGONIST
DIFLUPREDNATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	uveitis	EFO:1001231	3	AGONIST
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Abnormality of lipid metabolism	HP:0003119	4	INHIBITOR
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Abnormality of lipid metabolism	HP:0003119	4	INHIBITOR
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hyperlipidemia	EFO:0003774	4	INHIBITOR
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hyperlipidemia	EFO:0003774	4	INHIBITOR
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Abnormality of lipid metabolism	HP:0003119	4	INHIBITOR
PITAVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hyperlipidemia	EFO:0003774	4	INHIBITOR
BEPOTASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
BEPOTASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	4	ANTAGONIST
FESOTERODINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Urinary incontinence	HP:0000020	3	ANTAGONIST
FESOTERODINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Urinary incontinence	HP:0000020	3	ANTAGONIST
FESOTERODINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	4	ANTAGONIST
FESOTERODINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	4	ANTAGONIST
PRASUGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	acute coronary syndrome	EFO:0005672	4	ANTAGONIST
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	intermittent vascular claudication	EFO:0003876	2	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	Phenylketonuria	Orphanet:716	4	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	Sickle cell anemia	Orphanet:232	2	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	chronic kidney disease	EFO:0003884	2	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	coronary artery disease	EFO:0000378	2	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	hypertension	EFO:0000537	2	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	Hyperphenylalaninemia	Orphanet:238583	4	ACTIVATOR
SAPROPTERIN	Phenylalanine-4-hydroxylase activator	PAH	CHEMBL3076	pulmonary hypertension	EFO:0001361	1	ACTIVATOR
TAPENTADOL	Mu opioid receptor agonist	OPRM1	CHEMBL233	neuropathic pain	EFO:0005762	4	AGONIST
TAPENTADOL	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	4	INHIBITOR
TAPENTADOL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
TAPENTADOL	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	neuropathic pain	EFO:0005762	4	INHIBITOR
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	oral mucositis	EFO:1001904	3	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	mucositis	EFO:1001898	3	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	HIV infection	EFO:0000764	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	myelodysplastic syndrome	EFO:0000198	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	acute myeloid leukemia	EFO:0000222	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	head and neck malignant neoplasia	EFO:0006859	3	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	acute graft vs. host disease	EFO:0004599	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	Stevens-Johnson syndrome	EFO:0004276	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	Hodgkins lymphoma	EFO:0000183	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	multiple myeloma	EFO:0001378	3	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	toxic epidermal necrolysis	EFO:0004775	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	lymphoma	EFO:0000574	3	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	X-Linked Combined Immunodeficiency Diseases	EFO:1001451	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	asthma	EFO:0000270	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	plasma cell leukemia	EFO:0006475	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	multiple sclerosis	EFO:0003885	1	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	colon carcinoma	EFO:1001950	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	non-Hodgkins lymphoma	EFO:0005952	2	AGONIST
PALIFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	leukemia	EFO:0000565	3	AGONIST
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	neovascular glaucoma	EFO:1001060	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Myopia	HP:0000545	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	corneal neovascularization	EFO:1000880	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetic retinopathy	EFO:0003770	4	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Retinoblastoma	Orphanet:790	2	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	open-angle glaucoma	EFO:0004190	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anterior ischemic optic neuropathy	EFO:1000809	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	melanoma	EFO:0000756	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ocular vascular disease	EFO:0005753	4	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetes mellitus	EFO:0000400	2	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinopathy	EFO:0003839	2	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	glaucoma	EFO:0000516	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pathological myopia	EFO:0004207	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal vein occlusion	EFO:1001157	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	histoplasmosis	EFO:0007310	2	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	angioid streaks	EFO:1000805	1	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinopathy of prematurity	EFO:1001158	3	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal detachment	EFO:0005773	2	INHIBITOR
RANIBIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pterygium	EFO:0000678	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	carcinoid syndrome	EFO:1000852	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	4	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	rectum cancer	EFO:1000657	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	renal cell carcinoma	EFO:0000681	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal cancer	EFO:0005842	4	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate carcinoma	EFO:0001663	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bladder carcinoma	EFO:0000292	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal neoplasm	EFO:0004142	4	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	carcinoma	EFO:0000313	3	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cervical carcinoma	EFO:0001061	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal carcinoma	EFO:0002916	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
PANITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colon carcinoma	EFO:1001950	2	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	gout	EFO:0004274	3	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	hearing loss	EFO:0004238	0	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	type I diabetes mellitus	EFO:0001359	1	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Familial Mediterranean fever	Orphanet:342	2	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	chronic childhood arthritis	EFO:0002609	2	INHIBITOR
RILONACEPT	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Hepatitis, Alcoholic	EFO:1001345	2	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriasis	EFO:0000676	3	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	melanoma	EFO:0000756	1	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	Crohn's disease	EFO:0000384	4	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	ulcerative colitis	EFO:0000729	2	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic interstitial cystitis	EFO:1000869	3	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	ankylosing spondylitis	EFO:0003898	4	INHIBITOR
CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	4	INHIBITOR
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	myelodysplastic syndrome	EFO:0000198	2	AGONIST
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	hemorrhage	MP:0001914	4	AGONIST
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	aplastic anemia	HP:0001915	2	AGONIST
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	non-Hodgkins lymphoma	EFO:0005952	2	AGONIST
ROMIPLOSTIM	Thrombopoietin receptor agonist	MPL	CHEMBL1864	lymphoma	EFO:0000574	1	AGONIST
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	4	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ulcerative colitis	EFO:0000729	4	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	asthma	EFO:0000270	2	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	ankylosing spondylitis	EFO:0003898	4	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Sarcoidosis	Orphanet:797	2	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	osteoarthritis	EFO:0002506	3	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
GOLIMUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	spondyloarthropathy	EFO:0000706	3	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	chronic childhood arthritis	EFO:0002609	4	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	osteoarthritis	EFO:0002506	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	pyoderma	HP:0000999	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	age-related macular degeneration	EFO:0001365	1	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Mevalonate kinase deficiency	Orphanet:309025	4	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	mucocutaneous lymph node syndrome	EFO:0004246	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Sickle cell anemia	Orphanet:232	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	gout	EFO:0004274	3	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	diabetic retinopathy	EFO:0003770	1	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	urticaria	EFO:0005531	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	chronic obstructive pulmonary disease	EFO:0000341	1	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	pulmonary sarcoidosis	DOID:13406	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Abdominal Aortic Aneurysm	EFO:0004214	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	atrial fibrillation	EFO:0000275	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	diabetes mellitus	EFO:0000400	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	dry eye syndrome	EFO:1000906	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	adult-onset Still's disease	EFO:0007135	2	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	fever	HP:0001945	3	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	Familial Mediterranean fever	Orphanet:342	4	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	atherosclerosis	EFO:0003914	3	INHIBITOR
CANAKINUMAB	Interleukin-1 beta inhibitor	IL1B	CHEMBL1909490	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ECALLANTIDE	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	angioedema	EFO:0005532	2	INHIBITOR
ECALLANTIDE	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	Hereditary angioedema	Orphanet:91378	4	INHIBITOR
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	MODY	Orphanet:552	4	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Hyperglycemia	HP:0003074	3	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Parkinson's disease	EFO:0002508	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	obesity	EFO:0001073	3	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	abnormal glucose tolerance	EFO:0002546	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetes mellitus	EFO:0000400	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Primary short bowel syndrome	Orphanet:365563	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type I diabetes mellitus	EFO:0001359	3	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetic nephropathy	EFO:0000401	3	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	sleep apnea	EFO:0003877	1	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	prediabetes syndrome	EFO:1001121	3	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	heart failure	EFO:0003144	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Alzheimers disease	EFO:0000249	2	AGONIST
LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
DEFLAZACORT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	liver disease	EFO:0001421	1	AGONIST
DEFLAZACORT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Duchenne muscular dystrophy	Orphanet:98896	4	AGONIST
PARECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	3	INHIBITOR
PARECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
PARECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
PARECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
PARECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	bone fracture	EFO:0003931	3	INHIBITOR
ELAGOLIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	endometriosis	EFO:0001065	3	ANTAGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	4	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	sarcoma	EFO:0000691	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	HIV infection	EFO:0000764	1	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	central nervous system cancer	EFO:0000326	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Oral leukoplakia	HP:0002745	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	head and neck malignant neoplasia	EFO:0006859	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	pituitary-dependent Cushing's disease	EFO:1001110	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	congestive heart failure	EFO:0000373	2	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	insulin resistance	EFO:0002614	3	AGONIST
ROSIGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	atherosclerosis	EFO:0003914	3	AGONIST
PRUVANSERIN	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	2	ANTAGONIST
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, knee	EFO:0004616	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal carcinoma	EFO:1001951	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Alzheimers disease	EFO:0000249	2	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	polyp	EFO:0000662	2	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal adenoma	EFO:0005406	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	prostate carcinoma	EFO:0001663	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	stomach neoplasm	EFO:0003897	3	INHIBITOR
ROFECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
ACRIVASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	metastatic melanoma	EFO:0002617	4	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	multiple myeloma	EFO:0001378	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	cutaneous melanoma	EFO:0000389	4	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	lymphoma	EFO:0000574	1	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	thyroid carcinoma	EFO:0002892	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	4	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	hairy cell leukemia	EFO:1000956	2	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	central nervous system cancer	EFO:0000326	0	INHIBITOR
VEMURAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Craniopharyngioma	EFO:1000209	2	INHIBITOR
BMS-582949	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	vascular disease	EFO:0004264	2	INHIBITOR
BMS-582949	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	psoriasis	EFO:0000676	2	INHIBITOR
BMS-582949	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
SILMITASERTIB	Casein kinase II alpha inhibitor	CSNK2A1	CHEMBL3629	multiple myeloma	EFO:0001378	1	INHIBITOR
SILMITASERTIB	Casein kinase II alpha inhibitor	CSNK2A1	CHEMBL3629	cholangiocarcinoma	EFO:0005221	1	INHIBITOR
FORETINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
FORETINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
FORETINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	lung carcinoma	EFO:0001071	1	INHIBITOR
FORETINIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	breast carcinoma	EFO:0000305	2	INHIBITOR
FORETINIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
FORETINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FORETINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	1	INHIBITOR
FORETINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FORETINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
FORETINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lung carcinoma	EFO:0001071	1	INHIBITOR
FORETINIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FORETINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
FORETINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
FORETINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	breast carcinoma	EFO:0000305	2	INHIBITOR
FORETINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FORETINIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	lung carcinoma	EFO:0001071	1	INHIBITOR
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Urinary incontinence	HP:0000020	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Urinary incontinence	HP:0000020	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	neuropathy	EFO:0004149	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Urinary incontinence	HP:0000020	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	urgency urinary incontinence	EFO:0006865	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Neurogenic bladder	HP:0000011	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	urgency urinary incontinence	EFO:0006865	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Neurogenic bladder	HP:0000011	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Urinary incontinence	HP:0000020	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	neuropathy	EFO:0004149	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	urgency urinary incontinence	EFO:0006865	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	obstructive sleep apnea	EFO:0003918	1	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	urgency urinary incontinence	EFO:0006865	3	ANTAGONIST
OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive sleep apnea	EFO:0003918	1	ANTAGONIST
AZD-1480	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
AZD-1480	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	gastric carcinoma	EFO:0000178	1	INHIBITOR
AZD-1480	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	1	INHIBITOR
AZD-1480	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	essential thrombocythemia	EFO:0000479	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	ovarian neoplasm	EFO:0003893	2	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	lymphoma	EFO:0000574	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	leukemia	EFO:0000565	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute erythroblastic leukemia	EFO:1001257	1	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VOLASERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PF-04691502	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast neoplasm	EFO:0003869	2	INHIBITOR
PF-04691502	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
REFAMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
REFAMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
REFAMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
REFAMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
INT131	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	2	MODULATOR
INT131	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	relapsing-remitting multiple sclerosis	EFO:0003929	2	MODULATOR
OMIPALISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	idiopathic pulmonary fibrosis	EFO:0000768	1	INHIBITOR
LISINOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	myocardial infarction	EFO:0000612	4	INHIBITOR
LISINOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	congestive heart failure	EFO:0000373	4	INHIBITOR
LISINOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	4	INHIBITOR
TRAMADOL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	ischemia	EFO:0000556	2	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	ischemia reperfusion injury	EFO:0002687	1	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	systemic scleroderma	EFO:0000717	2	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	Raynaud disease	EFO:1001145	0	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	persistent fetal circulation syndrome	EFO:1001103	2	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	peripheral vascular disease	EFO:0003875	2	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	systemic scleroderma	EFO:0000717	1	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	3	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	Recurrent thrombophlebitis	HP:0004419	4	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	3	AGONIST
TREPROSTINIL	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	ovarian carcinoma	EFO:0001075	2	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	refractory anemia with excess blasts	EFO:0003811	3	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
RIGOSERTIB	Proteinase-activated receptor 1 inhibitor	F2R	CHEMBL3974	chronic myelomonocytic leukemia	EFO:1001779	3	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gliosarcoma	EFO:1001465	2	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	oligoastrocytoma	EFO:0000630	2	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gliosarcoma	EFO:1001465	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	oligoastrocytoma	EFO:0000630	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	oligoastrocytoma	EFO:0000630	2	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
TANDUTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
TANDUTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
TANDUTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
GANIRELIX ACETATE	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	polycystic ovary syndrome	EFO:0000660	0	ANTAGONIST
GANIRELIX ACETATE	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	infertility	EFO:0000545	3	ANTAGONIST
ABARELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	ANTAGONIST
APLAVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV infection	EFO:0000764	3	ANTAGONIST
ISOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	Inguinal hernia	HP:0000023	3	OPENER
ISOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	Inguinal hernia	HP:0000023	3	OPENER
ISOFLURANE	Potassium channel subfamily K member 2 opener	KCNK2	CHEMBL2321615	opioid dependence	EFO:0005611	2	OPENER
ISOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	Inguinal hernia	HP:0000023	3	OPENER
ISOFLURANE	Potassium channel subfamily K member 3 opener	KCNK3	CHEMBL2321613	opioid dependence	EFO:0005611	2	OPENER
ISOFLURANE	Potassium channel subfamily K member 9 opener	KCNK9	CHEMBL2321614	opioid dependence	EFO:0005611	2	OPENER
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	lung carcinoma	EFO:0001071	1	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	nicotine dependence	EFO:0003768	3	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	bronchiolitis obliterans	EFO:0007183	2	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	allergy	EFO:0003785	2	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	3	AGONIST
FORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
SALMETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
SALMETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
SALMETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	4	AGONIST
SALMETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic bronchitis	EFO:0006505	4	AGONIST
SALMETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	obesity	EFO:0001073	2	AGONIST
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	deep vein thrombosis	EFO:0003907	4	INHIBITOR
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Venous thrombosis	HP:0004936	4	INHIBITOR
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	stroke	EFO:0000712	4	INHIBITOR
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	pulmonary embolism	EFO:0003827	4	INHIBITOR
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	venous thromboembolism	EFO:0004286	3	INHIBITOR
EDOXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial fibrillation	EFO:0000275	4	INHIBITOR
SERTINDOLE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
SB-649868	Orexin receptor 1 antagonist	HCRTR1	CHEMBL5113	insomnia	EFO:0004698	2	ANTAGONIST
SB-649868	Orexin receptor 2 antagonist	HCRTR2	CHEMBL4792	insomnia	EFO:0004698	2	ANTAGONIST
NILUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
NILUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	nicotine dependence	EFO:0003768	0	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	ductal carcinoma in situ	EFO:0000432	0	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	endometrial neoplasm	EFO:0004230	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	retinopathy	EFO:0003839	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	endometriosis	EFO:0001065	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	Alzheimers disease	EFO:0000249	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	cocaine dependence	EFO:0002610	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	alcohol dependence	EFO:0003829	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	male breast carcinoma	EFO:0006861	1	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	pituitary-dependent Cushing's disease	EFO:1001110	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	prostate carcinoma	EFO:0001663	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	Cushing syndrome	EFO:0003099	3	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	HIV infection	EFO:0000764	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	male breast carcinoma	EFO:0006861	1	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	nicotine dependence	EFO:0003768	0	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	alcohol dependence	EFO:0003829	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	pituitary-dependent Cushing's disease	EFO:1001110	3	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	Cushing syndrome	EFO:0003099	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	hepatitis C infection	EFO:0003047	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	HIV infection	EFO:0000764	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	Meningioma	Orphanet:2495	3	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	hepatitis C infection	EFO:0003047	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	uterine fibroid	EFO:0000731	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	Alzheimers disease	EFO:0000249	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	endometriosis	EFO:0001065	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	cocaine dependence	EFO:0002610	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	ductal carcinoma in situ	EFO:0000432	0	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	retinopathy	EFO:0003839	2	ANTAGONIST
MIFEPRISTONE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	Meningioma	Orphanet:2495	3	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	prostate adenocarcinoma	EFO:0000673	2	ANTAGONIST
MIFEPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	breast carcinoma	EFO:0000305	2	ANTAGONIST
NARATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	3	AGONIST
NARATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	Headache	HP:0002315	3	AGONIST
NARATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	Headache	HP:0002315	3	AGONIST
NARATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	3	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	4	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	3	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine with aura	EFO:0005295	3	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	4	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine without aura	EFO:0005296	3	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine without aura	EFO:0005296	3	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	3	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine with aura	EFO:0005295	3	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine without aura	EFO:0005296	3	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine without aura	EFO:0005296	3	AGONIST
SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine with aura	EFO:0005295	3	AGONIST
SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine with aura	EFO:0005295	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	ependymoma	EFO:1000028	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	anaplastic astrocytoma	EFO:0002499	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	hepatitis B infection	EFO:0004197	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	chronic lymphocytic leukemia	EFO:0000095	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	influenza infection	EFO:0001669	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	melanoma	EFO:0000756	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	central nervous system cancer	EFO:0000326	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	breast carcinoma	EFO:0000305	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	human papilloma virus infection	EFO:0001668	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	glioblastoma multiforme	EFO:0000519	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	prostate adenocarcinoma	EFO:0000673	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	metastatic melanoma	EFO:0002617	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	skin neoplasm	EFO:0004198	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	localised scleroderma	EFO:1001361	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	hemangioma	EFO:1000635	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	osteosarcoma	EFO:0000637	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	cervical adenocarcinoma	EFO:0001416	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	vulvar carcinoma	EFO:0002921	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	dysplasia of cervix	EFO:1000910	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	soft tissue sarcoma	EFO:1001968	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	colorectal carcinoma	EFO:1001951	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	prostate carcinoma	EFO:0001663	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	Extramammary Paget Disease	EFO:1000249	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	vulvar intraepithelial neoplasia	EFO:0002627	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	cutaneous melanoma	EFO:0000389	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	anogenital venereal wart	EFO:0007147	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	leukemia	EFO:0000565	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	cutaneous Leishmaniasis	EFO:0005046	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	non-small cell lung carcinoma	EFO:0003060	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	basal cell carcinoma	EFO:0004193	3	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	cervical carcinoma	EFO:0001061	2	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	Cutaneous T-cell lymphoma	EFO:0002913	0	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	medulloblastoma	EFO:0002939	1	AGONIST
IMIQUIMOD	Toll-like receptor 7 agonist	TLR7	CHEMBL5936	squamous cell carcinoma	EFO:0000707	1	AGONIST
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	movement disorder	EFO:0004280	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	reflex epilepsy	EFO:1001146	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	restless legs syndrome	EFO:0004270	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	subarachnoid hemorrhage	EFO:0000713	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	Seizures	HP:0001250	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	Sickle cell anemia	Orphanet:232	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	essential tremor	EFO:0003108	1	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	epilepsy	EFO:0000474	4	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	partial epilepsy	EFO:0004263	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	neuropathy	EFO:0004149	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	alcohol withdrawal	EFO:0004777	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	opioid dependence	EFO:0005611	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	glioblastoma multiforme	EFO:0000519	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	cocaine dependence	EFO:0002610	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	geniculate herpes zoster	EFO:0007281	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	neuroblastoma	EFO:0000621	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	drug-Induced dyskinesia	EFO:1000904	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	alcohol dependence	EFO:0003829	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	dementia	HP:0000726	3	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	acute myeloid leukemia	EFO:0000222	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	Parkinson's disease	EFO:0002508	2	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	stroke	EFO:0000712	1	BLOCKER
LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	Alzheimers disease	EFO:0000249	2	BLOCKER
FEDRATINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	2	INHIBITOR
FEDRATINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	liver disease	EFO:0001421	1	INHIBITOR
FEDRATINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	primary myelofibrosis	EFO:0002430	2	INHIBITOR
FEDRATINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	liver disease	EFO:0001421	1	INHIBITOR
VERUCERFONT	Corticotropin releasing factor receptor 1 antagonist	CRHR1	CHEMBL1800	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
VERUCERFONT	Corticotropin releasing factor receptor 1 antagonist	CRHR1	CHEMBL1800	Congenital adrenal hyperplasia	Orphanet:418	1	ANTAGONIST
VERUCERFONT	Corticotropin releasing factor receptor 1 antagonist	CRHR1	CHEMBL1800	alcohol dependence	EFO:0003829	2	ANTAGONIST
METOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
METOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	angina pectoris	EFO:0003913	4	ANTAGONIST
METOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	congestive heart failure	EFO:0000373	4	ANTAGONIST
METOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	myocardial infarction	EFO:0000612	4	ANTAGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pemphigus vulgaris	EFO:0004719	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	optic neuritis	EFO:0007405	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic bronchopulmonary aspergillosis	EFO:0007140	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	croup	EFO:0007227	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	extrinsic allergic alveolitis	EFO:1001321	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mucocutaneous lymph node syndrome	EFO:0004246	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic kidney disease	EFO:0003884	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sarcoidosis	Orphanet:797	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Eczema	HP:0000964	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hepatitis, Alcoholic	EFO:1001345	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mycosis fungoides	EFO:1001051	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemangioma	EFO:1000635	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemolytic anemia	EFO:0005558	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lupus nephritis	EFO:0005761	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Headache	HP:0002315	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Familial lipoprotein lipase deficiency	Orphanet:309015	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Biliary atresia	Orphanet:30391	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pituitary-dependent Cushing's disease	EFO:1001110	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	meningeal tuberculosis	EFO:1000039	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hodgkins lymphoma	EFO:0000183	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leprosy	EFO:0001054	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	1	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vestibular neuronitis	EFO:0007537	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Churg-Strauss syndrome	EFO:0007208	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	IGA glomerulonephritis	EFO:0004194	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aphthous ulcer	EFO:0003938	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic childhood arthritis	EFO:0002609	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	HIV infection	EFO:0000764	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	infertility	EFO:0000545	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	1	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	West syndrome	Orphanet:3451	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	idiopathic pulmonary fibrosis	EFO:0000768	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pericarditis	EFO:0007427	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypercalcemia	HP:0003072	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neoplasm of mature B-cells	EFO:0000096	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-Hodgkins lymphoma	EFO:0005952	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypereosinophilic syndrome	EFO:1001467	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulpitis	EFO:1001139	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatitis herpetiformis	EFO:1000684	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ankylosing spondylitis	EFO:0003898	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Graves disease	EFO:0004237	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple sclerosis	EFO:0003885	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ocular toxoplasmosis	EFO:0007399	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	erythema multiforme	EFO:1000694	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	celiac disease	EFO:0001060	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	kidney disease	EFO:0003086	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Peptic ulcer	HP:0004398	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	contact dermatitis	EFO:0005319	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute myeloid leukemia	EFO:0000222	1	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hepatocellular carcinoma	EFO:0000182	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	subacute thyroiditis	EFO:1001194	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatomyositis	EFO:0000398	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Wegener's granulomatosis	EFO:0005297	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriatic arthritis	EFO:0003778	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nephrotic syndrome	EFO:0004255	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diffuse large B-cell lymphoma	EFO:0000403	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sympathetic ophthalmia	EFO:1001205	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tenosynovitis	EFO:1001435	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Anemia, Hemolytic, Autoimmune	EFO:1001264	3	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	unspecified peripheral T-cell lymphoma	EFO:0000211	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Duchenne muscular dystrophy	Orphanet:98896	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	angioimmunoblastic T-cell lymphoma	EFO:0000255	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	2	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary tuberculosis	EFO:1000049	4	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lipoma	EFO:0000759	1	AGONIST
PREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	trichinosis	EFO:0007520	4	AGONIST
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	nicotine dependence	EFO:0003768	2	INHIBITOR
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	Parkinson's disease	EFO:0002508	4	INHIBITOR
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	alcohol dependence	EFO:0003829	2	INHIBITOR
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	cocaine dependence	EFO:0002610	1	INHIBITOR
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	Pick disease	EFO:0003096	2	INHIBITOR
TOLCAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	neuroblastoma	EFO:0000621	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	male breast carcinoma	EFO:0006861	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	fibromatosis	EFO:0000497	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal carcinoma	EFO:0002890	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	sarcoma	EFO:0000691	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Ewing sarcoma	EFO:0000174	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	myeloid sarcoma	EFO:1001052	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	prostate carcinoma	EFO:0001663	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	ureteral neoplasm	EFO:0003844	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	urethral neoplasm	EFO:0003846	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	verrucous carcinoma	EFO:0007535	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	cutaneous melanoma	EFO:0000389	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	osteosarcoma	EFO:0000637	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	papillary renal cell carcinoma	EFO:0000640	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	tongue neoplasm	EFO:0003871	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	melanoma	EFO:0000756	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	gliosarcoma	EFO:1001465	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	central nervous system cancer	EFO:0000326	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	mesothelioma	EFO:0000588	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	bladder carcinoma	EFO:0000292	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	breast carcinoma	EFO:0000305	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	lung carcinoma	EFO:0001071	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	chromophobe renal cell carcinoma	EFO:0000335	3	INHIBITOR
SORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SORAFENIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
NITISINONE	4-hydroxyphenylpyruvate dioxygenase inhibitor	HPD	CHEMBL1861	Alkaptonuria	Orphanet:56	3	INHIBITOR
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	breast neoplasm	EFO:0003869	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	sexual dysfunction	EFO:0004714	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	osteoporosis	EFO:0003882	1	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	type II diabetes mellitus	EFO:0001360	1	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Turner syndrome	Orphanet:881	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	obesity	EFO:0001073	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	hypertension	EFO:0000537	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	atherosclerosis	EFO:0003914	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	carcinoid tumor	EFO:0004243	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	osteopenia	HP:0000938	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	multiple sclerosis	EFO:0003885	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	migraine disorder	EFO:0003821	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	endometriosis	EFO:0001065	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	polycystic ovary syndrome	EFO:0000660	1	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	muscular disease	EFO:0002970	0	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Alzheimers disease	EFO:0000249	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	postpartum depression	EFO:0007453	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	HIV infection	EFO:0000764	1	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	primary ovarian insufficiency	EFO:0004266	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Atrophy	EFO:1000096	3	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	prostate carcinoma	EFO:0001663	2	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	type I diabetes mellitus	EFO:0001359	1	AGONIST
ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	infertility	EFO:0000545	3	AGONIST
ARFORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
ARFORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic bronchitis	EFO:0006505	3	AGONIST
ARFORMOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	4	AGONIST
ESMIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	insomnia	EFO:0004698	3	ANTAGONIST
ESMIRTAZAPINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	insomnia	EFO:0004698	3	ANTAGONIST
ESMIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	3	ANTAGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sclerosing cholangitis	EFO:0004268	1	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	primary biliary cirrhosis	EFO:1001486	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	microscopic colitis	EFO:1001295	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sinusitis	EFO:0007486	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Autoimmune Hepatitis	EFO:0005676	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchopulmonary dysplasia	Orphanet:70589	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	proctitis	EFO:0005628	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bronchiolitis obliterans	EFO:0007183	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive sleep apnea	EFO:0003918	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	IGA glomerulonephritis	EFO:0004194	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative proctosigmoiditis	EFO:1001223	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	collagenous colitis	EFO:1001293	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	altitude sickness	EFO:1000782	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	emphysema	EFO:0000464	3	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diarrhea	HP:0002014	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic bronchopulmonary aspergillosis	EFO:0007140	2	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	4	AGONIST
BUDESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lung carcinoma	EFO:0001071	2	AGONIST
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	sleep apnea	EFO:0003877	1	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	narcolepsy with cataplexy	EFO:0000614	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Alzheimers disease	EFO:0000249	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	insomnia	EFO:0004698	1	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	drug dependence	EFO:0003890	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	cocaine dependence	EFO:0002610	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	orthostatic hypotension	EFO:0005252	1	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	metamphetamine dependence	EFO:0004701	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	postpoliomyelitis syndrome	EFO:0007454	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	melanoma	EFO:0000756	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Parkinson's disease	EFO:0002508	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Ewing sarcoma	EFO:0000174	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	stroke	EFO:0000712	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	multiple sclerosis	EFO:0003885	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	obstructive sleep apnea	EFO:0003918	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	nicotine dependence	EFO:0003768	1	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	ovarian carcinoma	EFO:0001075	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	brain neoplasm	EFO:0003833	3	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Dysphagia	HP:0002015	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	opioid dependence	EFO:0005611	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	colon carcinoma	EFO:1001950	2	INHIBITOR
MODAFINIL	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	alcohol dependence	EFO:0003829	2	INHIBITOR
IBUTAMOREN	Ghrelin receptor agonist	GHSR	CHEMBL4616	fibromyalgia	EFO:0005687	2	AGONIST
TOLTERODINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	3	ANTAGONIST
TOLTERODINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	3	ANTAGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	hepatitis C infection	EFO:0003047	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	HIV infection	EFO:0000764	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	chronic lymphocytic leukemia	EFO:0000095	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Menorrhagia	HP:0000132	3	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	osteoporosis	EFO:0003882	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	hemorrhage	MP:0001914	3	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	migraine disorder	EFO:0003821	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	osteopenia	HP:0000938	3	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	infection	EFO:0000544	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	ovarian carcinoma	EFO:0001075	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Cystic fibrosis	Orphanet:586	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	HIV infection	EFO:0000764	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Chronic Hepatitis C infection	EFO:0004220	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	hyperplasia	EFO:0000536	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	3	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	type II diabetes mellitus	EFO:0001360	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Chronic Hepatitis C infection	EFO:0004220	1	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Neural tube defect	Orphanet:3388	3	AGONIST
LEVONORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	pain	EFO:0003843	2	AGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	Duchenne muscular dystrophy	Orphanet:98896	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	1	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	congestive heart failure	EFO:0000373	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	pulmonary hypertension	EFO:0001361	1	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	atrial fibrillation	EFO:0000275	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	acne	EFO:0003894	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	polycystic ovary syndrome	EFO:0000660	1	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	chronic kidney disease	EFO:0003884	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	acute myeloid leukemia	EFO:0000222	1	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	Hepatic steatosis	HP:0001397	2	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	heart failure	EFO:0003144	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	leukemia	EFO:0000565	1	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	myocardial infarction	EFO:0000612	3	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	hypertension	EFO:0000537	2	ANTAGONIST
SPIRONOLACTONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diastolic heart failure	EFO:1000899	3	ANTAGONIST
CYPROTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	acne	EFO:0003894	3	AGONIST
CYPROTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	prostate adenocarcinoma	EFO:0000673	3	AGONIST
CYPROTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	3	AGONIST
CYPROTERONE ACETATE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	acne	EFO:0003894	3	ANTAGONIST
CYPROTERONE ACETATE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
CYPROTERONE ACETATE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
CYPROTERONE ACETATE	Androgen Receptor antagonist	AR	CHEMBL1871	endometriosis	EFO:0001065	3	ANTAGONIST
CYPROTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	prostate carcinoma	EFO:0001663	3	AGONIST
CYPROTERONE ACETATE	Androgen Receptor antagonist	AR	CHEMBL1871	polycystic ovary syndrome	EFO:0000660	2	ANTAGONIST
CYPROTERONE ACETATE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	ANTAGONIST
CYPROTERONE ACETATE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	endometriosis	EFO:0001065	3	ANTAGONIST
CYPROTERONE ACETATE	Glucocorticoid receptor antagonist	NR3C1	CHEMBL2034	polycystic ovary syndrome	EFO:0000660	2	ANTAGONIST
CYPROTERONE ACETATE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
CYPROTERONE ACETATE	Androgen Receptor antagonist	AR	CHEMBL1871	acne	EFO:0003894	3	ANTAGONIST
CYPROTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	polycystic ovary syndrome	EFO:0000660	2	AGONIST
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometrial neoplasm	EFO:0004230	1	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	hypertension	EFO:0000537	0	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	growth delay	HP:0001510	3	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	hypopituitarism	EFO:0001380	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	ovarian carcinoma	EFO:0001075	1	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast carcinoma	EFO:0000305	4	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast neoplasm	EFO:0003869	4	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	metabolic syndrome	EFO:0000195	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometrial carcinoma	EFO:1001512	1	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	carcinoma	EFO:0000313	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometriosis	EFO:0001065	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	invasive lobular carcinoma	EFO:0000553	3	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	male breast carcinoma	EFO:0006861	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ANASTROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	McCune-Albright syndrome	Orphanet:562	2	INHIBITOR
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	acute coronary syndrome	EFO:0005672	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	dilated cardiomyopathy	EFO:0000407	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	type II diabetes mellitus	EFO:0001360	3	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	pulmonary hypertension	EFO:0001361	1	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	angina pectoris	EFO:0003913	4	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	coronary artery disease	EFO:0000378	3	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	diastolic heart failure	EFO:1000899	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	Paramyotonia congenita of Von Eulenburg	Orphanet:684	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	angina pectoris	EFO:0003913	4	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	irritable bowel syndrome	EFO:0000555	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	vascular disease	EFO:0004264	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	pulmonary hypertension	EFO:0001361	1	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	prolonged QT interval	HP:0001657	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	prolonged QT interval	HP:0001657	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	atrial fibrillation	EFO:0000275	3	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	coronary artery disease	EFO:0000378	3	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Myocardial Ischemia	EFO:1001375	3	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	vascular disease	EFO:0004264	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	irritable bowel syndrome	EFO:0000555	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	dilated cardiomyopathy	EFO:0000407	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	Paramyotonia congenita of Von Eulenburg	Orphanet:684	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	type II diabetes mellitus	EFO:0001360	3	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	acute coronary syndrome	EFO:0005672	2	BLOCKER
RANOLAZINE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	Myocardial Ischemia	EFO:1001375	3	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	diastolic heart failure	EFO:1000899	2	BLOCKER
RANOLAZINE	Sodium channel protein type IV alpha subunit blocker	SCN4A	CHEMBL2072	atrial fibrillation	EFO:0000275	3	BLOCKER
ESTRONE	Estrogen receptor alpha agonist	ESR1	CHEMBL206	obesity	EFO:0001073	2	AGONIST
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Pineoblastoma	EFO:1000475	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Pineoblastoma	EFO:1000475	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	scleroderma	EFO:1001993	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	macroglobulinemia	EFO:0002616	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	metastatic melanoma	EFO:0002617	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Sezary's disease	EFO:1000785	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	macroglobulinemia	EFO:0002616	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	mycosis fungoides	EFO:1001051	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	MALT lymphoma	EFO:0000191	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	hairy cell leukemia	EFO:1000956	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	MALT lymphoma	EFO:0000191	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	gliosarcoma	EFO:1001465	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	scleroderma	EFO:1001993	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	melanoma	EFO:0000756	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	polycythemia vera	EFO:0002429	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lung carcinoma	EFO:0001071	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	central nervous system cancer	EFO:0000326	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	neuroblastoma	EFO:0000621	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	central nervous system cancer	EFO:0000326	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	leukemia	EFO:0000565	3	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	breast neoplasm	EFO:0003869	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic kidney disease	EFO:0003884	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	idiopathic pulmonary fibrosis	EFO:0000768	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	acute lymphoblastic leukemia	EFO:0000220	4	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Sezary's disease	EFO:1000785	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lymphoma	EFO:0000574	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	central nervous system cancer	EFO:0000326	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	neuroblastoma	EFO:0000621	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	macroglobulinemia	EFO:0002616	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lung carcinoma	EFO:0001071	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	idiopathic pulmonary fibrosis	EFO:0000768	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	melanoma	EFO:0000756	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	endometrial neoplasm	EFO:0004230	0	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	macroglobulinemia	EFO:0002616	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	metastatic melanoma	EFO:0002617	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gliosarcoma	EFO:1001465	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	multiple myeloma	EFO:0001378	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mycosis fungoides	EFO:1001051	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	metastatic melanoma	EFO:0002617	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	leukemia	EFO:0000565	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	metastatic melanoma	EFO:0002617	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	MALT lymphoma	EFO:0000191	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic kidney disease	EFO:0003884	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	gliosarcoma	EFO:1001465	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	endometrial neoplasm	EFO:0004230	0	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	polycythemia vera	EFO:0002429	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast neoplasm	EFO:0003869	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hairy cell leukemia	EFO:1000956	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	breast carcinoma	EFO:0000305	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast carcinoma	EFO:0000305	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	mycosis fungoides	EFO:1001051	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	multiple myeloma	EFO:0001378	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Sezary's disease	EFO:1000785	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	angioimmunoblastic T-cell lymphoma	EFO:0000255	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	chronic kidney disease	EFO:0003884	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	central nervous system cancer	EFO:0000326	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lymphoma	EFO:0000574	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	prostate carcinoma	EFO:0001663	3	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	neuroblastoma	EFO:0000621	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	leukemia	EFO:0000565	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	mycosis fungoides	EFO:1001051	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	neuroblastoma	EFO:0000621	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Pineoblastoma	EFO:1000475	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	3	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	angioimmunoblastic T-cell lymphoma	EFO:0000255	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate carcinoma	EFO:0001663	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	scleroderma	EFO:1001993	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	endometrial neoplasm	EFO:0004230	0	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	angioimmunoblastic T-cell lymphoma	EFO:0000255	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	mesothelioma	EFO:0000588	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chronic kidney disease	EFO:0003884	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	polycythemia vera	EFO:0002429	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	mesothelioma	EFO:0000588	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	lymphoma	EFO:0000574	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	mesothelioma	EFO:0000588	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Pineoblastoma	EFO:1000475	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	idiopathic pulmonary fibrosis	EFO:0000768	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	Sezary's disease	EFO:1000785	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	angioimmunoblastic T-cell lymphoma	EFO:0000255	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	melanoma	EFO:0000756	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	breast carcinoma	EFO:0000305	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	leukemia	EFO:0000565	3	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	polycythemia vera	EFO:0002429	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	idiopathic pulmonary fibrosis	EFO:0000768	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	hairy cell leukemia	EFO:1000956	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	MALT lymphoma	EFO:0000191	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	1	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate carcinoma	EFO:0001663	3	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoma	EFO:0000574	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
DASATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	multiple myeloma	EFO:0001378	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	breast neoplasm	EFO:0003869	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	lung carcinoma	EFO:0001071	2	INHIBITOR
DASATINIB	Ephrin type-A receptor 2 inhibitor	EPHA2	CHEMBL2068	endometrial neoplasm	EFO:0004230	0	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	scleroderma	EFO:1001993	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DASATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
DASATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	hairy cell leukemia	EFO:1000956	1	INHIBITOR
SITAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
SITAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	diabetes mellitus	EFO:0000400	1	INHIBITOR
PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	amyotrophic lateral sclerosis	EFO:0000253	2	ANTAGONIST
PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Tourette syndrome	EFO:0004895	2	ANTAGONIST
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	gestational diabetes	EFO:0004593	2	INHIBITOR
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	abnormal glucose tolerance	EFO:0002546	2	INHIBITOR
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	prediabetes syndrome	EFO:1001121	3	INHIBITOR
VILDAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	diabetes mellitus	EFO:0000400	4	INHIBITOR
NIMODIPINE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	infertility	EFO:0000545	2	ANTAGONIST
NIMODIPINE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	brain aneurysm	EFO:0003870	1	ANTAGONIST
NIMODIPINE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	subarachnoid hemorrhage	EFO:0000713	3	ANTAGONIST
NIMODIPINE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	cocaine dependence	EFO:0002610	2	ANTAGONIST
NIMODIPINE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	stroke	EFO:0000712	2	ANTAGONIST
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	skin disease	EFO:0000701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	reactive arthritis	EFO:0007460	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Primary systemic amyloidosis	Orphanet:314701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	anthrax infection	EFO:0000778	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	melanoma	EFO:0000756	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Abdominal Aortic Aneurysm	EFO:0004214	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Tuberculosis	Orphanet:3389	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	ulcerative colitis	EFO:0000729	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	rosacea	EFO:1000760	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	melanoma	EFO:0000756	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Sezary's disease	EFO:1000785	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Eye Burns	EFO:1001788	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	septicemic plague	EFO:0007481	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	atopic eczema	EFO:0000274	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	urethritis	EFO:0003878	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	diabetic foot	EFO:1001459	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	hemorrhage	MP:0001914	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	myocardial infarction	EFO:0000612	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Eye Burns	EFO:1001788	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	polyp	EFO:0000662	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Marfan syndrome	Orphanet:558	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Pelvic Inflammatory Disease	EFO:1001388	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	scrub typhus	EFO:0007480	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	skin disease	EFO:0000701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Marfan syndrome	Orphanet:558	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	reactive arthritis	EFO:0007460	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	periodontitis	EFO:0000649	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Cystic fibrosis	Orphanet:586	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	septicemic plague	EFO:0007481	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	skin disease	EFO:0000701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	rosacea	EFO:1000760	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Seizures	HP:0001250	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	mansonelliasis	EFO:0007357	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	diabetic retinopathy	EFO:0003770	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	urethritis	EFO:0003878	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Cutaneous T-cell lymphoma	EFO:0002913	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	hemorrhage	MP:0001914	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	diabetic foot	EFO:1001459	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	anthrax infection	EFO:0000778	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	mansonelliasis	EFO:0007357	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Alzheimers disease	EFO:0000249	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Seizures	HP:0001250	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Cystic fibrosis	Orphanet:586	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	diabetic retinopathy	EFO:0003770	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	polyp	EFO:0000662	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Sezary's disease	EFO:1000785	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Eye Burns	EFO:1001788	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	mycosis fungoides	EFO:1001051	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	age-related macular degeneration	EFO:0001365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	syphilis	EFO:0007504	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	pain	EFO:0003843	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	dry eye syndrome	EFO:1000906	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	atopic eczema	EFO:0000274	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	mansonelliasis	EFO:0007357	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Tuberculosis	Orphanet:3389	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	scrub typhus	EFO:0007480	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	diabetic retinopathy	EFO:0003770	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	osteoarthritis	EFO:0002506	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Pelvic Inflammatory Disease	EFO:1001388	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	pain	EFO:0003843	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Graves ophthalmopathy	EFO:1001466	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Marfan syndrome	Orphanet:558	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Alzheimers disease	EFO:0000249	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	polyp	EFO:0000662	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Seizures	HP:0001250	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Graves ophthalmopathy	EFO:1001466	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Cutaneous T-cell lymphoma	EFO:0002913	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Borrelia infectious disease	EFO:1000842	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	ulcerative colitis	EFO:0000729	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Crohn's disease	EFO:0000384	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Primary systemic amyloidosis	Orphanet:314701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	ulcerative colitis	EFO:0000729	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	hemorrhage	MP:0001914	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	reactive arthritis	EFO:0007460	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	dry eye syndrome	EFO:1000906	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	septicemic plague	EFO:0007481	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	scrub typhus	EFO:0007480	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	periodontitis	EFO:0000649	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	diabetic foot	EFO:1001459	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Sezary's disease	EFO:1000785	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	acne	EFO:0003894	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Cutaneous T-cell lymphoma	EFO:0002913	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	skin disease	EFO:0000701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Pelvic Inflammatory Disease	EFO:1001388	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Crohn's disease	EFO:0000384	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	syphilis	EFO:0007504	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	acne	EFO:0003894	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	pain	EFO:0003843	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	atopic eczema	EFO:0000274	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	age-related macular degeneration	EFO:0001365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	atopic eczema	EFO:0000274	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	scrub typhus	EFO:0007480	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Graves ophthalmopathy	EFO:1001466	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Tuberculosis	Orphanet:3389	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	mansonelliasis	EFO:0007357	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	anthrax infection	EFO:0000778	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	diabetic retinopathy	EFO:0003770	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Crohn's disease	EFO:0000384	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	osteoarthritis	EFO:0002506	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	dry eye syndrome	EFO:1000906	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Graves ophthalmopathy	EFO:1001466	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	periodontitis	EFO:0000649	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Seizures	HP:0001250	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	melanoma	EFO:0000756	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	acne	EFO:0003894	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	urethritis	EFO:0003878	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Cystic fibrosis	Orphanet:586	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Borrelia infectious disease	EFO:1000842	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	syphilis	EFO:0007504	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	osteoarthritis	EFO:0002506	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	rosacea	EFO:1000760	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Borrelia infectious disease	EFO:1000842	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	periodontitis	EFO:0000649	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	hemorrhage	MP:0001914	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Marfan syndrome	Orphanet:558	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Cutaneous T-cell lymphoma	EFO:0002913	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	mycosis fungoides	EFO:1001051	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Cystic fibrosis	Orphanet:586	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Borrelia infectious disease	EFO:1000842	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	Pelvic Inflammatory Disease	EFO:1001388	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	myocardial infarction	EFO:0000612	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	reactive arthritis	EFO:0007460	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	mycosis fungoides	EFO:1001051	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	septicemic plague	EFO:0007481	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Abdominal Aortic Aneurysm	EFO:0004214	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	rosacea	EFO:1000760	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	syphilis	EFO:0007504	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	myocardial infarction	EFO:0000612	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	myocardial infarction	EFO:0000612	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	osteoarthritis	EFO:0002506	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	melanoma	EFO:0000756	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	anthrax infection	EFO:0000778	1	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Abdominal Aortic Aneurysm	EFO:0004214	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Chlamydia trachomatis infectious disease	EFO:0007205	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	mycosis fungoides	EFO:1001051	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	urethritis	EFO:0003878	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	acne	EFO:0003894	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Sezary's disease	EFO:1000785	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Primary systemic amyloidosis	Orphanet:314701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	dry eye syndrome	EFO:1000906	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Alzheimers disease	EFO:0000249	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	osteomyelitis	EFO:0003102	0	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	diabetic foot	EFO:1001459	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Abdominal Aortic Aneurysm	EFO:0004214	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Primary systemic amyloidosis	Orphanet:314701	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	ulcerative colitis	EFO:0000729	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	Crohn's disease	EFO:0000384	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	Alzheimers disease	EFO:0000249	3	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Eye Burns	EFO:1001788	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	age-related macular degeneration	EFO:0001365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 8 inhibitor	MMP8	CHEMBL4588	pain	EFO:0003843	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	polyp	EFO:0000662	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	MMP13	CHEMBL280	age-related macular degeneration	EFO:0001365	2	INHIBITOR
DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	Tuberculosis	Orphanet:3389	2	INHIBITOR
REBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	dementia	HP:0000726	3	INHIBITOR
REBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	2	INHIBITOR
REBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	fibromyalgia	EFO:0005687	3	INHIBITOR
ILOPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	liver disease	EFO:0001421	1	ANTAGONIST
ILOPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	liver disease	EFO:0001421	1	ANTAGONIST
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	Ovarian hyperstimulation syndrome	Orphanet:64739	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	ovarian carcinoma	EFO:0001075	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast neoplasm	EFO:0003869	4	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	leiomyosarcoma	EFO:0000564	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	azoospermia	EFO:0000279	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	brain neoplasm	EFO:0003833	0	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometrial neoplasm	EFO:0004230	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	uterine fibroid	EFO:0000731	1	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast carcinoma	EFO:0000305	4	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	polycystic ovary syndrome	EFO:0000660	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	osteoporosis	EFO:0003882	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	growth delay	HP:0001510	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	infertility	EFO:0000545	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometrial carcinoma	EFO:1001512	3	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	cervical adenocarcinoma	EFO:0001416	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	Lymphangioleiomyomatosis	Orphanet:538	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	mesothelioma	EFO:0000588	1	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	endometriosis	EFO:0001065	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	ductal carcinoma in situ	EFO:0000432	2	INHIBITOR
LETROZOLE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	uterine neoplasm	EFO:0003859	2	INHIBITOR
FLUOXYMESTERONE	Androgen Receptor agonist	AR	CHEMBL1871	breast carcinoma	EFO:0000305	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic pancreatitis	EFO:0000342	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vascular disease	EFO:0004264	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin neoplasm	EFO:0004198	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetic retinopathy	EFO:0003770	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Keloid	EFO:0004212	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis, knee	EFO:0004616	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	abdominal pain	HP:0002027	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Vitiligo	EFO:0004208	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	freckles	EFO:0003963	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	age-related macular degeneration	EFO:0001365	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior ischemic optic neuropathy	EFO:1000809	1	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
TRIAMCINOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinal vein occlusion	EFO:1001157	3	AGONIST
LONAPRISAN	Progesterone receptor antagonist	PGR	CHEMBL208	breast carcinoma	EFO:0000305	2	ANTAGONIST
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	hypertension	EFO:0000537	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	Tumor Lysis Syndrome	EFO:1001479	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	lymphoma	EFO:0000574	4	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	heart failure	EFO:0003144	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	ulcerative colitis	EFO:0000729	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	diabetes mellitus	EFO:0000400	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	Leishmaniasis	EFO:0005044	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	gout	EFO:0004274	4	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	metabolic syndrome	EFO:0000195	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	multiple myeloma	EFO:0001378	1	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	Tuberculosis	Orphanet:3389	1	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	leukemia	EFO:0000565	4	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	inflammatory bowel disease	EFO:0003767	1	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	kidney stone	EFO:0003845	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	congestive heart failure	EFO:0000373	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	obesity	EFO:0001073	3	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
ALLOPURINOL	Xanthine dehydrogenase inhibitor	XDH	CHEMBL1929	heart disease	EFO:0003777	3	INHIBITOR
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	glioblastoma multiforme	EFO:0000519	1	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	breast carcinoma	EFO:0000305	3	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	gastroparesis	EFO:1000948	3	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Nausea and vomiting	HP:0002017	4	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	cocaine dependence	EFO:0002610	2	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	opioid dependence	EFO:0005611	1	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Nausea	HP:0002018	4	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	alcohol dependence	EFO:0003829	2	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	non-small cell lung carcinoma	EFO:0003060	3	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	acute myeloid leukemia	EFO:0000222	2	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	heroin dependence	EFO:0004240	1	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	marijuana dependence	EFO:0004218	2	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	multiple myeloma	EFO:0001378	3	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	germ cell tumor	EFO:0000514	3	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	HIV infection	EFO:0000764	1	ANTAGONIST
APREPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Pruritus	HP:0000989	2	ANTAGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polyp	EFO:0000662	2	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	croup	EFO:0007227	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic bronchitis	EFO:0006505	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	emphysema	EFO:0000464	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetes mellitus	EFO:0000400	1	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bronchogenic carcinoma	EFO:1001942	2	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive sleep apnea	EFO:0003918	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchiolitis	HP:0011950	2	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bronchiolitis obliterans	EFO:0007183	2	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	3	AGONIST
FLUTICASONE PROPIONATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	3	AGONIST
SELICICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	pituitary-dependent Cushing's disease	EFO:1001110	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	Cystic fibrosis	Orphanet:586	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	Cystic fibrosis	Orphanet:586	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	pituitary-dependent Cushing's disease	EFO:1001110	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	breast carcinoma	EFO:0000305	1	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	pituitary-dependent Cushing's disease	EFO:1001110	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Cystic fibrosis	Orphanet:586	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	breast carcinoma	EFO:0000305	1	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	pituitary-dependent Cushing's disease	EFO:1001110	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	Cystic fibrosis	Orphanet:586	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	pituitary-dependent Cushing's disease	EFO:1001110	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	breast carcinoma	EFO:0000305	1	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	Cystic fibrosis	Orphanet:586	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	breast carcinoma	EFO:0000305	1	INHIBITOR
SELICICLIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	breast carcinoma	EFO:0000305	1	INHIBITOR
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	Fanconi anemia	Orphanet:84	1	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	Fanconi anemia	Orphanet:84	1	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	2	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	diabetic retinopathy	EFO:0003770	3	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	aplastic anemia	HP:0001915	1	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	endometrial neoplasm	EFO:0004230	2	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	endometriosis	EFO:0001065	2	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	Dyskeratosis congenita	Orphanet:1775	1	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	autoimmune thrombocytopenic purpura	EFO:0007160	2	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	aplastic anemia	HP:0001915	1	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	diabetic retinopathy	EFO:0003770	3	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	autoimmune thrombocytopenic purpura	EFO:0007160	2	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	Dyskeratosis congenita	Orphanet:1775	1	AGONIST
DANAZOL	Androgen Receptor agonist	AR	CHEMBL1871	breast fibrocystic disease	EFO:0003014	2	AGONIST
DANAZOL	Progesterone receptor agonist	PGR	CHEMBL208	breast fibrocystic disease	EFO:0003014	2	AGONIST
VARESPLADIB	Phospholipase A2 group IIA inhibitor	PLA2G2A	CHEMBL3474	Sickle cell anemia	Orphanet:232	2	INHIBITOR
VARESPLADIB	Phospholipase A2 group IIA inhibitor	PLA2G2A	CHEMBL3474	coronary artery disease	EFO:0000378	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	influenza infection	EFO:0001669	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hepatitis C infection	EFO:0003047	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	atherosclerosis	EFO:0003914	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	brain infarction	EFO:0004277	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	diabetes mellitus	EFO:0000400	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	psoriasis	EFO:0000676	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	acute coronary syndrome	EFO:0005672	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	stroke	EFO:0000712	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	periodontitis	EFO:0000649	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	breast carcinoma	EFO:0000305	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic kidney disease	EFO:0003884	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	polycystic ovary syndrome	EFO:0000660	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	multiple myeloma	EFO:0001378	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	sepsis	HP:0100806	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	mucocutaneous lymph node syndrome	EFO:0004246	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	kidney disease	EFO:0003086	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	coronary artery disease	EFO:0000378	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Crohn's disease	EFO:0000384	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypertrophic cardiomyopathy	EFO:0000538	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	carotid artery disease	EFO:0003781	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	preeclampsia	EFO:0000668	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	breast neoplasm	EFO:0003869	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	IGA glomerulonephritis	EFO:0004194	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	insomnia	EFO:0004698	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	leukemia	EFO:0000565	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	heart failure	EFO:0003144	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	metabolic syndrome	EFO:0000195	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV infection	EFO:0000764	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	endometrial neoplasm	EFO:0004230	0	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	familial hypercholesterolemia	EFO:0004911	4	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hyperlipidemia	EFO:0003774	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypertension	EFO:0000537	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	4	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	epilepsy	EFO:0000474	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	coronary heart disease	EFO:0001645	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	vascular disease	EFO:0004264	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	myocardial infarction	EFO:0000612	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	systemic lupus erythematosus	EFO:0002690	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV-1 infection	EFO:0000180	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Abnormality of lipid metabolism	HP:0003119	4	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Hyperlipoproteinemia type 3	Orphanet:412	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	venous thromboembolism	EFO:0004286	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Sarcoidosis	Orphanet:797	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	asthma	EFO:0000270	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	focal segmental glomerulosclerosis	EFO:0004236	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Combined hyperlipidemia	Orphanet:79211	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	stricture	EFO:0006818	1	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Central diabetes insipidus	HP:0000863	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Alzheimers disease	EFO:0000249	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Vitiligo	EFO:0004208	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	osteoarthritis, knee	EFO:0004616	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	obstructive sleep apnea	EFO:0003918	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Hypertriglyceridemia	EFO:0004211	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	relapsing-remitting multiple sclerosis	EFO:0003929	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	prostate carcinoma	EFO:0001663	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	scleroderma	EFO:1001993	2	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	AIDS	EFO:0000765	3	INHIBITOR
ATORVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	multiple sclerosis	EFO:0003885	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	squamous cell carcinoma	EFO:0000707	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	acute erythroblastic leukemia	EFO:1001257	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	metastatic melanoma	EFO:0002617	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	breast carcinoma	EFO:0000305	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	ependymoma	EFO:1000028	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Beta-thalassemia major	Orphanet:231214	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	ependymoma	EFO:1000028	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	refractory anemia with excess blasts	EFO:0003811	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	thrombocytopenia	HP:0001873	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	refractory anemia with excess blasts	EFO:0003811	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	esophageal carcinoma	EFO:0002916	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	male breast carcinoma	EFO:0006861	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	lymphoma	EFO:0000574	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	ovarian carcinoma	EFO:0001075	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	colorectal carcinoma	EFO:1001951	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	multiple myeloma	EFO:0001378	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Beta-thalassemia major	Orphanet:231214	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	myelodysplastic syndrome	EFO:0000198	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	renal cell carcinoma	EFO:0000681	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	esophageal carcinoma	EFO:0002916	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	primary myelofibrosis	EFO:0002430	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	leukemia	EFO:0000565	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	prostate carcinoma	EFO:0001663	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	thrombocytopenia	HP:0001873	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	leukemia	EFO:0000565	3	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	liposarcoma	EFO:0000569	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Beta-thalassemia	Orphanet:848	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	squamous cell carcinoma	EFO:0000707	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	liposarcoma	EFO:0000569	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	colorectal carcinoma	EFO:1001951	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	Beta-thalassemia	Orphanet:848	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	chronic myelomonocytic leukemia	EFO:1001779	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	ovarian carcinoma	EFO:0001075	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	brain neoplasm	EFO:0003833	0	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	multiple myeloma	EFO:0001378	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	primary myelofibrosis	EFO:0002430	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	chronic myelomonocytic leukemia	EFO:1001779	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	metastatic melanoma	EFO:0002617	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	male breast carcinoma	EFO:0006861	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	cutaneous melanoma	EFO:0000389	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	lymphoma	EFO:0000574	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	breast carcinoma	EFO:0000305	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	cutaneous melanoma	EFO:0000389	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	myelodysplastic syndrome	EFO:0000198	4	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	acute erythroblastic leukemia	EFO:1001257	2	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	brain neoplasm	EFO:0003833	0	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 3A inhibitor	DNMT3A	CHEMBL1992	renal cell carcinoma	EFO:0000681	1	INHIBITOR
AZACITIDINE	DNA (cytosine-5)-methyltransferase 1 inhibitor	DNMT1	CHEMBL1993	prostate carcinoma	EFO:0001663	2	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	acute coronary syndrome	EFO:0005672	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	heart failure	EFO:0003144	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Combined hyperlipidemia	Orphanet:79211	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	familial hypercholesterolemia	EFO:0004911	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	coronary artery disease	EFO:0000378	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	3	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	diabetes mellitus	EFO:0000400	1	INHIBITOR
ROSUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
BETAMETHASONE VALERATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	1	AGONIST
BETAMETHASONE VALERATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
BETAMETHASONE VALERATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	3	AGONIST
BETAMETHASONE VALERATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE VALERATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	2	AGONIST
FLUOCINONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	2	AGONIST
FLUOCINONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pemphigus vulgaris	EFO:0004719	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	alopecia areata	EFO:0004192	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetic retinopathy	EFO:0003770	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Vitiligo	EFO:0004208	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hearing loss	EFO:0004238	1	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic pancreatitis	EFO:0000342	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	intermediate uveitis	EFO:1000986	1	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	uveitis	EFO:1001231	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	age-related macular degeneration	EFO:0001365	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mucositis	EFO:1001898	1	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lateral epicondylitis	EFO:1001896	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	1	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior ischemic optic neuropathy	EFO:1000809	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis, knee	EFO:0004616	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinal vein occlusion	EFO:1001157	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Dupuytren Contracture	EFO:0004229	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	glaucoma	EFO:0000516	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hand dermatosis	EFO:1000706	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
TRIAMCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	proliferative vitreoretinopathy	EFO:1001129	3	AGONIST
ALMOTRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	4	AGONIST
ALMOTRIPTAN	Serotonin 1f (5-HT1f) receptor agonist	HTR1F	CHEMBL1805	migraine disorder	EFO:0003821	4	AGONIST
ALMOTRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	4	AGONIST
ESCITALOPRAM	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Spinal cord injury	EFO:1001919	1	INHIBITOR
DROSPIRENONE	Progesterone receptor agonist	PGR	CHEMBL208	acne	EFO:0003894	3	AGONIST
DROSPIRENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	hypertension	EFO:0000537	3	ANTAGONIST
DROSPIRENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	acne	EFO:0003894	3	ANTAGONIST
DROSPIRENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	polycystic ovary syndrome	EFO:0000660	3	ANTAGONIST
DROSPIRENONE	Progesterone receptor agonist	PGR	CHEMBL208	polycystic ovary syndrome	EFO:0000660	3	AGONIST
DROSPIRENONE	Progesterone receptor agonist	PGR	CHEMBL208	hypertension	EFO:0000537	3	AGONIST
DROSPIRENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	hidradenitis suppurativa	EFO:1000710	2	ANTAGONIST
DROSPIRENONE	Progesterone receptor agonist	PGR	CHEMBL208	hidradenitis suppurativa	EFO:1000710	2	AGONIST
ESTRADIOL VALERATE	Estrogen receptor alpha agonist	ESR1	CHEMBL206	infertility	EFO:0000545	3	AGONIST
ESTRADIOL VALERATE	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Menorrhagia	HP:0000132	4	AGONIST
FLUNISOLIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
FLUNISOLIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
FLUNISOLIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
FLUNISOLIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
XALIPRODEN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	colorectal neoplasm	EFO:0004142	3	AGONIST
XALIPRODEN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	Alzheimers disease	EFO:0000249	3	AGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	atrial fibrillation	EFO:0000275	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetic nephropathy	EFO:0000401	0	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Marfan syndrome	Orphanet:558	2	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	4	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Ehlers-Danlos syndrome, vascular type	Orphanet:286	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Chronic Hepatitis C infection	EFO:0004220	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	IGA glomerulonephritis	EFO:0004194	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypercholesterolemia	HP:0003124	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	congestive heart failure	EFO:0000373	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	sepsis	HP:0100806	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Ebola hemorrhagic fever	EFO:0007243	1	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	chronic kidney disease	EFO:0003884	3	ANTAGONIST
IRBESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	focal segmental glomerulosclerosis	EFO:0004236	2	ANTAGONIST
METHIMAZOLE	Thyroid peroxidase inhibitor	TPO	CHEMBL1839	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
METHIMAZOLE	Thyroid peroxidase inhibitor	TPO	CHEMBL1839	polymyositis	EFO:0003063	2	INHIBITOR
METHIMAZOLE	Thyroid peroxidase inhibitor	TPO	CHEMBL1839	Graves ophthalmopathy	EFO:1001466	1	INHIBITOR
METHIMAZOLE	Thyroid peroxidase inhibitor	TPO	CHEMBL1839	dermatomyositis	EFO:0000398	2	INHIBITOR
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	atrial fibrillation	EFO:0000275	3	ANTAGONIST
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	atherosclerosis	EFO:0003914	3	ANTAGONIST
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	heart failure	EFO:0003144	3	ANTAGONIST
OLMESARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
DEXAMETHASONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
DEXAMETHASONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
ETONOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	2	AGONIST
ETONOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	AIDS	EFO:0000765	2	AGONIST
ETONOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	benign prostatic hyperplasia	EFO:0000284	2	AGONIST
DESOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	hemorrhage	MP:0001914	3	AGONIST
DESOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	Ondine syndrome	Orphanet:661	2	AGONIST
DESOGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	polycystic ovary syndrome	EFO:0000660	3	AGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 7 antagonist	TLR7	CHEMBL5936	systemic lupus erythematosus	EFO:0002690	2	ANTAGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 7 antagonist	TLR7	CHEMBL5936	interstitial lung disease	EFO:0004244	2	ANTAGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 7 antagonist	TLR7	CHEMBL5936	rheumatic disease	EFO:0005755	1	ANTAGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 9 antagonist	TLR9	CHEMBL5804	systemic lupus erythematosus	EFO:0002690	2	ANTAGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 9 antagonist	TLR9	CHEMBL5804	interstitial lung disease	EFO:0004244	2	ANTAGONIST
HYDROXYCHLOROQUINE	Toll-like receptor 9 antagonist	TLR9	CHEMBL5804	rheumatic disease	EFO:0005755	1	ANTAGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Abnormality of connective tissue	HP:0003549	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	ulcerative colitis	EFO:0000729	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Tuberculosis	Orphanet:3389	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	type II diabetes mellitus	EFO:0001360	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	migraine disorder	EFO:0003821	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	heart failure	EFO:0003144	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	type I diabetes mellitus	EFO:0001359	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic kidney disease	EFO:0003884	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	femoral neck fracture	EFO:1001792	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	restless legs syndrome	EFO:0004270	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	HIV infection	EFO:0000764	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	multiple sclerosis	EFO:0003885	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteitis deformans	EFO:0004261	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	obesity	EFO:0001073	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	lymphoma	EFO:0000574	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	insulin resistance	EFO:0002614	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	aortic stenosis	EFO:0000266	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	vitamin D deficiency	EFO:0003762	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hyperprolactinemia	EFO:0007319	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Sickle cell anemia	Orphanet:232	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Chronic Hepatitis C infection	EFO:0004220	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Alzheimers disease	EFO:0000249	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hip fracture	EFO:0003964	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Crohn's disease	EFO:0000384	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast carcinoma	EFO:0000305	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate adenocarcinoma	EFO:0000673	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	hepatitis C infection	EFO:0003047	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	Cystic fibrosis	Orphanet:586	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	sudden cardiac arrest	EFO:0004278	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	optic neuritis	EFO:0007405	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	leukemia	EFO:0000565	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	cutaneous lupus erythematosus	EFO:0003834	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteopenia	HP:0000938	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	colorectal carcinoma	EFO:1001951	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	postmenopausal osteoporosis	EFO:0003854	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	polycystic ovary syndrome	EFO:0000660	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	non-Hodgkins lymphoma	EFO:0005952	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	inflammatory bowel disease	EFO:0003767	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoarthritis	EFO:0002506	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast neoplasm	EFO:0003869	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	vitamin deficiency	EFO:0005878	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	nutritional disorder	EFO:0001069	2	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	cutaneous melanoma	EFO:0000389	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate carcinoma	EFO:0001663	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoporosis	EFO:0003882	3	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	lung carcinoma	EFO:0001071	1	AGONIST
ERGOCALCIFEROL	Vitamin D receptor agonist	VDR	CHEMBL1977	asthma	EFO:0000270	3	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Familial adenomatous polyposis	Orphanet:733	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	congestive heart failure	EFO:0000373	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	primary biliary cirrhosis	EFO:1001486	3	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	cirrhosis of liver	EFO:0001422	1	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	liver disease	EFO:0001421	3	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	obesity	EFO:0001073	1	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Huntington disease	Orphanet:399	1	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	type II diabetes mellitus	EFO:0001360	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	inflammation	MP:0001845	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Parkinson's disease	EFO:0002508	1	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	colorectal carcinoma	EFO:1001951	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	obstructive jaundice	EFO:1001068	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Glucose intolerance	HP:0000833	1	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	sclerosing cholangitis	EFO:0004268	2	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Chronic Hepatitis C infection	EFO:0004220	3	AGONIST
URSODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	cholelithiasis	EFO:0004799	3	AGONIST
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	4	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	congestive heart failure	EFO:0000373	4	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	diabetic nephropathy	EFO:0000401	4	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	heart disease	EFO:0003777	2	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	type II diabetes mellitus	EFO:0001360	1	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	diabetic retinopathy	EFO:0003770	4	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	pulmonary hypertension	EFO:0001361	1	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	myocardial infarction	EFO:0000612	4	INHIBITOR
CAPTOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	heart failure	EFO:0003144	4	INHIBITOR
MIGLITOL	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	diabetes mellitus	EFO:0000400	4	INHIBITOR
MIGLITOL	Lysosomal alpha-glucosidase inhibitor	GAA	CHEMBL2608	diabetes mellitus	EFO:0000400	4	INHIBITOR
MIGLITOL	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
MIGLITOL	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
MIGLITOL	Lysosomal alpha-glucosidase inhibitor	GAA	CHEMBL2608	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
MIGLITOL	Lysosomal alpha-glucosidase inhibitor	GAA	CHEMBL2608	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	diabetes mellitus	EFO:0000400	4	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	hypotension	EFO:0005251	2	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	diabetes mellitus	EFO:0000400	4	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	gestational diabetes	EFO:0004593	3	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	hypotension	EFO:0005251	2	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	hyperinsulinemic hypoglycemia	EFO:0007318	2	INHIBITOR
ACARBOSE	Maltase-glucoamylase inhibitor	MGAM	CHEMBL2074	metabolic syndrome	EFO:0000195	3	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	metabolic syndrome	EFO:0000195	3	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	gestational diabetes	EFO:0004593	3	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	hyperinsulinemic hypoglycemia	EFO:0007318	2	INHIBITOR
ACARBOSE	Pancreatic alpha-amylase inhibitor	AMY2A	CHEMBL2045	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	liver disease	EFO:0001421	1	RELEASING AGENT
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	1	RELEASING AGENT
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	drug dependence	EFO:0003890	1	RELEASING AGENT
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	obesity	EFO:0001073	4	RELEASING AGENT
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	diabetes mellitus	EFO:0000400	2	RELEASING AGENT
PHENTERMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	obesity	EFO:0001073	4	RELEASING AGENT
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	renal carcinoma	EFO:0002890	1	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	leukemia	EFO:0000565	2	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	hairy cell leukemia	EFO:1000956	2	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	lymphoma	EFO:0000574	2	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	Sickle cell anemia	Orphanet:232	1	INHIBITOR
PENTOSTATIN	Adenosine deaminase inhibitor	ADA	CHEMBL1910	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
PERINDOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	4	INHIBITOR
PERINDOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	coronary artery disease	EFO:0000378	4	INHIBITOR
PERINDOPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	4	INHIBITOR
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	folliculitis	EFO:1000702	2	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	idiopathic pulmonary fibrosis	EFO:0000768	2	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	4	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	infection	EFO:0000544	1	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	2	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	croup	EFO:0007227	3	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchopulmonary dysplasia	Orphanet:70589	2	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sinusitis	EFO:0007486	3	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BECLOMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
PSEUDOEPHEDRINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	sinusitis	EFO:0007486	2	RELEASING AGENT
PSEUDOEPHEDRINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	common cold	EFO:0007214	3	RELEASING AGENT
PSEUDOEPHEDRINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	allergic rhinitis	EFO:0005854	3	RELEASING AGENT
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	acute lymphoblastic leukemia	EFO:0000220	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	acute myeloid leukemia	EFO:0000222	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	autoimmune thrombocytopenic purpura	EFO:0007160	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	glaucoma	EFO:0000516	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	venous thromboembolism	EFO:0004286	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	sudden cardiac arrest	EFO:0004278	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Familial lipoprotein lipase deficiency	Orphanet:309015	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	22q11.2 deletion syndrome	Orphanet:567	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	mast-cell leukemia	EFO:0007359	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	diabetes mellitus	EFO:0000400	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	lung disease	EFO:0003818	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	focal segmental glomerulosclerosis	EFO:0004236	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	leukemia	EFO:0000565	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Hodgkins lymphoma	EFO:0000183	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	keratoconjunctivitis sicca	EFO:1001001	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	aplastic anemia	HP:0001915	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Abdominal Aortic Aneurysm	EFO:0004214	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	atopic eczema	EFO:0000274	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	skin neoplasm	EFO:0004198	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	chronic myelogenous leukemia	EFO:0000339	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	lymphoid neoplasm	EFO:0001642	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	dry eye syndrome	EFO:1000906	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	chronic interstitial cystitis	EFO:1000869	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Chronic granulomatous disease	Orphanet:379	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Mucopolysaccharidosis	Orphanet:79213	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	rheumatoid arthritis	EFO:0000685	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Beta-thalassemia	Orphanet:848	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	hepatocellular carcinoma	EFO:0000182	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	T-Cell Prolymphocytic Leukemia	EFO:1000560	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	hepatitis C infection	EFO:0003047	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	psoriasis	EFO:0000676	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Stevens-Johnson syndrome	EFO:0004276	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	pterygium	EFO:0000678	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Fanconi anemia	Orphanet:84	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	leprosy	EFO:0001054	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	lupus nephritis	EFO:0005761	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	aspergillosis	EFO:0007157	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Sickle cell anemia	Orphanet:232	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	lymphoid leukemia	EFO:0004289	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	bronchiolitis obliterans	EFO:0007183	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	tropical spastic paraparesis	EFO:0007527	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	periodontitis	EFO:0000649	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	juvenile dermatomyositis	EFO:0000557	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Hereditary angioedema	Orphanet:91378	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	chronic obstructive pulmonary disease	EFO:0000341	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	renal cell carcinoma	EFO:0000681	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Retinoblastoma	Orphanet:790	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	prostate carcinoma	EFO:0001663	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Autoimmune Hepatitis	EFO:0005676	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Osteogenesis imperfecta	Orphanet:666	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Chronic Hepatitis C infection	EFO:0004220	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	myocardial infarction	EFO:0000612	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	non-Hodgkins lymphoma	EFO:0005952	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	neuroblastoma	EFO:0000621	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	lymphoma	EFO:0000574	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	anemia	EFO:0004272	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	cutaneous melanoma	EFO:0000389	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	liver disease	EFO:0001421	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	type I diabetes mellitus	EFO:0001359	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	heart disease	EFO:0003777	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	allergic conjunctivitis	EFO:0007141	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	epidermolysis bullosa	EFO:1000690	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	membranous glomerulonephritis	EFO:0004254	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	multiple myeloma	EFO:0001378	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Lymphoma, AIDS-Related	EFO:1001365	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	acute graft vs. host disease	EFO:0004599	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	chronic kidney disease	EFO:0003884	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	infection	EFO:0000544	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	breast carcinoma	EFO:0000305	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	renal carcinoma	EFO:0002890	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	severe aplastic anemia	EFO:0006927	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Leber hereditary optic neuropathy	Orphanet:104	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	urticaria	EFO:0005531	1	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	sarcoma	EFO:0000691	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	HIV infection	EFO:0000764	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	chronic lymphocytic leukemia	EFO:0000095	2	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	colorectal carcinoma	EFO:1001951	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	myelodysplastic syndrome	EFO:0000198	3	MODULATOR
CYCLOSPORINE	Cyclophilin A modulator	PPIA	CHEMBL1949	Eczema	HP:0000964	3	MODULATOR
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	muscular disease	EFO:0002970	3	AGONIST
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	postmenopausal osteoporosis	EFO:0003854	3	AGONIST
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	calcification	EFO:0003837	2	AGONIST
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	sudden cardiac arrest	EFO:0004278	2	AGONIST
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	polycystic ovary syndrome	EFO:0000660	2	AGONIST
ALFACALCIDOL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoporosis	EFO:0003882	3	AGONIST
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	gallbladder neoplasm	EFO:0004606	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	lung carcinoma	EFO:0001071	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	thyroid carcinoma	EFO:0002892	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	sarcoma	EFO:0000691	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	Kaposi's sarcoma	EFO:0000558	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	rectum cancer	EFO:1000657	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast carcinoma	EFO:0000305	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	adenocarcinoma	EFO:0000228	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	rectum cancer	EFO:1000657	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast carcinoma	EFO:0000305	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	biliary tract neoplasm	EFO:0003891	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal neoplasm	EFO:0004142	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	lung carcinoma	EFO:0001071	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	papillary thyroid carcinoma	EFO:0000641	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cholangiocarcinoma	EFO:0005221	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	biliary tract neoplasm	EFO:0003891	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	gallbladder neoplasm	EFO:0004606	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cutaneous melanoma	EFO:0000389	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	gallbladder carcinoma	EFO:1001956	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	thyroid carcinoma	EFO:0002892	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	multiple myeloma	EFO:0001378	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cholangiocarcinoma	EFO:0005221	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colon carcinoma	EFO:1001950	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	melanoma	EFO:0000756	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colon carcinoma	EFO:1001950	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	gallbladder carcinoma	EFO:1001956	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal neoplasm	EFO:0004142	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	papillary thyroid carcinoma	EFO:0000641	3	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	melanoma	EFO:0000756	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	multiple myeloma	EFO:0001378	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cutaneous melanoma	EFO:0000389	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	sarcoma	EFO:0000691	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	Kaposi's sarcoma	EFO:0000558	1	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	adenocarcinoma	EFO:0000228	2	INHIBITOR
CC-401	c-Jun N-terminal kinase 3 inhibitor	MAPK10	CHEMBL2637	leukemia	EFO:0000565	1	INHIBITOR
CC-401	c-Jun N-terminal kinase 1 inhibitor	MAPK8	CHEMBL2276	leukemia	EFO:0000565	1	INHIBITOR
CC-401	c-Jun N-terminal kinase 2 inhibitor	MAPK9	CHEMBL4179	leukemia	EFO:0000565	1	INHIBITOR
TAK-733	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	metastatic melanoma	EFO:0002617	1	INHIBITOR
TAK-733	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	metastatic melanoma	EFO:0002617	1	INHIBITOR
LEVOCABASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	cutaneous melanoma	EFO:0000389	1	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	lung carcinoma	EFO:0001071	2	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	cutaneous melanoma	EFO:0000389	1	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	melanoma	EFO:0000756	1	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	prostate carcinoma	EFO:0001663	2	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lung carcinoma	EFO:0001071	2	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	lung carcinoma	EFO:0001071	2	INHIBITOR
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	prostate carcinoma	EFO:0001663	2	INHIBITOR
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	melanoma	EFO:0000756	1	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	prostate carcinoma	EFO:0001663	2	INHIBITOR
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
MUPARFOSTAT	Basic fibroblast growth factor inhibitor	FGF2	CHEMBL3107	lung carcinoma	EFO:0001071	2	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MUPARFOSTAT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	melanoma	EFO:0000756	1	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MUPARFOSTAT	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	cutaneous melanoma	EFO:0000389	1	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	cutaneous melanoma	EFO:0000389	1	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	prostate carcinoma	EFO:0001663	2	INHIBITOR
MUPARFOSTAT	Heparanase inhibitor	HPSE	CHEMBL3921	melanoma	EFO:0000756	1	INHIBITOR
CANRENOATE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	myocardial infarction	EFO:0000612	3	ANTAGONIST
PALIPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
PALIPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Nasal obstruction	HP:0001742	4	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	4	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Familial dysautonomia	Orphanet:1764	3	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	3	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive lung disease	HP:0006536	4	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	emphysema	EFO:0000464	4	ANTAGONIST
IPRATROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic bronchitis	EFO:0006505	4	ANTAGONIST
CLEMASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	1	ANTAGONIST
DOXEPIN	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	3	INHIBITOR
DOXEPIN	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	mucositis	EFO:1001898	3	INHIBITOR
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	liver disease	EFO:0001421	1	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	breast carcinoma	EFO:0000305	2	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	colorectal carcinoma	EFO:1001951	2	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	prostate carcinoma	EFO:0001663	3	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	intermittent vascular claudication	EFO:0003876	2	ANTAGONIST
ZIBOTENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	ovarian carcinoma	EFO:0001075	2	ANTAGONIST
ALISKIREN	Renin inhibitor	REN	CHEMBL286	hypertension	EFO:0000537	4	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	hepatitis B infection	EFO:0004197	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	hepatitis D	EFO:0007304	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	HIV infection	EFO:0000764	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	hepatitis C infection	EFO:0003047	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	chronic hepatitis B infection	EFO:0004239	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	infection	EFO:0000544	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	hemorrhagic fever with renal syndrome	EFO:0007299	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	breast carcinoma	EFO:0000305	1	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	thrombocytopenia	HP:0001873	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	cirrhosis of liver	EFO:0001422	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	Chronic Hepatitis C infection	EFO:0004220	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	Japanese encephalitis	EFO:0007332	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	influenza infection	EFO:0001669	2	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	Respiratory Syncytial Virus Infection	EFO:1001413	3	INHIBITOR
RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	IMPDH1	CHEMBL1822	hepatitis	HP:0012115	2	INHIBITOR
AC-480	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	1	INHIBITOR
AC-480	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	central nervous system cancer	EFO:0000326	1	INHIBITOR
AC-480	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	central nervous system cancer	EFO:0000326	1	INHIBITOR
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	subacute thyroiditis	EFO:1001194	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemolytic anemia	EFO:0005558	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	erythema multiforme	EFO:1000694	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polymyositis	EFO:0003063	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Peptic ulcer	HP:0004398	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nephrotic syndrome	EFO:0004255	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypercalcemia	HP:0003072	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	meningeal tuberculosis	EFO:1000039	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatitis herpetiformis	EFO:1000684	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic childhood arthritis	EFO:0002609	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tenosynovitis	EFO:1001435	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatomyositis	EFO:0000398	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Congenital adrenal hyperplasia	Orphanet:418	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	angioedema	EFO:0005532	3	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Stevens-Johnson syndrome	EFO:0004276	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary tuberculosis	EFO:1000049	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	contact dermatitis	EFO:0005319	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriatic arthritis	EFO:0003778	4	AGONIST
CORTISONE ACETATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sympathetic ophthalmia	EFO:1001205	4	AGONIST
TRELAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
TRELAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	diabetes mellitus	EFO:0000400	3	INHIBITOR
AR-12	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	lymphoma	EFO:0000574	1	INHIBITOR
POLMACOXIB	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	osteoarthritis	EFO:0002506	2	INHIBITOR
POLMACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	2	INHIBITOR
POLMACOXIB	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	rheumatic disease	EFO:0005755	3	INHIBITOR
POLMACOXIB	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	osteoarthritis	EFO:0002506	2	INHIBITOR
POLMACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
POLMACOXIB	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
POLMACOXIB	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	rheumatic disease	EFO:0005755	3	INHIBITOR
POLMACOXIB	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
POLMACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	3	INHIBITOR
MITOTANE	Cytochrome P450 11B1 inhibitor	CYP11B1	CHEMBL1908	prostate carcinoma	EFO:0001663	1	INHIBITOR
MITOTANE	Cytochrome P450 11B1 inhibitor	CYP11B1	CHEMBL1908	adrenocortical carcinoma	EFO:0003093	3	INHIBITOR
MITOTANE	Cytochrome P450 11B1 inhibitor	CYP11B1	CHEMBL1908	carcinoma	EFO:0000313	3	INHIBITOR
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	insomnia	EFO:0004698	2	ANTAGONIST
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	post operative nausea and vomiting	EFO:0004888	3	ANTAGONIST
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	overactive bladder	EFO:1000781	2	ANTAGONIST
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Nausea	HP:0002018	3	ANTAGONIST
CASOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Nausea and vomiting	HP:0002017	3	ANTAGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vasomotor rhinitis	EFO:0007533	3	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
FLUTICASONE FUROATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
HYDROCORTISONE BUTYRATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
DEZOCINE	Kappa opioid receptor antagonist	OPRK1	CHEMBL237	pain	EFO:0003843	4	ANTAGONIST
DEZOCINE	Mu opioid receptor partial agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	PARTIAL AGONIST
INCB-9471	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV infection	EFO:0000764	2	ANTAGONIST
DEBRISOQUIN	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	hypertension	EFO:0000537	4	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	Hypokalemic periodic paralysis	Orphanet:681	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	glaucoma	EFO:0000516	4	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Hyperkalemic periodic paralysis	Orphanet:682	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	Hyperkalemic periodic paralysis	Orphanet:682	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	glaucoma	EFO:0000516	4	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	4	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	Hypokalemic periodic paralysis	Orphanet:681	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	glaucoma	EFO:0000516	4	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	Hyperkalemic periodic paralysis	Orphanet:682	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Hypokalemic periodic paralysis	Orphanet:681	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Hypokalemic periodic paralysis	Orphanet:681	3	INHIBITOR
DICHLORPHENAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Hyperkalemic periodic paralysis	Orphanet:682	3	INHIBITOR
TERFENADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
SDX-101	Retinoid X receptor alpha modulator	RXRA	CHEMBL2061	multiple myeloma	EFO:0001378	2	MODULATOR
SDX-101	Retinoid X receptor alpha modulator	RXRA	CHEMBL2061	chronic lymphocytic leukemia	EFO:0000095	2	MODULATOR
SU-014813	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast neoplasm	EFO:0003869	2	INHIBITOR
SU-014813	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	2	INHIBITOR
DIHYDROERGOTAMINE	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	3	AGONIST
SOLIFENACIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	3	ANTAGONIST
SOLIFENACIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	3	ANTAGONIST
SOLIFENACIN	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	benign prostatic hyperplasia	EFO:0000284	3	ANTAGONIST
SOLIFENACIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	benign prostatic hyperplasia	EFO:0000284	3	ANTAGONIST
REBASTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
ALECTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
ALECTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
ENOBOSARM	Androgen Receptor modulator	AR	CHEMBL1871	breast carcinoma	EFO:0000305	2	MODULATOR
ENOBOSARM	Androgen Receptor modulator	AR	CHEMBL1871	Urinary incontinence	HP:0000020	2	MODULATOR
ENOBOSARM	Androgen Receptor modulator	AR	CHEMBL1871	non-small cell lung carcinoma	EFO:0003060	3	MODULATOR
ENOBOSARM	Androgen Receptor modulator	AR	CHEMBL1871	cachexia	HP:0004326	2	MODULATOR
AMELUBANT	Leukotriene B4 receptor 1 antagonist	LTB4R	CHEMBL3911	Cystic fibrosis	Orphanet:586	1	ANTAGONIST
AMELUBANT	Leukotriene B4 receptor 1 antagonist	LTB4R	CHEMBL3911	asthma	EFO:0000270	2	ANTAGONIST
AMELUBANT	Leukotriene B4 receptor 1 antagonist	LTB4R	CHEMBL3911	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
AMELUBANT	Leukotriene B4 receptor 1 antagonist	LTB4R	CHEMBL3911	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
BILASTINE	Histamine H1 receptor inverse agonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	INVERSE AGONIST
BILASTINE	Histamine H1 receptor inverse agonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	INVERSE AGONIST
BILASTINE	Histamine H1 receptor inverse agonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	INVERSE AGONIST
BILASTINE	Histamine H1 receptor inverse agonist	HRH1	CHEMBL231	urticaria	EFO:0005531	3	INVERSE AGONIST
BILASTINE	Histamine H1 receptor inverse agonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	2	INVERSE AGONIST
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ovarian neoplasm	EFO:0003893	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	carcinoid tumor	EFO:0004243	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	metastatic melanoma	EFO:0002617	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ovarian carcinoma	EFO:0001075	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pathological myopia	EFO:0004207	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	cutaneous melanoma	EFO:0000389	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal carcinoma	EFO:1001951	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	bladder carcinoma	EFO:0000292	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	ovarian carcinoma	EFO:0001075	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	rectum cancer	EFO:1000657	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	leukemia	EFO:0000565	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	retinal vein occlusion	EFO:1001157	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	oligoastrocytoma	EFO:0000630	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	urethral neoplasm	EFO:0003846	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	hemorrhage	MP:0001914	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	histoplasmosis	EFO:0007310	1	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	lymphoma	EFO:0000574	1	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	multiple myeloma	EFO:0001378	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal neoplasm	EFO:0004142	4	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	oligoastrocytoma	EFO:0000630	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	diabetic retinopathy	EFO:0003770	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	breast carcinoma	EFO:0000305	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pancreatic neoplasm	EFO:0003860	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinopathy	EFO:0003839	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	renal cell carcinoma	EFO:0000681	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	Retinitis pigmentosa	Orphanet:791	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	gliosarcoma	EFO:1001465	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	histoplasmosis	EFO:0007310	1	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ocular vascular disease	EFO:0005753	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	melanoma	EFO:0000756	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	renal cell carcinoma	EFO:0000681	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	age-related macular degeneration	EFO:0001365	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	endometrial carcinoma	EFO:1001512	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	colorectal carcinoma	EFO:1001951	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	bladder carcinoma	EFO:0000292	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Pseudoxanthoma elasticum	Orphanet:758	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	glaucoma	EFO:0000516	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	neovascular glaucoma	EFO:1001060	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	lung carcinoma	EFO:0001071	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	corneal neovascularization	EFO:1000880	1	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	multiple myeloma	EFO:0001378	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	colorectal neoplasm	EFO:0004142	4	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	ureteral neoplasm	EFO:0003844	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal vein occlusion	EFO:1001157	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lung carcinoma	EFO:0001071	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	endometrial carcinoma	EFO:1001512	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	carcinoid tumor	EFO:0004243	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	retinopathy	EFO:0003839	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	lymphoma	EFO:0000574	1	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	leukemia	EFO:0000565	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	breast carcinoma	EFO:0000305	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	melanoma	EFO:0000756	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	rectum cancer	EFO:1000657	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	Pseudoxanthoma elasticum	Orphanet:758	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetic retinopathy	EFO:0003770	4	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	pathological myopia	EFO:0004207	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	cutaneous melanoma	EFO:0000389	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	ovarian neoplasm	EFO:0003893	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	ureteral neoplasm	EFO:0003844	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	hemorrhage	MP:0001914	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	glaucoma	EFO:0000516	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	metastatic melanoma	EFO:0002617	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	urethral neoplasm	EFO:0003846	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	Retinitis pigmentosa	Orphanet:791	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	gliosarcoma	EFO:1001465	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	ocular vascular disease	EFO:0005753	4	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	pancreatic neoplasm	EFO:0003860	3	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
AFLIBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	neovascular glaucoma	EFO:1001060	3	INHIBITOR
AFLIBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	corneal neovascularization	EFO:1000880	1	INHIBITOR
CARLUMAB	C-C motif chemokine 2 inhibitor	CCL2	CHEMBL1649052	prostate carcinoma	EFO:0001663	2	INHIBITOR
CARLUMAB	C-C motif chemokine 2 inhibitor	CCL2	CHEMBL1649052	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	head and neck squamous cell carcinoma	EFO:0000181	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	Ewing sarcoma	EFO:0000174	1	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	melanoma	EFO:0000756	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	embryonal rhabdomyosarcoma	EFO:0000437	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	adrenocortical carcinoma	EFO:0003093	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	hepatocellular carcinoma	EFO:0000182	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	male breast carcinoma	EFO:0006861	1	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	colorectal carcinoma	EFO:1001951	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	mesothelioma	EFO:0000588	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	pancreatic carcinoma	EFO:0002618	1	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	osteosarcoma	EFO:0000637	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	prostate adenocarcinoma	EFO:0000673	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	large cell lung carcinoma	EFO:0003050	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	lung carcinoma	EFO:0001071	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	alveolar rhabdomyosarcoma	EFO:0000248	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	head and neck malignant neoplasia	EFO:0006859	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	prostate carcinoma	EFO:0001663	2	ANTAGONIST
CIXUTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	small cell lung carcinoma	EFO:0000702	2	ANTAGONIST
CRENEZUMAB	Beta amyloid A4 protein inhibitor	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	3	INHIBITOR
DACETUZUMAB	Tumor necrosis factor receptor superfamily member 5 inhibitor	CD40	CHEMBL1250358	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DACETUZUMAB	Tumor necrosis factor receptor superfamily member 5 inhibitor	CD40	CHEMBL1250358	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DACETUZUMAB	Tumor necrosis factor receptor superfamily member 5 inhibitor	CD40	CHEMBL1250358	multiple myeloma	EFO:0001378	1	INHIBITOR
DACETUZUMAB	Tumor necrosis factor receptor superfamily member 5 inhibitor	CD40	CHEMBL1250358	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	lung carcinoma	EFO:0001071	2	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	multiple myeloma	EFO:0001378	1	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	rectum cancer	EFO:1000657	2	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	colorectal carcinoma	EFO:1001951	1	ANTAGONIST
DALOTUZUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast neoplasm	EFO:0003869	2	ANTAGONIST
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	macroglobulinemia	EFO:0002616	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	AL amyloidosis	Orphanet:85443	1	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	amyloidosis	EFO:1001875	3	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	multiple myeloma	EFO:0001378	4	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	prostate carcinoma	EFO:0001663	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	lymphoma	EFO:0000574	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	monoclonal gammopathy	EFO:0000203	2	INHIBITOR
DARATUMUMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
FARLETUZUMAB	Folate receptor alpha inhibitor	FOLR1	CHEMBL2121	ovarian carcinoma	EFO:0001075	3	INHIBITOR
FARLETUZUMAB	Folate receptor alpha inhibitor	FOLR1	CHEMBL2121	adenoma	EFO:0000232	2	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	squamous cell carcinoma	EFO:0000707	1	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
FICLATUZUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	3	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	colorectal neoplasm	EFO:0004142	2	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	large cell lung carcinoma	EFO:0003050	3	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	lung carcinoma	EFO:0001071	1	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	Ewing sarcoma	EFO:0000174	1	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	sarcoma	EFO:0000691	1	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	head and neck malignant neoplasia	EFO:0006859	2	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast neoplasm	EFO:0003869	2	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	prostate adenocarcinoma	EFO:0000673	2	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	multiple myeloma	EFO:0001378	1	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	squamous cell carcinoma	EFO:0000707	3	ANTAGONIST
FIGITUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	small cell lung carcinoma	EFO:0000702	2	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	rhabdomyosarcoma	EFO:0002918	1	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	ovarian neoplasm	EFO:0003893	2	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	pancreatic carcinoma	EFO:0002618	1	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast neoplasm	EFO:0003869	2	ANTAGONIST
GANITUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	small cell lung carcinoma	EFO:0000702	1	ANTAGONIST
GANTENERUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	3	OTHER
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	pyoderma	HP:0000999	3	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	type I diabetes mellitus	EFO:0001359	2	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	type II diabetes mellitus	EFO:0001360	2	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	rheumatoid arthritis	EFO:0000685	2	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	uveitis	EFO:1001231	3	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	Behcet's syndrome	EFO:0003780	3	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	acne	EFO:0003894	2	NEGATIVE ALLOSTERIC MODULATOR
GEVOKIZUMAB	Interleukin-1 beta negative allosteric modulator	IL1B	CHEMBL1909490	osteoarthritis	EFO:0002506	2	NEGATIVE ALLOSTERIC MODULATOR
GIRENTUXIMAB	Carbonic anhydrase IX other	CA9	CHEMBL3594	clear cell renal carcinoma	EFO:0000349	3	OTHER
GIRENTUXIMAB	Carbonic anhydrase IX other	CA9	CHEMBL3594	renal carcinoma	EFO:0002890	3	OTHER
ICRUCUMAB	Vascular endothelial growth factor receptor 1 antagonist	FLT1	CHEMBL1868	breast carcinoma	EFO:0000305	2	ANTAGONIST
LUCATUMUMAB	Tumor necrosis factor receptor superfamily member 5 antagonist	CD40	CHEMBL1250358	non-Hodgkins lymphoma	EFO:0005952	1	ANTAGONIST
LUCATUMUMAB	Tumor necrosis factor receptor superfamily member 5 antagonist	CD40	CHEMBL1250358	Hodgkins lymphoma	EFO:0000183	1	ANTAGONIST
LUCATUMUMAB	Tumor necrosis factor receptor superfamily member 5 antagonist	CD40	CHEMBL1250358	chronic lymphocytic leukemia	EFO:0000095	1	ANTAGONIST
LUCATUMUMAB	Tumor necrosis factor receptor superfamily member 5 antagonist	CD40	CHEMBL1250358	multiple myeloma	EFO:0001378	2	ANTAGONIST
LUCATUMUMAB	Tumor necrosis factor receptor superfamily member 5 antagonist	CD40	CHEMBL1250358	neoplasm of mature B-cells	EFO:0000096	1	ANTAGONIST
MILATUZUMAB	HLA-DR antigens-associated invariant chain antagonist	CD74	CHEMBL4692	lymphoma	EFO:0000574	1	ANTAGONIST
MILATUZUMAB	HLA-DR antigens-associated invariant chain antagonist	CD74	CHEMBL4692	plasmacytoma	EFO:0006738	1	ANTAGONIST
MILATUZUMAB	HLA-DR antigens-associated invariant chain antagonist	CD74	CHEMBL4692	multiple myeloma	EFO:0001378	1	ANTAGONIST
MILATUZUMAB	HLA-DR antigens-associated invariant chain antagonist	CD74	CHEMBL4692	chronic lymphocytic leukemia	EFO:0000095	1	ANTAGONIST
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	hepatocellular carcinoma	EFO:0000182	1	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	Cutaneous T-cell lymphoma	EFO:0002913	3	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	T-cell acute lymphoblastic leukemia	EFO:0000209	2	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	carcinoma	EFO:0000313	1	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	asthma	EFO:0000270	1	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	unspecified peripheral T-cell lymphoma	EFO:0000211	2	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	Human T-lymphotropic virus 1 infectious disease	EFO:0007316	3	CROSS-LINKING AGENT
MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CCR4	CHEMBL2414	non-small cell lung carcinoma	EFO:0003060	1	CROSS-LINKING AGENT
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	non-Hodgkins lymphoma	EFO:0005952	1	OTHER
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	leukemia	EFO:0000565	1	OTHER
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	acute lymphoblastic leukemia	EFO:0000220	2	OTHER
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	lymphoma	EFO:0000574	1	OTHER
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	hairy cell leukemia	EFO:1000956	3	OTHER
MOXETUMOMAB PASUDOTOX	CD22 other	CD22	CHEMBL3218	B-cell acute lymphoblastic leukemia	EFO:0000094	2	OTHER
NECITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
NECITUMUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	1	INHIBITOR
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	sarcoma	EFO:0000691	4	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	ovarian neoplasm	EFO:0003893	2	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	glioblastoma multiforme	EFO:0000519	2	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	pancreatic carcinoma	EFO:0002618	1	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	Gastrointestinal stromal tumor	Orphanet:44890	2	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	leiomyosarcoma	EFO:0000564	1	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	prostate carcinoma	EFO:0001663	2	ANTAGONIST
OLARATUMAB	Platelet-derived growth factor receptor alpha antagonist	PDGFRA	CHEMBL2007	soft tissue sarcoma	EFO:1001968	4	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	breast carcinoma	EFO:0000305	2	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	hepatocellular carcinoma	EFO:0000182	1	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	glioblastoma multiforme	EFO:0000519	2	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	colorectal carcinoma	EFO:1001951	2	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	3	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	3	ANTAGONIST
ONARTUZUMAB	Hepatocyte growth factor receptor antagonist	MET	CHEMBL3717	lung carcinoma	EFO:0001071	1	ANTAGONIST
OZORALIZUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
PEGSUNERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
PONEZUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	cerebral amyloid angiopathy	EFO:0006790	2	OTHER
PONEZUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	2	OTHER
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	cutaneous melanoma	EFO:0000389	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	central nervous system cancer	EFO:0000326	1	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	melanoma	EFO:0000756	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	carcinoma	EFO:0000313	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	stomach neoplasm	EFO:0003897	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast carcinoma	EFO:0000305	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	carcinoid tumor	EFO:0004243	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	prostate carcinoma	EFO:0001663	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	esophageal carcinoma	EFO:0002916	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	adenocarcinoma	EFO:0000228	2	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal carcinoma	EFO:1001951	3	INHIBITOR
RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	3	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	prostate carcinoma	EFO:0001663	1	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	mesothelioma	EFO:0000588	2	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	gliosarcoma	EFO:1001465	2	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	central nervous system cancer	EFO:0000326	2	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	gastric carcinoma	EFO:0000178	3	INHIBITOR
RILOTUMUMAB	Hepatocyte growth factor inhibitor	HGF	CHEMBL5479	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ROBATUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	colorectal carcinoma	EFO:1001951	2	ANTAGONIST
SOLANEZUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	3	OTHER
TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	sarcoma	EFO:0000691	2	ANTAGONIST
TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	Graves ophthalmopathy	EFO:1001466	3	ANTAGONIST
TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	ANTAGONIST
TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	diabetic retinopathy	EFO:0003770	1	ANTAGONIST
TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	2	INHIBITOR
TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	4	INHIBITOR
TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	4	INHIBITOR
TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DYPHYLLINE	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	obstructive lung disease	HP:0006536	4	INHIBITOR
CONIVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	liver disease	EFO:0001421	1	ANTAGONIST
CONIVAPTAN	Vasopressin V1a receptor antagonist	AVPR1A	CHEMBL1889	liver disease	EFO:0001421	1	ANTAGONIST
CONIVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Hyponatremia	HP:0002902	3	ANTAGONIST
CONIVAPTAN	Vasopressin V1a receptor antagonist	AVPR1A	CHEMBL1889	Hyponatremia	HP:0002902	3	ANTAGONIST
ESTRAMUSTINE PHOSPHATE	Estrogen receptor beta modulator	ESR2	CHEMBL242	prostate carcinoma	EFO:0001663	3	MODULATOR
ESTRAMUSTINE PHOSPHATE	Estrogen receptor beta modulator	ESR2	CHEMBL242	prostate adenocarcinoma	EFO:0000673	3	MODULATOR
ESTRAMUSTINE PHOSPHATE	Estrogen receptor beta modulator	ESR2	CHEMBL242	renal carcinoma	EFO:0002890	2	MODULATOR
ESTRAMUSTINE PHOSPHATE	Estrogen receptor beta modulator	ESR2	CHEMBL242	breast carcinoma	EFO:0000305	2	MODULATOR
ESTRAMUSTINE PHOSPHATE	Estrogen receptor beta modulator	ESR2	CHEMBL242	lymphoma	EFO:0000574	2	MODULATOR
TERBUTALINE	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	pancreatic carcinoma	EFO:0002618	1	ANTAGONIST
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	lymphoid neoplasm	EFO:0001642	1	ANTAGONIST
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	liver disease	EFO:0001421	1	ANTAGONIST
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	Alport syndrome	Orphanet:63	2	ANTAGONIST
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	diabetic nephropathy	EFO:0000401	2	INHIBITOR
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	Alport syndrome	Orphanet:63	2	INHIBITOR
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	melanoma	EFO:0000756	2	ANTAGONIST
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	pulmonary hypertension	EFO:0001361	3	INHIBITOR
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	liver disease	EFO:0001421	1	INHIBITOR
BARDOXOLONE METHYL	Peroxisome proliferator-activated receptor gamma antagonist	PPARG	CHEMBL235	pulmonary hypertension	EFO:0001361	3	ANTAGONIST
BARDOXOLONE METHYL	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	melanoma	EFO:0000756	2	INHIBITOR
DESOXIMETASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	3	AGONIST
ERTUGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	intermediate coronary syndrome	EFO:1000985	4	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	breast neoplasm	EFO:0003869	2	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	ischemia	EFO:0000556	4	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	acute coronary syndrome	EFO:0005672	4	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	coronary artery disease	EFO:0000378	1	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	stroke	EFO:0000712	4	ANTAGONIST
CLOPIDOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	myocardial infarction	EFO:0000612	4	ANTAGONIST
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	melanoma	EFO:0000756	1	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	breast carcinoma	EFO:0000305	4	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal cancer	EFO:0005842	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	esophageal carcinoma	EFO:0002916	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	adenocarcinoma	EFO:0000228	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	ovarian carcinoma	EFO:0001075	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	stomach neoplasm	EFO:0003897	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colon carcinoma	EFO:1001950	4	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	nasopharyngeal neoplasm	EFO:0004252	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	central nervous system cancer	EFO:0000326	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	carcinoma	EFO:0000313	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	cervical carcinoma	EFO:0001061	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	mesothelioma	EFO:0000588	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	lymphoma	EFO:0000574	1	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	cholangiocarcinoma	EFO:0005221	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	anal neoplasm	EFO:0003835	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	breast neoplasm	EFO:0003869	4	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic neuroendocrine tumor	EFO:1000045	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric carcinoma	EFO:0000178	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colonic neoplasm	EFO:0004288	4	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	Merkel cell skin cancer	EFO:1001471	1	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	glioma	EFO:0005543	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal neoplasm	EFO:0004142	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	rectum cancer	EFO:1000657	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	prostate carcinoma	EFO:0001663	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	kidney neoplasm	EFO:0003865	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	renal carcinoma	EFO:0002890	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	thyroid carcinoma	EFO:0002892	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	neuroendocrine neoplasm	EFO:1001901	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	brain disease	EFO:0005774	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	male breast carcinoma	EFO:0006861	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	lung carcinoma	EFO:0001071	2	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal carcinoma	EFO:1001951	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	renal cell carcinoma	EFO:0000681	3	INHIBITOR
CAPECITABINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic neoplasm	EFO:0003860	3	INHIBITOR
TARAFENACIN	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	2	ANTAGONIST
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myeloproliferative disorder	EFO:0004251	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloblastic leukemia without maturation	EFO:0003027	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	2	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	sarcoma	EFO:0000691	1	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	4	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast carcinoma	EFO:0000305	1	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute megakaryoblastic leukaemia	EFO:0003025	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	refractory anemia	EFO:0003802	2	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myelomonocytic leukemia	EFO:0000223	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myelodysplastic syndrome	EFO:0000198	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute basophilic leukemia	EFO:0003029	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute monocytic leukemia	EFO:0000221	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoma	EFO:0000574	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoma	EFO:0000574	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	sarcoma	EFO:0000691	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	hepatitis B infection	EFO:0004197	3	INHIBITOR
DAUNORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myeloid sarcoma	EFO:1001052	3	INHIBITOR
AZD7325	GABA receptor alpha-3 subunit positive allosteric modulator	GABRA3	CHEMBL3026	Fragile X syndrome	Orphanet:908	1	POSITIVE ALLOSTERIC MODULATOR
AZD7325	GABA receptor alpha-2 subunit positive allosteric modulator	GABRA2	CHEMBL4956	Fragile X syndrome	Orphanet:908	1	POSITIVE ALLOSTERIC MODULATOR
RUXOLITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	breast carcinoma	EFO:0000305	1	INHIBITOR
RUXOLITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	4	INHIBITOR
RUXOLITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	polycythemia vera	EFO:0002429	4	INHIBITOR
RUXOLITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	breast carcinoma	EFO:0000305	1	INHIBITOR
RUXOLITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	polycythemia vera	EFO:0002429	4	INHIBITOR
RUXOLITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	primary myelofibrosis	EFO:0002430	4	INHIBITOR
RANITIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastroesophageal reflux disease	EFO:0003948	4	ANTAGONIST
RANITIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	Peptic ulcer	HP:0004398	4	ANTAGONIST
RANITIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	HIV infection	EFO:0000764	2	ANTAGONIST
ZICONOTIDE ACETATE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	pain	EFO:0003843	4	BLOCKER
ZICONOTIDE ACETATE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	fever	HP:0001945	4	BLOCKER
RELUGOLIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	endometriosis	EFO:0001065	2	ANTAGONIST
RELUGOLIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	ANTAGONIST
RELUGOLIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	uterine fibroid	EFO:0000731	3	ANTAGONIST
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	3	INHIBITOR
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	carcinoma	EFO:0000313	1	INHIBITOR
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	1	INHIBITOR
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	3	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	3	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	colorectal carcinoma	EFO:1001951	1	INHIBITOR
NERATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	carcinoma	EFO:0000313	1	INHIBITOR
NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	3	INHIBITOR
ANACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	familial hypercholesterolemia	EFO:0004911	3	INHIBITOR
ANACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	Homozygous familial hypercholesterolemia	Orphanet:391665	3	INHIBITOR
ANACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	coronary heart disease	EFO:0001645	3	INHIBITOR
ANACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	hypercholesterolemia	HP:0003124	3	INHIBITOR
ANACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
ESREBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	fibromyalgia	EFO:0005687	3	INHIBITOR
ESREBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	diabetic neuropathy	EFO:1000783	2	INHIBITOR
ESREBOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	2	INHIBITOR
AZD-8055	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AZD-8055	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
AZD-8055	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
AZD-8055	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
AZD-8055	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	1	INHIBITOR
BEXAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
BEXAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetes mellitus	EFO:0000400	3	INHIBITOR
BEXAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
BEXAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetes mellitus	EFO:0000400	3	INHIBITOR
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	obesity	EFO:0001073	2	OPENER
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	type II diabetes mellitus	EFO:0001360	2	OPENER
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	Hypertriglyceridemia	EFO:0004211	2	OPENER
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	Hypoglycemia	HP:0001943	4	OPENER
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	Prader-Willi syndrome	Orphanet:739	2	OPENER
DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	KCNJ11	CHEMBL1886	hypertension	EFO:0000537	4	OPENER
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Rett syndrome	Orphanet:778	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Parkinson's disease	EFO:0002508	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	metabolic disease	EFO:0000589	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	noise-induced hearing loss	EFO:1001254	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Mitochondrial disease	Orphanet:68380	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Leigh syndrome	Orphanet:506	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Friedreich ataxia	Orphanet:95	2	MODULATOR
VATIQUINONE	Quinone reductase 1) modulator	NQO1	CHEMBL3623	Tourette syndrome	EFO:0004895	1	MODULATOR
SELEPRESSIN	Vasopressin V1a receptor agonist	AVPR1A	CHEMBL1889	septic shock	EFO:0006834	2	AGONIST
NAVEGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	2	AGONIST
NAVEGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	2	AGONIST
CE-224535	P2X purinoceptor 7 antagonist	P2RX7	CHEMBL4805	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
CE-224535	P2X purinoceptor 7 antagonist	P2RX7	CHEMBL4805	osteoarthritis	EFO:0002506	2	ANTAGONIST
FASIGLIFAM	Free fatty acid receptor 1 positive allosteric modulator	FFAR1	CHEMBL4422	type II diabetes mellitus	EFO:0001360	3	POSITIVE ALLOSTERIC MODULATOR
FASIGLIFAM	Free fatty acid receptor 1 positive allosteric modulator	FFAR1	CHEMBL4422	diabetes mellitus	EFO:0000400	3	POSITIVE ALLOSTERIC MODULATOR
APRICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	breast carcinoma	EFO:0000305	2	INHIBITOR
APRICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
APRICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DRONEDARONE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	HCN4	CHEMBL1250417	atrial fibrillation	EFO:0000275	4	BLOCKER
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	multiple myeloma	EFO:0001378	4	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	acute myeloid leukemia	EFO:0000222	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Chronic granulomatous disease	Orphanet:379	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	diabetic foot	EFO:1001459	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	chronic lymphocytic leukemia	EFO:0000095	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Mantle cell lymphoma	EFO:1001469	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Hodgkins lymphoma	EFO:0000183	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	myelodysplastic syndrome	EFO:0000198	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	gliosarcoma	EFO:1001465	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	non-Hodgkins lymphoma	EFO:0005952	4	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	type I diabetes mellitus	EFO:0001359	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Thalassemia	EFO:1001996	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	leukemia	EFO:0000565	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	diffuse large B-cell lymphoma	EFO:0000403	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	acute graft vs. host disease	EFO:0004599	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Sickle cell anemia	Orphanet:232	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	lymphoid neoplasm	EFO:0001642	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	pancreatic carcinoma	EFO:0002618	1	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	acute lymphoblastic leukemia	EFO:0000220	4	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	Fanconi anemia	Orphanet:84	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	lymphoma	EFO:0000574	2	PARTIAL AGONIST
PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	CXCR4	CHEMBL2107	systemic scleroderma	EFO:0000717	2	PARTIAL AGONIST
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	esophageal carcinoma	EFO:0002916	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	multiple myeloma	EFO:0001378	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic neoplasm	EFO:0003860	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gallbladder neoplasm	EFO:0004606	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	adenocarcinoma	EFO:0000228	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	ependymoma	EFO:1000028	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colonic neoplasm	EFO:0004288	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	breast carcinoma	EFO:0000305	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric carcinoma	EFO:0000178	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	upper aerodigestive tract neoplasm	EFO:0004284	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	stomach neoplasm	EFO:0003897	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	rectum cancer	EFO:1000657	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	uterine neoplasm	EFO:0003859	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colon carcinoma	EFO:1001950	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	renal carcinoma	EFO:0002890	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	carcinoma	EFO:0000313	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	bladder carcinoma	EFO:0000292	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	proliferative vitreoretinopathy	EFO:1001129	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	skin neoplasm	EFO:0004198	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	anal neoplasm	EFO:0003835	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	nasopharyngeal neoplasm	EFO:0004252	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	Merkel cell skin cancer	EFO:1001471	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	leukemia	EFO:0000565	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal neoplasm	EFO:0004142	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	renal cell carcinoma	EFO:0000681	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	breast neoplasm	EFO:0003869	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	esophageal squamous cell carcinoma	EFO:0005922	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	Lymphoma, AIDS-Related	EFO:1001365	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	Hepatoblastoma	EFO:1000292	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	urethral neoplasm	EFO:0003846	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	peripheral neuropathy	EFO:0003100	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal cancer	EFO:0005842	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	cervical carcinoma	EFO:0001061	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	laryngeal neoplasm	EFO:0003817	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	glaucoma	EFO:0000516	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	lymphoma	EFO:0000574	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	ovarian carcinoma	EFO:0001075	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	melanoma	EFO:0000756	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	biliary tract neoplasm	EFO:0003891	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	dysplasia of cervix	EFO:1000910	1	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
FLUOROURACIL	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	bile duct carcinoma	EFO:0005540	2	INHIBITOR
MURAGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	3	AGONIST
MURAGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	diabetes mellitus	EFO:0000400	3	AGONIST
MURAGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Disorder of lipid metabolism	Orphanet:309005	2	AGONIST
MURAGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	diabetes mellitus	EFO:0000400	3	AGONIST
MURAGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	3	AGONIST
MURAGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	2	AGONIST
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	carcinoid tumor	EFO:0004243	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	cutaneous melanoma	EFO:0000389	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	food allergy	EFO:1001890	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	lymphoid leukemia	EFO:0004289	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	leukemia	EFO:0000565	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	Mantle cell lymphoma	EFO:1001469	4	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	macroglobulinemia	EFO:0002616	4	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	colon carcinoma	EFO:1001950	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	melanoma	EFO:0000756	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	metastatic melanoma	EFO:0002617	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	chronic lymphocytic leukemia	EFO:0000095	4	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	prostate carcinoma	EFO:0001663	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	amyloidosis	EFO:1001875	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	multiple myeloma	EFO:0001378	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	lymphoma	EFO:0000574	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	lung carcinoma	EFO:0001071	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	liver disease	EFO:0001421	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	breast neoplasm	EFO:0003869	1	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	Burkitts lymphoma	EFO:0000309	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	hairy cell leukemia	EFO:1000956	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	esophageal carcinoma	EFO:0002916	2	INHIBITOR
IBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	renal cell carcinoma	EFO:0000681	1	INHIBITOR
DACTOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	renal carcinoma	EFO:0002890	1	INHIBITOR
DACTOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	2	INHIBITOR
DACTOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	1	INHIBITOR
DACTOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	Transitional Cell Carcinoma	EFO:1000601	2	INHIBITOR
DACTOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
TROSPIUM	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	overactive bladder	EFO:1000781	4	ANTAGONIST
TROSPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
TROSPIUM	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
TROSPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	overactive bladder	EFO:1000781	4	ANTAGONIST
LADARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	type I diabetes mellitus	EFO:0001359	2	MODULATOR
LADARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	type I diabetes mellitus	EFO:0001359	2	MODULATOR
LADARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	bullous pemphigoid	EFO:0007187	2	MODULATOR
LADARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	bullous pemphigoid	EFO:0007187	2	MODULATOR
SURINABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	obesity	EFO:0001073	2	ANTAGONIST
METHAZOLAMIDE	Carbonic anhydrase VII inhibitor	CA7	CHEMBL2326	altitude sickness	EFO:1000782	1	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase VII inhibitor	CA7	CHEMBL2326	glaucoma	EFO:0000516	4	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	cervical carcinoma	EFO:0001061	2	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	cervical carcinoma	EFO:0001061	2	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	glaucoma	EFO:0000516	4	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase VII inhibitor	CA7	CHEMBL2326	cervical carcinoma	EFO:0001061	2	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	altitude sickness	EFO:1000782	1	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	cervical carcinoma	EFO:0001061	2	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	4	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	glaucoma	EFO:0000516	4	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	altitude sickness	EFO:1000782	1	INHIBITOR
METHAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	altitude sickness	EFO:1000782	1	INHIBITOR
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic bronchitis	EFO:0006505	4	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	3	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	emphysema	EFO:0000464	4	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	4	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Spinal cord injury	EFO:1001919	2	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Cystic fibrosis	Orphanet:586	3	ANTAGONIST
TIOTROPIUM	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	obstructive lung disease	HP:0006536	4	ANTAGONIST
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	cocaine dependence	EFO:0002610	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Huntington disease	Orphanet:399	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Seizures	HP:0001250	3	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Childhood absence epilepsy	Orphanet:64280	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	epilepsy	EFO:0000474	3	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	pain	EFO:0003843	3	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Dravet syndrome	Orphanet:33069	3	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	acute graft vs. host disease	EFO:0004599	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	West syndrome	Orphanet:3451	3	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	nicotine dependence	EFO:0003768	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	lung carcinoma	EFO:0001071	1	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Hepatic steatosis	HP:0001397	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	marijuana dependence	EFO:0004218	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Sturge-Weber syndrome	Orphanet:3205	1	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	ulcerative colitis	EFO:0000729	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Prader-Willi syndrome	Orphanet:739	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Parkinson's disease	EFO:0002508	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	Crohn's disease	EFO:0000384	1	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	opioid dependence	EFO:0005611	2	NEGATIVE ALLOSTERIC MODULATOR
CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	CNR1	CHEMBL218	amyotrophic lateral sclerosis	EFO:0000253	2	NEGATIVE ALLOSTERIC MODULATOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	cervical carcinoma	EFO:0001061	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Transitional Cell Carcinoma	EFO:1000601	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Tuberous sclerosis	Orphanet:805	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	uveitis	EFO:1001231	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Malignant epithelial tumor of ovary	Orphanet:398934	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chondrosarcoma	EFO:0000333	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	bladder carcinoma	EFO:0000292	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Autosomal dominant polycystic kidney disease	EFO:1001496	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	ependymoma	EFO:1000028	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	peritoneal neoplasm	EFO:1001100	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	multiple myeloma	EFO:0001378	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Peutz-Jeghers syndrome	Orphanet:2869	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	brain neoplasm	EFO:0003833	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	gastric carcinoma	EFO:0000178	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	osteosarcoma	EFO:0000637	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lymphoid leukemia	EFO:0004289	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	uterine neoplasm	EFO:0003859	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	glioma	EFO:0005543	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	fibroma	EFO:0002424	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Lymphangioleiomyomatosis	Orphanet:538	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	oligoastrocytoma	EFO:0000630	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	germ cell tumor	EFO:0000514	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	breast carcinoma	EFO:0000305	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	islet cell tumor	EFO:0007331	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	marginal zone B-cell lymphoma	EFO:1000630	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Meningioma	Orphanet:2495	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lymphoma	EFO:0000574	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Hutchinson-Gilford progeria syndrome	Orphanet:740	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	astrocytoma	EFO:0000272	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	thyroid carcinoma	EFO:0002892	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Neurofibromatosis type 2	Orphanet:637	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	renal carcinoma	EFO:0002890	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	sarcoma	EFO:0000691	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Fallopian Tube Carcinoma	EFO:1000251	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hepatitis C infection	EFO:0003047	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute coronary syndrome	EFO:0005672	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic kidney disease	EFO:0003884	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	stomach neoplasm	EFO:0003897	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	renal cell carcinoma	EFO:0000681	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	anaplastic astrocytoma	EFO:0002499	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	infection	EFO:0000544	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pulmonary neuroendocrine tumor	EFO:0005220	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	prostate carcinoma	EFO:0001663	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	coronary stenosis	EFO:1000882	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	PTEN hamartoma tumor syndrome	Orphanet:306498	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	age-related macular degeneration	EFO:0001365	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	skin neoplasm	EFO:0004198	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	metastatic melanoma	EFO:0002617	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	cutaneous melanoma	EFO:0000389	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	oligodendroglioma	EFO:0000632	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	central nervous system cancer	EFO:0000326	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Cutaneous T-cell lymphoma	EFO:0002913	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Coronary Restenosis	EFO:0004224	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	male breast carcinoma	EFO:0006861	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	kidney disease	EFO:0003086	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	colorectal carcinoma	EFO:1001951	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	leukemia	EFO:0000565	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	synovial sarcoma	EFO:0001376	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	epilepsy	EFO:0000474	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	ovarian carcinoma	EFO:0001075	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	urogenital neoplasm	EFO:0003863	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	carcinoid syndrome	EFO:1000852	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Tuberculosis	Orphanet:3389	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	breast neoplasm	EFO:0003869	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pancreatic neuroendocrine tumor	EFO:1000045	4	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	adenocarcinoma	EFO:0000228	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	melanoma	EFO:0000756	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	esophageal carcinoma	EFO:0002916	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	carcinoma	EFO:0000313	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	mesothelioma	EFO:0000588	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	colon carcinoma	EFO:1001950	1	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	macroglobulinemia	EFO:0002616	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	cytomegalovirus infection	EFO:0001062	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lung carcinoma	EFO:0001071	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	coronary artery disease	EFO:0000378	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	endometrial neoplasm	EFO:0004230	2	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
EVEROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	thymus neoplasm	EFO:0002626	2	INHIBITOR
ONAPRISTONE	Progesterone receptor antagonist	PGR	CHEMBL208	metastatic prostate cancer	EFO:0000196	1	ANTAGONIST
SEOCALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	hepatocellular carcinoma	EFO:0000182	3	AGONIST
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	3	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	psoriasis	EFO:0000676	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple sclerosis	EFO:0003885	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	metastatic melanoma	EFO:0002617	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic progressive multiple sclerosis	EFO:0003840	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian carcinoma	EFO:0001075	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	amyotrophic lateral sclerosis	EFO:0000253	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Alzheimers disease	EFO:0000249	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	multiple sclerosis	EFO:0003885	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	Alzheimers disease	EFO:0000249	2	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	asthma	EFO:0000270	3	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	ovarian carcinoma	EFO:0001075	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	multiple myeloma	EFO:0001378	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	amyotrophic lateral sclerosis	EFO:0000253	3	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	metastatic melanoma	EFO:0002617	3	INHIBITOR
MASITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	psoriasis	EFO:0000676	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	chronic progressive multiple sclerosis	EFO:0003840	2	INHIBITOR
MASITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	asthma	EFO:0000270	3	INHIBITOR
GSK-461364	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
KW-2449	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
KW-2449	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
KW-2449	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
KW-2449	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
IDRAPARINUX	Coagulation factor X inhibitor	F10	CHEMBL244	deep vein thrombosis	EFO:0003907	3	INHIBITOR
IDRAPARINUX	Coagulation factor X inhibitor	F10	CHEMBL244	atrial fibrillation	EFO:0000275	3	INHIBITOR
IDRAPARINUX	Coagulation factor X inhibitor	F10	CHEMBL244	pulmonary embolism	EFO:0003827	3	INHIBITOR
LOSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
LOSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Marfan syndrome	Orphanet:558	3	ANTAGONIST
LOSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	Proteinuria	HP:0000093	3	ANTAGONIST
MK3207	Calcitonin gene-related peptide type 1 receptor antagonist	CALCRL	CHEMBL3798	migraine disorder	EFO:0003821	2	ANTAGONIST
REPARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	ischemia reperfusion injury	EFO:0002687	2	MODULATOR
REPARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	type I diabetes mellitus	EFO:0001359	3	MODULATOR
REPARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	breast carcinoma	EFO:0000305	2	MODULATOR
REPARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	ischemia reperfusion injury	EFO:0002687	2	MODULATOR
REPARIXIN	Interleukin-8 receptor A modulator	CXCR1	CHEMBL4029	chronic pancreatitis	EFO:0000342	2	MODULATOR
REPARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	chronic pancreatitis	EFO:0000342	2	MODULATOR
REPARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	breast carcinoma	EFO:0000305	2	MODULATOR
REPARIXIN	Interleukin-8 receptor B modulator	CXCR2	CHEMBL2434	type I diabetes mellitus	EFO:0001359	3	MODULATOR
AZD1981	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
AZD1981	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	infertility	EFO:0000545	1	ANTAGONIST
AZD1981	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	urticaria	EFO:0005531	2	ANTAGONIST
AZD1981	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
PF-03893787	Histamine H4 receptor antagonist	HRH4	CHEMBL3759	asthma	EFO:0000270	1	ANTAGONIST
PF-03893787	Histamine H4 receptor antagonist	HRH4	CHEMBL3759	psoriasis	EFO:0000676	2	ANTAGONIST
PF-03893787	Histamine H4 receptor antagonist	HRH4	CHEMBL3759	atopic eczema	EFO:0000274	2	ANTAGONIST
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	erectile dysfunction	EFO:0004234	3	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	pulmonary hypertension	EFO:0001361	3	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	age-related macular degeneration	EFO:0001365	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	preeclampsia	EFO:0000668	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	prostate carcinoma	EFO:0001663	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	obesity	EFO:0001073	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Nephroblastoma	Orphanet:654	1	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	hepatitis C infection	EFO:0003047	1	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	hypertension	EFO:0000537	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	stroke	EFO:0000712	1	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	macroglobulinemia	EFO:0002616	2	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	fetal growth restriction	EFO:0000495	3	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	heart failure	EFO:0003144	3	INHIBITOR
SILDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	infertility	EFO:0000545	2	INHIBITOR
ORTERONEL	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate carcinoma	EFO:0001663	3	INHIBITOR
ORTERONEL	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	breast carcinoma	EFO:0000305	2	INHIBITOR
ORTERONEL	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
APITOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	1	INHIBITOR
APITOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial carcinoma	EFO:1001512	2	INHIBITOR
APITOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
APITOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
APITOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FIBOFLAPON	5-lipoxygenase activating protein inhibitor	ALOX5AP	CHEMBL4550	asthma	EFO:0000270	2	INHIBITOR
FIBOFLAPON	5-lipoxygenase activating protein inhibitor	ALOX5AP	CHEMBL4550	Cystic fibrosis	Orphanet:586	2	INHIBITOR
FIBOFLAPON	5-lipoxygenase activating protein inhibitor	ALOX5AP	CHEMBL4550	asthma	EFO:0000270	2	INHIBITOR
FIBOFLAPON	5-lipoxygenase activating protein inhibitor	ALOX5AP	CHEMBL4550	HIV-Associated Lipodystrophy Syndrome	EFO:1001348	1	INHIBITOR
MOXONIDINE	Nischarin agonist	NISCH	CHEMBL3923	heart disease	EFO:0003777	3	AGONIST
MOXONIDINE	Nischarin agonist	NISCH	CHEMBL3923	hypertension	EFO:0000537	4	AGONIST
MK-0893	Glucagon receptor antagonist	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
PF-03715455	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	asthma	EFO:0000270	2	INHIBITOR
PF-03715455	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
MILVETEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
TG-02	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	gliosarcoma	EFO:1001465	1	INHIBITOR
TG-02	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gliosarcoma	EFO:1001465	1	INHIBITOR
TG-02	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	gliosarcoma	EFO:1001465	1	INHIBITOR
TG-02	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	gliosarcoma	EFO:1001465	1	INHIBITOR
TG-02	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	rectum cancer	EFO:1000657	1	INHIBITOR
TG-02	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
TG-02	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	gliosarcoma	EFO:1001465	1	INHIBITOR
TG-02	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TG-02	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	gliosarcoma	EFO:1001465	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	rectum cancer	EFO:1000657	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	age-related macular degeneration	EFO:0001365	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colon carcinoma	EFO:1001950	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	osteosarcoma	EFO:0000637	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	bile duct carcinoma	EFO:0005540	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	colorectal cancer	EFO:0005842	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	colorectal neoplasm	EFO:0004142	3	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	melanoma	EFO:0000756	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	renal cell carcinoma	EFO:0000681	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	angiosarcoma	EFO:0003968	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	esophageal carcinoma	EFO:0002916	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	urogenital neoplasm	EFO:0003863	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	ovarian carcinoma	EFO:0001075	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	ovarian neoplasm	EFO:0003893	2	INHIBITOR
REGORAFENIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	thyroid carcinoma	EFO:0002892	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	FRK	CHEMBL4223	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
REGORAFENIB	MAP kinase p38 beta inhibitor	MAPK11	CHEMBL3961	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
REGORAFENIB	Discoidin domain-containing receptor 2 inhibitor	DDR2	CHEMBL5122	liposarcoma	EFO:0000569	2	INHIBITOR
REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	carcinoma	EFO:0000313	2	INHIBITOR
REGORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	osteosarcoma	EFO:0000637	2	INHIBITOR
TANZISERTIB	c-Jun N-terminal kinase 3 inhibitor	MAPK10	CHEMBL2637	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
TANZISERTIB	c-Jun N-terminal kinase 2 inhibitor	MAPK9	CHEMBL4179	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
TANZISERTIB	c-Jun N-terminal kinase 1 inhibitor	MAPK8	CHEMBL2276	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
SONEDENOSON	Adenosine A2a receptor agonist	ADORA2A	CHEMBL251	diabetic foot	EFO:1001459	2	AGONIST
VIDUPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	asthma	EFO:0000270	2	ANTAGONIST
VIDUPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
AZD5672	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
ULIMORELIN	Ghrelin receptor agonist	GHSR	CHEMBL4616	gastroparesis	EFO:1000948	2	AGONIST
AVANAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	erectile dysfunction	EFO:0004234	4	INHIBITOR
TAFLUPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	ocular hypertension	EFO:1001069	4	AGONIST
TAFLUPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	open-angle glaucoma	EFO:0004190	4	AGONIST
TAFLUPROST	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	glaucoma	EFO:0000516	4	AGONIST
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	squamous cell carcinoma	EFO:0000707	1	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	lung carcinoma	EFO:0001071	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	prostate carcinoma	EFO:0001663	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	bladder carcinoma	EFO:0000292	1	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	glioblastoma multiforme	EFO:0000519	0	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	endometrioid carcinoma	EFO:0000466	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	ovarian carcinoma	EFO:0001075	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	breast carcinoma	EFO:0000305	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	lymphoma	EFO:0000574	1	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	sarcoma	EFO:0000691	2	INHIBITOR
AZD-1775	Serine/threonine-protein kinase WEE1 inhibitor	WEE1	CHEMBL5491	cervical carcinoma	EFO:0001061	1	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	venous thromboembolism	EFO:0004286	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	cirrhosis of liver	EFO:0001422	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	antiphospholipid syndrome	EFO:0002689	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	hemorrhage	MP:0001914	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	heart disease	EFO:0003777	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	pulmonary embolism	EFO:0003827	4	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Sickle cell anemia	Orphanet:232	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Venous thrombosis	HP:0004936	4	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	multiple myeloma	EFO:0001378	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	acute coronary syndrome	EFO:0005672	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	deep vein thrombosis	EFO:0003907	4	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	chronic kidney disease	EFO:0003884	1	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	rheumatic heart disease	EFO:1001161	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	stroke	EFO:0000712	3	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	ischemia	EFO:0000556	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial fibrillation	EFO:0000275	4	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	coronary artery disease	EFO:0000378	2	INHIBITOR
RIVAROXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
AUS-131	Estrogen receptor beta agonist	ESR2	CHEMBL242	Alzheimers disease	EFO:0000249	1	AGONIST
AUS-131	Estrogen receptor beta agonist	ESR2	CHEMBL242	benign prostatic hyperplasia	EFO:0000284	2	AGONIST
AUS-131	Estrogen receptor beta agonist	ESR2	CHEMBL242	breast carcinoma	EFO:0000305	0	AGONIST
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	central nervous system cancer	EFO:0000326	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	pseudotumor cerebri	EFO:1001132	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	pain	EFO:0003843	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	normal pressure hydrocephalus	EFO:1001065	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	stroke	EFO:0000712	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	multiple sclerosis	EFO:0003885	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	multiple sclerosis	EFO:0003885	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	Landau-Kleffner syndrome	EFO:1001010	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Landau-Kleffner syndrome	EFO:1001010	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	heart failure	EFO:0003144	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	central nervous system cancer	EFO:0000326	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	stroke	EFO:0000712	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	pain	EFO:0003843	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	kidney disease	EFO:0003086	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	central nervous system cancer	EFO:0000326	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	pseudotumor cerebri	EFO:1001132	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Cardiodysrhythmic potassium-sensitive periodic paralysis	Orphanet:37553	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	Cardiodysrhythmic potassium-sensitive periodic paralysis	Orphanet:37553	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	altitude sickness	EFO:1000782	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	normal pressure hydrocephalus	EFO:1001065	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	normal pressure hydrocephalus	EFO:1001065	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	multiple sclerosis	EFO:0003885	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	pain	EFO:0003843	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	central nervous system cancer	EFO:0000326	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	kidney disease	EFO:0003086	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	altitude sickness	EFO:1000782	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	cysticercosis	EFO:0007231	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	multiple sclerosis	EFO:0003885	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	cysticercosis	EFO:0007231	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	kidney disease	EFO:0003086	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	heart failure	EFO:0003144	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	pseudotumor cerebri	EFO:1001132	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Cardiodysrhythmic potassium-sensitive periodic paralysis	Orphanet:37553	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	altitude sickness	EFO:1000782	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	Landau-Kleffner syndrome	EFO:1001010	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	pseudotumor cerebri	EFO:1001132	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	kidney disease	EFO:0003086	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Landau-Kleffner syndrome	EFO:1001010	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	pulmonary hypertension	EFO:0001361	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	epilepsy	EFO:0000474	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	heart failure	EFO:0003144	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	normal pressure hydrocephalus	EFO:1001065	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	heart failure	EFO:0003144	3	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	cysticercosis	EFO:0007231	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	stroke	EFO:0000712	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	cysticercosis	EFO:0007231	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	CA1	CHEMBL261	stroke	EFO:0000712	2	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	altitude sickness	EFO:1000782	4	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	orthostatic hypotension	EFO:0005252	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	CA12	CHEMBL3242	Cardiodysrhythmic potassium-sensitive periodic paralysis	Orphanet:37553	1	INHIBITOR
ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	pain	EFO:0003843	2	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	colorectal carcinoma	EFO:1001951	2	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	prostate carcinoma	EFO:0001663	2	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	4	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	4	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	esophageal carcinoma	EFO:0002916	1	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	3	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	ovarian carcinoma	EFO:0001075	3	INHIBITOR
PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	male breast carcinoma	EFO:0006861	1	INHIBITOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	chronic bronchitis	EFO:0006505	2	POSITIVE MODULATOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	Primary ciliary dyskinesia	Orphanet:244	2	POSITIVE MODULATOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	sinusitis	EFO:0007486	0	POSITIVE MODULATOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	Cystic fibrosis	Orphanet:586	4	POSITIVE MODULATOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	liver disease	EFO:0001421	1	POSITIVE MODULATOR
IVACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	chronic obstructive pulmonary disease	EFO:0000341	0	POSITIVE MODULATOR
LY377604	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	obesity	EFO:0001073	2	ANTAGONIST
LY377604	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	obesity	EFO:0001073	2	AGONIST
LY377604	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	obesity	EFO:0001073	2	ANTAGONIST
VELNEPERIT	Neuropeptide Y receptor type 5 antagonist	NPY5R	CHEMBL4561	obesity	EFO:0001073	2	ANTAGONIST
EVACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	Disorder of lipid metabolism	Orphanet:309005	2	INHIBITOR
EVACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	hypercholesterolemia	HP:0003124	3	INHIBITOR
EVACETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	hyperlipidemia	EFO:0003774	3	INHIBITOR
R428	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
R428	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
R428	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
R428	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	melanoma	EFO:0000756	1	INHIBITOR
AZILSARTAN MEDOXOMIL	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	4	ANTAGONIST
DABRAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	4	INHIBITOR
DABRAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	metastatic melanoma	EFO:0002617	4	INHIBITOR
REMOGLIFLOZIN ETABONATE	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
ICATIBANT	Bradykinin B2 receptor antagonist	BDKRB2	CHEMBL3157	inflammation	MP:0001845	2	ANTAGONIST
ICATIBANT	Bradykinin B2 receptor antagonist	BDKRB2	CHEMBL3157	Hereditary angioedema	Orphanet:91378	4	ANTAGONIST
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	primary myelofibrosis	EFO:0002430	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	colorectal carcinoma	EFO:1001951	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	acute graft vs. host disease	EFO:0004599	1	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	myeloproliferative disorder	EFO:0004251	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	myeloproliferative disorder	EFO:0004251	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	leukemia	EFO:0000565	2	INHIBITOR
PACRITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute graft vs. host disease	EFO:0004599	1	INHIBITOR
EPROTIROME	Thyroid hormone receptor beta-1 agonist	THRB	CHEMBL1947	hypercholesterolemia	HP:0003124	2	AGONIST
EPROTIROME	Thyroid hormone receptor beta-1 agonist	THRB	CHEMBL1947	familial hypercholesterolemia	EFO:0004911	3	AGONIST
DARAPLADIB	LDL-associated phospholipase A2 inhibitor	PLA2G7	CHEMBL3514	atherosclerosis	EFO:0003914	3	INHIBITOR
DARAPLADIB	LDL-associated phospholipase A2 inhibitor	PLA2G7	CHEMBL3514	diabetic retinopathy	EFO:0003770	2	INHIBITOR
DARAPLADIB	LDL-associated phospholipase A2 inhibitor	PLA2G7	CHEMBL3514	acute coronary syndrome	EFO:0005672	3	INHIBITOR
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	3	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
CICLESONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
GLASDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	acute myeloid leukemia	EFO:0000222	3	ANTAGONIST
GLASDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	acute graft vs. host disease	EFO:0004599	1	ANTAGONIST
GLASDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	myelodysplastic syndrome	EFO:0000198	1	ANTAGONIST
CANAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetes mellitus	EFO:0000400	1	INHIBITOR
CANAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetic nephropathy	EFO:0000401	3	INHIBITOR
CANAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
CANAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	obesity	EFO:0001073	2	INHIBITOR
CANAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
NETUPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
NETUPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
NETUPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	breast carcinoma	EFO:0000305	3	ANTAGONIST
AFEGOSTAT	Beta-glucocerebrosidase stabiliser	GBA	CHEMBL2179	Gaucher disease	Orphanet:355	2	STABILISER
BAFETINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	prostate carcinoma	EFO:0001663	2	INHIBITOR
BAFETINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate carcinoma	EFO:0001663	2	INHIBITOR
BAFETINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
BAFETINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
BREMELANOTIDE	Melanocortin receptor 3 agonist	MC3R	CHEMBL4644	sexual dysfunction	EFO:0004714	3	AGONIST
BREMELANOTIDE	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	sexual dysfunction	EFO:0004714	3	AGONIST
BREMELANOTIDE	Melanocortin receptor 1 agonist	MC1R	CHEMBL3795	sexual dysfunction	EFO:0004714	3	AGONIST
SB-705498	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	pain	EFO:0003843	2	ANTAGONIST
SB-705498	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
SB-705498	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	atopic eczema	EFO:0000274	1	ANTAGONIST
SB-705498	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	migraine disorder	EFO:0003821	2	ANTAGONIST
TELATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	2	INHIBITOR
TELATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gastric carcinoma	EFO:0000178	2	INHIBITOR
TELATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	2	INHIBITOR
TELATINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	gastric carcinoma	EFO:0000178	2	INHIBITOR
SOLABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	overactive bladder	EFO:1000781	2	AGONIST
VELUSETRAG	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	gastroparesis	EFO:1000948	2	AGONIST
VELUSETRAG	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	Alzheimers disease	EFO:0000249	1	AGONIST
VELUSETRAG	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	constipation	HP:0002019	2	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	overactive bladder	EFO:1000781	4	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	heart failure	EFO:0003144	2	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	pain	EFO:0003843	2	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	left ventricular hypertrophy	EFO:0003896	2	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	Urinary incontinence	HP:0000020	3	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	Neurogenic bladder	HP:0000011	2	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	liver disease	EFO:0001421	1	AGONIST
MIRABEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	chronic interstitial cystitis	EFO:1000869	3	AGONIST
NALUZOTAN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	temporal lobe epilepsy	EFO:0000773	2	AGONIST
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	intermediate coronary syndrome	EFO:1000985	4	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	abnormality of blood and blood-forming tissues	HP:0001871	3	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	aortic stenosis	EFO:0000266	3	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	Venous thrombosis	HP:0004936	2	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	deep vein thrombosis	EFO:0003907	2	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	myocardial infarction	EFO:0000612	3	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	coronary artery disease	EFO:0000378	3	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	hemorrhage	MP:0001914	3	INHIBITOR
BIVALIRUDIN	Thrombin inhibitor	F2	CHEMBL204	acute coronary syndrome	EFO:0005672	3	INHIBITOR
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	MALT lymphoma	EFO:0000191	1	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	macroglobulinemia	EFO:0002616	1	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	chronic lymphocytic leukemia	EFO:0000095	1	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	breast neoplasm	EFO:0003869	2	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	melanoma	EFO:0000756	2	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	neoplasm of mature B-cells	EFO:0000096	2	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	non-Hodgkins lymphoma	EFO:0005952	2	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	Cutaneous T-cell lymphoma	EFO:0002913	1	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	Mantle cell lymphoma	EFO:1001469	2	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	diffuse large B-cell lymphoma	EFO:0000403	1	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	non-small cell lung carcinoma	EFO:0003060	3	AGONIST
AGATOLIMOD	Toll-like receptor 9 agonist	TLR9	CHEMBL5804	lymphoma	EFO:0000574	1	AGONIST
ARHALOFENATE	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	2	MODULATOR
ARHALOFENATE	Solute carrier family 22 member 12 inhibitor	SLC22A12	CHEMBL6120	gout	EFO:0004274	2	INHIBITOR
ARHALOFENATE	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	gout	EFO:0004274	2	MODULATOR
ARHALOFENATE	Solute carrier family 22 member 12 inhibitor	SLC22A12	CHEMBL6120	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
ELINOGREL	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	myocardial infarction	EFO:0000612	2	ANTAGONIST
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	Anemia, Hemolytic, Autoimmune	EFO:1001264	2	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	IGA glomerulonephritis	EFO:0004194	2	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	lymphoma	EFO:0000574	1	INHIBITOR
FOSTAMATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	ovarian carcinoma	EFO:0001075	1	INHIBITOR
PARDOPRUNOX	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	Parkinson's disease	EFO:0002508	3	AGONIST
TAFAMIDIS	Transthyretin stabiliser	TTR	CHEMBL3194	cardiomyopathy	EFO:0000318	3	STABILISER
TAFAMIDIS	Transthyretin stabiliser	TTR	CHEMBL3194	Familial amyloid polyneuropathy	Orphanet:85447	3	STABILISER
TAFAMIDIS	Transthyretin stabiliser	TTR	CHEMBL3194	neuropathy	EFO:0004149	2	STABILISER
TAFAMIDIS	Transthyretin stabiliser	TTR	CHEMBL3194	Familial amyloid polyneuropathy	Orphanet:85447	2	STABILISER
TAFAMIDIS	Transthyretin stabiliser	TTR	CHEMBL3194	cardiomyopathy	EFO:0000318	3	STABILISER
DILMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
DILMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	acute lung injury	EFO:0004610	2	INHIBITOR
DILMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
DILMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	neuropathic pain	EFO:0005762	2	INHIBITOR
DILMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	coronary heart disease	EFO:0001645	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	leukemia	EFO:0000565	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	gliosarcoma	EFO:1001465	1	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	liposarcoma	EFO:0000569	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	sarcoma	EFO:0000691	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	primary myelofibrosis	EFO:0002430	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast neoplasm	EFO:0003869	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	leiomyosarcoma	EFO:0000564	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
RIDAFOROLIMUS	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	osteosarcoma	EFO:0000637	3	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	breast carcinoma	EFO:0000305	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoid leukemia	EFO:0004289	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	lymphoid leukemia	EFO:0004289	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	melanoma	EFO:0000756	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	breast carcinoma	EFO:0000305	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	multiple myeloma	EFO:0001378	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	melanoma	EFO:0000756	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	lymphoid leukemia	EFO:0004289	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	breast carcinoma	EFO:0000305	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	male breast carcinoma	EFO:0006861	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	male breast carcinoma	EFO:0006861	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	multiple myeloma	EFO:0001378	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	male breast carcinoma	EFO:0006861	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	breast carcinoma	EFO:0000305	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	male breast carcinoma	EFO:0006861	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	multiple myeloma	EFO:0001378	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	multiple myeloma	EFO:0001378	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	melanoma	EFO:0000756	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	cutaneous melanoma	EFO:0000389	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	lymphoid leukemia	EFO:0004289	1	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	melanoma	EFO:0000756	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DINACICLIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VARLITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	2	INHIBITOR
VARLITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
VARLITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
VARLITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VARLITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VARLITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
VARLITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
VARLITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	2	INHIBITOR
ULIPRISTAL	Progesterone receptor modulator	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	MODULATOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	vascular dementia	EFO:0004718	2	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	systolic heart failure	EFO:1001207	3	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	heart disease	EFO:0003777	3	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Alzheimers disease	EFO:0000249	3	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	erectile dysfunction	EFO:0004234	3	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	diastolic heart failure	EFO:1000899	3	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	liver disease	EFO:0001421	1	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Raynaud disease	EFO:1001145	2	INHIBITOR
UDENAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	pulmonary hypertension	EFO:0001361	3	INHIBITOR
AMUVATINIB	Platelet-derived growth factor receptor alpha inhibitor	PDGFRA	CHEMBL2007	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AMUVATINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AMUVATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AMUVATINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ATOPAXAR	Proteinase-activated receptor 1 antagonist	F2R	CHEMBL3974	acute coronary syndrome	EFO:0005672	2	ANTAGONIST
ATOPAXAR	Proteinase-activated receptor 1 antagonist	F2R	CHEMBL3974	coronary artery disease	EFO:0000378	2	ANTAGONIST
NARONAPRIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	constipation	HP:0002019	2	AGONIST
BAVISANT	Histamine H3 receptor antagonist	HRH3	CHEMBL264	alcohol dependence	EFO:0003829	2	ANTAGONIST
LUMACAFTOR	Cystic fibrosis transmembrane conductance regulator stabiliser	CFTR	CHEMBL4051	Cystic fibrosis	Orphanet:586	4	STABILISER
LUMACAFTOR	Cystic fibrosis transmembrane conductance regulator stabiliser	CFTR	CHEMBL4051	liver disease	EFO:0001421	1	STABILISER
TRAMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	metastatic melanoma	EFO:0002617	4	INHIBITOR
TRAMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	metastatic melanoma	EFO:0002617	4	INHIBITOR
MAPRACORAT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	1	AGONIST
MAPRACORAT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
MAPRACORAT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	2	AGONIST
MAPRACORAT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	3	AGONIST
MAPRACORAT	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	2	AGONIST
CERLAPIRDINE	Serotonin 6 (5-HT6) receptor antagonist	HTR6	CHEMBL3371	Alzheimers disease	EFO:0000249	2	ANTAGONIST
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	esophageal carcinoma	EFO:0002916	1	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	multiple myeloma	EFO:0001378	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	breast carcinoma	EFO:0000305	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	germ cell tumor	EFO:0000514	2	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
TIVANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
AVATROMBOPAG	Thrombopoietin receptor agonist	MPL	CHEMBL1864	liver disease	EFO:0001421	3	AGONIST
AVATROMBOPAG	Thrombopoietin receptor agonist	MPL	CHEMBL1864	thrombocytopenia	HP:0001873	3	AGONIST
AVATROMBOPAG	Thrombopoietin receptor agonist	MPL	CHEMBL1864	autoimmune thrombocytopenic purpura	EFO:0007160	3	AGONIST
VAPREOTIDE	Somatostatin receptor 3 agonist	SSTR3	CHEMBL2028	hemorrhage	MP:0001914	3	AGONIST
VAPREOTIDE	Somatostatin receptor 2 agonist	SSTR2	CHEMBL1804	hemorrhage	MP:0001914	3	AGONIST
VAPREOTIDE	Somatostatin receptor 3 agonist	SSTR3	CHEMBL2028	portal hypertension	EFO:0000666	3	AGONIST
VAPREOTIDE	Somatostatin receptor 5 agonist	SSTR5	CHEMBL1792	post-operative sign or symptom	EFO:0005323	3	AGONIST
VAPREOTIDE	Somatostatin receptor 2 agonist	SSTR2	CHEMBL1804	portal hypertension	EFO:0000666	3	AGONIST
VAPREOTIDE	Somatostatin receptor 5 agonist	SSTR5	CHEMBL1792	hemorrhage	MP:0001914	3	AGONIST
VAPREOTIDE	Somatostatin receptor 2 agonist	SSTR2	CHEMBL1804	post-operative sign or symptom	EFO:0005323	3	AGONIST
VAPREOTIDE	Somatostatin receptor 3 agonist	SSTR3	CHEMBL2028	post-operative sign or symptom	EFO:0005323	3	AGONIST
VAPREOTIDE	Somatostatin receptor 5 agonist	SSTR5	CHEMBL1792	portal hypertension	EFO:0000666	3	AGONIST
BALAGLITAZONE	Peroxisome proliferator-activated receptor gamma partial agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	3	PARTIAL AGONIST
INSULIN DETEMIR	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	4	AGONIST
INSULIN DETEMIR	Insulin receptor agonist	INSR	CHEMBL1981	Cystic fibrosis	Orphanet:586	2	AGONIST
INSULIN DETEMIR	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN DETEMIR	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	4	AGONIST
RIVOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	3	AGONIST
RIVOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	dry eye syndrome	EFO:1000906	2	AGONIST
BECOCALCIDIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	2	AGONIST
RILAPLADIB	LDL-associated phospholipase A2 inhibitor	PLA2G7	CHEMBL3514	atherosclerosis	EFO:0003914	2	INHIBITOR
RILAPLADIB	LDL-associated phospholipase A2 inhibitor	PLA2G7	CHEMBL3514	Alzheimers disease	EFO:0000249	2	INHIBITOR
TEDUGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	HIV infection	EFO:0000764	2	AGONIST
TEDUGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	hyperlipidemia	EFO:0003774	2	AGONIST
TEDUGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	Crohn's disease	EFO:0000384	2	AGONIST
TEDUGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	liver disease	EFO:0001421	1	AGONIST
TEDUGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	Primary short bowel syndrome	Orphanet:365563	4	AGONIST
INECALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic myelogenous leukemia	EFO:0000339	2	AGONIST
INECALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	acute myeloid leukemia	EFO:0000222	2	AGONIST
THENALIDINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	4	ANTAGONIST
THENALIDINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
DAVALINTIDE	Calcitonin gene-related peptide type 1 receptor agonist	CALCRL	CHEMBL3798	obesity	EFO:0001073	2	AGONIST
PALOVAROTENE	Retinoic acid receptor gamma agonist	RARG	CHEMBL2003	Fibrodysplasia ossificans progressiva	Orphanet:337	3	AGONIST
VARESPLADIB METHYL	Group X secretory phospholipase A2 inhibitor	PLA2G10	CHEMBL4342	acute coronary syndrome	EFO:0005672	3	INHIBITOR
VARESPLADIB METHYL	Phospholipase A2 group IIA inhibitor	PLA2G2A	CHEMBL3474	coronary artery disease	EFO:0000378	2	INHIBITOR
VARESPLADIB METHYL	Phospholipase A2 group IIA inhibitor	PLA2G2A	CHEMBL3474	acute coronary syndrome	EFO:0005672	3	INHIBITOR
VARESPLADIB METHYL	Group X secretory phospholipase A2 inhibitor	PLA2G10	CHEMBL4342	coronary artery disease	EFO:0000378	2	INHIBITOR
VARESPLADIB METHYL	Phospholipase A2 group V inhibitor	PLA2G5	CHEMBL4323	acute coronary syndrome	EFO:0005672	3	INHIBITOR
VARESPLADIB METHYL	Phospholipase A2 group V inhibitor	PLA2G5	CHEMBL4323	coronary artery disease	EFO:0000378	2	INHIBITOR
LITRONESIB	Kinesin-like protein 1 inhibitor	KIF11	CHEMBL4581	breast carcinoma	EFO:0000305	2	INHIBITOR
LITRONESIB	Kinesin-like protein 1 inhibitor	KIF11	CHEMBL4581	leukemia	EFO:0000565	1	INHIBITOR
LITRONESIB	Kinesin-like protein 1 inhibitor	KIF11	CHEMBL4581	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
TELAPRISTONE ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	MODULATOR
TELAPRISTONE ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	liver disease	EFO:0001421	1	MODULATOR
TELAPRISTONE ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	breast carcinoma	EFO:0000305	2	MODULATOR
TELAPRISTONE ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	endometriosis	EFO:0001065	2	MODULATOR
LUNACALCIPOL	Vitamin D receptor agonist	VDR	CHEMBL1977	secondary hyperparathyroidism	EFO:1001173	2	AGONIST
LUNACALCIPOL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	2	AGONIST
LUNACALCIPOL	Vitamin D receptor agonist	VDR	CHEMBL1977	chronic kidney disease	EFO:0003884	2	AGONIST
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	thyroid carcinoma	EFO:0002892	4	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	papillary thyroid carcinoma	EFO:0000641	4	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gliosarcoma	EFO:1001465	1	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	astrocytoma	EFO:0000272	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	thyroid carcinoma	EFO:0002892	4	INHIBITOR
CABOZANTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	astrocytoma	EFO:0000272	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	papillary thyroid carcinoma	EFO:0000641	4	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gliosarcoma	EFO:1001465	1	INHIBITOR
CABOZANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
LESINURAD	Solute carrier family 22 member 12 inhibitor	SLC22A12	CHEMBL6120	gout	EFO:0004274	4	INHIBITOR
NIVOCASAN	Caspase-9 inhibitor	CASP9	CHEMBL2273	infection	EFO:0000544	2	INHIBITOR
NIVOCASAN	Caspase-8 inhibitor	CASP8	CHEMBL3776	infection	EFO:0000544	2	INHIBITOR
NIVOCASAN	Caspase-1 inhibitor	CASP1	CHEMBL4801	infection	EFO:0000544	2	INHIBITOR
CRENOLANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
CRENOLANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	central nervous system cancer	EFO:0000326	2	INHIBITOR
CRENOLANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
CRENOLANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
CRENOLANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SONIDEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	4	INHIBITOR
GALETERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate carcinoma	EFO:0001663	3	INHIBITOR
GALETERONE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
TOZADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	liver disease	EFO:0001421	1	ANTAGONIST
TOZADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	3	ANTAGONIST
TOZADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	cocaine dependence	EFO:0002610	0	ANTAGONIST
NALDEMEDINE	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	4	ANTAGONIST
NALDEMEDINE	Mu opioid receptor antagonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	2	ANTAGONIST
NALDEMEDINE	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	3	ANTAGONIST
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	atopic eczema	EFO:0000274	3	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	psoriasis	EFO:0000676	2	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	psoriasis	EFO:0000676	2	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	atopic eczema	EFO:0000274	3	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	acute graft vs. host disease	EFO:0004599	1	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	acute graft vs. host disease	EFO:0004599	1	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	diabetic nephropathy	EFO:0000401	2	INHIBITOR
BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	diabetic nephropathy	EFO:0000401	2	INHIBITOR
BREXPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	3	ANTAGONIST
BREXPIPRAZOLE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	insomnia	EFO:0004698	3	PARTIAL AGONIST
BREXPIPRAZOLE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	insomnia	EFO:0004698	3	PARTIAL AGONIST
OMARIGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
OMARIGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	diabetes mellitus	EFO:0000400	3	INHIBITOR
CORTIVAZOL	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
LABRADIMIL	Bradykinin B2 receptor agonist	BDKRB2	CHEMBL3157	medulloblastoma	EFO:0002939	1	AGONIST
LABRADIMIL	Bradykinin B2 receptor agonist	BDKRB2	CHEMBL3157	cryptococcal meningitis	EFO:0007228	1	AGONIST
LABRADIMIL	Bradykinin B2 receptor agonist	BDKRB2	CHEMBL3157	central nervous system cancer	EFO:0000326	2	AGONIST
TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AR	CHEMBL1871	sexual dysfunction	EFO:0004714	2	AGONIST
TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AR	CHEMBL1871	renal cell carcinoma	EFO:0000681	2	AGONIST
TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AR	CHEMBL1871	eunuchism	EFO:0007266	3	AGONIST
TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AR	CHEMBL1871	coronary heart disease	EFO:0001645	2	AGONIST
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	lung carcinoma	EFO:0001071	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	ovarian carcinoma	EFO:0001075	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	renal carcinoma	EFO:0002890	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	male breast carcinoma	EFO:0006861	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	biliary tract neoplasm	EFO:0003891	3	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	neuroblastoma	EFO:0000621	2	INHIBITOR
BECATECARIN	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	Cutaneous T-cell lymphoma	EFO:0002913	2	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	obstructive sleep apnea	EFO:0003918	2	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	chronic progressive multiple sclerosis	EFO:0003840	3	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	psoriasis	EFO:0000676	3	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	multiple sclerosis	EFO:0003885	4	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	relapsing-remitting multiple sclerosis	EFO:0003929	3	INHIBITOR
DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	KEAP1	CHEMBL2069156	gliosarcoma	EFO:1001465	1	INHIBITOR
SELODENOSON	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	atrial fibrillation	EFO:0000275	2	AGONIST
NEBENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	prostate adenocarcinoma	EFO:0000673	2	ANTAGONIST
NEBENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	prostate carcinoma	EFO:0001663	2	ANTAGONIST
RALFINAMIDE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	neuropathic pain	EFO:0005762	2	BLOCKER
RALFINAMIDE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	pain	EFO:0003843	3	INHIBITOR
RALFINAMIDE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	pain	EFO:0003843	3	BLOCKER
RALFINAMIDE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	neuropathic pain	EFO:0005762	2	INHIBITOR
RITOBEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	overactive bladder	EFO:1000781	3	AGONIST
RITOBEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	Neurogenic bladder	HP:0000011	1	AGONIST
SATAVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	inappropriate ADH syndrome	EFO:1000982	3	ANTAGONIST
SATAVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Ascites	HP:0001541	3	ANTAGONIST
SATAVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	cirrhosis of liver	EFO:0001422	3	ANTAGONIST
SATAVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Hyponatremia	HP:0002902	3	ANTAGONIST
SEMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	Crohn's disease	EFO:0000384	2	INHIBITOR
NORGESTREL	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	AGONIST
ALDOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ALDOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ALDOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	sarcoma	EFO:0000691	3	INHIBITOR
VIBEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	overactive bladder	EFO:1000781	2	AGONIST
VIBEGRON	Beta-3 adrenergic receptor agonist	ADRB3	CHEMBL246	hypertension	EFO:0000537	1	AGONIST
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	kidney disease	EFO:0003086	2	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	Hyponatremia	HP:0002902	2	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	gestational diabetes	EFO:0004593	3	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	prediabetes syndrome	EFO:1001121	2	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	heart failure	EFO:0003144	3	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetes mellitus	EFO:0000400	3	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	myocardial infarction	EFO:0000612	3	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	inappropriate ADH syndrome	EFO:1000982	2	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	polycystic ovary syndrome	EFO:0000660	2	INHIBITOR
EMPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	melanoma	EFO:0000756	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	melanoma	EFO:0000756	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast carcinoma	EFO:0000305	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast carcinoma	EFO:0000305	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PIMASERTIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	congestive heart failure	EFO:0000373	2	AGONIST
ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type I diabetes mellitus	EFO:0001359	2	AGONIST
ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetes mellitus	EFO:0000400	3	AGONIST
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	primary myelofibrosis	EFO:0002430	2	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	multiple myeloma	EFO:0001378	2	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	breast carcinoma	EFO:0000305	1	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	myelodysplastic syndrome	EFO:0000198	3	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	polycythemia vera	EFO:0002429	2	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	neuroblastoma	EFO:0000621	1	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	essential thrombocythemia	EFO:0000479	2	INHIBITOR
IMETELSTAT	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	lymphoma	EFO:0000574	1	INHIBITOR
TASPOGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	3	AGONIST
ZALUTUMUMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	3	ANTAGONIST
ZALUTUMUMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	3	ANTAGONIST
ZALUTUMUMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	ANTAGONIST
ZALUTUMUMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	upper aerodigestive tract neoplasm	EFO:0004284	3	ANTAGONIST
ZALUTUMUMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	1	ANTAGONIST
INSULIN DEGLUDEC	Insulin receptor agonist	INSR	CHEMBL1981	diabetes mellitus	EFO:0000400	4	AGONIST
INSULIN DEGLUDEC	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN DEGLUDEC	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	3	AGONIST
PEGNIVACOGIN	Coagulation factor IX inhibitor	F9	CHEMBL2016	acute coronary syndrome	EFO:0005672	2	INHIBITOR
PEGNIVACOGIN	Coagulation factor IX inhibitor	F9	CHEMBL2016	coronary artery disease	EFO:0000378	3	INHIBITOR
DELCASERTIB	Protein kinase C delta inhibitor	PRKCD	CHEMBL2996	myocardial infarction	EFO:0000612	2	INHIBITOR
RETEPLASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
RETEPLASE	Plasminogen activator	PLG	CHEMBL1801	myocardial infarction	EFO:0000612	3	ACTIVATOR
RETEPLASE	Plasminogen activator	PLG	CHEMBL1801	stroke	EFO:0000712	2	ACTIVATOR
ONERCEPT	TNF-alpha inhibitor	TNF	CHEMBL1825	psoriatic arthritis	EFO:0003778	3	INHIBITOR
DULAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
ERTUMAXOMAB	Receptor protein-tyrosine kinase erbB-2 other	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	2	OTHER
MATUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	ovarian carcinoma	EFO:0001075	2	INHIBITOR
MATUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PARATHYROID HORMONE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	psoriasis	EFO:0000676	1	AGONIST
PARATHYROID HORMONE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoporosis	EFO:0003882	3	AGONIST
PARATHYROID HORMONE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	postmenopausal osteoporosis	EFO:0003854	1	AGONIST
PARATHYROID HORMONE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	Hypocalcemia	HP:0002901	4	AGONIST
TRAFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	periodontitis	EFO:0000649	3	AGONIST
TRAFERMIN	Fibroblast growth factor receptor 2 agonist	FGFR2	CHEMBL4142	diabetic foot	EFO:1001459	3	AGONIST
STREPTOKINASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
STREPTOKINASE	Plasminogen activator	PLG	CHEMBL1801	myocardial infarction	EFO:0000612	3	ACTIVATOR
STREPTOKINASE	Plasminogen activator	PLG	CHEMBL1801	Venous thrombosis	HP:0004936	3	ACTIVATOR
CROFELEMER	Cystic fibrosis transmembrane conductance regulator inhibitor	CFTR	CHEMBL4051	breast carcinoma	EFO:0000305	2	INHIBITOR
CROFELEMER	Anoctamin-1 blocker	ANO1	CHEMBL2046267	irritable bowel syndrome	EFO:0000555	2	BLOCKER
CROFELEMER	Anoctamin-1 blocker	ANO1	CHEMBL2046267	breast carcinoma	EFO:0000305	2	BLOCKER
CROFELEMER	Cystic fibrosis transmembrane conductance regulator inhibitor	CFTR	CHEMBL4051	irritable bowel syndrome	EFO:0000555	2	INHIBITOR
CROFELEMER	Anoctamin-1 blocker	ANO1	CHEMBL2046267	diarrhea	HP:0002014	4	BLOCKER
CROFELEMER	Cystic fibrosis transmembrane conductance regulator inhibitor	CFTR	CHEMBL4051	diarrhea	HP:0002014	4	INHIBITOR
CORIFOLLITROPIN ALFA	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
AGALSIDASE ALFA	Alpha-galactosidase A activator	GLA	CHEMBL2524	Fabry disease	Orphanet:324	3	ACTIVATOR
ANISTREPLASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
OZARELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	2	ANTAGONIST
OZARELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	benign prostatic hyperplasia	EFO:0000284	2	ANTAGONIST
CONBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	diabetic retinopathy	EFO:0003770	3	INHIBITOR
CONBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	age-related macular degeneration	EFO:0001365	2	INHIBITOR
CONBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	diabetic retinopathy	EFO:0003770	3	INHIBITOR
CONBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	pathological myopia	EFO:0004207	3	INHIBITOR
CONBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	retinal vein occlusion	EFO:1001157	2	INHIBITOR
CONBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	2	INHIBITOR
CONBERCEPT	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	pathological myopia	EFO:0004207	3	INHIBITOR
CONBERCEPT	Placenta growth factor inhibitor	PGF	CHEMBL1697671	retinal vein occlusion	EFO:1001157	2	INHIBITOR
ELSIGLUTIDE	Glucagon-like peptide 2 receptor agonist	GLP2R	CHEMBL5844	diarrhea	HP:0002014	2	AGONIST
LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetes mellitus	EFO:0000400	1	AGONIST
LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Parkinson's disease	EFO:0002508	2	AGONIST
LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	acute coronary syndrome	EFO:0005672	3	AGONIST
LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type I diabetes mellitus	EFO:0001359	1	AGONIST
EPRATUZUMAB 90Y	CD22 binding agent	CD22	CHEMBL3218	non-Hodgkins lymphoma	EFO:0005952	1	BINDING AGENT
SERELAXIN	Relaxin receptor 1 activator	RXFP1	CHEMBL1293316	liver disease	EFO:0001421	1	ACTIVATOR
SERELAXIN	Relaxin receptor 1 activator	RXFP1	CHEMBL1293316	preeclampsia	EFO:0000668	2	ACTIVATOR
SERELAXIN	Relaxin receptor 1 activator	RXFP1	CHEMBL1293316	heart failure	EFO:0003144	3	ACTIVATOR
SERELAXIN	Relaxin receptor 1 activator	RXFP1	CHEMBL1293316	coronary artery disease	EFO:0000378	2	ACTIVATOR
SERELAXIN	Relaxin receptor 2 activator	RXFP2	CHEMBL1628482	liver disease	EFO:0001421	1	ACTIVATOR
SERELAXIN	Relaxin receptor 1 activator	RXFP1	CHEMBL1293316	chronic kidney disease	EFO:0003884	1	ACTIVATOR
SERELAXIN	Relaxin receptor 2 activator	RXFP2	CHEMBL1628482	coronary artery disease	EFO:0000378	2	ACTIVATOR
SERELAXIN	Relaxin receptor 2 activator	RXFP2	CHEMBL1628482	chronic kidney disease	EFO:0003884	1	ACTIVATOR
SERELAXIN	Relaxin receptor 2 activator	RXFP2	CHEMBL1628482	preeclampsia	EFO:0000668	2	ACTIVATOR
SERELAXIN	Relaxin receptor 2 activator	RXFP2	CHEMBL1628482	heart failure	EFO:0003144	3	ACTIVATOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cervical adenocarcinoma	EFO:0001416	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal carcinoma	EFO:0002916	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	stomach neoplasm	EFO:0003897	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	rectum cancer	EFO:1000657	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal cancer	EFO:0005842	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cervical carcinoma	EFO:0001061	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal squamous cell carcinoma	EFO:0005922	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	nasopharyngeal neoplasm	EFO:0004252	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	brain stem neoplasm	EFO:1001767	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	adenocarcinoma	EFO:0000228	2	INHIBITOR
NIMOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	2	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	lymphoma	EFO:0000574	3	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	leukemia	EFO:0000565	2	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	systemic lupus erythematosus	EFO:0002690	3	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	macroglobulinemia	EFO:0002616	2	INHIBITOR
EPRATUZUMAB	CD22 inhibitor	CD22	CHEMBL3218	B-cell acute lymphoblastic leukemia	EFO:0000094	2	INHIBITOR
MENOTROPINS	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	infertility	EFO:0000545	3	AGONIST
MENOTROPINS	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	azoospermia	EFO:0000279	2	AGONIST
MENOTROPINS	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	azoospermia	EFO:0000279	2	AGONIST
MENOTROPINS	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	infertility	EFO:0000545	3	AGONIST
MENOTROPINS	Luteinizing hormone/Choriogonadotropin receptor agonist	LHCGR	CHEMBL1854	polycystic ovary syndrome	EFO:0000660	3	AGONIST
MENOTROPINS	Follicle stimulating hormone receptor agonist	FSHR	CHEMBL2024	polycystic ovary syndrome	EFO:0000660	3	AGONIST
INSULIN PEGLISPRO	Insulin receptor agonist	INSR	CHEMBL1981	type II diabetes mellitus	EFO:0001360	3	AGONIST
INSULIN PEGLISPRO	Insulin receptor agonist	INSR	CHEMBL1981	type I diabetes mellitus	EFO:0001359	1	AGONIST
BAPINEUZUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	3	OTHER
CATUMAXOMAB	High affinity immunoglobulin gamma Fc receptor I cross-linking agent	FCGR1A	CHEMBL5349	gastric carcinoma	EFO:0000178	2	CROSS-LINKING AGENT
CATUMAXOMAB	High affinity immunoglobulin gamma Fc receptor I cross-linking agent	FCGR1A	CHEMBL5349	carcinoma	EFO:0000313	2	CROSS-LINKING AGENT
CATUMAXOMAB	High affinity immunoglobulin gamma Fc receptor I cross-linking agent	FCGR1A	CHEMBL5349	Ascites	HP:0001541	2	CROSS-LINKING AGENT
CATUMAXOMAB	High affinity immunoglobulin gamma Fc receptor I cross-linking agent	FCGR1A	CHEMBL5349	ovarian carcinoma	EFO:0001075	2	CROSS-LINKING AGENT
CATUMAXOMAB	High affinity immunoglobulin gamma Fc receptor I cross-linking agent	FCGR1A	CHEMBL5349	gastric adenocarcinoma	EFO:0000503	2	CROSS-LINKING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	diffuse large B-cell lymphoma	EFO:0000403	2	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	neoplasm of mature B-cells	EFO:0000096	3	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	non-Hodgkins lymphoma	EFO:0005952	3	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	B-cell acute lymphoblastic leukemia	EFO:0000094	4	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	acute lymphoblastic leukemia	EFO:0000220	3	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	lymphoma	EFO:0000574	2	BINDING AGENT
INOTUZUMAB OZOGAMICIN	CD22 binding agent	CD22	CHEMBL3218	leukemia	EFO:0000565	1	BINDING AGENT
YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN	CD22 inhibitor	CD22	CHEMBL3218	B-cell acute lymphoblastic leukemia	EFO:0000094	2	INHIBITOR
YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN	CD22 inhibitor	CD22	CHEMBL3218	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN	CD22 inhibitor	CD22	CHEMBL3218	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN	CD22 inhibitor	CD22	CHEMBL3218	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
RAMATERCEPT	Growth/differentiation factor 8 inhibitor	MSTN	CHEMBL3407325	Duchenne muscular dystrophy	Orphanet:98896	2	INHIBITOR
RAMATERCEPT	Growth/differentiation factor 8 inhibitor	MSTN	CHEMBL3407325	muscular disease	EFO:0002970	1	INHIBITOR
IMETELSTAT SODIUM	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	breast carcinoma	EFO:0000305	2	INHIBITOR
IMETELSTAT SODIUM	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	multiple myeloma	EFO:0001378	1	INHIBITOR
IMETELSTAT SODIUM	Telomerase reverse transcriptase inhibitor	TERT	CHEMBL2916	lung carcinoma	EFO:0001071	1	INHIBITOR
IODINE I 124 GIRENTUXIMAB	Carbonic anhydrase IX binding agent	CA9	CHEMBL3594	renal carcinoma	EFO:0002890	2	BINDING AGENT
IODINE I 124 GIRENTUXIMAB	Carbonic anhydrase IX binding agent	CA9	CHEMBL3594	renal cell carcinoma	EFO:0000681	2	BINDING AGENT
SEMAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
SEMAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	obesity	EFO:0001073	2	AGONIST
SEMAGLUTIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetes mellitus	EFO:0000400	1	AGONIST
PLACULUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
PLACULUMAB	TNF-alpha inhibitor	TNF	CHEMBL1825	Sciatica	HP:0011868	1	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	psoriasis	EFO:0000676	2	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	chronic kidney disease	EFO:0003884	1	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	acute graft vs. host disease	EFO:0004599	1	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	kidney disease	EFO:0003086	1	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	leukemia	EFO:0000565	1	INHIBITOR
SIPLIZUMAB	T-cell surface antigen CD2 inhibitor	CD2	CHEMBL2040	lymphoma	EFO:0000574	1	INHIBITOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	sudden cardiac arrest	EFO:0004278	3	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	pulmonary embolism	EFO:0003827	3	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	acute respiratory distress syndrome	EFO:1000637	1	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	brain infarction	EFO:0004277	2	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Cerebral ischemia	HP:0002637	2	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	stroke	EFO:0000712	3	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	Recurrent thrombophlebitis	HP:0004419	4	ACTIVATOR
TENECTEPLASE	Plasminogen activator	PLG	CHEMBL1801	myocardial infarction	EFO:0000612	3	ACTIVATOR
YTTRIUM Y 90 EPRATUZUMAB	CD22 binding agent	CD22	CHEMBL3218	leukemia	EFO:0000565	1	BINDING AGENT
YTTRIUM Y 90 EPRATUZUMAB	CD22 binding agent	CD22	CHEMBL3218	lymphoma	EFO:0000574	1	BINDING AGENT
SIBROTUZUMAB	Fibroblast activation protein alpha binding agent	FAP	CHEMBL4683	non-small cell lung carcinoma	EFO:0003060	1	BINDING AGENT
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor VIII inhibitor	F8	CHEMBL3143	pulmonary embolism	EFO:0003827	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor VIII inhibitor	F8	CHEMBL3143	sepsis	HP:0100806	3	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	F5	CHEMBL3618	chronic kidney disease	EFO:0003884	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	F5	CHEMBL3618	acute respiratory distress syndrome	EFO:1000637	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	F5	CHEMBL3618	pulmonary embolism	EFO:0003827	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor VIII inhibitor	F8	CHEMBL3143	acute respiratory distress syndrome	EFO:1000637	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor VIII inhibitor	F8	CHEMBL3143	chronic kidney disease	EFO:0003884	2	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	F5	CHEMBL3618	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor VIII inhibitor	F8	CHEMBL3143	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	F5	CHEMBL3618	sepsis	HP:0100806	3	INHIBITOR
DESMOTEPLASE	Plasminogen activator	PLG	CHEMBL1801	stroke	EFO:0000712	3	ACTIVATOR
ASCRINVACUMAB	Serine/threonine-protein kinase receptor R3 inhibitor	ACVRL1	CHEMBL5311	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
ASCRINVACUMAB	Serine/threonine-protein kinase receptor R3 inhibitor	ACVRL1	CHEMBL5311	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ASCRINVACUMAB	Serine/threonine-protein kinase receptor R3 inhibitor	ACVRL1	CHEMBL5311	colorectal carcinoma	EFO:1001951	1	INHIBITOR
GSK933776	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	1	OTHER
IMC-CS4	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	pancreatic carcinoma	EFO:0002618	0	INHIBITOR
IMC-EB10	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	1	INHIBITOR
MLN-1202	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	melanoma	EFO:0000756	1	ANTAGONIST
MLN-1202	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	multiple sclerosis	EFO:0003885	2	ANTAGONIST
MLN-1202	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
MLN-1202	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	atherosclerosis	EFO:0003914	2	ANTAGONIST
CCR5MAB004	C-C chemokine receptor type 5 inhibitor	CCR5	CHEMBL274	HIV infection	EFO:0000764	1	INHIBITOR
PRO-140	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV infection	EFO:0000764	2	ANTAGONIST
BL22	CD22 binding agent	CD22	CHEMBL3218	leukemia	EFO:0000565	2	BINDING AGENT
BL22	CD22 binding agent	CD22	CHEMBL3218	lymphoma	EFO:0000574	1	BINDING AGENT
BL22	CD22 binding agent	CD22	CHEMBL3218	hairy cell leukemia	EFO:1000956	2	BINDING AGENT
MONO-DGA-RFB4	CD22 binding agent	CD22	CHEMBL3218	lymphoma	EFO:0000574	1	BINDING AGENT
AVE-1642	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	breast neoplasm	EFO:0003869	2	ANTAGONIST
AVE-1642	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	multiple myeloma	EFO:0001378	1	ANTAGONIST
AVE-1642	Insulin-like growth factor I receptor antagonist	IGF1R	CHEMBL1957	carcinoma	EFO:0000313	1	ANTAGONIST
LMB-2	Interleukin-2 receptor alpha chain binding agent	IL2RA	CHEMBL1778	lymphoma	EFO:0000574	2	BINDING AGENT
LMB-2	Interleukin-2 receptor alpha chain binding agent	IL2RA	CHEMBL1778	leukemia	EFO:0000565	2	BINDING AGENT
LMB-2	Interleukin-2 receptor alpha chain binding agent	IL2RA	CHEMBL1778	hairy cell leukemia	EFO:1000956	2	BINDING AGENT
LMB-2	Interleukin-2 receptor alpha chain binding agent	IL2RA	CHEMBL1778	cutaneous melanoma	EFO:0000389	2	BINDING AGENT
FUTUXIMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	2	ANTAGONIST
FUTUXIMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	ANTAGONIST
FUTUXIMAB	Epidermal growth factor receptor erbB1 antagonist	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
IMGATUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	2	INHIBITOR
IMGATUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
IMGATUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MAB-425	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
MDX-447	High affinity immunoglobulin gamma Fc receptor I other	FCGR1A	CHEMBL5349	central nervous system cancer	EFO:0000326	1	OTHER
MDX-447	Epidermal growth factor receptor erbB1 other	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	1	OTHER
AMG-888	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
AMG-888	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	breast carcinoma	EFO:0000305	1	INHIBITOR
T-DM1	Receptor protein-tyrosine kinase erbB-2 binding agent	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	1	BINDING AGENT
MM-121	Receptor tyrosine-protein kinase erbB-3 antagonist	ERBB3	CHEMBL5838	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
MM-121	Receptor tyrosine-protein kinase erbB-3 antagonist	ERBB3	CHEMBL5838	breast carcinoma	EFO:0000305	2	ANTAGONIST
PATRITUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	breast carcinoma	EFO:0000305	2	INHIBITOR
PATRITUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
PATRITUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	breast neoplasm	EFO:0003869	2	INHIBITOR
PATRITUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
PATRITUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
LAMPALIZUMAB	Complement factor D inhibitor	CFD	CHEMBL2176771	age-related macular degeneration	EFO:0001365	3	INHIBITOR
TB-402	Coagulation factor VIII inhibitor	F8	CHEMBL3143	venous thromboembolism	EFO:0004286	2	INHIBITOR
PG-102	Tumor necrosis factor receptor superfamily member 5 inhibitor	CD40	CHEMBL1250358	psoriatic arthritis	EFO:0003778	1	INHIBITOR
BI-505	Intercellular adhesion molecule-1 antagonist	ICAM1	CHEMBL3070	multiple myeloma	EFO:0001378	2	ANTAGONIST
INCLACUMAB	P-selectin antagonist	SELP	CHEMBL5378	coronary heart disease	EFO:0001645	2	ANTAGONIST
INCLACUMAB	P-selectin antagonist	SELP	CHEMBL5378	myocardial infarction	EFO:0000612	2	ANTAGONIST
J591 177LU	Glutamate carboxypeptidase II binding agent	FOLH1	CHEMBL1892	prostate carcinoma	EFO:0001663	2	BINDING AGENT
GSK-249320	Myelin-associated glycoprotein inhibitor	MAG	CHEMBL5807	stroke	EFO:0000712	2	INHIBITOR
FGI-101-1A6	Tumor susceptibility gene 101 protein inhibitor	TSG101	CHEMBL6157	influenza infection	EFO:0001669	1	INHIBITOR
ABX-IL8	Interleukin-8 inhibitor	CXCL8	CHEMBL2157	chronic bronchitis	EFO:0006505	2	INHIBITOR
BC8 131I	Leukocyte common antigen binding agent	PTPRC	CHEMBL3243	acute myeloid leukemia	EFO:0000222	2	BINDING AGENT
BC8 131I	Leukocyte common antigen binding agent	PTPRC	CHEMBL3243	multiple myeloma	EFO:0001378	1	BINDING AGENT
BC8 131I	Leukocyte common antigen binding agent	PTPRC	CHEMBL3243	leukemia	EFO:0000565	2	BINDING AGENT
F19 131I	Fibroblast activation protein alpha binding agent	FAP	CHEMBL4683	colorectal carcinoma	EFO:1001951	1	BINDING AGENT
HUJ591 111IN	Glutamate carboxypeptidase II binding agent	FOLH1	CHEMBL1892	prostate carcinoma	EFO:0001663	2	BINDING AGENT
HUJ591 177LU	Glutamate carboxypeptidase II binding agent	FOLH1	CHEMBL1892	prostate carcinoma	EFO:0001663	2	BINDING AGENT
ANAMORELIN	Ghrelin receptor agonist	GHSR	CHEMBL4616	cachexia	HP:0004326	2	AGONIST
EZATIOSTAT	Glutathione S-transferase Pi inhibitor	GSTP1	CHEMBL3902	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
EZATIOSTAT	Glutathione S-transferase Pi inhibitor	GSTP1	CHEMBL3902	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ELIGLUSTAT	Ceramide glucosyltransferase inhibitor	UGCG	CHEMBL2063	Gaucher disease	Orphanet:355	4	INHIBITOR
CENICRIVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV-1 infection	EFO:0000180	2	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	sclerosing cholangitis	EFO:0004268	2	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	sclerosing cholangitis	EFO:0004268	2	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	infection	EFO:0000544	1	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	liver disease	EFO:0001421	1	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	HIV-1 infection	EFO:0000180	2	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	liver disease	EFO:0001421	1	ANTAGONIST
CENICRIVIROC	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	infection	EFO:0000544	1	ANTAGONIST
POMAGLUMETAD METHIONIL	Metabotropic glutamate receptor 3 agonist	GRM3	CHEMBL2888	metamphetamine dependence	EFO:0004701	1	AGONIST
POMAGLUMETAD METHIONIL	Metabotropic glutamate receptor 2 agonist	GRM2	CHEMBL5137	metamphetamine dependence	EFO:0004701	1	AGONIST
CHLORPHENOXAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	4	ANTAGONIST
BUSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	infertility	EFO:0000545	1	AGONIST
BUSERELIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	3	AGONIST
DAPOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	erectile dysfunction	EFO:0004234	3	INHIBITOR
DAPOXETINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	sexual dysfunction	EFO:0004714	3	INHIBITOR
BEDORADRINE	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	2	AGONIST
BEDORADRINE	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
MIFAMURTIDE	Nucleotide-binding oligomerization domain-containing protein 2 other	NOD2	CHEMBL1293266	osteosarcoma	EFO:0000637	2	OTHER
PIMAVANSERIN	Serotonin 2a (5-HT2a) receptor inverse agonist	HTR2A	CHEMBL224	Parkinson's disease	EFO:0002508	4	INVERSE AGONIST
PIMAVANSERIN	Serotonin 2a (5-HT2a) receptor inverse agonist	HTR2A	CHEMBL224	Alzheimers disease	EFO:0000249	2	INVERSE AGONIST
PALOMID-529	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	age-related macular degeneration	EFO:0001365	1	INHIBITOR
TALADEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	small cell lung carcinoma	EFO:0000702	1	ANTAGONIST
TALADEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	esophageal carcinoma	EFO:0002916	1	ANTAGONIST
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	thyroid carcinoma	EFO:0002892	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	metastatic melanoma	EFO:0002617	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	thyroid carcinoma	EFO:0002892	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	Craniopharyngioma	EFO:1000209	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	melanoma	EFO:0000756	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	metastatic melanoma	EFO:0002617	4	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast neoplasm	EFO:0003869	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	Craniopharyngioma	EFO:1000209	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cutaneous melanoma	EFO:0000389	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	breast carcinoma	EFO:0000305	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	multiple myeloma	EFO:0001378	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast neoplasm	EFO:0003869	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	melanoma	EFO:0000756	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	metastatic melanoma	EFO:0002617	4	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	breast carcinoma	EFO:0000305	2	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cutaneous melanoma	EFO:0000389	3	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	multiple myeloma	EFO:0001378	1	INHIBITOR
COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	metastatic melanoma	EFO:0002617	3	INHIBITOR
PF-03654746	Histamine H3 receptor antagonist	HRH3	CHEMBL264	Alzheimers disease	EFO:0000249	1	ANTAGONIST
PF-03654746	Histamine H3 receptor antagonist	HRH3	CHEMBL264	allergic rhinitis	EFO:0005854	2	ANTAGONIST
PF-03654746	Histamine H3 receptor antagonist	HRH3	CHEMBL264	Tourette syndrome	EFO:0004895	2	ANTAGONIST
AZD0328	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	1	AGONIST
ENCENICLINE	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	dementia	HP:0000726	3	PARTIAL AGONIST
ENCENICLINE	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	3	PARTIAL AGONIST
ENCENICLINE	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	liver disease	EFO:0001421	1	PARTIAL AGONIST
ELUXADOLINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	irritable bowel syndrome	EFO:0000555	4	AGONIST
NAVARIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
NAVARIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	psoriasis	EFO:0000676	2	ANTAGONIST
NAVARIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	asthma	EFO:0000270	2	ANTAGONIST
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	male breast carcinoma	EFO:0006861	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	osteosarcoma	EFO:0000637	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Alzheimers disease	EFO:0000249	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	melanoma	EFO:0000756	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast carcinoma	EFO:0000305	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	alcohol dependence	EFO:0003829	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	osteosarcoma	EFO:0000637	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	breast carcinoma	EFO:0000305	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	prostate carcinoma	EFO:0001663	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	Alzheimers disease	EFO:0000249	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	melanoma	EFO:0000756	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	ovarian carcinoma	EFO:0001075	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	alcohol dependence	EFO:0003829	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Thymoma	EFO:1000581	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	Lymphangioleiomyomatosis	Orphanet:538	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Lymphangioleiomyomatosis	Orphanet:538	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	Thymoma	EFO:1000581	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate carcinoma	EFO:0001663	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	male breast carcinoma	EFO:0006861	2	INHIBITOR
SARACATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	ovarian carcinoma	EFO:0001075	2	INHIBITOR
RIMEGEPANT	Calcitonin gene-related peptide type 1 receptor antagonist	CALCRL	CHEMBL3798	migraine disorder	EFO:0003821	3	ANTAGONIST
AZD4818	C-C chemokine receptor type 1 antagonist	CCR1	CHEMBL2413	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
VERCIRNON	C-C chemokine receptor type 9 antagonist	CCR9	CHEMBL5815	ulcerative colitis	EFO:0000729	2	ANTAGONIST
VERCIRNON	C-C chemokine receptor type 9 antagonist	CCR9	CHEMBL5815	celiac disease	EFO:0001060	2	ANTAGONIST
VERCIRNON	C-C chemokine receptor type 9 antagonist	CCR9	CHEMBL5815	Crohn's disease	EFO:0000384	2	ANTAGONIST
ELUBRIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
ELUBRIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	ulcerative colitis	EFO:0000729	2	ANTAGONIST
BIFEPRUNOX	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	Alzheimers disease	EFO:0000249	3	PARTIAL AGONIST
BIFEPRUNOX	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Alzheimers disease	EFO:0000249	3	PARTIAL AGONIST
FINERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	heart failure	EFO:0003144	2	ANTAGONIST
FINERENONE	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	3	ANTAGONIST
FORODESINE	Purine nucleoside phosphorylase inhibitor	PNP	CHEMBL4338	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
FORODESINE	Purine nucleoside phosphorylase inhibitor	PNP	CHEMBL4338	lymphoma	EFO:0000574	1	INHIBITOR
FORODESINE	Purine nucleoside phosphorylase inhibitor	PNP	CHEMBL4338	lymphoid leukemia	EFO:0004289	1	INHIBITOR
DORZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	3	INHIBITOR
DORZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	open-angle glaucoma	EFO:0004190	2	INHIBITOR
GW590735	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	2	AGONIST
TARANABANT	Cannabinoid CB1 receptor inverse agonist	CNR1	CHEMBL218	Urinary incontinence	HP:0000020	2	INVERSE AGONIST
TARANABANT	Cannabinoid CB1 receptor inverse agonist	CNR1	CHEMBL218	nicotine dependence	EFO:0003768	2	INVERSE AGONIST
TARANABANT	Cannabinoid CB1 receptor inverse agonist	CNR1	CHEMBL218	obesity	EFO:0001073	3	INVERSE AGONIST
TARANABANT	Cannabinoid CB1 receptor inverse agonist	CNR1	CHEMBL218	type II diabetes mellitus	EFO:0001360	3	INVERSE AGONIST
BRINZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	glaucoma	EFO:0000516	4	INHIBITOR
BRINZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	open-angle glaucoma	EFO:0004190	4	INHIBITOR
BRINZOLAMIDE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	ocular hypertension	EFO:1001069	4	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Parkinson's disease	EFO:0002508	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	multiple sclerosis	EFO:0003885	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	essential tremor	EFO:0003108	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	alcohol dependence	EFO:0003829	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	liver disease	EFO:0001421	1	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Sciatica	HP:0011868	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Seizures	HP:0001250	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	metamphetamine dependence	EFO:0004701	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	migraine disorder	EFO:0003821	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Cerebral ischemia	HP:0002637	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	diabetes mellitus	EFO:0000400	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	partial epilepsy	EFO:0004263	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	epilepsy	EFO:0000474	4	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	binge eating	EFO:0005924	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	dementia	HP:0000726	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Seizures	HP:0001250	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	obesity	EFO:0001073	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Tourette syndrome	EFO:0004895	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Parkinson's disease	EFO:0002508	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	peripheral neuropathy	EFO:0003100	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	migraine disorder	EFO:0003821	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	essential tremor	EFO:0003108	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Prader-Willi syndrome	Orphanet:739	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	binge eating	EFO:0005924	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	cocaine dependence	EFO:0002610	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	multiple sclerosis	EFO:0003885	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Cerebral ischemia	HP:0002637	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	peripheral neuropathy	EFO:0003100	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	obesity	EFO:0001073	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	cocaine dependence	EFO:0002610	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Prader-Willi syndrome	Orphanet:739	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	liver disease	EFO:0001421	1	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Tourette syndrome	EFO:0004895	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	dementia	HP:0000726	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	Headache	HP:0002315	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	metamphetamine dependence	EFO:0004701	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	marijuana dependence	EFO:0004218	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	nicotine dependence	EFO:0003768	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	alcohol dependence	EFO:0003829	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	partial epilepsy	EFO:0004263	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	marijuana dependence	EFO:0004218	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Sciatica	HP:0011868	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	epilepsy	EFO:0000474	4	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	diabetes mellitus	EFO:0000400	2	INHIBITOR
TOPIRAMATE	Carbonic anhydrase II inhibitor	CA2	CHEMBL205	nicotine dependence	EFO:0003768	3	INHIBITOR
TOPIRAMATE	Carbonic anhydrase IV inhibitor	CA4	CHEMBL3729	Headache	HP:0002315	2	INHIBITOR
TAK-441	Smoothened homolog antagonist	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	1	ANTAGONIST
PF-03654764	Histamine H3 receptor antagonist	HRH3	CHEMBL264	allergic rhinitis	EFO:0005854	2	ANTAGONIST
SARIZOTAN	Dopamine D3 receptor agonist	DRD3	CHEMBL234	movement disorder	EFO:0004280	3	AGONIST
SARIZOTAN	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	movement disorder	EFO:0004280	3	PARTIAL AGONIST
SARIZOTAN	Dopamine D4 receptor agonist	DRD4	CHEMBL219	movement disorder	EFO:0004280	3	AGONIST
SARIZOTAN	Dopamine D3 receptor agonist	DRD3	CHEMBL234	Parkinson's disease	EFO:0002508	2	AGONIST
SARIZOTAN	Dopamine D4 receptor agonist	DRD4	CHEMBL219	Parkinson's disease	EFO:0002508	2	AGONIST
SARIZOTAN	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Parkinson's disease	EFO:0002508	2	PARTIAL AGONIST
SARIZOTAN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	Parkinson's disease	EFO:0002508	2	AGONIST
SARIZOTAN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	movement disorder	EFO:0004280	3	AGONIST
DIMETHINDENE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	4	ANTAGONIST
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	allergic rhinitis	EFO:0005854	1	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	amyloidosis	EFO:1001875	2	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	non-Hodgkins lymphoma	EFO:0005952	4	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	lymphoma	EFO:0000574	3	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	4	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic lymphocytic leukemia	EFO:0000095	4	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	macroglobulinemia	EFO:0002616	2	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	multiple myeloma	EFO:0001378	1	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	primary myelofibrosis	EFO:0002430	1	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	pancreatic ductal adenocarcinoma	EFO:0002517	1	INHIBITOR
IDELALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	marijuana dependence	EFO:0004218	2	AGONIST
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	post operative nausea and vomiting	EFO:0004888	2	AGONIST
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	fibromyalgia	EFO:0005687	2	AGONIST
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	Nausea	HP:0002018	4	AGONIST
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	neuropathic pain	EFO:0005762	2	AGONIST
NABILONE	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	diabetic neuropathy	EFO:1000783	3	AGONIST
BARUSIBAN	Oxytocin receptor antagonist	OXTR	CHEMBL2049	infertility	EFO:0000545	2	ANTAGONIST
FLUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	breast carcinoma	EFO:0000305	2	INHIBITOR
FLUVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	3	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 2 inhibitor	FGFR2	CHEMBL4142	breast carcinoma	EFO:0000305	2	INHIBITOR
LUCITANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	breast carcinoma	EFO:0000305	2	INHIBITOR
LINIFANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	2	INHIBITOR
LINIFANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	2	INHIBITOR
LINIFANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LINIFANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	renal cell carcinoma	EFO:0000681	2	INHIBITOR
LINIFANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
LINIFANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
LINIFANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	age-related macular degeneration	EFO:0001365	2	INHIBITOR
LINIFANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
LINIFANIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LINIFANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	age-related macular degeneration	EFO:0001365	2	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	mesothelioma	EFO:0000588	3	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal cancer	EFO:0005842	3	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal carcinoma	EFO:1001951	3	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	esophageal carcinoma	EFO:0002916	2	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric carcinoma	EFO:0000178	2	INHIBITOR
RALTITREXED	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	rectum cancer	EFO:1000657	2	INHIBITOR
GW842166X	Cannabinoid CB2 receptor agonist	CNR2	CHEMBL253	osteoarthritis	EFO:0002506	2	AGONIST
GW842166X	Cannabinoid CB2 receptor agonist	CNR2	CHEMBL253	pain	EFO:0003843	2	AGONIST
TG100-115	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	myocardial infarction	EFO:0000612	1	INHIBITOR
TG100-115	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	myocardial infarction	EFO:0000612	1	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	pulmonary embolism	EFO:0003827	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	hemorrhage	MP:0001914	2	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	acute coronary syndrome	EFO:0005672	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	chronic kidney disease	EFO:0003884	1	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	venous thromboembolism	EFO:0004286	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial flutter	EFO:0003911	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Sickle cell anemia	Orphanet:232	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial fibrillation	EFO:0000275	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	stroke	EFO:0000712	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	deep vein thrombosis	EFO:0003907	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	Venous thrombosis	HP:0004936	4	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	lymphoma	EFO:0000574	3	INHIBITOR
APIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	aortic stenosis	EFO:0000266	3	INHIBITOR
DARUSENTAN	Endothelin receptor ET-B antagonist	EDNRB	CHEMBL1785	hypertension	EFO:0000537	3	ANTAGONIST
DARUSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	hypertension	EFO:0000537	3	ANTAGONIST
SF-1126	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
SF-1126	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
SF-1126	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	neuroblastoma	EFO:0000621	1	INHIBITOR
MK0686	Bradykinin B1 receptor antagonist	BDKRB1	CHEMBL4308	pain	EFO:0003843	2	ANTAGONIST
MK0686	Bradykinin B1 receptor antagonist	BDKRB1	CHEMBL4308	osteoarthritis	EFO:0002506	2	ANTAGONIST
MK0686	Bradykinin B1 receptor antagonist	BDKRB1	CHEMBL4308	geniculate herpes zoster	EFO:0007281	2	ANTAGONIST
RG-7603	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-8 agonist	S1PR5	CHEMBL2274	polymyositis	EFO:0003063	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-8 agonist	S1PR5	CHEMBL2274	relapsing-remitting multiple sclerosis	EFO:0003929	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-8 agonist	S1PR5	CHEMBL2274	chronic progressive multiple sclerosis	EFO:0003840	3	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	liver disease	EFO:0001421	1	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	relapsing-remitting multiple sclerosis	EFO:0003929	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-8 agonist	S1PR5	CHEMBL2274	liver disease	EFO:0001421	1	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-8 agonist	S1PR5	CHEMBL2274	dermatomyositis	EFO:0000398	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	dermatomyositis	EFO:0000398	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	polymyositis	EFO:0003063	2	AGONIST
SIPONIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	chronic progressive multiple sclerosis	EFO:0003840	3	AGONIST
DIPRAGLURANT	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	Parkinson's disease	EFO:0002508	2	MODULATOR
AZD3514	Androgen Receptor modulator	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	1	MODULATOR
CLOMIPHENE	Estrogen receptor alpha modulator	ESR1	CHEMBL206	Klinefelter's syndrome	EFO:1001006	2	MODULATOR
CLOMIPHENE	Estrogen receptor alpha modulator	ESR1	CHEMBL206	polycystic ovary syndrome	EFO:0000660	3	MODULATOR
CLOMIPHENE	Estrogen receptor alpha modulator	ESR1	CHEMBL206	obesity	EFO:0001073	2	MODULATOR
TIPIRACIL	Thymidine phosphorylase inhibitor	TYMP	CHEMBL3106	rectum cancer	EFO:1000657	1	INHIBITOR
TIPIRACIL	Thymidine phosphorylase inhibitor	TYMP	CHEMBL3106	colorectal adenocarcinoma	EFO:0000365	4	INHIBITOR
CEBRANOPADOL	Nociceptin receptor agonist	OPRL1	CHEMBL2014	pain	EFO:0003843	2	AGONIST
CEBRANOPADOL	Nociceptin receptor agonist	OPRL1	CHEMBL2014	diabetic neuropathy	EFO:1000783	2	AGONIST
CEBRANOPADOL	Nociceptin receptor agonist	OPRL1	CHEMBL2014	osteoarthritis, knee	EFO:0004616	2	AGONIST
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	central nervous system cancer	EFO:0000326	1	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	sarcoma	EFO:0000691	1	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	breast carcinoma	EFO:0000305	1	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	rectum cancer	EFO:1000657	2	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	pancreatic neoplasm	EFO:0003860	1	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	prostate carcinoma	EFO:0001663	2	INHIBITOR
GALUNISERTIB	TGF-beta receptor type I inhibitor	TGFBR1	CHEMBL4439	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
LATANOPROSTENE BUNOD	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	open-angle glaucoma	EFO:0004190	4	AGONIST
LATANOPROSTENE BUNOD	Prostanoid FP receptor agonist	PTGFR	CHEMBL1987	ocular hypertension	EFO:1001069	4	AGONIST
MAVATREP	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	osteoarthritis	EFO:0002506	1	ANTAGONIST
METHYLSAMIDORPHAN	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	2	ANTAGONIST
PRADIGASTAT	Diacylglycerol O-acyltransferase 1 inhibitor	DGAT1	CHEMBL6009	liver disease	EFO:0001421	1	INHIBITOR
PRADIGASTAT	Diacylglycerol O-acyltransferase 1 inhibitor	DGAT1	CHEMBL6009	hepatitis C infection	EFO:0003047	2	INHIBITOR
RALIMETINIB	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	breast carcinoma	EFO:0000305	2	INHIBITOR
UBROGEPANT	Calcitonin gene-related peptide type 1 receptor antagonist	CALCRL	CHEMBL3798	migraine disorder	EFO:0003821	3	ANTAGONIST
MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	3	INHIBITOR
TOVETUMAB	Platelet-derived growth factor receptor alpha inhibitor	PDGFRA	CHEMBL2007	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ANIFROLUMAB	Interferon-alpha/beta receptor alpha chain antagonist	IFNAR1	CHEMBL1887	systemic lupus erythematosus	EFO:0002690	3	ANTAGONIST
ANIFROLUMAB	Interferon-alpha/beta receptor alpha chain antagonist	IFNAR1	CHEMBL1887	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
ANIFROLUMAB	Interferon-alpha/beta receptor alpha chain antagonist	IFNAR1	CHEMBL1887	lupus nephritis	EFO:0005761	2	ANTAGONIST
ANIFROLUMAB	Interferon-alpha/beta receptor alpha chain antagonist	IFNAR1	CHEMBL1887	scleroderma	EFO:1001993	1	ANTAGONIST
ERGOLOID	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	vascular dementia	EFO:0004718	2	AGONIST
ERGOLOID	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	vascular dementia	EFO:0004718	2	AGONIST
TELCAGEPANT	Calcitonin gene-related peptide type 1 receptor antagonist	CALCRL	CHEMBL3798	migraine disorder	EFO:0003821	3	ANTAGONIST
DOLASETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	diabetes mellitus	EFO:0000400	4	INHIBITOR
LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	hypertension	EFO:0000537	1	INHIBITOR
SETIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
SETIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
SETIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	Alopecia	Orphanet:79364	2	ANTAGONIST
SCH-900776	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
SCH-900776	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
SCH-900776	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
SCH-900776	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
SCH-900776	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
SELEXIPAG	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	3	AGONIST
SELEXIPAG	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	Recurrent thrombophlebitis	HP:0004419	4	AGONIST
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	esophageal squamous cell carcinoma	EFO:0005922	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	rectum cancer	EFO:1000657	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	multiple myeloma	EFO:0001378	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	breast neoplasm	EFO:0003869	3	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	oropharynx cancer	EFO:1001931	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	liver disease	EFO:0001421	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	breast carcinoma	EFO:0000305	3	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	colorectal carcinoma	EFO:1001951	1	INHIBITOR
ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	myocardial infarction	EFO:0000612	4	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	left ventricular hypertrophy	EFO:0003896	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	angina pectoris	EFO:0003913	4	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	osteoporosis	EFO:0003882	0	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	heart disease	EFO:0003777	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	coronary artery disease	EFO:0000378	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	atrial fibrillation	EFO:0000275	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hemangioma	EFO:1000635	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	vascular disease	EFO:0004264	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	cerebrovascular disorder	EFO:0003763	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	heart failure	EFO:0003144	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	mitral valve stenosis	EFO:0007372	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	Marfan syndrome	Orphanet:558	3	ANTAGONIST
ATENOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	Myocardial Ischemia	EFO:1001375	3	ANTAGONIST
CERITINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	thyroid carcinoma	EFO:0002892	2	INHIBITOR
CERITINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
CERITINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	anaplastic large cell lymphoma	EFO:0003032	1	INHIBITOR
CHENODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	irritable bowel syndrome	EFO:0000555	2	AGONIST
CHENODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Cerebrotendinous xanthomatosis	Orphanet:909	2	AGONIST
CHENODIOL	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Spastic paraplegia	HP:0001258	2	AGONIST
PRELADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	liver disease	EFO:0001421	1	ANTAGONIST
PRELADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	3	ANTAGONIST
SRX246	Vasopressin V1a receptor antagonist	AVPR1A	CHEMBL1889	Huntington disease	Orphanet:399	1	ANTAGONIST
QAV680	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
QAV680	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	allergic rhinitis	EFO:0005854	2	ANTAGONIST
QAV680	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
OLICERIDINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	3	AGONIST
BETAHISTINE	Histamine H3 receptor antagonist	HRH3	CHEMBL264	obesity	EFO:0001073	2	ANTAGONIST
BETAHISTINE	Histamine H1 receptor agonist	HRH1	CHEMBL231	obesity	EFO:0001073	2	AGONIST
BETAHISTINE	Histamine H1 receptor agonist	HRH1	CHEMBL231	Meniere disease	EFO:0006862	3	AGONIST
BETAHISTINE	Histamine H3 receptor antagonist	HRH3	CHEMBL264	hypercholesterolemia	HP:0003124	2	ANTAGONIST
BETAHISTINE	Histamine H1 receptor agonist	HRH1	CHEMBL231	hypercholesterolemia	HP:0003124	2	AGONIST
BETAHISTINE	Histamine H3 receptor antagonist	HRH3	CHEMBL264	body weight gain	EFO:0004566	2	ANTAGONIST
BETAHISTINE	Histamine H3 receptor antagonist	HRH3	CHEMBL264	Meniere disease	EFO:0006862	3	ANTAGONIST
BETAHISTINE	Histamine H1 receptor agonist	HRH1	CHEMBL231	body weight gain	EFO:0004566	2	AGONIST
SILODOSIN	Alpha-1a adrenergic receptor antagonist	ADRA1A	CHEMBL229	benign prostatic hyperplasia	EFO:0000284	4	ANTAGONIST
SILODOSIN	Alpha-1a adrenergic receptor antagonist	ADRA1A	CHEMBL229	prostate carcinoma	EFO:0001663	3	ANTAGONIST
SILODOSIN	Alpha-1a adrenergic receptor antagonist	ADRA1A	CHEMBL229	kidney stone	EFO:0003845	3	ANTAGONIST
SILODOSIN	Alpha-1a adrenergic receptor antagonist	ADRA1A	CHEMBL229	prostatitis	EFO:0003830	2	ANTAGONIST
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	ovarian carcinoma	EFO:0001075	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	renal carcinoma	EFO:0002890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	gliosarcoma	EFO:1001465	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	thyroid carcinoma	EFO:0002892	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	thyroid neoplasm	EFO:0003841	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	breast carcinoma	EFO:0000305	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	gastric carcinoma	EFO:0000178	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	neuroblastoma	EFO:0000621	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	thyroid neoplasm	EFO:0003841	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	gastric carcinoma	EFO:0000178	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	central nervous system cancer	EFO:0000326	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	breast neoplasm	EFO:0003869	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	ovarian carcinoma	EFO:0001075	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	thyroid neoplasm	EFO:0003841	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	ovarian carcinoma	EFO:0001075	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	mesothelioma	EFO:0000588	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	lung carcinoma	EFO:0001071	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	neuroblastoma	EFO:0000621	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	multiple myeloma	EFO:0001378	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	renal carcinoma	EFO:0002890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	breast carcinoma	EFO:0000305	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	thyroid carcinoma	EFO:0002892	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	oligoastrocytoma	EFO:0000630	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	central nervous system cancer	EFO:0000326	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	thyroid carcinoma	EFO:0002892	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	oligoastrocytoma	EFO:0000630	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	urethral neoplasm	EFO:0003846	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	breast neoplasm	EFO:0003869	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	gliosarcoma	EFO:1001465	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	multiple myeloma	EFO:0001378	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	gastric carcinoma	EFO:0000178	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	urethral neoplasm	EFO:0003846	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	ovarian carcinoma	EFO:0001075	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	bladder carcinoma	EFO:0000292	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	lung carcinoma	EFO:0001071	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	central nervous system cancer	EFO:0000326	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	oligoastrocytoma	EFO:0000630	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	urethral neoplasm	EFO:0003846	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	neuroblastoma	EFO:0000621	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	mesothelioma	EFO:0000588	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	bladder carcinoma	EFO:0000292	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	oligoastrocytoma	EFO:0000630	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	thyroid neoplasm	EFO:0003841	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	breast neoplasm	EFO:0003869	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate carcinoma	EFO:0001663	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	prostate carcinoma	EFO:0001663	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	multiple myeloma	EFO:0001378	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	verrucous carcinoma	EFO:0007535	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	verrucous carcinoma	EFO:0007535	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	gliosarcoma	EFO:1001465	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	prostate carcinoma	EFO:0001663	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	lung carcinoma	EFO:0001071	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast carcinoma	EFO:0000305	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal carcinoma	EFO:0002890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	urethral neoplasm	EFO:0003846	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	gastric carcinoma	EFO:0000178	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	verrucous carcinoma	EFO:0007535	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	bladder carcinoma	EFO:0000292	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	mesothelioma	EFO:0000588	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	neuroblastoma	EFO:0000621	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	renal carcinoma	EFO:0002890	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	mesothelioma	EFO:0000588	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	prostate carcinoma	EFO:0001663	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	bladder carcinoma	EFO:0000292	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	gliosarcoma	EFO:1001465	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	verrucous carcinoma	EFO:0007535	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	multiple myeloma	EFO:0001378	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast neoplasm	EFO:0003869	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	central nervous system cancer	EFO:0000326	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	lung carcinoma	EFO:0001071	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	thyroid carcinoma	EFO:0002892	4	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	breast carcinoma	EFO:0000305	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase BRK inhibitor	PTK6	CHEMBL4601	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VANDETANIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	Congenital adrenal hyperplasia	Orphanet:418	1	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate carcinoma	EFO:0001663	4	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	metastatic prostate cancer	EFO:0000196	4	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	liver disease	EFO:0001421	1	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	1	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate adenocarcinoma	EFO:0000673	4	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	salivary gland neoplasm	EFO:0003826	2	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	breast carcinoma	EFO:0000305	2	INHIBITOR
ABIRATERONE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
ABIRATERONE	Androgen Receptor antagonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	3	ANTAGONIST
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
ABIRATERONE	Cytochrome P450 17A1 inhibitor	CYP17A1	CHEMBL3522	prostate carcinoma	EFO:0001663	3	INHIBITOR
ABIRATERONE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
MGCD-265	Macrophage-stimulating protein receptor inhibitor	MST1R	CHEMBL2689	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MGCD-265	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MGCD-265	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
NILOTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
NILOTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	systemic scleroderma	EFO:0000717	2	INHIBITOR
NILOTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Parkinson's disease	EFO:0002508	2	INHIBITOR
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	gastric carcinoma	EFO:0000178	3	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	pain	EFO:0003843	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	common cold	EFO:0007214	1	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	frozen shoulder	EFO:1000941	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	Tendinopathy	EFO:1001434	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	Cough	HP:0012735	3	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	pain	EFO:0003843	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	gastric carcinoma	EFO:0000178	3	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	arthritis	EFO:0005856	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	pain	EFO:0003843	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	nicotine dependence	EFO:0003768	3	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	Tendinopathy	EFO:1001434	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	arthritis	EFO:0005856	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	Dysphagia	HP:0002015	2	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	Dysphagia	HP:0002015	2	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	hypertension	EFO:0000537	2	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	nicotine dependence	EFO:0003768	3	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	frozen shoulder	EFO:1000941	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	pain	EFO:0003843	4	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	common cold	EFO:0007214	1	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	diabetic neuropathy	EFO:1000783	1	OPENER
MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	TRPA1	CHEMBL6007	diabetic neuropathy	EFO:1000783	1	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	hypertension	EFO:0000537	2	OPENER
MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	TRPM8	CHEMBL1075319	Cough	HP:0012735	3	OPENER
EPLIVANSERIN	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	3	ANTAGONIST
MLN-8054	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	pancreatic neoplasm	EFO:0003860	1	INHIBITOR
MLN-8054	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	breast neoplasm	EFO:0003869	1	INHIBITOR
MLN-8054	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	colonic neoplasm	EFO:0004288	1	INHIBITOR
MILNACIPRAN	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	fibromyalgia	EFO:0005687	4	INHIBITOR
MILNACIPRAN	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	fibromyalgia	EFO:0005687	4	INHIBITOR
ULIPRISTAL ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	MODULATOR
ULIPRISTAL ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	hemorrhage	MP:0001914	3	MODULATOR
ULIPRISTAL ACETATE	Progesterone receptor modulator	PGR	CHEMBL208	breast carcinoma	EFO:0000305	2	MODULATOR
INDIPLON	GABA receptor alpha-1 subunit positive allosteric modulator	GABRA1	CHEMBL1962	insomnia	EFO:0004698	3	POSITIVE ALLOSTERIC MODULATOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	bladder carcinoma	EFO:0000292	1	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	prostate carcinoma	EFO:0001663	3	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	renal cell carcinoma	EFO:0000681	1	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	Leishmaniasis	EFO:0005044	3	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	adrenocortical carcinoma	EFO:0003093	2	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	multiple myeloma	EFO:0001378	2	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	breast carcinoma	EFO:0000305	1	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	central nervous system cancer	EFO:0000326	2	INHIBITOR
SURAMIN	Acidic fibroblast growth factor inhibitor	FGF1	CHEMBL2120	trypanosomiasis	DOID:10113	3	INHIBITOR
IBODUTANT	Neurokinin 2 receptor antagonist	TACR2	CHEMBL2327	irritable bowel syndrome	EFO:0000555	3	ANTAGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	diabetes mellitus	EFO:0000400	3	AGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	Hypoglycemia	HP:0001943	3	AGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	3	AGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	Congenital isolated hyperinsulinism	Orphanet:657	2	AGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	type I diabetes mellitus	EFO:0001359	3	AGONIST
GLUCAGON	Glucagon receptor agonist	GCGR	CHEMBL1985	obesity	EFO:0001073	1	AGONIST
ASOPRISNIL	Progesterone receptor modulator	PGR	CHEMBL208	uterine fibroid	EFO:0000731	3	MODULATOR
ASOPRISNIL	Progesterone receptor modulator	PGR	CHEMBL208	endometriosis	EFO:0001065	2	MODULATOR
ASOPRISNIL	Progesterone receptor modulator	PGR	CHEMBL208	Menorrhagia	HP:0000132	3	MODULATOR
NALFURAFINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	chronic kidney disease	EFO:0003884	1	AGONIST
NALFURAFINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	liver disease	EFO:0001421	2	AGONIST
TACROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Eczema	HP:0000964	4	INHIBITOR
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	soft tissue sarcoma	EFO:1001968	2	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	colorectal neoplasm	EFO:0004142	3	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	type II diabetes mellitus	EFO:0001360	1	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	cutaneous melanoma	EFO:0000389	2	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	cocaine dependence	EFO:0002610	2	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	movement disorder	EFO:0004280	2	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	cocaine dependence	EFO:0002610	2	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	type II diabetes mellitus	EFO:0001360	1	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	migraine disorder	EFO:0003821	3	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	hypertension	EFO:0000537	4	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	cirrhosis of liver	EFO:0001422	3	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	migraine disorder	EFO:0003821	3	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	cutaneous melanoma	EFO:0000389	2	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	colorectal neoplasm	EFO:0004142	3	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	cirrhosis of liver	EFO:0001422	3	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	soft tissue sarcoma	EFO:1001968	2	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	prostate carcinoma	EFO:0001663	2	ANTAGONIST
PROPRANOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	prostate carcinoma	EFO:0001663	2	ANTAGONIST
PROPRANOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	movement disorder	EFO:0004280	2	ANTAGONIST
ALVIMOPAN	Mu opioid receptor antagonist	OPRM1	CHEMBL233	bladder carcinoma	EFO:0000292	3	ANTAGONIST
ALVIMOPAN	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	3	ANTAGONIST
HYODEOXYCHOLIC_ACID	LXR-beta agonist	NR1H2	CHEMBL4093	hypercholesterolemia	HP:0003124	1	AGONIST
HYODEOXYCHOLIC_ACID	LXR-alpha agonist	NR1H3	CHEMBL2808	hypercholesterolemia	HP:0003124	1	AGONIST
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	leiomyosarcoma	EFO:0000564	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	lymphoma	EFO:0000574	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	lung carcinoma	EFO:0001071	1	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	lung carcinoma	EFO:0001071	1	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	carcinoma	EFO:0000313	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	carcinoma	EFO:0000313	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	lung carcinoma	EFO:0001071	1	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	leiomyosarcoma	EFO:0000564	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	leiomyosarcoma	EFO:0000564	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	leiomyosarcoma	EFO:0000564	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	lung carcinoma	EFO:0001071	1	INHIBITOR
MOCETINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	carcinoma	EFO:0000313	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	lymphoma	EFO:0000574	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	lymphoma	EFO:0000574	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	lymphoma	EFO:0000574	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	carcinoma	EFO:0000313	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	carcinoma	EFO:0000313	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	leiomyosarcoma	EFO:0000564	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 11 inhibitor	HDAC11	CHEMBL3310	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	lymphoma	EFO:0000574	2	INHIBITOR
MOCETINOSTAT	Histone deacetylase 8 inhibitor	HDAC8	CHEMBL3192	lung carcinoma	EFO:0001071	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal carcinoma	EFO:1001951	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast carcinoma	EFO:0000305	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	multiple myeloma	EFO:0001378	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal carcinoma	EFO:0002890	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	lung carcinoma	EFO:0001071	1	INHIBITOR
ORANTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	prostate carcinoma	EFO:0001663	1	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	central nervous system cancer	EFO:0000326	1	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cervical carcinoma	EFO:0001061	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal carcinoma	EFO:0002890	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	1	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	3	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
SEMAXANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	2	INHIBITOR
BROMAZEPAM	GABA receptor alpha-2 subunit positive allosteric modulator	GABRA2	CHEMBL4956	dementia	HP:0000726	3	POSITIVE ALLOSTERIC MODULATOR
ANTIPYRINE	Cyclooxygenase-1 inhibitor	PTGS1	CHEMBL221	Otitis media	EFO:0004992	2	INHIBITOR
ANTIPYRINE	Cyclooxygenase-1 inhibitor	PTGS1	CHEMBL221	asthma	EFO:0000270	2	INHIBITOR
NEOSTIGMINE	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Myasthenia gravis	EFO:0004991	4	INHIBITOR
MACIMORELIN	Ghrelin receptor agonist	GHSR	CHEMBL4616	cachexia	HP:0004326	2	AGONIST
ERTEBEREL	Estrogen receptor beta agonist	ESR2	CHEMBL242	benign prostatic hyperplasia	EFO:0000284	2	AGONIST
MARIMASTAT	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 3 inhibitor	MMP3	CHEMBL283	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	lung carcinoma	EFO:0001071	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 3 inhibitor	MMP3	CHEMBL283	lung carcinoma	EFO:0001071	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase-2 inhibitor	MMP2	CHEMBL333	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 12 inhibitor	MMP12	CHEMBL4393	lung carcinoma	EFO:0001071	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase-2 inhibitor	MMP2	CHEMBL333	lung carcinoma	EFO:0001071	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 12 inhibitor	MMP12	CHEMBL4393	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	breast carcinoma	EFO:0000305	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase 7 inhibitor	MMP7	CHEMBL4073	lung carcinoma	EFO:0001071	3	INHIBITOR
MARIMASTAT	Matrix metalloproteinase-1 inhibitor	MMP1	CHEMBL332	lung carcinoma	EFO:0001071	3	INHIBITOR
TERBOGREL	Thromboxane A2 receptor antagonist	TBXA2R	CHEMBL2069	pulmonary hypertension	EFO:0001361	2	ANTAGONIST
TERBOGREL	Thromboxane-A synthase inhibitor	TBXAS1	CHEMBL1835	pulmonary hypertension	EFO:0001361	2	INHIBITOR
BROMPERIDOL	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
TESAGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	3	AGONIST
TESAGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	3	AGONIST
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	gliosarcoma	EFO:1001465	1	INHIBITOR
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
AXL-1717	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IROSUSTAT	Steryl-sulfatase inhibitor	STS	CHEMBL3559	prostate carcinoma	EFO:0001663	1	INHIBITOR
IROSUSTAT	Steryl-sulfatase inhibitor	STS	CHEMBL3559	breast neoplasm	EFO:0003869	2	INHIBITOR
IROSUSTAT	Steryl-sulfatase inhibitor	STS	CHEMBL3559	breast carcinoma	EFO:0000305	2	INHIBITOR
IROSUSTAT	Steryl-sulfatase inhibitor	STS	CHEMBL3559	endometrial neoplasm	EFO:0004230	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	dementia	HP:0000726	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	dementia	HP:0000726	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	breast carcinoma	EFO:0000305	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast neoplasm	EFO:0003869	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	dementia	HP:0000726	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast carcinoma	EFO:0000305	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	leukemia	EFO:0000565	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	breast neoplasm	EFO:0003869	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	dementia	HP:0000726	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	leukemia	EFO:0000565	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	breast carcinoma	EFO:0000305	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	leukemia	EFO:0000565	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	breast neoplasm	EFO:0003869	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	breast carcinoma	EFO:0000305	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	HCK	CHEMBL3234	leukemia	EFO:0000565	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	LYN	CHEMBL3905	breast neoplasm	EFO:0003869	2	INHIBITOR
BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	4	INHIBITOR
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Nausea	HP:0002018	4	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	cervical carcinoma	EFO:0001061	3	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	2	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	central nervous system cancer	EFO:0000326	2	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	mast-cell leukemia	EFO:0007359	2	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Nausea	HP:0002018	3	ANTAGONIST
GRANISETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	lymphoma	EFO:0000574	2	ANTAGONIST
CEP-1347	Mitogen-activated protein kinase kinase kinase 9 inhibitor	MAP3K9	CHEMBL2872	Parkinson's disease	EFO:0002508	2	INHIBITOR
CEP-1347	Mitogen-activated protein kinase kinase kinase 10 inhibitor	MAP3K10	CHEMBL2873	Parkinson's disease	EFO:0002508	2	INHIBITOR
CEP-1347	Mitogen-activated protein kinase kinase kinase 12 inhibitor	MAP3K12	CHEMBL1908389	Parkinson's disease	EFO:0002508	2	INHIBITOR
CEP-1347	Mitogen-activated protein kinase kinase kinase 11 inhibitor	MAP3K11	CHEMBL2708	Parkinson's disease	EFO:0002508	2	INHIBITOR
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	arthralgia	HP:0002829	4	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	prostate carcinoma	EFO:0001663	2	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	HIV infection	EFO:0000764	2	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Tendinopathy	EFO:1001434	4	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	amyotrophic lateral sclerosis	EFO:0000253	0	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	migraine disorder	EFO:0003821	0	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	burning mouth syndrome	EFO:1000850	0	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	neuropathic pain	EFO:0005762	2	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Cystinosis	Orphanet:213	0	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	arthritis	EFO:0005856	4	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	frozen shoulder	EFO:1000941	4	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	myofascial pain syndrome	EFO:1001054	2	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	diabetic neuropathy	EFO:1000783	3	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pain	EFO:0003843	3	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	osteoarthritis	EFO:0002506	3	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	head and neck malignant neoplasia	EFO:0006859	3	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pain	EFO:0003843	4	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	pulmonary hypertension	EFO:0001361	2	OPENER
CAPSAICIN	Vanilloid receptor opener	TRPV1	CHEMBL4794	Pruritus	HP:0000989	1	OPENER
ASTEMIZOLE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
BMS-387032	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	multiple myeloma	EFO:0001378	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	multiple myeloma	EFO:0001378	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
BMS-387032	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	multiple myeloma	EFO:0001378	1	INHIBITOR
BENPERIDOL	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
ECOPIPAM	Dopamine D1 receptor antagonist	DRD1	CHEMBL2056	restless legs syndrome	EFO:0004270	1	ANTAGONIST
ECOPIPAM	Dopamine D1 receptor antagonist	DRD1	CHEMBL2056	Tourette syndrome	EFO:0004895	2	ANTAGONIST
ECOPIPAM	Dopamine D1 receptor antagonist	DRD1	CHEMBL2056	Lesch-Nyhan syndrome	Orphanet:510	1	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	Peptic ulcer	HP:0004398	4	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastrointestinal hemorrhage	HP:0002239	3	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	endometrial neoplasm	EFO:0004230	2	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastroesophageal reflux disease	EFO:0003948	4	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	amyotrophic lateral sclerosis	EFO:0000253	1	ANTAGONIST
CIMETIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	hemorrhage	MP:0001914	3	ANTAGONIST
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	colorectal carcinoma	EFO:1001951	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	multiple myeloma	EFO:0001378	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	ovarian carcinoma	EFO:0001075	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	gliosarcoma	EFO:1001465	1	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	colorectal adenocarcinoma	EFO:0000365	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	lung carcinoma	EFO:0001071	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	macroglobulinemia	EFO:0002616	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	central nervous system cancer	EFO:0000326	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	lymphoma	EFO:0000574	3	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	Cutaneous T-cell lymphoma	EFO:0002913	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	lymphoid leukemia	EFO:0004289	1	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	prostate carcinoma	EFO:0001663	2	INHIBITOR
ENZASTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	breast carcinoma	EFO:0000305	2	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	lymphoma	EFO:0000574	3	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	liver disease	EFO:0001421	1	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	leukemia	EFO:0000565	2	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	asthma	EFO:0000270	2	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	unspecified peripheral T-cell lymphoma	EFO:0000211	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	unspecified peripheral T-cell lymphoma	EFO:0000211	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	leukemia	EFO:0000565	2	INHIBITOR
DUVELISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	lymphoma	EFO:0000574	3	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	liver disease	EFO:0001421	1	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	asthma	EFO:0000270	2	INHIBITOR
DUVELISIB	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 1 inhibitor	SLC5A1	CHEMBL4979	diabetes mellitus	EFO:0000400	1	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 1 inhibitor	SLC5A1	CHEMBL4979	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	liver disease	EFO:0001421	1	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 1 inhibitor	SLC5A1	CHEMBL4979	congestive heart failure	EFO:0000373	2	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 1 inhibitor	SLC5A1	CHEMBL4979	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	congestive heart failure	EFO:0000373	2	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 1 inhibitor	SLC5A1	CHEMBL4979	liver disease	EFO:0001421	1	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	diabetes mellitus	EFO:0000400	1	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
SOTAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
DECERNOTINIB	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ELOBIXIBAT	Ileal bile acid transporter inhibitor	SLC10A2	CHEMBL2778	constipation	HP:0002019	3	INHIBITOR
ELOBIXIBAT	Ileal bile acid transporter inhibitor	SLC10A2	CHEMBL2778	Disorder of lipid metabolism	Orphanet:309005	2	INHIBITOR
RABUSERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	pancreatic neoplasm	EFO:0003860	1	INHIBITOR
RABUSERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
BATEFENTEROL	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
BATEFENTEROL	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
BATEFENTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
LASMIDITAN	Serotonin 1f (5-HT1f) receptor agonist	HTR1F	CHEMBL1805	drug dependence	EFO:0003890	1	AGONIST
LASMIDITAN	Serotonin 1f (5-HT1f) receptor agonist	HTR1F	CHEMBL1805	migraine disorder	EFO:0003821	3	AGONIST
VINTAFOLIDE	Folate receptor alpha binding agent	FOLR1	CHEMBL2121	non-small cell lung carcinoma	EFO:0003060	2	BINDING AGENT
VINTAFOLIDE	Folate receptor alpha binding agent	FOLR1	CHEMBL2121	breast neoplasm	EFO:0003869	2	BINDING AGENT
VINTAFOLIDE	Folate receptor alpha binding agent	FOLR1	CHEMBL2121	ovarian carcinoma	EFO:0001075	3	BINDING AGENT
GOLVATINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	1	INHIBITOR
GOLVATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	1	INHIBITOR
ABEDITEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	2	AGONIST
ABEDITEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
DANIRIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	Respiratory Syncytial Virus Infection	EFO:1001413	1	ANTAGONIST
DANIRIXIN	Interleukin-8 receptor B antagonist	CXCR2	CHEMBL2434	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
ADUCANUMAB	Beta amyloid A4 protein other	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	3	OTHER
ULOCUPLUMAB	C-X-C chemokine receptor type 4 inhibitor	CXCR4	CHEMBL2107	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ULOCUPLUMAB	C-X-C chemokine receptor type 4 inhibitor	CXCR4	CHEMBL2107	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
ULOCUPLUMAB	C-X-C chemokine receptor type 4 inhibitor	CXCR4	CHEMBL2107	leukemia	EFO:0000565	1	INHIBITOR
ULOCUPLUMAB	C-X-C chemokine receptor type 4 inhibitor	CXCR4	CHEMBL2107	macroglobulinemia	EFO:0002616	1	INHIBITOR
ULOCUPLUMAB	C-X-C chemokine receptor type 4 inhibitor	CXCR4	CHEMBL2107	multiple myeloma	EFO:0001378	1	INHIBITOR
LUSPATERCEPT	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	myelodysplastic syndrome	EFO:0000198	3	ANTAGONIST
LUSPATERCEPT	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	Beta-thalassemia	Orphanet:848	3	ANTAGONIST
LUSPATERCEPT	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	anemia	EFO:0004272	2	ANTAGONIST
LUSPATERCEPT	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	Thalassemia	EFO:1001996	2	ANTAGONIST
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	breast carcinoma	EFO:0000305	3	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	ovarian carcinoma	EFO:0001075	2	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	anaplastic oligodendroglioma	EFO:0002501	2	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	colorectal carcinoma	EFO:1001951	2	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ETIRINOTECAN PEGOL	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
IRINOTECAN SUCROSOFATE	DNA topoisomerase I inhibitor	TOP1	CHEMBL1781	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
PASIREOTIDE	Somatostatin receptor 1 agonist	SSTR1	CHEMBL1917	acromegaly	EFO:1001485	4	AGONIST
PASIREOTIDE	Somatostatin receptor 3 agonist	SSTR3	CHEMBL2028	acromegaly	EFO:1001485	4	AGONIST
PASIREOTIDE	Somatostatin receptor 2 agonist	SSTR2	CHEMBL1804	acromegaly	EFO:1001485	4	AGONIST
PASIREOTIDE	Somatostatin receptor 5 agonist	SSTR5	CHEMBL1792	acromegaly	EFO:1001485	4	AGONIST
RIVENPROST	Prostanoid EP4 receptor agonist	PTGER4	CHEMBL1836	ulcerative colitis	EFO:0000729	2	AGONIST
DUVOGLUSTAT	Lysosomal alpha-glucosidase stabiliser	GAA	CHEMBL2608	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	2	STABILISER
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	alcohol dependence	EFO:0003829	0	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	Parkinson's disease	EFO:0002508	2	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	cocaine dependence	EFO:0002610	2	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	chorea	EFO:0004152	2	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	gastroesophageal reflux disease	EFO:0003948	1	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	Huntington disease	Orphanet:399	2	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	liver disease	EFO:0001421	1	ANTAGONIST
MAVOGLURANT	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	Fragile X syndrome	Orphanet:908	2	ANTAGONIST
GSK239512	Histamine H3 receptor antagonist	HRH3	CHEMBL264	relapsing-remitting multiple sclerosis	EFO:0003929	2	ANTAGONIST
GSK239512	Histamine H3 receptor antagonist	HRH3	CHEMBL264	multiple sclerosis	EFO:0003885	1	ANTAGONIST
GSK239512	Histamine H3 receptor antagonist	HRH3	CHEMBL264	dementia	HP:0000726	1	ANTAGONIST
GSK239512	Histamine H3 receptor antagonist	HRH3	CHEMBL264	Alzheimers disease	EFO:0000249	2	ANTAGONIST
OSI-027	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	1	INHIBITOR
DALCETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	coronary heart disease	EFO:0001645	3	INHIBITOR
DALCETRAPIB	Cholesteryl ester transfer protein inhibitor	CETP	CHEMBL3572	acute coronary syndrome	EFO:0005672	3	INHIBITOR
LEQ506	Smoothened homolog antagonist	SMO	CHEMBL5971	medulloblastoma	EFO:0002939	1	ANTAGONIST
LEQ506	Smoothened homolog antagonist	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	1	ANTAGONIST
SACUBITRIL	Neprilysin inhibitor	MME	CHEMBL1944	myocardial infarction	EFO:0000612	3	INHIBITOR
SACUBITRIL	Neprilysin inhibitor	MME	CHEMBL1944	hypertension	EFO:0000537	2	INHIBITOR
SACUBITRIL	Neprilysin inhibitor	MME	CHEMBL1944	heart failure	EFO:0003144	4	INHIBITOR
SACUBITRIL	Neprilysin inhibitor	MME	CHEMBL1944	congestive heart failure	EFO:0000373	4	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	multiple myeloma	EFO:0001378	3	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	leukemia	EFO:0000565	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	Mantle cell lymphoma	EFO:1001469	3	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoma	EFO:0000574	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	systemic lupus erythematosus	EFO:0002690	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoid leukemia	EFO:0004289	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	AL amyloidosis	Orphanet:85443	1	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
VENETOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	chronic lymphocytic leukemia	EFO:0000095	4	INHIBITOR
AXELOPRAN	Mu opioid receptor antagonist	OPRM1	CHEMBL233	constipation	HP:0002019	2	ANTAGONIST
ESUBERAPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	2	AGONIST
FOSDAGROCORAT	Glucocorticoid receptor modulator	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	2	MODULATOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	breast neoplasm	EFO:0003869	3	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	prostate carcinoma	EFO:0001663	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	breast neoplasm	EFO:0003869	3	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	endometrial neoplasm	EFO:0004230	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	breast carcinoma	EFO:0000305	3	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	endometrial neoplasm	EFO:0004230	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	prostate carcinoma	EFO:0001663	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	breast carcinoma	EFO:0000305	3	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	ovarian carcinoma	EFO:0001075	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	PARP1	CHEMBL3105	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	PARP2	CHEMBL5366	ovarian carcinoma	EFO:0001075	2	INHIBITOR
DEFACTINIB	Protein tyrosine kinase 2 beta inhibitor	PTK2B	CHEMBL5469	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
DEFACTINIB	Protein tyrosine kinase 2 beta inhibitor	PTK2B	CHEMBL5469	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DEFACTINIB	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
DEFACTINIB	Protein tyrosine kinase 2 beta inhibitor	PTK2B	CHEMBL5469	ovarian carcinoma	EFO:0001075	1	INHIBITOR
DEFACTINIB	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DEFACTINIB	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	ovarian carcinoma	EFO:0001075	1	INHIBITOR
DEFACTINIB	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DEFACTINIB	Protein tyrosine kinase 2 beta inhibitor	PTK2B	CHEMBL5469	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FEVIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	3	ANTAGONIST
FEVIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	atopic eczema	EFO:0000274	2	ANTAGONIST
FEVIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	liver disease	EFO:0001421	1	ANTAGONIST
FEVIPIPRANT	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	allergic rhinitis	EFO:0005854	2	ANTAGONIST
DULIGOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
DULIGOTUZUMAB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DULIGOTUZUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DULIGOTUZUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
BIMAGRUMAB	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	cachexia	HP:0004326	2	ANTAGONIST
BIMAGRUMAB	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	hip fracture	EFO:0003964	2	ANTAGONIST
BIMAGRUMAB	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
BIMAGRUMAB	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	inclusion body myositis	EFO:0007323	3	ANTAGONIST
BIMAGRUMAB	Activin receptor type-2B antagonist	ACVR2B	CHEMBL5466	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
NIZATIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	Peptic ulcer	HP:0004398	4	ANTAGONIST
NIZATIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastroesophageal reflux disease	EFO:0003948	4	ANTAGONIST
APALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	3	ANTAGONIST
APALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	liver disease	EFO:0001421	1	ANTAGONIST
APALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
APALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	melanoma	EFO:0000756	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	stomach neoplasm	EFO:0003897	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	ovarian neoplasm	EFO:0003893	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	lung carcinoma	EFO:0001071	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	lymphoma	EFO:0000574	1	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal carcinoma	EFO:1001951	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	thyroid carcinoma	EFO:0002892	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	Ascites	HP:0001541	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	ovarian carcinoma	EFO:0001075	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	central nervous system cancer	EFO:0000326	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast neoplasm	EFO:0003869	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast carcinoma	EFO:0000305	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	esophageal carcinoma	EFO:0002916	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	intrahepatic cholangiocarcinoma	EFO:1001961	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	osteosarcoma	EFO:0000637	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal neoplasm	EFO:0004142	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal cancer	EFO:0005842	3	INHIBITOR
APATINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	liver disease	EFO:0001421	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	leukemia	EFO:0000565	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cutaneous melanoma	EFO:0000389	3	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	cardiac hypertrophy	EFO:0002503	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	carcinoma	EFO:0000313	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	multiple myeloma	EFO:0001378	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	multiple myeloma	EFO:0001378	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	lung carcinoma	EFO:0001071	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	carcinoma	EFO:0000313	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	leukemia	EFO:0000565	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	melanoma	EFO:0000756	3	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cardiac hypertrophy	EFO:0002503	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	cutaneous melanoma	EFO:0000389	3	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	lung carcinoma	EFO:0001071	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	liver disease	EFO:0001421	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	1	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	metastatic melanoma	EFO:0002617	3	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	melanoma	EFO:0000756	3	INHIBITOR
BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	metastatic melanoma	EFO:0002617	3	INHIBITOR
CAPMATINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
GSK-2636771	PI3-kinase p110-beta subunit inhibitor	PIK3CB	CHEMBL3145	metastatic melanoma	EFO:0002617	1	INHIBITOR
GSK-2636771	PI3-kinase p110-beta subunit inhibitor	PIK3CB	CHEMBL3145	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	breast neoplasm	EFO:0003869	2	INHIBITOR
CANERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	2	INHIBITOR
CANERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	lung carcinoma	EFO:0001071	2	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	lung carcinoma	EFO:0001071	2	INHIBITOR
CANERTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	2	INHIBITOR
CANERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	2	INHIBITOR
COPANLISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	4	INHIBITOR
COPANLISIB	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	neoplasm of mature B-cells	EFO:0000096	4	INHIBITOR
BGT-226	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	1	INHIBITOR
BGT-226	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	Cowden syndrome	Orphanet:201	1	INHIBITOR
CAPADENOSON	Adenosine A1 receptor partial agonist	ADORA1	CHEMBL226	atrial fibrillation	EFO:0000275	2	PARTIAL AGONIST
NETAZEPIDE	Cholecystokinin B receptor antagonist	CCKBR	CHEMBL298	Barrett's esophagus	EFO:0000280	2	ANTAGONIST
NETAZEPIDE	Cholecystokinin B receptor antagonist	CCKBR	CHEMBL298	Zollinger-Ellison Syndrome	EFO:0007549	2	ANTAGONIST
NETAZEPIDE	Cholecystokinin B receptor antagonist	CCKBR	CHEMBL298	peptic esophagitis	EFO:1001095	1	ANTAGONIST
NETAZEPIDE	Cholecystokinin B receptor antagonist	CCKBR	CHEMBL298	carcinoid tumor	EFO:0004243	2	ANTAGONIST
ALEPLASININ	Plasminogen activator inhibitor-1 inhibitor	SERPINE1	CHEMBL3475	Alzheimers disease	EFO:0000249	1	INHIBITOR
MGL-3196	Thyroid hormone receptor beta-1 agonist	THRB	CHEMBL1947	familial hypercholesterolemia	EFO:0004911	2	AGONIST
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ENTOSPLETINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
FENOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	3	AGONIST
FENOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	congestive heart failure	EFO:0000373	1	AGONIST
FENOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
FENOTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	obstructive lung disease	HP:0006536	4	AGONIST
IDALOPIRDINE	Serotonin 6 (5-HT6) receptor antagonist	HTR6	CHEMBL3371	Alzheimers disease	EFO:0000249	3	ANTAGONIST
PEGPLERANIB SODIUM	Platelet-derived growth factor subunit B inhibitor	PDGFB	CHEMBL3108633	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
PEGPLERANIB SODIUM	Platelet-derived growth factor subunit B inhibitor	PDGFB	CHEMBL3108633	age-related macular degeneration	EFO:0001365	3	INHIBITOR
EMIBETUZUMAB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
EMIBETUZUMAB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	2	INHIBITOR
ABALOPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoporosis	EFO:0003882	4	AGONIST
ABALOPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	postmenopausal osteoporosis	EFO:0003854	3	AGONIST
PINATUZUMAB VEDOTIN	CD22 binding agent	CD22	CHEMBL3218	chronic lymphocytic leukemia	EFO:0000095	1	BINDING AGENT
PINATUZUMAB VEDOTIN	CD22 binding agent	CD22	CHEMBL3218	diffuse large B-cell lymphoma	EFO:0000403	1	BINDING AGENT
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	bladder carcinoma	EFO:0000292	4	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	melanoma	EFO:0000756	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	prostate carcinoma	EFO:0001663	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	polycythemia vera	EFO:0002429	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	plasmacytoma	EFO:0006738	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	oropharynx cancer	EFO:1001931	0	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	lung carcinoma	EFO:0001071	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	renal cell carcinoma	EFO:0000681	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	lymphoma	EFO:0000574	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	primary myelofibrosis	EFO:0002430	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	breast carcinoma	EFO:0000305	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	large cell lung carcinoma	EFO:0003050	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	mesothelioma	EFO:0000588	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	colorectal carcinoma	EFO:1001951	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	rectum cancer	EFO:1000657	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	colorectal cancer	EFO:0005842	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	squamous cell lung carcinoma	EFO:0000708	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	ovarian carcinoma	EFO:0001075	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	multiple myeloma	EFO:0001378	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	breast neoplasm	EFO:0003869	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	adenocarcinoma	EFO:0000228	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	sarcoma	EFO:0000691	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	thyroid carcinoma	EFO:0002892	1	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	Genital neoplasm, female	EFO:1001331	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	germ cell tumor	EFO:0000514	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	esophageal carcinoma	EFO:0002916	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	bladder tumor	EFO:0000294	4	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	urogenital neoplasm	EFO:0003863	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
TAREXTUMAB	Neurogenic locus notch homolog protein 3 inhibitor	NOTCH3	CHEMBL3407319	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
TAREXTUMAB	Neurogenic locus notch homolog protein 3 inhibitor	NOTCH3	CHEMBL3407319	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
TAREXTUMAB	Neurogenic locus notch homolog protein 2 inhibitor	NOTCH2	CHEMBL3407320	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
TAREXTUMAB	Neurogenic locus notch homolog protein 2 inhibitor	NOTCH2	CHEMBL3407320	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
RALINEPAG	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	2	AGONIST
SOLCITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
SOLCITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	ulcerative colitis	EFO:0000729	1	INHIBITOR
SOLCITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	psoriasis	EFO:0000676	2	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	Crohn's disease	EFO:0000384	3	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	ulcerative colitis	EFO:0000729	3	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	Sjogren syndrome	EFO:0000699	2	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	cutaneous lupus erythematosus	EFO:0003834	2	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	uveitis	EFO:1001231	2	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	ankylosing spondylitis	EFO:0003898	2	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
FILGOTINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	psoriatic arthritis	EFO:0003778	2	INHIBITOR
TOREFORANT	Histamine H4 receptor antagonist	HRH4	CHEMBL3759	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoma	EFO:0000574	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	rhabdomyosarcoma	EFO:0002918	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast carcinoma	EFO:0000305	4	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	dedifferentiated liposarcoma	EFO:0003085	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	mesothelioma	EFO:0000588	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	melanoma	EFO:0000756	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast carcinoma	EFO:0000305	4	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	osteosarcoma	EFO:0000637	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Ewing sarcoma	EFO:0000174	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast neoplasm	EFO:0003869	4	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Ewing sarcoma	EFO:0000174	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoma	EFO:0000574	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	brain neoplasm	EFO:0003833	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	colorectal carcinoma	EFO:1001951	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	neuroblastoma	EFO:0000621	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	mesothelioma	EFO:0000588	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	dedifferentiated liposarcoma	EFO:0003085	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	melanoma	EFO:0000756	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast neoplasm	EFO:0003869	4	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	upper aerodigestive tract neoplasm	EFO:0004284	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	malignant rhabdoid tumour	EFO:0005701	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	osteosarcoma	EFO:0000637	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	brain neoplasm	EFO:0003833	2	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	colorectal carcinoma	EFO:1001951	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	neuroblastoma	EFO:0000621	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	malignant rhabdoid tumour	EFO:0005701	1	INHIBITOR
ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	multiple myeloma	EFO:0001378	2	INHIBITOR
ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	3	INHIBITOR
ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	metastatic melanoma	EFO:0002617	3	INHIBITOR
ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	1	INHIBITOR
ENCORAFENIB	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	liver disease	EFO:0001421	1	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	liver disease	EFO:0001421	1	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
GILTERITINIB	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
SETMELANOTIDE	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	Prader-Willi syndrome	Orphanet:739	2	AGONIST
SETMELANOTIDE	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	morbid obesity	EFO:0001074	1	AGONIST
SETMELANOTIDE	Melanocortin receptor 4 agonist	MC4R	CHEMBL259	obesity	EFO:0001073	3	AGONIST
SPEBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
SPEBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
SPEBRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	leukemia	EFO:0000565	1	INHIBITOR
BASIMGLURANT	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	Fragile X syndrome	Orphanet:908	2	MODULATOR
CARBETOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	preeclampsia	EFO:0000668	3	AGONIST
CARBETOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	hemorrhage	MP:0001914	3	AGONIST
LUMATEPERONE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Alzheimers disease	EFO:0000249	1	INHIBITOR
LUMATEPERONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Alzheimers disease	EFO:0000249	1	ANTAGONIST
LUMATEPERONE	Dopamine D2 receptor partial agonist	DRD2	CHEMBL217	Alzheimers disease	EFO:0000249	1	PARTIAL AGONIST
SAVOLITINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	renal cell carcinoma	EFO:0000681	3	INHIBITOR
SAVOLITINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
SAVOLITINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SAVOLITINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	prostate carcinoma	EFO:0001663	2	INHIBITOR
SAVOLITINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
CANGRELOR	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	myocardial infarction	EFO:0000612	4	ANTAGONIST
CANGRELOR	Purinergic receptor P2Y12 antagonist	P2RY12	CHEMBL2001	Recurrent thrombophlebitis	HP:0004419	4	ANTAGONIST
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal cancer	EFO:0005842	2	INHIBITOR
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	3	INHIBITOR
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	respiratory system neoplasm	EFO:0003853	2	INHIBITOR
OSIMERTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	adenocarcinoma	EFO:0000228	2	INHIBITOR
ETRASIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	ulcerative colitis	EFO:0000729	2	AGONIST
ETRASIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	inflammatory bowel disease	EFO:0003767	2	AGONIST
ETRASIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	primary biliary cirrhosis	EFO:1001486	2	AGONIST
ETRASIMOD	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	pyoderma	HP:0000999	2	AGONIST
TEPOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	ALOX12	CHEMBL3687	rheumatic disease	EFO:0005755	4	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	stricture	EFO:0006818	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	uveitis	EFO:1001231	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	brain neoplasm	EFO:0003833	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	cervical carcinoma	EFO:0001061	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	sensorineural hearing loss	EFO:1001176	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	ulcerative colitis	EFO:0000729	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	mesothelioma	EFO:0000588	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	lymphoid neoplasm	EFO:0001642	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	medulloblastoma	EFO:0002939	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	coronary artery disease	EFO:0000378	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Myasthenia gravis	EFO:0004991	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	ependymoma	EFO:1000028	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	HIV infection	EFO:0000764	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Gestational trophoblastic neoplasm	Orphanet:59305	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	retinopathy	EFO:0003839	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	dermatomyositis	EFO:0000398	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	alopecia areata	EFO:0004192	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Merkel cell skin cancer	EFO:1001471	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Langerhans Cell Histiocytosis	EFO:1000318	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	T-cell acute lymphoblastic leukemia	EFO:0000209	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Hodgkins lymphoma	EFO:0000183	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	systemic lupus erythematosus	EFO:0002690	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	systemic scleroderma	EFO:0000717	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	inflammation	MP:0001845	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	osteoarthritis	EFO:0002506	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	ovarian carcinoma	EFO:0001075	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	sarcoma	EFO:0000691	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Lymphoma, AIDS-Related	EFO:1001365	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	renal carcinoma	EFO:0002890	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	breast carcinoma	EFO:0000305	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	central nervous system cancer	EFO:0000326	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	myelodysplastic syndrome	EFO:0000198	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Osteopetrosis	Orphanet:2781	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	mycosis fungoides	EFO:1001051	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	primary biliary cirrhosis	EFO:1001486	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	multiple myeloma	EFO:0001378	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	multiple sclerosis	EFO:0003885	0	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	lymphoma	EFO:0000574	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	breast neoplasm	EFO:0003869	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	osteosarcoma	EFO:0000637	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	colorectal cancer	EFO:0005842	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	plasma cell leukemia	EFO:0006475	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	chronic myelomonocytic leukemia	EFO:1001779	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	atopic eczema	EFO:0000274	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	temporal arteritis	EFO:1001209	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	ankylosing spondylitis	EFO:0003898	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	acute promyelocytic leukemia	EFO:0000224	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	polymyositis	EFO:0003063	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	cutaneous melanoma	EFO:0000389	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	bullous pemphigoid	EFO:0007187	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	myeloproliferative disorder	EFO:0004251	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	choroid plexus cancer	EFO:0007206	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	lymphoid leukemia	EFO:0004289	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	urethral neoplasm	EFO:0003846	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Fanconi anemia	Orphanet:84	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	leukemia	EFO:0000565	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	aplastic anemia	HP:0001915	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	psoriasis	EFO:0000676	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	primitive neuroectodermal tumor	EFO:0005235	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Juvenile Myelomonocytic Leukemia	EFO:1000309	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	malaria	EFO:0001068	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Burkitts lymphoma	EFO:0000309	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	colorectal carcinoma	EFO:1001951	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	primary myelofibrosis	EFO:0002430	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	upper aerodigestive tract neoplasm	EFO:0004284	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Sickle cell anemia	Orphanet:232	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	urticaria	EFO:0005531	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	myocardial infarction	EFO:0000612	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Hydatidiform Mole	EFO:1000298	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	B-cell acute lymphoblastic leukemia	EFO:0000094	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	anaplastic large cell lymphoma	EFO:0003032	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	posterior uveitis	EFO:1001119	1	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Crohn's disease	EFO:0000384	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	asthma	EFO:0000270	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	bladder carcinoma	EFO:0000292	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Wegener's granulomatosis	EFO:0005297	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	psoriatic arthritis	EFO:0003778	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	unspecified peripheral T-cell lymphoma	EFO:0000211	2	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	juvenile dermatomyositis	EFO:0000557	3	INHIBITOR
METHOTREXATE	Dihydrofolate reductase inhibitor	DHFR	CHEMBL202	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Autosomal dominant polycystic kidney disease	EFO:1001496	3	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	kidney disease	EFO:0003086	2	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	congestive heart failure	EFO:0000373	3	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	cardiac edema	EFO:1001771	3	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Hyponatremia	HP:0002902	4	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	cirrhosis of liver	EFO:0001422	3	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	heart failure	EFO:0003144	3	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	nephrolithiasis	EFO:0004253	1	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	carcinoma	EFO:0000313	2	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	chronic kidney disease	EFO:0003884	2	ANTAGONIST
TOLVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	inappropriate ADH syndrome	EFO:1000982	3	ANTAGONIST
PICLOZOTAN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	stroke	EFO:0000712	2	AGONIST
PICLOZOTAN	Serotonin 1a (5-HT1a) receptor agonist	HTR1A	CHEMBL214	Parkinson's disease	EFO:0002508	2	AGONIST
TARIQUIDAR	P-glycoprotein 1 inhibitor	ABCB1	CHEMBL4302	adrenal cortex carcinoma	EFO:1000796	2	INHIBITOR
TARIQUIDAR	P-glycoprotein 1 inhibitor	ABCB1	CHEMBL4302	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
LY2452473	Androgen Receptor modulator	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	2	MODULATOR
LY2452473	Androgen Receptor modulator	AR	CHEMBL1871	erectile dysfunction	EFO:0004234	2	MODULATOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	colorectal neoplasm	EFO:0004142	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	squamous cell lung carcinoma	EFO:0000708	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	upper aerodigestive tract neoplasm	EFO:0004284	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	squamous cell lung carcinoma	EFO:0000708	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	colorectal neoplasm	EFO:0004142	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	ovarian carcinoma	EFO:0001075	2	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	upper aerodigestive tract neoplasm	EFO:0004284	1	INHIBITOR
PREXASERTIB	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VIXOTRIGINE	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	neuropathic pain	EFO:0005762	1	BLOCKER
VIXOTRIGINE	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	trigeminal neuralgia	EFO:1001219	2	BLOCKER
TEZACAFTOR	Cystic fibrosis transmembrane conductance regulator positive modulator	CFTR	CHEMBL4051	Cystic fibrosis	Orphanet:586	4	POSITIVE MODULATOR
ONO-4059	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
ONO-4059	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ONO-4059	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	Sjogren syndrome	EFO:0000699	2	INHIBITOR
PF-04965842	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	psoriasis	EFO:0000676	2	INHIBITOR
PF-04965842	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	atopic eczema	EFO:0000274	3	INHIBITOR
TAK-659	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
TAK-659	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
TAK-659	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	lymphoma	EFO:0000574	1	INHIBITOR
TAK-659	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TAK-659	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	primary myelofibrosis	EFO:0002430	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	multiple myeloma	EFO:0001378	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	macroglobulinemia	EFO:0002616	1	INHIBITOR
TAK-901	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	lymphoma	EFO:0000574	1	INHIBITOR
VS-4718	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
VS-4718	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VS-4718	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
X-396	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
XL-844	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	lymphoma	EFO:0000574	1	INHIBITOR
XL-844	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	lymphoma	EFO:0000574	1	INHIBITOR
XL-844	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
XL-844	Serine/threonine-protein kinase Chk2 inhibitor	CHEK2	CHEMBL2527	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
SAR-113945	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	osteoarthritis	EFO:0002506	2	INHIBITOR
PF-06291874	Glucagon receptor antagonist	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
BURAPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	overactive bladder	EFO:1000781	2	ANTAGONIST
KLH-2109	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	endometriosis	EFO:0001065	2	ANTAGONIST
PF-04531083	Sodium channel protein type X alpha subunit blocker	SCN10A	CHEMBL5451	pain	EFO:0003843	2	BLOCKER
RG3487	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	2	PARTIAL AGONIST
SAF312	Vanilloid receptor inhibitor	TRPV1	CHEMBL4794	pain	EFO:0003843	2	INHIBITOR
SAF312	Vanilloid receptor inhibitor	TRPV1	CHEMBL4794	Neurogenic bladder	HP:0000011	2	INHIBITOR
ZOPTARELIN DOXORUBICIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	breast carcinoma	EFO:0000305	2	AGONIST
ZOPTARELIN DOXORUBICIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	carcinoma	EFO:0000313	1	AGONIST
ZOPTARELIN DOXORUBICIN	Gonadotropin-releasing hormone receptor agonist	GNRHR	CHEMBL1855	endometrial neoplasm	EFO:0004230	3	AGONIST
PYROTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	1	INHIBITOR
PYROTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PYROTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	3	INHIBITOR
PYROTINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	1	INHIBITOR
PYROTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	3	INHIBITOR
PYROTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DS-3078A	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	1	INHIBITOR
GSK-2256098	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	Meningioma	Orphanet:2495	2	INHIBITOR
GSK-2256098	Focal adhesion kinase 1 inhibitor	PTK2	CHEMBL2695	pulmonary hypertension	EFO:0001361	1	INHIBITOR
GSK-610677	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	1	INHIBITOR
HM-71224	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
TESEVATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
TESEVATINIB	Ephrin type-B receptor 4 inhibitor	EPHB4	CHEMBL5147	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
TESEVATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
TESEVATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	1	INHIBITOR
TESEVATINIB	Ephrin type-B receptor 4 inhibitor	EPHB4	CHEMBL5147	breast carcinoma	EFO:0000305	1	INHIBITOR
TESEVATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
TESEVATINIB	Ephrin type-B receptor 4 inhibitor	EPHB4	CHEMBL5147	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
TESEVATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	Autosomal dominant polycystic kidney disease	EFO:1001496	2	INHIBITOR
TESEVATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	1	INHIBITOR
TRADIPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	atopic eczema	EFO:0000274	2	ANTAGONIST
TRADIPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	gastroparesis	EFO:1000948	2	ANTAGONIST
TRADIPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Pruritus	HP:0000989	1	ANTAGONIST
TRADIPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	alcohol dependence	EFO:0003829	2	ANTAGONIST
DOMAGROZUMAB	Growth/differentiation factor 8 inhibitor	MSTN	CHEMBL3407325	Duchenne muscular dystrophy	Orphanet:98896	2	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	2	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast neoplasm	EFO:0003869	1	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	colorectal neoplasm	EFO:0004142	1	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	2	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	mesothelioma	EFO:0000588	1	INHIBITOR
LY-3023414	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	1	INHIBITOR
MK-8353	MAP kinase ERK2 inhibitor	MAPK1	CHEMBL4040	colorectal carcinoma	EFO:1001951	1	INHIBITOR
MK-8353	MAP kinase ERK1 inhibitor	MAPK3	CHEMBL3385	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	Histiocytosis	HP:0100727	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	thyroid carcinoma	EFO:0002892	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	cholangiocarcinoma	EFO:0005221	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	hairy cell leukemia	EFO:1000956	1	INHIBITOR
PLX-8394	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PBF-509	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	1	ANTAGONIST
PBF-509	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
ORDOPIDINE	Dopamine D2 receptor modulator	DRD2	CHEMBL217	Parkinson's disease	EFO:0002508	1	MODULATOR
RAD1901	Estrogen receptor alpha degrader	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	1	DEGRADER
CB-03-01	Androgen Receptor antagonist	AR	CHEMBL1871	acne	EFO:0003894	3	ANTAGONIST
CB-03-01	Androgen Receptor antagonist	AR	CHEMBL1871	androgenetic alopecia	EFO:0004191	2	ANTAGONIST
GTX-758	Estrogen receptor alpha agonist	ESR1	CHEMBL206	prostate carcinoma	EFO:0001663	2	AGONIST
MBX-2044	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	2	MODULATOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Ewing sarcoma	EFO:0000174	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	Ewing sarcoma	EFO:0000174	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gastric carcinoma	EFO:0000178	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Ewing sarcoma	EFO:0000174	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	gastric carcinoma	EFO:0000178	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	Ewing sarcoma	EFO:0000174	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	esophageal squamous cell carcinoma	EFO:0005922	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	2	INHIBITOR
ANLOTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ANLOTINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ANLOTINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ULIXERTINIB	MAP kinase ERK1 inhibitor	MAPK3	CHEMBL3385	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ULIXERTINIB	MAP kinase ERK1 inhibitor	MAPK3	CHEMBL3385	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ULIXERTINIB	MAP kinase ERK2 inhibitor	MAPK1	CHEMBL4040	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ULIXERTINIB	MAP kinase ERK2 inhibitor	MAPK1	CHEMBL4040	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
ULIXERTINIB	MAP kinase ERK1 inhibitor	MAPK3	CHEMBL3385	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
ULIXERTINIB	MAP kinase ERK2 inhibitor	MAPK1	CHEMBL4040	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	2	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	breast neoplasm	EFO:0003869	2	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast neoplasm	EFO:0003869	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FAMITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast neoplasm	EFO:0003869	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	breast neoplasm	EFO:0003869	2	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	3	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	renal cell carcinoma	EFO:0000681	2	INHIBITOR
FAMITINIB	Vascular endothelial growth factor receptor 3 inhibitor	FLT4	CHEMBL1955	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FAMITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
XL-281	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal carcinoma	EFO:1001951	1	INHIBITOR
XL-281	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	melanoma	EFO:0000756	1	INHIBITOR
XL-281	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
XL-281	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
XL-281	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	1	INHIBITOR
XL-281	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
XL-281	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal carcinoma	EFO:1001951	1	INHIBITOR
XL-281	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
ABT-288	Histamine H3 receptor antagonist	HRH3	CHEMBL264	Alzheimers disease	EFO:0000249	2	ANTAGONIST
JNJ-17216498	Histamine H3 receptor antagonist	HRH3	CHEMBL264	narcolepsy with cataplexy	EFO:0000614	2	ANTAGONIST
MK-1029	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
PF-04634817	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
PF-04634817	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
LY2828360	Cannabinoid CB2 receptor agonist	CNR2	CHEMBL253	osteoarthritis	EFO:0002506	2	AGONIST
REVEXEPRIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	gastroesophageal reflux disease	EFO:0003948	2	AGONIST
STX107	Metabotropic glutamate receptor 5 negative allosteric modulator	GRM5	CHEMBL3227	Fragile X syndrome	Orphanet:908	2	NEGATIVE ALLOSTERIC MODULATOR
AZD1386	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	pain	EFO:0003843	2	ANTAGONIST
AZD1386	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	neuropathic pain	EFO:0005762	2	ANTAGONIST
AZD7009	HERG blocker	KCNH2	CHEMBL240	atrial fibrillation	EFO:0000275	2	BLOCKER
AZD7009	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	atrial fibrillation	EFO:0000275	2	BLOCKER
ASAPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
GSK2849466	Androgen Receptor modulator	AR	CHEMBL1871	cachexia	HP:0004326	1	MODULATOR
BMS-852927	LXR-beta modulator	NR1H2	CHEMBL4093	hypercholesterolemia	HP:0003124	1	MODULATOR
BMS-852927	LXR-alpha modulator	NR1H3	CHEMBL2808	hypercholesterolemia	HP:0003124	1	MODULATOR
AMG-319	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
AMG-319	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
AMG-319	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
AMG-319	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
INCB-40093	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
INK-128	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
INK-128	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	lymphoma	EFO:0000574	1	INHIBITOR
SERIBANTUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	breast carcinoma	EFO:0000305	2	INHIBITOR
LANDOGROZUMAB	Growth/differentiation factor 8 inhibitor	MSTN	CHEMBL3407325	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
LANDOGROZUMAB	Growth/differentiation factor 8 inhibitor	MSTN	CHEMBL3407325	muscular disease	EFO:0002970	2	INHIBITOR
LY-2584702	Ribosomal protein S6 kinase 1 inhibitor	RPS6KB1	CHEMBL4501	renal cell carcinoma	EFO:0000681	1	INHIBITOR
LY-2584702	Ribosomal protein S6 kinase 1 inhibitor	RPS6KB1	CHEMBL4501	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
PLX-5622	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 5 inhibitor	CDK5	CHEMBL4036	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
RGB-286638	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
XL-228	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
XL-228	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
XL-228	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
XL-228	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	lymphoma	EFO:0000574	1	INHIBITOR
XL-228	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lymphoma	EFO:0000574	1	INHIBITOR
XL-228	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
LY2881835	Free fatty acid receptor 1 agonist	FFAR1	CHEMBL4422	type II diabetes mellitus	EFO:0001360	1	AGONIST
GSK159802	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
ZYH7	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hypertriglyceridemia	EFO:0004211	2	AGONIST
ZYH7	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	2	AGONIST
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	macroglobulinemia	EFO:0002616	1	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	Merkel cell skin cancer	EFO:1001471	1	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast neoplasm	EFO:0003869	2	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	2	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	multiple myeloma	EFO:0001378	1	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	2	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	renal cell carcinoma	EFO:0000681	2	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SAPANISERTIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	2	INHIBITOR
ASP7991	Calcium sensing receptor positive allosteric modulator	CASR	CHEMBL1878	secondary hyperparathyroidism	EFO:1001173	2	POSITIVE ALLOSTERIC MODULATOR
KRP203	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	ulcerative colitis	EFO:0000729	2	AGONIST
KRP203	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	cutaneous lupus erythematosus	EFO:0003834	2	AGONIST
KRP203	Sphingosine 1-phosphate receptor Edg-1 agonist	S1PR1	CHEMBL4333	lymphoid neoplasm	EFO:0001642	1	AGONIST
AZD3199	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	2	AGONIST
AZD3199	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
MODIMELANOTIDE	Melanocortin receptor 3 agonist	MC3R	CHEMBL4644	aortic aneurysm	EFO:0001666	2	AGONIST
MODIMELANOTIDE	Melanocortin receptor 1 agonist	MC1R	CHEMBL3795	aortic aneurysm	EFO:0001666	2	AGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	acute myeloid leukemia	EFO:0000222	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	non-Hodgkins lymphoma	EFO:0005952	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	breast carcinoma	EFO:0000305	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	myelodysplastic syndrome	EFO:0000198	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	acute lymphoblastic leukemia	EFO:0000220	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	chronic lymphocytic leukemia	EFO:0000095	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	chronic myelogenous leukemia	EFO:0000339	1	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	multiple myeloma	EFO:0001378	2	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	myocardial infarction	EFO:0000612	2	ANTAGONIST
POL6326	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	myeloproliferative disorder	EFO:0004251	1	ANTAGONIST
TM30339	Neuropeptide Y receptor type 4 agonist	NPY4R	CHEMBL4877	obesity	EFO:0001073	2	AGONIST
AZD9056	P2X purinoceptor 7 antagonist	P2RX7	CHEMBL4805	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
ARRY-502	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	glioma	EFO:0005543	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast carcinoma	EFO:0000305	4	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	neuroblastoma	EFO:0000621	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast carcinoma	EFO:0000305	3	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	metastatic prostate cancer	EFO:0000196	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoma	EFO:0000574	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	neuroblastoma	EFO:0000621	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	melanoma	EFO:0000756	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	central nervous system cancer	EFO:0000326	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	prostate carcinoma	EFO:0001663	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	prostate carcinoma	EFO:0001663	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	malignant rhabdoid tumour	EFO:0005701	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast carcinoma	EFO:0000305	4	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	colorectal carcinoma	EFO:1001951	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	ovarian carcinoma	EFO:0001075	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast neoplasm	EFO:0003869	3	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast carcinoma	EFO:0000305	3	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	glioma	EFO:0005543	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	melanoma	EFO:0000756	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	malignant rhabdoid tumour	EFO:0005701	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	colorectal carcinoma	EFO:1001951	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	primary myelofibrosis	EFO:0002430	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	liposarcoma	EFO:0000569	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	dedifferentiated liposarcoma	EFO:0003085	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoma	EFO:0000574	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	dedifferentiated liposarcoma	EFO:0003085	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	metastatic prostate cancer	EFO:0000196	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	central nervous system cancer	EFO:0000326	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	primary myelofibrosis	EFO:0002430	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	liposarcoma	EFO:0000569	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	uterine neoplasm	EFO:0003859	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast neoplasm	EFO:0003869	3	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	ovarian carcinoma	EFO:0001075	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	uterine neoplasm	EFO:0003859	2	INHIBITOR
HEMAY-022	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	1	INHIBITOR
ME-401	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
ME-401	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
ABL-001	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
ABL-001	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
EPITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
ISATUXIMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ISATUXIMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	multiple myeloma	EFO:0001378	3	INHIBITOR
ISATUXIMAB	Lymphocyte differentiation antigen CD38 inhibitor	CD38	CHEMBL4660	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
MIRVETUXIMAB SORAVTANSINE	Folate receptor alpha binding agent	FOLR1	CHEMBL2121	breast neoplasm	EFO:0003869	2	BINDING AGENT
MIRVETUXIMAB SORAVTANSINE	Folate receptor alpha binding agent	FOLR1	CHEMBL2121	breast carcinoma	EFO:0000305	2	BINDING AGENT
RP-6530	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	lymphoma	EFO:0000574	1	INHIBITOR
RP-6530	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
RP-6530	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
RP-6530	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	lymphoma	EFO:0000574	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	multiple myeloma	EFO:0001378	1	INHIBITOR
CC-223	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	1	INHIBITOR
CT-327	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	psoriasis	EFO:0000676	2	INHIBITOR
CT-327	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	atopic eczema	EFO:0000274	2	INHIBITOR
CT-327	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	neuropathic pain	EFO:0005762	1	INHIBITOR
JI-101	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colon carcinoma	EFO:1001950	1	INHIBITOR
JI-101	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	ovarian carcinoma	EFO:0001075	1	INHIBITOR
JI-101	Ephrin type-B receptor 4 inhibitor	EPHB4	CHEMBL5147	colon carcinoma	EFO:1001950	1	INHIBITOR
JI-101	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	ovarian carcinoma	EFO:0001075	1	INHIBITOR
JI-101	Ephrin type-B receptor 4 inhibitor	EPHB4	CHEMBL5147	ovarian carcinoma	EFO:0001075	1	INHIBITOR
JI-101	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	colon carcinoma	EFO:1001950	1	INHIBITOR
KW-2450	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	1	INHIBITOR
KW-2450	Insulin receptor inhibitor	INSR	CHEMBL1981	breast carcinoma	EFO:0000305	1	INHIBITOR
TIDEGLUSIB	Glycogen synthase kinase-3 beta inhibitor	GSK3B	CHEMBL262	Myotonic dystrophy	Orphanet:206647	2	INHIBITOR
TIDEGLUSIB	Glycogen synthase kinase-3 beta inhibitor	GSK3B	CHEMBL262	Alzheimers disease	EFO:0000249	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	melanoma	EFO:0000756	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	melanoma	EFO:0000756	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	pigmented villonodular synovitis	EFO:1001106	3	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pigmented villonodular synovitis	EFO:1001106	3	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast neoplasm	EFO:0003869	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast neoplasm	EFO:0003869	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate carcinoma	EFO:0001663	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate carcinoma	EFO:0001663	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	metastatic melanoma	EFO:0002617	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
PLX-3397	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	metastatic melanoma	EFO:0002617	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
PLX-3397	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	metastatic melanoma	EFO:0002617	2	INHIBITOR
PLX-3397	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	pigmented villonodular synovitis	EFO:1001106	3	INHIBITOR
R-333	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
R-333	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
LY545694	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	diabetic neuropathy	EFO:1000783	2	ANTAGONIST
LY545694	Metabotropic glutamate receptor 5 antagonist	GRM5	CHEMBL3227	osteoarthritis	EFO:0002506	2	ANTAGONIST
PBF-680	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	asthma	EFO:0000270	2	ANTAGONIST
AZD2066	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	neuropathic pain	EFO:0005762	2	MODULATOR
AZD2066	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	diabetic neuropathy	EFO:1000783	2	MODULATOR
AZD2066	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	gastroesophageal reflux disease	EFO:0003948	1	MODULATOR
AZD2066	Metabotropic glutamate receptor 5 modulator	GRM5	CHEMBL3227	pain	EFO:0003843	2	MODULATOR
AFACIFENACIN	Sodium channel protein type X alpha subunit blocker	SCN10A	CHEMBL5451	overactive bladder	EFO:1000781	2	BLOCKER
DRINABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	Alzheimers disease	EFO:0000249	1	ANTAGONIST
FE 202767	Oxytocin receptor agonist	OXTR	CHEMBL2049	premature birth	EFO:0003917	2	AGONIST
IMD-1041	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	IKBKB	CHEMBL1991	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
AZD1305	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	atrial flutter	EFO:0003911	2	BLOCKER
AZD1305	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	atrial fibrillation	EFO:0000275	2	BLOCKER
AZD1305	HERG blocker	KCNH2	CHEMBL240	atrial flutter	EFO:0003911	2	BLOCKER
AZD1305	HERG blocker	KCNH2	CHEMBL240	atrial fibrillation	EFO:0000275	2	BLOCKER
PF-05089771	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	Erythromelalgia	Orphanet:1956	2	BLOCKER
PF-05089771	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	pain	EFO:0003843	2	BLOCKER
PF-05089771	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	diabetic neuropathy	EFO:1000783	2	BLOCKER
CNV2197944	Voltage-gated N-type calcium channel alpha-1B subunit blocker	CACNA1B	CHEMBL4478	diabetic neuropathy	EFO:1000783	2	BLOCKER
GSK2881078	Androgen Receptor modulator	AR	CHEMBL1871	cachexia	HP:0004326	2	MODULATOR
PF-03882845	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	1	ANTAGONIST
PF-03882845	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	type II diabetes mellitus	EFO:0001360	1	ANTAGONIST
DB959	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Alzheimers disease	EFO:0000249	1	AGONIST
DB959	Peroxisome proliferator-activated receptor delta agonist	PPARD	CHEMBL3979	Alzheimers disease	EFO:0000249	1	AGONIST
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	lymphoma	EFO:0000574	1	INHIBITOR
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	breast carcinoma	EFO:0000305	2	INHIBITOR
AZD-6738	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
AZD-7451	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AZD-7451	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AZD-7451	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VELCALCETIDE	Calcium sensing receptor agonist	CASR	CHEMBL1878	secondary hyperparathyroidism	EFO:1001173	4	AGONIST
VELCALCETIDE	Calcium sensing receptor agonist	CASR	CHEMBL1878	chronic kidney disease	EFO:0003884	1	AGONIST
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	multiple myeloma	EFO:0001378	3	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	prostate carcinoma	EFO:0001663	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	dedifferentiated liposarcoma	EFO:0003085	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	melanoma	EFO:0000756	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	Thymoma	EFO:1000581	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	breast carcinoma	EFO:0000305	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	rectum cancer	EFO:1000657	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	colorectal neoplasm	EFO:0004142	1	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
SELINEXOR	Exportin-1 inhibitor	XPO1	CHEMBL5661	diabetic foot	EFO:1001459	1	INHIBITOR
LANADELUMAB	Plasma kallikrein inhibitor	KLKB1	CHEMBL2000	Hereditary angioedema	Orphanet:91378	3	INHIBITOR
MSC-2364447	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	systemic lupus erythematosus	EFO:0002690	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase A-Raf inhibitor	ARAF	CHEMBL1169596	melanoma	EFO:0000756	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	colorectal neoplasm	EFO:0004142	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase A-Raf inhibitor	ARAF	CHEMBL1169596	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	colorectal neoplasm	EFO:0004142	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	melanoma	EFO:0000756	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase RAF inhibitor	RAF1	CHEMBL1906	melanoma	EFO:0000756	1	INHIBITOR
LY-3009120	Serine/threonine-protein kinase A-Raf inhibitor	ARAF	CHEMBL1169596	colorectal neoplasm	EFO:0004142	1	INHIBITOR
RG-7741	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	lymphoma	EFO:0000574	1	INHIBITOR
GSK1482160	P2X purinoceptor 7 negative allosteric modulator	P2RX7	CHEMBL4805	pain	EFO:0003843	1	NEGATIVE ALLOSTERIC MODULATOR
AZD3161	Sodium channel protein type IX alpha subunit blocker	SCN9A	CHEMBL4296	neuropathic pain	EFO:0005762	1	BLOCKER
SR16234	Estrogen receptor alpha antagonist	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	2	ANTAGONIST
AMG-337	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	sarcoma	EFO:0000691	2	INHIBITOR
AMG-337	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	stomach neoplasm	EFO:0003897	2	INHIBITOR
AMG-337	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
AMG-337	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	2	INHIBITOR
FX-005	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	osteoarthritis	EFO:0002506	1	INHIBITOR
NS-018	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	1	INHIBITOR
VORUCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
VORUCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	melanoma	EFO:0000756	1	INHIBITOR
LY2590443	Serotonin 7 (5-HT7) receptor antagonist	HTR7	CHEMBL3155	migraine disorder	EFO:0003821	2	ANTAGONIST
AZD2423	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	neuropathic pain	EFO:0005762	2	ANTAGONIST
AZD2423	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
AZD2423	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	pain	EFO:0003843	2	ANTAGONIST
AZD8683	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
GW493838	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	neuropathic pain	EFO:0005762	2	AGONIST
BURIXAFOR	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	multiple myeloma	EFO:0001378	2	ANTAGONIST
BURIXAFOR	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	non-Hodgkins lymphoma	EFO:0005952	2	ANTAGONIST
BURIXAFOR	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	Hodgkins lymphoma	EFO:0000183	2	ANTAGONIST
BURIXAFOR	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	prostate carcinoma	EFO:0001663	1	ANTAGONIST
INCB-047986	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
INCB-047986	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
INCB-047986	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
INCB-047986	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	breast carcinoma	EFO:0000305	1	INHIBITOR
NGD-8243	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	pain	EFO:0003843	2	ANTAGONIST
ABT-126	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	2	AGONIST
AQW051	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	2	PARTIAL AGONIST
EGF816	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
EGF816	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	2	INHIBITOR
SIMOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
BPI-9016	Tyrosine-protein kinase receptor UFO inhibitor	AXL	CHEMBL4895	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
BPI-9016	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
HE3235	Androgen Receptor modulator	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	1	MODULATOR
PF-05019702	Progesterone receptor antagonist	PGR	CHEMBL208	uterine fibroid	EFO:0000731	1	ANTAGONIST
AC-430	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
CAL-263	PI3-kinase p110-gamma subunit inhibitor	PIK3CG	CHEMBL3267	allergic rhinitis	EFO:0005854	1	INHIBITOR
CAL-263	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	allergic rhinitis	EFO:0005854	1	INHIBITOR
DS-7423	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	1	INHIBITOR
DS-7423	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	colorectal carcinoma	EFO:1001951	1	INHIBITOR
GSK-2269557	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
GSK-2269557	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	asthma	EFO:0000270	1	INHIBITOR
SULFATINIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
SULFATINIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	thyroid carcinoma	EFO:0002892	2	INHIBITOR
VANUCIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	colorectal carcinoma	EFO:1001951	2	INHIBITOR
SAR425899	Glucagon receptor agonist	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	2	AGONIST
PBF-999	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Huntington disease	Orphanet:399	1	ANTAGONIST
PBF-999	Phosphodiesterase 10A inhibitor	PDE10A	CHEMBL4409	Huntington disease	Orphanet:399	1	INHIBITOR
LAS190792	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	1	AGONIST
LAS190792	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
LAS190792	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	1	ANTAGONIST
LAS190792	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	1	AGONIST
LY2623091	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	chronic kidney disease	EFO:0003884	2	ANTAGONIST
CP-778875	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	2	AGONIST
AKN-028	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
KC-706	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	pemphigus vulgaris	EFO:0004719	2	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase TYK2 inhibitor	TYK2	CHEMBL3553	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase TYK2 inhibitor	TYK2	CHEMBL3553	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CERDULATINIB	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	ovarian carcinoma	EFO:0001075	2	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian carcinoma	EFO:0001075	2	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	2	INHIBITOR
XL-999	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
XL-999	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	2	INHIBITOR
CCX140	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
CCX140	C-C chemokine receptor type 2 antagonist	CCR2	CHEMBL4015	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
LY2624803	Histamine H1 receptor antagonist	HRH1	CHEMBL231	insomnia	EFO:0004698	2	ANTAGONIST
V81444	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	1	ANTAGONIST
QBW251	Cystic fibrosis transmembrane conductance regulator activator	CFTR	CHEMBL4051	chronic obstructive pulmonary disease	EFO:0000341	2	ACTIVATOR
QBW251	Cystic fibrosis transmembrane conductance regulator activator	CFTR	CHEMBL4051	Cystic fibrosis	Orphanet:586	1	ACTIVATOR
FGF401	Fibroblast growth factor receptor 4 inhibitor	FGFR4	CHEMBL3973	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
ODM-201	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
ODM-201	Androgen Receptor antagonist	AR	CHEMBL1871	breast carcinoma	EFO:0000305	0	ANTAGONIST
ODM-201	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
PEXMETINIB	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
PEXMETINIB	Tyrosine-protein kinase TIE-2 inhibitor	TEK	CHEMBL4128	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
HMPL-523	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	rheumatoid arthritis	EFO:0000685	1	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	cutaneous melanoma	EFO:0000389	1	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	colorectal carcinoma	EFO:1001951	1	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
MERESTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	breast carcinoma	EFO:0000305	1	INHIBITOR
ROCILETINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
BRIGATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
BRIGATINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
RINUCUMAB	Platelet-derived growth factor subunit B inhibitor	PDGFB	CHEMBL3108633	age-related macular degeneration	EFO:0001365	2	INHIBITOR
JNJ-40346527	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
XL-019	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	polycythemia vera	EFO:0002429	1	INHIBITOR
XL-019	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	essential thrombocythemia	EFO:0000479	1	INHIBITOR
XL-019	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
XL-019	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	1	INHIBITOR
GLPG-0259	MAP kinase-activated protein kinase 5 inhibitor	MAPKAPK5	CHEMBL3094	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ADC3680	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
PF-05212377	Serotonin 6 (5-HT6) receptor antagonist	HTR6	CHEMBL3371	Alzheimers disease	EFO:0000249	2	ANTAGONIST
UR-63325	Histamine H4 receptor antagonist	HRH4	CHEMBL3759	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
AZD2516	Metabotropic glutamate receptor 5 negative allosteric modulator	GRM5	CHEMBL3227	gastroesophageal reflux disease	EFO:0003948	2	NEGATIVE ALLOSTERIC MODULATOR
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	multiple myeloma	EFO:0001378	3	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	acute lymphoblastic leukemia	EFO:0000220	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	aplastic anemia	HP:0001915	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	gastric adenocarcinoma	EFO:0000503	1	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	acute myeloid leukemia	EFO:0000222	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	myeloproliferative disorder	EFO:0004251	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	non-Hodgkins lymphoma	EFO:0005952	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	myelodysplastic syndrome	EFO:0000198	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	chronic myelogenous leukemia	EFO:0000339	2	ANTAGONIST
BKT140	C-X-C chemokine receptor type 4 antagonist	CXCR4	CHEMBL2107	Hodgkins lymphoma	EFO:0000183	2	ANTAGONIST
CAFUSERTIB	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
VK5211	Androgen Receptor modulator	AR	CHEMBL1871	hip fracture	EFO:0003964	2	MODULATOR
4SC-203	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ASP-3026	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
VOXTALISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	1	INHIBITOR
VOXTALISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VOXTALISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LEMBOREXANT	Orexin receptor 1 antagonist	HCRTR1	CHEMBL5113	insomnia	EFO:0004698	3	ANTAGONIST
LEMBOREXANT	Orexin receptor 2 antagonist	HCRTR2	CHEMBL4792	insomnia	EFO:0004698	3	ANTAGONIST
LEMBOREXANT	Orexin receptor 1 antagonist	HCRTR1	CHEMBL5113	liver disease	EFO:0001421	1	ANTAGONIST
LEMBOREXANT	Orexin receptor 2 antagonist	HCRTR2	CHEMBL4792	liver disease	EFO:0001421	1	ANTAGONIST
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	Thymic Carcinoma	EFO:1000576	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	cutaneous melanoma	EFO:0000389	3	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	endometrial carcinoma	EFO:1001512	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	carcinoma	EFO:0000313	3	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	lymphoma	EFO:0000574	1	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	renal cell carcinoma	EFO:0000681	3	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	melanoma	EFO:0000756	3	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	sarcoma	EFO:0000691	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
EPACADOSTAT	Indoleamine 2,3-dioxygenase inhibitor	IDO1	CHEMBL4685	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
EMACTUZUMAB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Genital neoplasm, female	EFO:1001331	2	INHIBITOR
EMACTUZUMAB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
LY-2606368	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	ovarian carcinoma	EFO:0001075	2	INHIBITOR
LY-2606368	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	leukemia	EFO:0000565	1	INHIBITOR
LY-2606368	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	breast carcinoma	EFO:0000305	2	INHIBITOR
MLN-1117	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	renal cell carcinoma	EFO:0000681	2	INHIBITOR
MLN-1117	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	endometrial neoplasm	EFO:0004230	2	INHIBITOR
R-348	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
R-348	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	keratoconjunctivitis sicca	EFO:1001001	2	INHIBITOR
R-348	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	keratoconjunctivitis sicca	EFO:1001001	2	INHIBITOR
R-348	Tyrosine-protein kinase SYK inhibitor	SYK	CHEMBL2599	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
BI113823	Bradykinin B1 receptor antagonist	BDKRB1	CHEMBL4308	osteoarthritis	EFO:0002506	1	ANTAGONIST
SAD448	Cannabinoid CB2 receptor agonist	CNR2	CHEMBL253	ocular hypertension	EFO:1001069	1	AGONIST
SAD448	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	ocular hypertension	EFO:1001069	1	AGONIST
MT-3995	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
XL550	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	hypertension	EFO:0000537	3	ANTAGONIST
XL550	Mineralocorticoid receptor antagonist	NR3C2	CHEMBL1994	diabetic nephropathy	EFO:0000401	2	ANTAGONIST
BI-811283	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
BMS-690514	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
BMS-690514	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
BMS-690514	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	2	INHIBITOR
BMS-690514	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	2	INHIBITOR
BMS-690514	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	breast carcinoma	EFO:0000305	2	INHIBITOR
BMS-690514	Receptor protein-tyrosine kinase erbB-4 inhibitor	ERBB4	CHEMBL3009	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ACALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
PG-760564	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
XL-820	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	stomach neoplasm	EFO:0003897	1	ANTAGONIST
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	Gorlin syndrome	Orphanet:377	1	ANTAGONIST
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	small cell lung carcinoma	EFO:0000702	1	ANTAGONIST
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	leukemia	EFO:0000565	2	ANTAGONIST
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	1	ANTAGONIST
BMS-833923	Smoothened homolog antagonist	SMO	CHEMBL5971	esophageal carcinoma	EFO:0002916	1	ANTAGONIST
CCX354	C-C chemokine receptor type 1 antagonist	CCR1	CHEMBL2413	rheumatoid arthritis	EFO:0000685	2	ANTAGONIST
BAY1067197	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	heart failure	EFO:0003144	2	AGONIST
LY2940094	Nociceptin receptor antagonist	OPRL1	CHEMBL2014	alcohol dependence	EFO:0003829	2	ANTAGONIST
TRABODENOSON	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	ocular hypertension	EFO:1001069	3	AGONIST
TRABODENOSON	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	open-angle glaucoma	EFO:0004190	3	AGONIST
BVT.115959	Adenosine A2a receptor agonist	ADORA2A	CHEMBL251	neuropathic pain	EFO:0005762	2	AGONIST
TC-6987	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	CHRNA7	CHEMBL2492	asthma	EFO:0000270	2	AGONIST
TC-6987	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	CHRNA7	CHEMBL2492	type II diabetes mellitus	EFO:0001360	2	AGONIST
K-877	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hypertriglyceridemia	EFO:0004211	3	AGONIST
K-877	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	1	AGONIST
FLUMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
SMC021	Calcitonin receptor agonist	CALCR	CHEMBL1832	osteoarthritis	EFO:0002506	3	AGONIST
SMC021	Calcitonin receptor agonist	CALCR	CHEMBL1832	postmenopausal osteoporosis	EFO:0003854	1	AGONIST
SMC021	Calcitonin receptor agonist	CALCR	CHEMBL1832	osteoporosis	EFO:0003882	3	AGONIST
BMS-779788	LXR-beta agonist	NR1H2	CHEMBL4093	atherosclerosis	EFO:0003914	1	AGONIST
AG-24322	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AG-24322	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AG-24322	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
CC-115	DNA-dependent protein kinase inhibitor	PRKDC	CHEMBL3142	prostate carcinoma	EFO:0001663	1	INHIBITOR
CC-115	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	osteosarcoma	EFO:0000637	1	INHIBITOR
CC-115	DNA-dependent protein kinase inhibitor	PRKDC	CHEMBL3142	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
CC-115	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CC-115	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
CC-115	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	prostate carcinoma	EFO:0001663	1	INHIBITOR
CC-115	DNA-dependent protein kinase inhibitor	PRKDC	CHEMBL3142	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CC-115	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
CC-115	DNA-dependent protein kinase inhibitor	PRKDC	CHEMBL3142	osteosarcoma	EFO:0000637	1	INHIBITOR
CC-115	DNA-dependent protein kinase inhibitor	PRKDC	CHEMBL3142	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CM-082	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CM-082	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CM-082	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CM-082	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CM-082	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	age-related macular degeneration	EFO:0001365	1	INHIBITOR
CM-082	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	age-related macular degeneration	EFO:0001365	1	INHIBITOR
CM-082	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	gastric carcinoma	EFO:0000178	1	INHIBITOR
CM-082	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gastric carcinoma	EFO:0000178	1	INHIBITOR
CM-082	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gastric carcinoma	EFO:0000178	1	INHIBITOR
CM-082	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	age-related macular degeneration	EFO:0001365	1	INHIBITOR
CM-082	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	age-related macular degeneration	EFO:0001365	1	INHIBITOR
CM-082	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	1	INHIBITOR
CHIAURANIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	ovarian carcinoma	EFO:0001075	1	INHIBITOR
CHIAURANIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
CHIAURANIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
CHIAURANIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
ETAZOLATE	GABA receptor beta-3 subunit positive allosteric modulator	GABRB3	CHEMBL1847	Alzheimers disease	EFO:0000249	2	POSITIVE ALLOSTERIC MODULATOR
BRILANESTRANT	Estrogen receptor alpha antagonist	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	2	ANTAGONIST
LORCASERIN	Serotonin 2c (5-HT2c) receptor agonist	HTR2C	CHEMBL225	obesity	EFO:0001073	2	AGONIST
FIMEPINOSTAT	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	lymphoma	EFO:0000574	2	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-beta subunit inhibitor	PIK3CB	CHEMBL3145	thyroid carcinoma	EFO:0002892	2	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-beta subunit inhibitor	PIK3CB	CHEMBL3145	multiple myeloma	EFO:0001378	1	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-beta subunit inhibitor	PIK3CB	CHEMBL3145	lymphoma	EFO:0000574	2	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	thyroid carcinoma	EFO:0002892	2	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	multiple myeloma	EFO:0001378	1	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	multiple myeloma	EFO:0001378	1	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-alpha subunit inhibitor	PIK3CA	CHEMBL4005	lymphoma	EFO:0000574	2	INHIBITOR
FIMEPINOSTAT	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	melanoma	EFO:0000756	1	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	Pruritus	HP:0000989	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	endometrial neoplasm	EFO:0004230	1	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	psoriasis	EFO:0000676	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	myeloproliferative disorder	EFO:0004251	2	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	breast carcinoma	EFO:0000305	1	INHIBITOR
ITACITINIB	Tyrosine-protein kinase JAK1 inhibitor	JAK1	CHEMBL2835	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
LY-2090314	Glycogen synthase kinase-3 alpha inhibitor	GSK3A	CHEMBL2850	leukemia	EFO:0000565	2	INHIBITOR
LY-2090314	Glycogen synthase kinase-3 beta inhibitor	GSK3B	CHEMBL262	leukemia	EFO:0000565	2	INHIBITOR
LY-2090314	Glycogen synthase kinase-3 alpha inhibitor	GSK3A	CHEMBL2850	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
LY-2090314	Glycogen synthase kinase-3 beta inhibitor	GSK3B	CHEMBL262	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
TAK-715	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
GSK2798745	Transient receptor potential cation channel subfamily V member 4 antagonist	TRPV4	CHEMBL3119	Cough	HP:0012735	2	ANTAGONIST
GSK2798745	Transient receptor potential cation channel subfamily V member 4 antagonist	TRPV4	CHEMBL3119	congestive heart failure	EFO:0000373	2	ANTAGONIST
GSK2798745	Transient receptor potential cation channel subfamily V member 4 antagonist	TRPV4	CHEMBL3119	pulmonary edema	EFO:1001134	2	ANTAGONIST
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	bladder carcinoma	EFO:0000292	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	Sezary's disease	EFO:1000785	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	carcinoma	EFO:0000313	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	breast neoplasm	EFO:0003869	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	mycosis fungoides	EFO:1001051	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	Cutaneous T-cell lymphoma	EFO:0002913	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	renal carcinoma	EFO:0002890	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	ovarian neoplasm	EFO:0003893	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	melanoma	EFO:0000756	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	alveolar soft part sarcoma	EFO:0007143	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	rectum cancer	EFO:1000657	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	renal cell carcinoma	EFO:0000681	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	cervical carcinoma	EFO:0001061	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	gastric adenocarcinoma	EFO:0000503	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	prostate carcinoma	EFO:0001663	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	thyroid carcinoma	EFO:0002892	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	multiple myeloma	EFO:0001378	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	gliosarcoma	EFO:1001465	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	urogenital neoplasm	EFO:0003863	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	lymphoma	EFO:0000574	2	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	ovarian carcinoma	EFO:0001075	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	malignant pleural mesothelioma	EFO:0000770	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	colorectal carcinoma	EFO:1001951	3	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	CD274	CHEMBL3580522	breast carcinoma	EFO:0000305	3	INHIBITOR
ASM-024	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
ASM-024	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	asthma	EFO:0000270	2	ANTAGONIST
ASM-024	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
ASM-024	Neuronal acetylcholine receptor protein alpha-7 subunit modulator	CHRNA7	CHEMBL2492	asthma	EFO:0000270	2	MODULATOR
ASM-024	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
ASM-024	Neuronal acetylcholine receptor protein alpha-7 subunit modulator	CHRNA7	CHEMBL2492	chronic obstructive pulmonary disease	EFO:0000341	2	MODULATOR
ASM-024	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	asthma	EFO:0000270	2	ANTAGONIST
ASM-024	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	asthma	EFO:0000270	2	ANTAGONIST
DEPATUXIZUMAB MAFODOTIN	Epidermal growth factor receptor erbB1 binding agent	EGFR	CHEMBL203	gliosarcoma	EFO:1001465	3	BINDING AGENT
DEPATUXIZUMAB MAFODOTIN	Epidermal growth factor receptor erbB1 binding agent	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	3	BINDING AGENT
CROTEDUMAB	Glucagon receptor inhibitor	GCGR	CHEMBL1985	type II diabetes mellitus	EFO:0001360	1	INHIBITOR
CG250 111IN	Carbonic anhydrase IX binding agent	CA9	CHEMBL3594	renal cell carcinoma	EFO:0000681	1	BINDING AGENT
XEN-D0501	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	Cough	HP:0012735	2	ANTAGONIST
XEN-D0501	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	chronic obstructive pulmonary disease	EFO:0000341	2	ANTAGONIST
XEN-D0501	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
CG250 177LU	Carbonic anhydrase IX binding agent	CA9	CHEMBL3594	renal cell carcinoma	EFO:0000681	1	BINDING AGENT
GRC-17536	Transient receptor potential cation channel subfamily A member 1 antagonist	TRPA1	CHEMBL6007	diabetic neuropathy	EFO:1000783	2	ANTAGONIST
GRC-15300	Transient receptor potential cation channel subfamily V member 3 antagonist	TRPV3	CHEMBL5522	neuropathic pain	EFO:0005762	2	ANTAGONIST
ROLAPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	multiple myeloma	EFO:0001378	1	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	macroglobulinemia	EFO:0002616	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	neoplasm of mature B-cells	EFO:0000096	1	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	Mantle cell lymphoma	EFO:1001469	4	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	ovarian carcinoma	EFO:0001075	2	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
ACALABRUTINIB	Tyrosine-protein kinase BTK inhibitor	BTK	CHEMBL5251	lymphoid leukemia	EFO:0004289	1	INHIBITOR
SYL-1001	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	dry eye syndrome	EFO:1000906	3	ANTAGONIST
SYL-1001	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	pain	EFO:0003843	2	ANTAGONIST
BROLUCIZUMAB	Vascular endothelial growth factor A inhibitor	VEGFA	CHEMBL1783	age-related macular degeneration	EFO:0001365	3	INHIBITOR
PAC-14028	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	rosacea	EFO:1000760	2	ANTAGONIST
PAC-14028	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	atopic eczema	EFO:0000274	3	ANTAGONIST
PAC-14028	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	seborrheic dermatitis	EFO:1000764	2	ANTAGONIST
PAC-14028	Vanilloid receptor antagonist	TRPV1	CHEMBL4794	Pruritus	HP:0000989	2	ANTAGONIST
INDANTADOL	Monoamine oxidase A inhibitor	MAOA	CHEMBL1951	pain	EFO:0003843	2	INHIBITOR
INDANTADOL	Monoamine oxidase A inhibitor	MAOA	CHEMBL1951	diabetic neuropathy	EFO:1000783	2	INHIBITOR
INDANTADOL	Monoamine oxidase A inhibitor	MAOA	CHEMBL1951	Cough	HP:0012735	2	INHIBITOR
INDANTADOL	Monoamine oxidase A inhibitor	MAOA	CHEMBL1951	neuropathic pain	EFO:0005762	2	INHIBITOR
LUMRETUZUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
LUMRETUZUMAB	Receptor tyrosine-protein kinase erbB-3 inhibitor	ERBB3	CHEMBL5838	breast carcinoma	EFO:0000305	1	INHIBITOR
RIVIPANSEL	P-selectin antagonist	SELP	CHEMBL5378	liver disease	EFO:0001421	1	ANTAGONIST
RIVIPANSEL	Leukocyte adhesion molecule-1 antagonist	SELL	CHEMBL3161	liver disease	EFO:0001421	1	ANTAGONIST
RIVIPANSEL	P-selectin antagonist	SELP	CHEMBL5378	Sickle cell anemia	Orphanet:232	3	ANTAGONIST
RIVIPANSEL	Selectin E antagonist	SELE	CHEMBL3890	Sickle cell anemia	Orphanet:232	3	ANTAGONIST
RIVIPANSEL	Selectin E antagonist	SELE	CHEMBL3890	liver disease	EFO:0001421	1	ANTAGONIST
RIVIPANSEL	Leukocyte adhesion molecule-1 antagonist	SELL	CHEMBL3161	Sickle cell anemia	Orphanet:232	3	ANTAGONIST
GEFAPIXANT	P2X purinoceptor 3 antagonist	P2RX3	CHEMBL2998	Cough	HP:0012735	3	ANTAGONIST
GEFAPIXANT	P2X purinoceptor 3 antagonist	P2RX3	CHEMBL2998	idiopathic pulmonary fibrosis	EFO:0000768	2	ANTAGONIST
GEFAPIXANT	P2X purinoceptor 3 antagonist	P2RX3	CHEMBL2998	asthma	EFO:0000270	1	ANTAGONIST
GEFAPIXANT	P2X purinoceptor 3 antagonist	P2RX3	CHEMBL2998	chronic interstitial cystitis	EFO:1000869	2	ANTAGONIST
GEFAPIXANT	P2X purinoceptor 3 antagonist	P2RX3	CHEMBL2998	osteoarthritis, knee	EFO:0004616	2	ANTAGONIST
LECOZOTAN	Serotonin 1a (5-HT1a) receptor antagonist	HTR1A	CHEMBL214	Alzheimers disease	EFO:0000249	2	ANTAGONIST
ALOGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
APC-100	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	1	ANTAGONIST
OLMUTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ATOSIBAN	Oxytocin receptor antagonist	OXTR	CHEMBL2049	premature birth	EFO:0003917	3	ANTAGONIST
ELENBECESTAT	Beta-secretase 1 inhibitor	BACE1	CHEMBL4822	Alzheimers disease	EFO:0000249	3	INHIBITOR
BAN2401	Beta amyloid A4 protein inhibitor	APP	CHEMBL2487	Alzheimers disease	EFO:0000249	2	INHIBITOR
ERENUMAB	Calcitonin gene-related peptide type 1 receptor antagonist	CALCRL	CHEMBL3798	migraine disorder	EFO:0003821	3	ANTAGONIST
BIIB054	Alpha-synuclein inhibitor	SNCA	CHEMBL6152	Parkinson's disease	EFO:0002508	2	INHIBITOR
MM-302	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast carcinoma	EFO:0000305	2	INHIBITOR
MM-302	Receptor protein-tyrosine kinase erbB-2 binding agent	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	2	BINDING AGENT
BEGELOMAB	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	bladder carcinoma	EFO:0000292	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	carcinoma	EFO:0000313	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	glioblastoma multiforme	EFO:0000519	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	Gestational trophoblastic neoplasm	Orphanet:59305	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	lymphoma	EFO:0000574	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	endometrial neoplasm	EFO:0004230	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	breast neoplasm	EFO:0003869	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	melanoma	EFO:0000756	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	neoplasm of mature B-cells	EFO:0000096	0	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	osteosarcoma	EFO:0000637	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	urogenital neoplasm	EFO:0003863	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	head and neck squamous cell carcinoma	EFO:0000181	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	breast carcinoma	EFO:0000305	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	Merkel cell skin cancer	EFO:1001471	4	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	diffuse large B-cell lymphoma	EFO:0000403	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	ovarian carcinoma	EFO:0001075	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	Hodgkins lymphoma	EFO:0000183	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	acute myeloid leukemia	EFO:0000222	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	hepatocellular carcinoma	EFO:0000182	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	mesothelioma	EFO:0000588	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	nasopharyngeal neoplasm	EFO:0004252	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	non-small cell lung carcinoma	EFO:0003060	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	renal cell carcinoma	EFO:0000681	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	prostate carcinoma	EFO:0001663	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	rectum cancer	EFO:1000657	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	adenocarcinoma	EFO:0000228	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	colorectal carcinoma	EFO:1001951	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	gastric adenocarcinoma	EFO:0000503	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	Meningioma	Orphanet:2495	1	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	pancreatic carcinoma	EFO:0002618	2	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	gastric carcinoma	EFO:0000178	3	OTHER
AVELUMAB	Programmed cell death 1 ligand 1 other	CD274	CHEMBL3580522	squamous cell carcinoma	EFO:0000707	3	OTHER
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	ulcerative colitis	EFO:0000729	2	INHIBITOR
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	Crohn's disease	EFO:0000384	2	INHIBITOR
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	Cystic fibrosis	Orphanet:586	2	INHIBITOR
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	chronic obstructive pulmonary disease	EFO:0000341	1	INHIBITOR
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	gastric adenocarcinoma	EFO:0000503	3	INHIBITOR
ANDECALIXIMAB	Matrix metalloproteinase 9 inhibitor	MMP9	CHEMBL321	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	erythema multiforme	EFO:1000694	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Congenital adrenal hyperplasia	Orphanet:418	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ovarian carcinoma	EFO:0001075	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Aortic Coarctation	EFO:1001267	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leptospirosis	EFO:0007344	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatic disease	EFO:0005755	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neoplasm of mature B-cells	EFO:0000096	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	premature birth	EFO:0003917	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	tooth disease	EFO:1001216	0	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	brain edema	EFO:1000845	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypercalcemia	HP:0003072	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Plantar Fasciitis	EFO:1001909	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cataract	EFO:0001059	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dry eye syndrome	EFO:1000906	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	intracranial hypertension	EFO:1000992	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	unspecified peripheral T-cell lymphoma	EFO:0000211	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute myeloid leukemia	EFO:0000222	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute respiratory distress syndrome	EFO:1000637	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	POEMS syndrome	EFO:1001115	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hearing loss	EFO:0004238	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	inflammation	MP:0001845	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	intrahepatic cholangiocarcinoma	EFO:1001961	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mesothelioma	EFO:0000588	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diffuse large B-cell lymphoma	EFO:0000403	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior uveitis	EFO:1000811	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bone fracture	EFO:0003931	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	HELLP syndrome	EFO:0007297	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mycosis fungoides	EFO:1001051	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sarcoma	EFO:0000691	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	migraine without aura	EFO:0005296	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myxoid liposarcoma	EFO:0000613	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	B-cell acute lymphoblastic leukemia	EFO:0000094	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriatic arthritis	EFO:0003778	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	appendicitis	EFO:0007149	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	head and neck malignant neoplasia	EFO:0006859	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemolytic anemia	EFO:0005558	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	intermediate uveitis	EFO:1000986	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	contact dermatitis	EFO:0005319	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lung carcinoma	EFO:0001071	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cirrhosis of liver	EFO:0001422	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	AL amyloidosis	Orphanet:85443	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	plasmacytoma	EFO:0006738	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	deafness	EFO:0001063	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	adrenal gland hyperfunction	EFO:1000797	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	endometrial neoplasm	EFO:0004230	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	congestive heart failure	EFO:0000373	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	head and neck squamous cell carcinoma	EFO:0000181	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	small cell lung carcinoma	EFO:0000702	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	migraine disorder	EFO:0003821	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tuberculosis	Orphanet:3389	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinal vein occlusion	EFO:1001157	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute promyelocytic leukemia	EFO:0000224	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cryptococcal meningitis	EFO:0007228	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tenosynovitis	EFO:1001435	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nausea and vomiting	HP:0002017	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Eczema	HP:0000964	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	liver disease	EFO:0001421	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic lymphocytic leukemia	EFO:0000095	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bladder carcinoma	EFO:0000292	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Henoch-Schoenlein purpura	EFO:1000965	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sickle cell anemia	Orphanet:232	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sciatica	HP:0011868	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	plasma cell leukemia	EFO:0006475	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchiolitis	HP:0011950	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoid leukemia	EFO:0004289	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	carcinoma	EFO:0000313	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sensorineural hearing loss	EFO:1001176	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ankylosing spondylitis	EFO:0003898	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Graves disease	EFO:0004237	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic kidney disease	EFO:0003884	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	trichinosis	EFO:0007520	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	post operative nausea and vomiting	EFO:0004888	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Burkitts lymphoma	EFO:0000309	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	colorectal adenocarcinoma	EFO:0000365	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myelodysplastic syndrome	EFO:0000198	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	squamous cell carcinoma	EFO:0000707	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	soft tissue sarcoma	EFO:1001968	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-Hodgkins lymphoma	EFO:0005952	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nephrotic syndrome	EFO:0004255	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	optic neuritis	EFO:0007405	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pemphigus vulgaris	EFO:0004719	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ocular toxoplasmosis	EFO:0007399	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	bacterial vaginosis	EFO:0003932	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatitis herpetiformis	EFO:1000684	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Ovarian hyperstimulation syndrome	Orphanet:64739	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast neoplasm	EFO:0003869	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Radiation-induced nausea and vomiting	EFO:0006912	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	subacute thyroiditis	EFO:1001194	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	idiopathic pulmonary fibrosis	EFO:0000768	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary tuberculosis	EFO:1000049	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	age-related macular degeneration	EFO:0001365	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	proliferative vitreoretinopathy	EFO:1001129	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Herpetic encephalitis	Orphanet:1930	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sarcoidosis	Orphanet:797	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rectum cancer	EFO:1000657	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Peptic ulcer	HP:0004398	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	urinary tract infection	EFO:0003103	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	eosinophilic pneumonia	EFO:0007257	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoid neoplasm	EFO:0001642	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neuropathic pain	EFO:0005762	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary systemic amyloidosis	Orphanet:314701	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Headache	HP:0002315	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	amyloidosis	EFO:1001875	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sympathetic ophthalmia	EFO:1001205	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nausea	HP:0002018	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic childhood arthritis	EFO:0002609	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Cutaneous T-cell lymphoma	EFO:0002913	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-small cell lung carcinoma	EFO:0003060	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	malaria	EFO:0001068	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	meningeal tuberculosis	EFO:1000039	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	glaucoma	EFO:0000516	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Mantle cell lymphoma	EFO:1001469	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	T-cell acute lymphoblastic leukemia	EFO:0000209	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Dysphagia	HP:0002015	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pancreatic carcinoma	EFO:0002618	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Stevens-Johnson syndrome	EFO:0004276	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	esophageal carcinoma	EFO:0002916	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetic retinopathy	EFO:0003770	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	4	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemorrhage	MP:0001914	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hepatocellular carcinoma	EFO:0000182	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchopulmonary dysplasia	Orphanet:70589	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cysticercosis	EFO:0007231	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Retinoblastoma	Orphanet:790	1	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	focal segmental glomerulosclerosis	EFO:0004236	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	macroglobulinemia	EFO:0002616	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	brain neoplasm	EFO:0003833	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nasopharyngeal neoplasm	EFO:0004252	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	renal cell carcinoma	EFO:0000681	2	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	infection	EFO:0000544	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Otitis media	EFO:0004992	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hodgkins lymphoma	EFO:0000183	3	AGONIST
DEXAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	4	AGONIST
SAXAGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	Klinefelter's syndrome	EFO:1001006	4	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	orchitis	EFO:1001078	4	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	coronary artery disease	EFO:0000378	3	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	obesity	EFO:0001073	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	weight loss	HP:0001824	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	infertility	EFO:0000545	3	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	breast carcinoma	EFO:0000305	0	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	testicular carcinoma	EFO:0005088	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	polycystic ovary syndrome	EFO:0000660	0	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	sexual dysfunction	EFO:0004714	3	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	heart failure	EFO:0003144	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	AIDS	EFO:0000765	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	eunuchism	EFO:0007266	3	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	Spinal cord injury	EFO:1001919	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	muscular disease	EFO:0002970	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	sexual dysfunction	EFO:0004714	1	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	HIV wasting syndrome	EFO:0007312	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	diabetic neuropathy	EFO:1000783	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	multiple sclerosis	EFO:0003885	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	growth delay	HP:0001510	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	erectile dysfunction	EFO:0004234	2	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	insulin resistance	EFO:0002614	0	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	Abnormality of connective tissue	HP:0003549	1	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	Facioscapulohumeral dystrophy	Orphanet:269	1	AGONIST
TESTOSTERONE	Androgen Receptor agonist	AR	CHEMBL1871	metabolic syndrome	EFO:0000195	3	AGONIST
BENZBROMARONE	Solute carrier family 22 member 12 inhibitor	SLC22A12	CHEMBL6120	gout	EFO:0004274	4	INHIBITOR
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myelodysplastic syndrome	EFO:0000198	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sepsis	HP:0100806	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	insulin resistance	EFO:0002614	0	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myeloproliferative disorder	EFO:0004251	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cirrhosis of liver	EFO:0001422	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	infection	EFO:0000544	1	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Cerebral ischemia	HP:0002637	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myocardial infarction	EFO:0000612	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Eczema	HP:0000964	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	heart failure	EFO:0003144	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoid leukemia	EFO:0004289	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Congenital adrenal hyperplasia	Orphanet:418	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	HIV infection	EFO:0000764	0	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute myeloid leukemia	EFO:0000222	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sudden cardiac arrest	EFO:0004278	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	alcohol dependence	EFO:0003829	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	type I diabetes mellitus	EFO:0001359	1	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hypotension	EFO:0005251	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	1	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	septic shock	EFO:0006834	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	fibromyalgia	EFO:0005687	0	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Herpes Labialis	EFO:1001347	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	adrenocortical carcinoma	EFO:0003093	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	opioid dependence	EFO:0005611	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	alopecia areata	EFO:0004192	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	heroin dependence	EFO:0004240	1	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	oral submucous fibrosis	EFO:1001818	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mast-cell leukemia	EFO:0007359	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obesity	EFO:0001073	1	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	central nervous system cancer	EFO:0000326	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchopulmonary dysplasia	Orphanet:70589	3	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	2	AGONIST
HYDROCORTISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	3	AGONIST
SELONSERTIB	Mitogen-activated protein kinase kinase kinase 5 inhibitor	MAP3K5	CHEMBL5285	diabetic nephropathy	EFO:0000401	1	INHIBITOR
TECADENOSON	Adenosine A1 receptor agonist	ADORA1	CHEMBL226	atrial fibrillation	EFO:0000275	2	AGONIST
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	polycythemia vera	EFO:0002429	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	rectum cancer	EFO:1000657	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	gastric carcinoma	EFO:0000178	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	primary myelofibrosis	EFO:0002430	1	INHIBITOR
UMBRALISIB	PI3-kinase p110-delta subunit inhibitor	PIK3CD	CHEMBL3130	colorectal carcinoma	EFO:1001951	1	INHIBITOR
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	body weight gain	EFO:0004566	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	obesity	EFO:0001073	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	alcohol withdrawal	EFO:0004777	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	cardiac arrhythmia	EFO:0004269	0	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	Atrophy	EFO:1000096	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	cocaine dependence	EFO:0002610	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	opioid dependence	EFO:0005611	1	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	Prader-Willi syndrome	Orphanet:739	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	pain	EFO:0003843	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	myocardial infarction	EFO:0000612	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	ductal carcinoma in situ	EFO:0000432	0	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	neuropathic pain	EFO:0005762	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	gastroparesis	EFO:1000948	0	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	inflammation	MP:0001845	1	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	preeclampsia	EFO:0000668	0	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	alcohol dependence	EFO:0003829	3	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	sexual dysfunction	EFO:0004714	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	hemorrhage	MP:0001914	3	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	obstructive sleep apnea	EFO:0003918	2	AGONIST
OXYTOCIN	Oxytocin receptor agonist	OXTR	CHEMBL2049	Fragile X syndrome	Orphanet:908	2	AGONIST
SAFINAMIDE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	Parkinson's disease	EFO:0002508	4	INHIBITOR
SAFINAMIDE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	Parkinson's disease	EFO:0002508	4	INHIBITOR
SAFINAMIDE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	liver disease	EFO:0001421	1	INHIBITOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	brain aneurysm	EFO:0003870	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	chronic kidney disease	EFO:0003884	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	aortic stenosis	EFO:0000266	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	myocardial infarction	EFO:0000612	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	pneumonia	EFO:0003106	2	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	Sickle cell anemia	Orphanet:232	2	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	internal carotid artery stenosis	EFO:0002615	2	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	type II diabetes mellitus	EFO:0001360	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	Recurrent thrombophlebitis	HP:0004419	4	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	atrial fibrillation	EFO:0000275	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	acute coronary syndrome	EFO:0005672	4	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	ischemia	EFO:0000556	1	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	Abdominal Aortic Aneurysm	EFO:0004214	2	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	coronary heart disease	EFO:0001645	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	coronary artery disease	EFO:0000378	3	NEGATIVE ALLOSTERIC MODULATOR
TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	P2RY12	CHEMBL2001	stroke	EFO:0000712	3	NEGATIVE ALLOSTERIC MODULATOR
HYDROMORPHONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis, hip	EFO:1000786	3	AGONIST
HYDROMORPHONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	3	AGONIST
AVOSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	diabetic nephropathy	EFO:0000401	3	ANTAGONIST
PEFCALCITOL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	3	AGONIST
TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	2	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	cervical adenocarcinoma	EFO:0001416	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	pulmonary neuroendocrine tumor	EFO:0005220	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	peritoneal neoplasm	EFO:1001100	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	ovarian neoplasm	EFO:0003893	1	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	ureteral neoplasm	EFO:0003844	2	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	renal carcinoma	EFO:0002890	2	INHIBITOR
BERZOSERTIB	Serine-protein kinase ATR inhibitor	ATR	CHEMBL5024	ovarian carcinoma	EFO:0001075	1	INHIBITOR
AVACOPAN	C5a anaphylatoxin chemotactic receptor antagonist	C5AR1	CHEMBL2373	vasculitis	EFO:0006803	2	ANTAGONIST
AVACOPAN	C5a anaphylatoxin chemotactic receptor antagonist	C5AR1	CHEMBL2373	IGA glomerulonephritis	EFO:0004194	2	ANTAGONIST
BENFLUOREX	Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor	SOAT1	CHEMBL2782	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
BENFLUOREX	Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor	SOAT1	CHEMBL2782	diabetes mellitus	EFO:0000400	4	INHIBITOR
LUMIRACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, hip	EFO:1000786	3	INHIBITOR
LUMIRACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
LUMIRACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
LUMIRACOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	3	INHIBITOR
AMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	cocaine dependence	EFO:0002610	1	RELEASING AGENT
AMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
AMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	1	RELEASING AGENT
AMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	2	RELEASING AGENT
AMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	cocaine dependence	EFO:0002610	2	RELEASING AGENT
AMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
SENICAPOC	Intermediate conductance calcium-activated potassium channel protein 4 blocker	KCNN4	CHEMBL4305	Sickle cell anemia	Orphanet:232	3	BLOCKER
SENICAPOC	Intermediate conductance calcium-activated potassium channel protein 4 blocker	KCNN4	CHEMBL4305	asthma	EFO:0000270	2	BLOCKER
TROGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	diabetes mellitus	EFO:0000400	4	AGONIST
TROGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	sarcoma	EFO:0000691	2	AGONIST
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	lung carcinoma	EFO:0001071	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	metastatic melanoma	EFO:0002617	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Bcl-2-related protein A1 inhibitor	BCL2A1	CHEMBL6044	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	Hodgkins lymphoma	EFO:0000183	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	multiple myeloma	EFO:0001378	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	small cell lung carcinoma	EFO:0000702	3	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	lymphoid leukemia	EFO:0004289	1	INHIBITOR
OBATOCLAX	Bcl-2-like protein 10 inhibitor	BCL2L10	CHEMBL5988	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
OBATOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	primary myelofibrosis	EFO:0002430	2	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
OBATOCLAX	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	MCL1	CHEMBL4361	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
ANGIOTENSIN II	Type-1 angiotensin II receptor agonist	AGTR1	CHEMBL227	septic shock	EFO:0006834	4	AGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	breast neoplasm	EFO:0003869	3	ANTAGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	metastatic prostate cancer	EFO:0000196	3	ANTAGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	salivary gland neoplasm	EFO:0003826	2	ANTAGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	breast carcinoma	EFO:0000305	3	ANTAGONIST
BICALUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
DIETHYLSTILBESTROL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	prostate carcinoma	EFO:0001663	3	AGONIST
IBIPINABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	type II diabetes mellitus	EFO:0001360	2	ANTAGONIST
IBIPINABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	obesity	EFO:0001073	2	ANTAGONIST
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Autosomal dominant polycystic kidney disease	EFO:1001496	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	systemic scleroderma	EFO:0000717	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	aplastic anemia	HP:0001915	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	amyotrophic lateral sclerosis	EFO:0000253	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	severe aplastic anemia	EFO:0006927	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	uveitis	EFO:1001231	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	relapsing-remitting multiple sclerosis	EFO:0003929	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	central nervous system cancer	EFO:0000326	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lung carcinoma	EFO:0001071	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Pineoblastoma	EFO:1000475	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	posterior uveitis	EFO:1001119	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	bladder carcinoma	EFO:0000292	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Lymphangioleiomyomatosis	Orphanet:538	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	carcinoma	EFO:0000313	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	kidney disease	EFO:0003086	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	intermediate uveitis	EFO:1000986	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Cutaneous T-cell lymphoma	EFO:0002913	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	thyroid carcinoma	EFO:0002892	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	coronary stenosis	EFO:1000882	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	multiple myeloma	EFO:0001378	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	fibroma	EFO:0002424	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Cerebral arteriovenous malformation	Orphanet:46724	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lichen planus	EFO:1000726	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	squamous cell lung carcinoma	EFO:0000708	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	osteosarcoma	EFO:0000637	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	IGA glomerulonephritis	EFO:0004194	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	sarcoma	EFO:0000691	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	anterior uveitis	EFO:1000811	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	HIV-1 infection	EFO:0000180	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hypertension	EFO:0000537	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	rectum cancer	EFO:1000657	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pulmonary hypertension	EFO:0001361	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	neuroblastoma	EFO:0000621	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Sickle cell anemia	Orphanet:232	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	renal cell carcinoma	EFO:0000681	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	lymphoma	EFO:0000574	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	age-related macular degeneration	EFO:0001365	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Abnormality of the cardiovascular system	HP:0001626	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	prostate carcinoma	EFO:0001663	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	skin neoplasm	EFO:0004198	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	vascular malformation	EFO:0006888	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	hypercholesterolemia	HP:0003124	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Pachyonychia congenita	Orphanet:2309	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	liver disease	EFO:0001421	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	inclusion body myositis	EFO:0007323	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	germ cell tumor	EFO:0000514	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Hodgkins lymphoma	EFO:0000183	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Familial adenomatous polyposis	Orphanet:733	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	gliosarcoma	EFO:1001465	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Sturge-Weber syndrome	Orphanet:3205	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic kidney disease	EFO:0003884	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pemphigus vulgaris	EFO:0004719	0	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Fanconi anemia	Orphanet:84	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	dry eye syndrome	EFO:1000906	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	diabetic retinopathy	EFO:0003770	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Coronary Restenosis	EFO:0004224	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	Severe combined immunodeficiency	Orphanet:183660	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	breast carcinoma	EFO:0000305	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	leukemia	EFO:0000565	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	focal segmental glomerulosclerosis	EFO:0004236	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	pneumonia	EFO:0003106	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SIROLIMUS	FK506-binding protein 1A inhibitor	FKBP1A	CHEMBL1902	acute graft vs. host disease	EFO:0004599	3	INHIBITOR
TONAPOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	congestive heart failure	EFO:0000373	2	ANTAGONIST
TONAPOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	liver disease	EFO:0001421	1	ANTAGONIST
TONAPOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	heart failure	EFO:0003144	2	ANTAGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	polycystic ovary syndrome	EFO:0000660	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	diabetes mellitus	EFO:0000400	3	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Hyperglycemia	HP:0003074	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	alcohol dependence	EFO:0003829	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	morbid obesity	EFO:0001074	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	hyperinsulinemic hypoglycemia	EFO:0007318	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type I diabetes mellitus	EFO:0001359	3	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	coronary artery disease	EFO:0000378	3	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	Parkinson's disease	EFO:0002508	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	obesity	EFO:0001073	3	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	myocardial infarction	EFO:0000612	3	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	cocaine dependence	EFO:0002610	1	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	stroke	EFO:0000712	2	AGONIST
EXENATIDE	Glucagon-like peptide 1 receptor agonist	GLP1R	CHEMBL1784	type II diabetes mellitus	EFO:0001360	4	AGONIST
BARASERTIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	leukemia	EFO:0000565	1	INHIBITOR
BARASERTIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	lymphoma	EFO:0000574	1	INHIBITOR
BARASERTIB	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DEGARELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	prostate carcinoma	EFO:0001663	4	ANTAGONIST
DEGARELIX	Gonadotropin-releasing hormone receptor antagonist	GNRHR	CHEMBL1855	prostate adenocarcinoma	EFO:0000673	4	ANTAGONIST
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Tuberculosis	Orphanet:3389	1	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	HIV infection	EFO:0000764	2	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	bone neoplasm	EFO:0003820	2	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	ankylosing spondylitis	EFO:0003898	3	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis, knee	EFO:0004616	3	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	prostate carcinoma	EFO:0001663	2	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	melanoma	EFO:0000756	1	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
ETORICOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	3	INHIBITOR
CLOZAPINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
CLOZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	Chemotherapy-induced nausea and vomiting	EFO:0006911	1	INHIBITOR
SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	neuropathy	EFO:0004149	2	INHIBITOR
SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	osteomyelitis	EFO:0003102	0	INHIBITOR
SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	ankylosing spondylitis	EFO:0003898	2	INHIBITOR
BETAXOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	ocular hypertension	EFO:1001069	4	ANTAGONIST
BETAXOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	open-angle glaucoma	EFO:0004190	4	ANTAGONIST
LY-518674	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	hypercholesterolemia	HP:0003124	2	AGONIST
LY-518674	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	hypertension	EFO:0000537	2	AGONIST
LY-518674	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	metabolic syndrome	EFO:0000195	2	AGONIST
SAMIDORPHAN	Mu opioid receptor antagonist	OPRM1	CHEMBL233	cocaine dependence	EFO:0002610	1	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	Disorder of lipid metabolism	Orphanet:309005	3	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	hypercholesterolemia	HP:0003124	3	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	hyperlipidemia	EFO:0003774	3	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	rosacea	EFO:1000760	1	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	Combined hyperlipidemia	Orphanet:79211	3	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	familial hypercholesterolemia	EFO:0004911	3	ANTAGONIST
LAROPIPRANT	Prostanoid DP receptor antagonist	PTGDR	CHEMBL4427	type II diabetes mellitus	EFO:0001360	3	ANTAGONIST
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	multiple myeloma	EFO:0001378	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	prostate carcinoma	EFO:0001663	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	male breast carcinoma	EFO:0006861	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 9 inhibitor	CDK9	CHEMBL3116	esophageal carcinoma	EFO:0002916	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	cutaneous melanoma	EFO:0000389	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	renal carcinoma	EFO:0002890	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 7 inhibitor	CDK7	CHEMBL3055	sarcoma	EFO:0000691	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	leukemia	EFO:0000565	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	breast carcinoma	EFO:0000305	1	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoma	EFO:0000574	2	INHIBITOR
ALVOCIDIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
RETOSIBAN	Oxytocin receptor antagonist	OXTR	CHEMBL2049	premature birth	EFO:0003917	3	ANTAGONIST
DAPAGLIFLOZIN	Sodium/glucose cotransporter 2 inhibitor	SLC5A2	CHEMBL3884	type II diabetes mellitus	EFO:0001360	4	INHIBITOR
NAMODENOSON	Adenosine A3 receptor agonist	ADORA3	CHEMBL256	hepatocellular carcinoma	EFO:0000182	2	AGONIST
NAMODENOSON	Adenosine A3 receptor agonist	ADORA3	CHEMBL256	Chronic Hepatitis C infection	EFO:0004220	1	AGONIST
ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	3	ANTAGONIST
ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	liver disease	EFO:0001421	1	ANTAGONIST
ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	drug dependence	EFO:0003890	1	ANTAGONIST
NEBIVOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
NEBIVOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	hypertension	EFO:0000537	4	ANTAGONIST
LAPAQUISTAT ACETATE	Squalene synthetase inhibitor	FDFT1	CHEMBL3338	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
LAPAQUISTAT ACETATE	Squalene synthetase inhibitor	FDFT1	CHEMBL3338	hypercholesterolemia	HP:0003124	3	INHIBITOR
LAPAQUISTAT ACETATE	Squalene synthetase inhibitor	FDFT1	CHEMBL3338	hyperlipidemia	EFO:0003774	2	INHIBITOR
LAPAQUISTAT ACETATE	Squalene synthetase inhibitor	FDFT1	CHEMBL3338	Disorder of lipid metabolism	Orphanet:309005	3	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	prostate carcinoma	EFO:0001663	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	primary myelofibrosis	EFO:0002430	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	ovarian carcinoma	EFO:0001075	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	prostate carcinoma	EFO:0001663	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	lymphoma	EFO:0000574	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	ovarian carcinoma	EFO:0001075	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	ovarian carcinoma	EFO:0001075	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	lymphoma	EFO:0000574	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	lymphoma	EFO:0000574	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	primary myelofibrosis	EFO:0002430	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-X inhibitor	BCL2L1	CHEMBL4625	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	primary myelofibrosis	EFO:0002430	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	prostate carcinoma	EFO:0001663	2	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-W inhibitor	BCL2L2	CHEMBL4677	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
NAVITOCLAX	Apoptosis regulator Bcl-2 inhibitor	BCL2	CHEMBL4860	acute lymphoblastic leukemia	EFO:0000220	1	INHIBITOR
NORTRIPTYLINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	gastroparesis	EFO:1000948	3	INHIBITOR
NORTRIPTYLINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
NORTRIPTYLINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
NORTRIPTYLINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	atopic eczema	EFO:0000274	1	INHIBITOR
NORTRIPTYLINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	psoriasis	EFO:0000676	2	INHIBITOR
NORTRIPTYLINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	gastroparesis	EFO:1000948	3	INHIBITOR
NORTRIPTYLINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	psoriasis	EFO:0000676	2	INHIBITOR
NORTRIPTYLINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	atopic eczema	EFO:0000274	1	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoma	EFO:0000574	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	central nervous system cancer	EFO:0000326	3	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	multiple myeloma	EFO:0001378	1	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lung carcinoma	EFO:0001071	3	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Hodgkins lymphoma	EFO:0000183	3	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	rhabdomyosarcoma	EFO:0002918	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoid leukemia	EFO:0004289	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	medulloblastoma	EFO:0002939	2	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	neuroblastoma	EFO:0000621	3	INHIBITOR
ETOPOSIDE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	carcinoma	EFO:0000313	3	INHIBITOR
VIPADENANT	Adenosine A2a receptor antagonist	ADORA2A	CHEMBL251	Parkinson's disease	EFO:0002508	2	ANTAGONIST
SERLOPITANT	Neurokinin 1 receptor antagonist	TACR1	CHEMBL249	Pruritus	HP:0000989	2	ANTAGONIST
LESOGABERAN	GABA-B receptor 1 agonist	GABBR1	CHEMBL2064	gastroesophageal reflux disease	EFO:0003948	2	AGONIST
PRINABEREL	Estrogen receptor beta agonist	ESR2	CHEMBL242	prolonged QT interval	HP:0001657	1	AGONIST
PRINABEREL	Estrogen receptor beta agonist	ESR2	CHEMBL242	Crohn's disease	EFO:0000384	1	AGONIST
PRINABEREL	Estrogen receptor beta agonist	ESR2	CHEMBL242	endometriosis	EFO:0001065	2	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	anemia	EFO:0004272	1	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Alzheimers disease	EFO:0000249	0	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Myocardial Ischemia	EFO:1001375	2	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	1	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	coronary heart disease	EFO:0001645	3	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hypertriglyceridemia	EFO:0004211	1	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	nicotine dependence	EFO:0003768	2	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	coronary artery disease	EFO:0000378	2	AGONIST
GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	HIV infection	EFO:0000764	1	AGONIST
MB07811	Thyroid hormone receptor beta-1 agonist	THRB	CHEMBL1947	hypercholesterolemia	HP:0003124	2	AGONIST
TALAROZOLE	Cytochrome P450 26A1 inhibitor	CYP26A1	CHEMBL5141	inflammation	MP:0001845	1	INHIBITOR
TALAROZOLE	Cytochrome P450 26A1 inhibitor	CYP26A1	CHEMBL5141	acne	EFO:0003894	2	INHIBITOR
TALAROZOLE	Cytochrome P450 26A1 inhibitor	CYP26A1	CHEMBL5141	psoriasis	EFO:0000676	2	INHIBITOR
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Nausea	HP:0002018	4	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	sarcoma	EFO:0000691	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	central nervous system cancer	EFO:0000326	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	pain	EFO:0003843	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	brain disease	EFO:0005774	1	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	HIV infection	EFO:0000764	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	cocaine dependence	EFO:0002610	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	neoplasm of mature B-cells	EFO:0000096	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	alcohol dependence	EFO:0003829	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	breast carcinoma	EFO:0000305	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	non-Hodgkins lymphoma	EFO:0005952	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Radiation-induced nausea and vomiting	EFO:0006912	4	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	pancreatic carcinoma	EFO:0002618	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	gastroenteritis	EFO:1001463	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	nicotine dependence	EFO:0003768	2	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	cervical carcinoma	EFO:0001061	3	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	ANTAGONIST
ONDANSETRON	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	Nausea and vomiting	HP:0002017	3	ANTAGONIST
ELTROMBOPAG	Thrombopoietin receptor agonist	MPL	CHEMBL1864	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
ELTROMBOPAG	Thrombopoietin receptor agonist	MPL	CHEMBL1864	severe aplastic anemia	EFO:0006927	4	AGONIST
PITOLISANT	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	drug dependence	EFO:0003890	1	INVERSE AGONIST
PITOLISANT	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	Parkinson's disease	EFO:0002508	3	INVERSE AGONIST
PITOLISANT	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	narcolepsy with cataplexy	EFO:0000614	3	INVERSE AGONIST
PITOLISANT	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	alcohol dependence	EFO:0003829	2	INVERSE AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	irritable bowel syndrome	EFO:0000555	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	opioid dependence	EFO:0005611	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	migraine with aura	EFO:0005295	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	dementia	HP:0000726	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	Tourette syndrome	EFO:0004895	3	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	HIV infection	EFO:0000764	1	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	migraine without aura	EFO:0005296	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	amyotrophic lateral sclerosis	EFO:0000253	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	Chemotherapy-induced nausea and vomiting	EFO:0006911	4	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	alcohol dependence	EFO:0003829	1	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	pain	EFO:0003843	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	marijuana dependence	EFO:0004218	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	obstructive sleep apnea	EFO:0003918	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	Alzheimers disease	EFO:0000249	2	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	drug dependence	EFO:0003890	1	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	Nausea	HP:0002018	4	AGONIST
DRONABINOL	Cannabinoid CB1 receptor agonist	CNR1	CHEMBL218	multiple sclerosis	EFO:0003885	1	AGONIST
SOTALOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	atrial fibrillation	EFO:0000275	3	ANTAGONIST
SOTALOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	heart failure	EFO:0003144	3	ANTAGONIST
SOTALOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	atrial fibrillation	EFO:0000275	3	ANTAGONIST
SOTALOL	HERG blocker	KCNH2	CHEMBL240	atrial fibrillation	EFO:0000275	3	BLOCKER
SOTALOL	HERG blocker	KCNH2	CHEMBL240	heart failure	EFO:0003144	3	BLOCKER
SOTALOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	heart failure	EFO:0003144	3	ANTAGONIST
IVABRADINE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	HCN4	CHEMBL1250417	heart failure	EFO:0003144	4	BLOCKER
IVABRADINE	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	HCN4	CHEMBL1250417	congestive heart failure	EFO:0000373	4	BLOCKER
DOFETILIDE	HERG blocker	KCNH2	CHEMBL240	cardiac arrhythmia	EFO:0004269	4	BLOCKER
DOFETILIDE	HERG blocker	KCNH2	CHEMBL240	prolonged QT interval	HP:0001657	1	BLOCKER
DOFETILIDE	HERG blocker	KCNH2	CHEMBL240	atrial fibrillation	EFO:0000275	3	BLOCKER
DOFETILIDE	HERG blocker	KCNH2	CHEMBL240	heart failure	EFO:0003144	3	BLOCKER
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	breast carcinoma	EFO:0000305	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	ovarian carcinoma	EFO:0001075	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	Meningioma	Orphanet:2495	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	central nervous system cancer	EFO:0000326	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	prostate carcinoma	EFO:0001663	1	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	4	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	medulloblastoma	EFO:0002939	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	stomach neoplasm	EFO:0003897	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	Gorlin syndrome	Orphanet:377	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	gliosarcoma	EFO:1001465	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	pancreatic ductal adenocarcinoma	EFO:0002517	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	primary myelofibrosis	EFO:0002430	1	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	multiple myeloma	EFO:0001378	1	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
VISMODEGIB	Smoothened homolog inhibitor	SMO	CHEMBL5971	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
MK-0249	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	obstructive sleep apnea	EFO:0003918	2	INVERSE AGONIST
MK-0249	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	Alzheimers disease	EFO:0000249	2	INVERSE AGONIST
MK-0249	Histamine H3 receptor inverse agonist	HRH3	CHEMBL264	dementia	HP:0000726	1	INVERSE AGONIST
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	lung carcinoma	EFO:0001071	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	follicular thyroid carcinoma	EFO:0000501	1	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate carcinoma	EFO:0001663	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	collecting duct carcinoma	EFO:0003016	4	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	cutaneous melanoma	EFO:0000389	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	chromophobe renal cell carcinoma	EFO:0000335	4	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	angiosarcoma	EFO:0003968	3	INHIBITOR
PAZOPANIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	male breast carcinoma	EFO:0006861	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase ITK/TSK inhibitor	ITK	CHEMBL2959	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	sarcoma	EFO:0000691	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Tyrosine-protein kinase LCK inhibitor	LCK	CHEMBL258	breast carcinoma	EFO:0000305	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	bladder carcinoma	EFO:0000292	2	INHIBITOR
PAZOPANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	gliosarcoma	EFO:1001465	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	urethral neoplasm	EFO:0003846	2	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 1 inhibitor	FGFR1	CHEMBL3650	renal cell carcinoma	EFO:0000681	4	INHIBITOR
PAZOPANIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	papillary thyroid carcinoma	EFO:0000641	1	INHIBITOR
THIORIDAZINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
THIORIDAZINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	acute myeloid leukemia	EFO:0000222	1	ANTAGONIST
THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	acute myeloid leukemia	EFO:0000222	1	ANTAGONIST
ODANACATIB	Cathepsin K inhibitor	CTSK	CHEMBL268	breast carcinoma	EFO:0000305	3	INHIBITOR
ODANACATIB	Cathepsin K inhibitor	CTSK	CHEMBL268	osteoporosis	EFO:0003882	3	INHIBITOR
ODANACATIB	Cathepsin K inhibitor	CTSK	CHEMBL268	prostate carcinoma	EFO:0001663	3	INHIBITOR
ODANACATIB	Cathepsin K inhibitor	CTSK	CHEMBL268	postmenopausal osteoporosis	EFO:0003854	3	INHIBITOR
PEXACERFONT	Corticotropin releasing factor receptor 1 antagonist	CRHR1	CHEMBL1800	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-2076	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	multiple myeloma	EFO:0001378	1	INHIBITOR
ENMD-2076	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	lymphoid neoplasm	EFO:0001642	1	INHIBITOR
ENMD-2076	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	clear cell adenocarcinoma	EFO:0000348	2	INHIBITOR
ENMD-2076	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	multiple myeloma	EFO:0001378	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	Mantle cell lymphoma	EFO:1001469	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	breast carcinoma	EFO:0000305	2	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	neuroblastoma	EFO:0000621	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	ovarian carcinoma	EFO:0001075	2	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	multiple myeloma	EFO:0001378	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	unspecified peripheral T-cell lymphoma	EFO:0000211	3	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	lymphoma	EFO:0000574	1	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
ALISERTIB	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
CP-724714	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	2	INHIBITOR
CP-724714	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	2	INHIBITOR
DABIGATRAN	Thrombin inhibitor	F2	CHEMBL204	CADASIL	Orphanet:136	2	INHIBITOR
DABIGATRAN	Thrombin inhibitor	F2	CHEMBL204	atrial fibrillation	EFO:0000275	3	INHIBITOR
DABIGATRAN	Thrombin inhibitor	F2	CHEMBL204	disease	EFO:0000408	2	INHIBITOR
DABIGATRAN	Thrombin inhibitor	F2	CHEMBL204	venous thromboembolism	EFO:0004286	3	INHIBITOR
AMINOGLUTETHIMIDE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	prostate carcinoma	EFO:0001663	2	INHIBITOR
AMINOGLUTETHIMIDE	Cytochrome P450 19A1 inhibitor	CYP19A1	CHEMBL1978	breast carcinoma	EFO:0000305	3	INHIBITOR
CAMICINAL	Motilin receptor agonist	MLNR	CHEMBL2203	gastroparesis	EFO:1000948	2	AGONIST
BUSPIRONE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	Spinal cord injury	EFO:1001919	1	PARTIAL AGONIST
BUSPIRONE	Serotonin 1a (5-HT1a) receptor partial agonist	HTR1A	CHEMBL214	sexual dysfunction	EFO:0004714	2	PARTIAL AGONIST
MK-0533	Peroxisome proliferator-activated receptor gamma modulator	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	2	MODULATOR
CLENBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	obstructive lung disease	HP:0006536	4	AGONIST
CLENBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	1	AGONIST
HYDROXYFLUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	ovarian carcinoma	EFO:0001075	2	ANTAGONIST
HYDROXYFLUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	polycystic ovary syndrome	EFO:0000660	2	ANTAGONIST
HYDROXYFLUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate adenocarcinoma	EFO:0000673	3	ANTAGONIST
HYDROXYFLUTAMIDE	Androgen Receptor antagonist	AR	CHEMBL1871	prostate carcinoma	EFO:0001663	3	ANTAGONIST
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	alveolar soft part sarcoma	EFO:0007143	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian carcinoma	EFO:0001075	3	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rectum cancer	EFO:1000657	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	leukemia	EFO:0000565	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	biliary tract neoplasm	EFO:0003891	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian neoplasm	EFO:0003893	3	INHIBITOR
CEDIRANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
VORAPAXAR	Proteinase-activated receptor 1 antagonist	F2R	CHEMBL3974	myocardial infarction	EFO:0000612	4	ANTAGONIST
VORAPAXAR	Proteinase-activated receptor 1 antagonist	F2R	CHEMBL3974	stroke	EFO:0000712	4	ANTAGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	Recurrent thrombophlebitis	HP:0004419	4	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	lung carcinoma	EFO:0001071	2	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	sudden cardiac arrest	EFO:0004278	2	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	septic shock	EFO:0006834	2	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	chronic kidney disease	EFO:0003884	2	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	pulmonary hypertension	EFO:0001361	3	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	acute respiratory distress syndrome	EFO:1000637	3	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	asthma	EFO:0000270	0	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	systemic scleroderma	EFO:0000717	2	AGONIST
ILOPROST	Prostanoid IP receptor agonist	PTGIR	CHEMBL1995	chronic obstructive pulmonary disease	EFO:0000341	2	AGONIST
LIXIVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	Hyponatremia	HP:0002902	3	ANTAGONIST
LIXIVAPTAN	Vasopressin V2 receptor antagonist	AVPR2	CHEMBL1790	congestive heart failure	EFO:0000373	2	ANTAGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	age-related macular degeneration	EFO:0001365	3	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	erectile dysfunction	EFO:0004234	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	sexual dysfunction	EFO:0004714	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	sexual dysfunction	EFO:0004714	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	peripheral vascular disease	EFO:0003875	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	heart failure	EFO:0003144	3	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	prostate carcinoma	EFO:0001663	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	peripheral vascular disease	EFO:0003875	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	prostate carcinoma	EFO:0001663	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	arteriosclerosis obliterans	EFO:1000820	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	erectile dysfunction	EFO:0004234	2	AGONIST
ALPROSTADIL	Prostanoid EP2 receptor agonist	PTGER2	CHEMBL1881	arteriosclerosis obliterans	EFO:1000820	2	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	heart failure	EFO:0003144	3	AGONIST
ALPROSTADIL	Prostanoid EP1 receptor agonist	PTGER1	CHEMBL1811	age-related macular degeneration	EFO:0001365	3	AGONIST
AT-9283	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	multiple myeloma	EFO:0001378	2	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	multiple myeloma	EFO:0001378	2	INHIBITOR
AT-9283	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	multiple myeloma	EFO:0001378	2	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK3 inhibitor	JAK3	CHEMBL2148	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	multiple myeloma	EFO:0001378	2	INHIBITOR
AT-9283	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	leukemia	EFO:0000565	1	INHIBITOR
AT-9283	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-Hodgkins lymphoma	EFO:0005952	1	INHIBITOR
AT-9283	Serine/threonine-protein kinase Aurora-B inhibitor	AURKB	CHEMBL2185	multiple myeloma	EFO:0001378	2	INHIBITOR
AMG-208	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	prostate carcinoma	EFO:0001663	2	INHIBITOR
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hemangioma	EFO:1000635	2	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	open-angle glaucoma	EFO:0004190	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	ocular hypertension	EFO:1001069	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	melanoma	EFO:0000756	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	glaucoma	EFO:0000516	4	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hemangioma	EFO:1000635	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	ocular hypertension	EFO:1001069	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	anterior ischemic optic neuropathy	EFO:1000809	1	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	open-angle glaucoma	EFO:0004190	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	corneal edema	EFO:1000879	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	Skin ulcer	HP:0200042	2	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	ocular hypertension	EFO:1001069	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	hemangioma	EFO:1000635	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	open-angle glaucoma	EFO:0004190	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	Hereditary hemorrhagic telangiectasia	Orphanet:774	2	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	corneal edema	EFO:1000879	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	open-angle glaucoma	EFO:0004190	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	Hereditary hemorrhagic telangiectasia	Orphanet:774	2	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	glaucoma	EFO:0000516	3	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	Skin ulcer	HP:0200042	2	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	ocular hypertension	EFO:1001069	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	glaucoma	EFO:0000516	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	anterior ischemic optic neuropathy	EFO:1000809	1	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	melanoma	EFO:0000756	3	ANTAGONIST
TIMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	glaucoma	EFO:0000516	4	ANTAGONIST
TIMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	hemangioma	EFO:1000635	2	ANTAGONIST
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Rett syndrome	Orphanet:778	3	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	neuropathic pain	EFO:0005762	2	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	vascular dementia	EFO:0004718	3	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	dementia	HP:0000726	2	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Down syndrome	EFO:0001064	3	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	central nervous system cancer	EFO:0000326	2	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	migraine disorder	EFO:0003821	2	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	brain neoplasm	EFO:0003833	3	INHIBITOR
DONEPEZIL	Acetylcholinesterase inhibitor	ACHE	CHEMBL220	Alzheimers disease	EFO:0000249	4	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	inflammation	MP:0001845	0	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Rett syndrome	Orphanet:778	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	stroke	EFO:0000712	1	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	metabolic disease	EFO:0000589	1	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	ovarian carcinoma	EFO:0001075	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	hypercholesterolemia	HP:0003124	3	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	coronary artery disease	EFO:0000378	3	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	prostate carcinoma	EFO:0001663	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Fragile X syndrome	Orphanet:908	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	asthma	EFO:0000270	1	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Cerebrotendinous xanthomatosis	Orphanet:909	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	intermittent vascular claudication	EFO:0003876	3	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Parkinson's disease	EFO:0002508	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	HIV infection	EFO:0000764	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	melanoma	EFO:0000756	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	Myocardial Ischemia	EFO:1001375	3	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	breast carcinoma	EFO:0000305	2	INHIBITOR
LOVASTATIN	HMG-CoA reductase inhibitor	HMGCR	CHEMBL402	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
CHLORPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	2	ANTAGONIST
CHLORPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	sunburn	EFO:0003958	2	ANTAGONIST
REMINERTANT	Neurotensin receptor 1 antagonist	NTSR1	CHEMBL4123	small cell lung carcinoma	EFO:0000702	2	ANTAGONIST
DENUFOSOL	Purinergic receptor P2Y2 agonist	P2RY2	CHEMBL4398	Cystic fibrosis	Orphanet:586	3	AGONIST
DENUFOSOL	Purinergic receptor P2Y2 agonist	P2RY2	CHEMBL4398	Rhinitis, Allergic, Perennial	EFO:1001417	2	AGONIST
DENUFOSOL	Purinergic receptor P2Y2 agonist	P2RY2	CHEMBL4398	retinal detachment	EFO:0005773	2	AGONIST
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	MAP2K2	CHEMBL2964	colorectal carcinoma	EFO:1001951	1	INHIBITOR
PD-0325901	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	MAP2K1	CHEMBL3587	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	opioid dependence	EFO:0005611	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	HIV infection	EFO:0000764	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	diabetic neuropathy	EFO:1000783	2	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	substance withdrawal syndrome	EFO:0005800	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	cocaine dependence	EFO:0002610	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	Parkinson's disease	EFO:0002508	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	opioid dependence	EFO:0005611	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	cocaine dependence	EFO:0002610	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	hepatitis C infection	EFO:0003047	1	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	drug dependence	EFO:0003890	4	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	restless legs syndrome	EFO:0004270	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	drug dependence	EFO:0003890	1	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	heroin dependence	EFO:0004240	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	drug dependence	EFO:0003890	1	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	Parkinson's disease	EFO:0002508	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	heroin dependence	EFO:0004240	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	restless legs syndrome	EFO:0004270	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	neuropathic pain	EFO:0005762	2	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	substance withdrawal syndrome	EFO:0005800	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	HIV infection	EFO:0000764	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	lumbar disc degeneration	EFO:0004994	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	osteoarthritis	EFO:0002506	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	diabetic neuropathy	EFO:1000783	2	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	pain	EFO:0003843	4	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	neonatal abstinence syndrome	EFO:0005799	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	morphine dependence	EFO:0005612	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	neonatal abstinence syndrome	EFO:0005799	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	3	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	neuropathic pain	EFO:0005762	2	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis	EFO:0002506	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	drug dependence	EFO:0003890	4	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	lumbar disc degeneration	EFO:0004994	3	AGONIST
BUPRENORPHINE	Kappa opioid receptor agonist	OPRK1	CHEMBL237	hepatitis C infection	EFO:0003047	1	AGONIST
BUPRENORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	morphine dependence	EFO:0005612	3	AGONIST
BETRIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial flutter	EFO:0003911	2	INHIBITOR
BETRIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	atrial fibrillation	EFO:0000275	2	INHIBITOR
BETRIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	venous thromboembolism	EFO:0004286	4	INHIBITOR
BETRIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	hemorrhage	MP:0001914	2	INHIBITOR
BETRIXABAN	Coagulation factor X inhibitor	F10	CHEMBL244	liver disease	EFO:0001421	1	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	sarcoma	EFO:0000691	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	anaplastic astrocytoma	EFO:0002499	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	cutaneous melanoma	EFO:0000389	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	Mantle cell lymphoma	EFO:1001469	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	unspecified peripheral T-cell lymphoma	EFO:0000211	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	glioblastoma multiforme	EFO:0000519	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	anaplastic oligodendroglioma	EFO:0002501	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	colorectal carcinoma	EFO:1001951	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	Hodgkins lymphoma	EFO:0000183	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	Burkitts lymphoma	EFO:0000309	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	astrocytoma	EFO:0000272	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	leukemia	EFO:0000565	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	prostate carcinoma	EFO:0001663	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	breast carcinoma	EFO:0000305	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	autoimmune disease	EFO:0005140	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	central nervous system cancer	EFO:0000326	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	relapsing-remitting multiple sclerosis	EFO:0003929	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	gliosarcoma	EFO:1001465	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	multiple myeloma	EFO:0001378	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	Cutaneous T-cell lymphoma	EFO:0002913	1	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	medulloblastoma	EFO:0002939	4	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	melanoma	EFO:0000756	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	plasma cell leukemia	EFO:0006475	1	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	lymphoma	EFO:0000574	3	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	ovarian carcinoma	EFO:0001075	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	brain neoplasm	EFO:0003833	2	INHIBITOR
CARMUSTINE	Glutathione reductase inhibitor	GSR	CHEMBL2755	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	lymphoma	EFO:0000574	1	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	pancreatic neoplasm	EFO:0003860	2	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
BI-2536	Serine/threonine-protein kinase PLK1 inhibitor	PLK1	CHEMBL3024	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
TALMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	multiple myeloma	EFO:0001378	2	INHIBITOR
TALMAPIMOD	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
EMICERFONT	Corticotropin releasing factor receptor 1 antagonist	CRHR1	CHEMBL1800	irritable bowel syndrome	EFO:0000555	2	ANTAGONIST
GOSOGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	3	INHIBITOR
GOSOGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	chronic kidney disease	EFO:0003884	1	INHIBITOR
GSK189254	Histamine H3 receptor antagonist	HRH3	CHEMBL264	narcolepsy with cataplexy	EFO:0000614	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Hypoglycemia	HP:0001943	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	ventilator-associated pneumonia	EFO:1001865	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	hemorrhage	MP:0001914	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	allergic rhinitis	EFO:0005854	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Hypoglycemia	HP:0001943	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	sudden cardiac arrest	EFO:0004278	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	seasonal allergic rhinitis	EFO:0003956	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Hypoglycemia	HP:0001943	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	ventilator-associated pneumonia	EFO:1001865	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Myopia	HP:0000545	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	allergic rhinitis	EFO:0005854	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Myopia	HP:0000545	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Parkinson's disease	EFO:0002508	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	seasonal allergic rhinitis	EFO:0003956	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	breast carcinoma	EFO:0000305	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	insulin resistance	EFO:0002614	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	prediabetes syndrome	EFO:1001121	1	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	post operative nausea and vomiting	EFO:0004888	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Peptic ulcer	HP:0004398	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	pain	EFO:0003843	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Parkinson's disease	EFO:0002508	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	sudden cardiac arrest	EFO:0004278	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	hypospadias	EFO:0004209	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	pain	EFO:0003843	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	seasonal allergic rhinitis	EFO:0003956	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	pain	EFO:0003843	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Peptic ulcer	HP:0004398	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	hemorrhage	MP:0001914	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	breast carcinoma	EFO:0000305	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Myopia	HP:0000545	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	hypospadias	EFO:0004209	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	ventilator-associated pneumonia	EFO:1001865	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	hemorrhage	MP:0001914	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	insulin resistance	EFO:0002614	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	breast carcinoma	EFO:0000305	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Myopia	HP:0000545	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	post-operative sign or symptom	EFO:0005323	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	prediabetes syndrome	EFO:1001121	1	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	sudden cardiac arrest	EFO:0004278	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	prediabetes syndrome	EFO:1001121	1	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	seasonal allergic rhinitis	EFO:0003956	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	insulin resistance	EFO:0002614	0	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	Peptic ulcer	HP:0004398	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Myopia	HP:0000545	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	allergic rhinitis	EFO:0005854	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	post operative nausea and vomiting	EFO:0004888	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	post operative nausea and vomiting	EFO:0004888	3	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	CHRM1	CHEMBL216	hypospadias	EFO:0004209	2	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	CHRM2	CHEMBL211	Parkinson's disease	EFO:0002508	4	ANTAGONIST
ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	CHRM3	CHEMBL245	Myopia	HP:0000545	3	ANTAGONIST
ALEGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	3	AGONIST
ALEGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	3	AGONIST
XIMELAGATRAN	Thrombin inhibitor	F2	CHEMBL204	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Von Hippel-Lindau disease	Orphanet:892	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	adrenocortical carcinoma	EFO:0003093	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	3	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gliosarcoma	EFO:1001465	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	melanoma	EFO:0000756	1	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate carcinoma	EFO:0001663	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	bladder carcinoma	EFO:0000292	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	prostate carcinoma	EFO:0001663	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	1	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	thyroid carcinoma	EFO:0002892	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	adrenocortical carcinoma	EFO:0003093	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Von Hippel-Lindau disease	Orphanet:892	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	bladder carcinoma	EFO:0000292	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	urogenital neoplasm	EFO:0003863	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	urogenital neoplasm	EFO:0003863	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	gastric carcinoma	EFO:0000178	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	thyroid carcinoma	EFO:0002892	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	urogenital neoplasm	EFO:0003863	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	gliosarcoma	EFO:1001465	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gastric carcinoma	EFO:0000178	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	renal cell carcinoma	EFO:0000681	3	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	endometrial stromal tumor	EFO:1000920	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell renal carcinoma	EFO:0000349	3	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	3	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	breast carcinoma	EFO:0000305	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	multiple myeloma	EFO:0001378	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	Von Hippel-Lindau disease	Orphanet:892	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	endometrial stromal tumor	EFO:1000920	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	endometrial stromal tumor	EFO:1000920	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	thyroid carcinoma	EFO:0002892	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	adrenocortical carcinoma	EFO:0003093	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	melanoma	EFO:0000756	1	INHIBITOR
DOVITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	bladder carcinoma	EFO:0000292	2	INHIBITOR
DOVITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	malignant pleural mesothelioma	EFO:0000770	2	INHIBITOR
DOVITINIB	Fibroblast growth factor receptor 3 inhibitor	FGFR3	CHEMBL2742	adenoid cystic carcinoma	EFO:0000231	2	INHIBITOR
ROLOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	heart failure	EFO:0003144	3	ANTAGONIST
ROLOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	congestive heart failure	EFO:0000373	3	ANTAGONIST
DEXTROMETHORPHAN	Sigma opioid receptor agonist	SIGMAR1	CHEMBL287	pain	EFO:0003843	3	AGONIST
DEXTROMETHORPHAN	Sigma opioid receptor agonist	SIGMAR1	CHEMBL287	prostate carcinoma	EFO:0001663	1	AGONIST
DEXTROMETHORPHAN	Sigma opioid receptor agonist	SIGMAR1	CHEMBL287	type II diabetes mellitus	EFO:0001360	2	AGONIST
DEXTROMETHORPHAN	Sigma opioid receptor agonist	SIGMAR1	CHEMBL287	migraine disorder	EFO:0003821	2	AGONIST
DEXTROMETHORPHAN	Sigma opioid receptor agonist	SIGMAR1	CHEMBL287	diabetic retinopathy	EFO:0003770	1	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoporosis	EFO:0003882	3	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	bone fracture	EFO:0003931	3	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	Hypocalcemia	HP:0002901	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	radius fracture	EFO:0003957	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoarthritis	EFO:0002506	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	neurogenic arthropathy	EFO:1001378	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	postmenopausal osteoporosis	EFO:0003854	3	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	osteoarthritis, knee	EFO:0004616	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	Osteogenesis imperfecta	Orphanet:666	2	AGONIST
TERIPARATIDE	Parathyroid hormone receptor agonist	PTH1R	CHEMBL1793	hip fracture	EFO:0003964	3	AGONIST
ENMD-981693	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
ENMD-981693	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
ENMD-981693	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-981693	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
ENMD-981693	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-981693	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	colorectal carcinoma	EFO:1001951	2	INHIBITOR
ENMD-981693	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	2	INHIBITOR
ENMD-981693	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
ENMD-981693	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	breast carcinoma	EFO:0000305	2	INHIBITOR
ENMD-981693	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
ENMD-981693	Serine/threonine-protein kinase Aurora-A inhibitor	AURKA	CHEMBL4722	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
ENMD-981693	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	colorectal carcinoma	EFO:1001951	2	INHIBITOR
KETOTIFEN	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Eczema	HP:0000964	3	ANTAGONIST
KETOTIFEN	Histamine H1 receptor antagonist	HRH1	CHEMBL231	pain	EFO:0003843	1	ANTAGONIST
KETOTIFEN	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
KETOTIFEN	Histamine H1 receptor antagonist	HRH1	CHEMBL231	atopic eczema	EFO:0000274	3	ANTAGONIST
KETOTIFEN	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	3	ANTAGONIST
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	alveolar rhabdomyosarcoma	EFO:0000248	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	osteosarcoma	EFO:0000637	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Retinoblastoma	Orphanet:790	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Hodgkins lymphoma	EFO:0000183	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast carcinoma	EFO:0000305	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	mesothelioma	EFO:0000588	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	primitive neuroectodermal tumor	EFO:0005235	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Hepatoblastoma	EFO:1000292	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	gastric carcinoma	EFO:0000178	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	endometrial neoplasm	EFO:0004230	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	adrenocortical carcinoma	EFO:0003093	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	rhabdomyosarcoma	EFO:0002918	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Ewing sarcoma	EFO:0000174	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	bladder carcinoma	EFO:0000292	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	urethral neoplasm	EFO:0003846	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Nephroblastoma	Orphanet:654	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	sarcoma	EFO:0000691	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	uterine neoplasm	EFO:0003859	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast neoplasm	EFO:0003869	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lung carcinoma	EFO:0001071	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoma	EFO:0000574	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoid leukemia	EFO:0004289	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Kaposi's sarcoma	EFO:0000558	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	esophageal carcinoma	EFO:0002916	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	T-cell acute lymphoblastic leukemia	EFO:0000209	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	embryonal rhabdomyosarcoma	EFO:0000437	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	multiple myeloma	EFO:0001378	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	ovarian carcinoma	EFO:0001075	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	neuroblastoma	EFO:0000621	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	ovarian neoplasm	EFO:0003893	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	autoimmune thrombocytopenic purpura	EFO:0007160	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	central nervous system cancer	EFO:0000326	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Lymphoma, AIDS-Related	EFO:1001365	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	carcinoma	EFO:0000313	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Malignant epithelial tumor of ovary	Orphanet:398934	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	male breast carcinoma	EFO:0006861	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	unspecified peripheral T-cell lymphoma	EFO:0000211	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Burkitts lymphoma	EFO:0000309	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	renal cell carcinoma	EFO:0000681	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	renal carcinoma	EFO:0002890	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	prostate carcinoma	EFO:0001663	3	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	cervical carcinoma	EFO:0001061	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	B-cell acute lymphoblastic leukemia	EFO:0000094	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	ureteral neoplasm	EFO:0003844	2	INHIBITOR
DOXORUBICIN	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	esophageal carcinoma	EFO:0002916	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	oligoastrocytoma	EFO:0000630	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	mesothelioma	EFO:0000588	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	metastatic melanoma	EFO:0002617	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	oligoastrocytoma	EFO:0000630	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	pancreatic neuroendocrine tumor	EFO:1000045	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	stomach neoplasm	EFO:0003897	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	germ cell tumor	EFO:0000514	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	male breast carcinoma	EFO:0006861	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	pancreatic endocrine carcinoma	EFO:0007416	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	oligodendroglioma	EFO:0000632	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Gastrointestinal stromal tumor	Orphanet:44890	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	pancreatic neuroendocrine tumor	EFO:1000045	4	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal cell carcinoma	EFO:0000681	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	germ cell tumor	EFO:0000514	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast carcinoma	EFO:0000305	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	lung carcinoma	EFO:0001071	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	male breast carcinoma	EFO:0006861	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	bladder carcinoma	EFO:0000292	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate carcinoma	EFO:0001663	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	oligodendroglioma	EFO:0000632	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	bladder carcinoma	EFO:0000292	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	esophageal carcinoma	EFO:0002916	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Gastrointestinal stromal tumor	Orphanet:44890	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast neoplasm	EFO:0003869	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	lung carcinoma	EFO:0001071	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	stomach neoplasm	EFO:0003897	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal cell carcinoma	EFO:0000681	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	gliosarcoma	EFO:1001465	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	mesothelioma	EFO:0000588	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	pancreatic endocrine carcinoma	EFO:0007416	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	oligodendroglioma	EFO:0000632	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic endocrine carcinoma	EFO:0007416	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	bladder carcinoma	EFO:0000292	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	oligoastrocytoma	EFO:0000630	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Gastrointestinal stromal tumor	Orphanet:44890	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	stomach neoplasm	EFO:0003897	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	kidney neoplasm	EFO:0003865	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	multiple myeloma	EFO:0001378	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	stomach neoplasm	EFO:0003897	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	renal carcinoma	EFO:0002890	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	multiple myeloma	EFO:0001378	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	kidney neoplasm	EFO:0003865	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	mesothelioma	EFO:0000588	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal cell carcinoma	EFO:0000681	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	renal cell carcinoma	EFO:0000681	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	pancreatic endocrine carcinoma	EFO:0007416	3	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	male breast carcinoma	EFO:0006861	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast neoplasm	EFO:0003869	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate carcinoma	EFO:0001663	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	esophageal carcinoma	EFO:0002916	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	lymphoid leukemia	EFO:0004289	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	kidney neoplasm	EFO:0003865	3	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	soft tissue sarcoma	EFO:1001968	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	multiple myeloma	EFO:0001378	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	oligoastrocytoma	EFO:0000630	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	urethral neoplasm	EFO:0003846	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	lung carcinoma	EFO:0001071	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	germ cell tumor	EFO:0000514	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	breast neoplasm	EFO:0003869	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	renal carcinoma	EFO:0002890	4	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary renal cell carcinoma	EFO:0000640	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	pancreatic neuroendocrine tumor	EFO:1000045	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	clear cell renal carcinoma	EFO:0000349	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	urethral neoplasm	EFO:0003846	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	renal carcinoma	EFO:0002890	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	colorectal carcinoma	EFO:1001951	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	gliosarcoma	EFO:1001465	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	metastatic melanoma	EFO:0002617	1	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	male breast carcinoma	EFO:0006861	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	germ cell tumor	EFO:0000514	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic neuroendocrine tumor	EFO:1000045	4	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal carcinoma	EFO:0002890	4	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast neoplasm	EFO:0003869	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	diffuse large B-cell lymphoma	EFO:0000403	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	chronic lymphocytic leukemia	EFO:0000095	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	bladder carcinoma	EFO:0000292	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate carcinoma	EFO:0001663	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	oligodendroglioma	EFO:0000632	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	metastatic melanoma	EFO:0002617	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	urethral neoplasm	EFO:0003846	2	INHIBITOR
SUNITINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	urethral neoplasm	EFO:0003846	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	breast carcinoma	EFO:0000305	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	papillary thyroid carcinoma	EFO:0000641	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	esophageal carcinoma	EFO:0002916	2	INHIBITOR
SUNITINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	Kaposi's sarcoma	EFO:0000558	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Von Hippel-Lindau disease	Orphanet:892	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast carcinoma	EFO:0000305	3	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	follicular thyroid carcinoma	EFO:0000501	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	metastatic melanoma	EFO:0002617	1	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	gliosarcoma	EFO:1001465	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
SUNITINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	kidney neoplasm	EFO:0003865	3	INHIBITOR
PATIDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	chondrosarcoma	EFO:0000333	2	ANTAGONIST
PATIDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	Gorlin syndrome	Orphanet:377	2	ANTAGONIST
PATIDEGIB	Smoothened homolog antagonist	SMO	CHEMBL5971	basal cell carcinoma	EFO:0004193	2	ANTAGONIST
SPARSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	focal segmental glomerulosclerosis	EFO:0004236	2	ANTAGONIST
SPARSENTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	focal segmental glomerulosclerosis	EFO:0004236	2	ANTAGONIST
SPARSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	hypertension	EFO:0000537	2	ANTAGONIST
SPARSENTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	2	ANTAGONIST
DABIGATRAN ETEXILATE	Thrombin inhibitor	F2	CHEMBL204	deep vein thrombosis	EFO:0003907	4	INHIBITOR
DABIGATRAN ETEXILATE	Thrombin inhibitor	F2	CHEMBL204	atrial fibrillation	EFO:0000275	4	INHIBITOR
DABIGATRAN ETEXILATE	Thrombin inhibitor	F2	CHEMBL204	stroke	EFO:0000712	4	INHIBITOR
HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Tourette syndrome	EFO:0004895	4	ANTAGONIST
HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	nicotine dependence	EFO:0003768	1	ANTAGONIST
HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	post-operative sign or symptom	EFO:0005323	3	ANTAGONIST
HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Alzheimers disease	EFO:0000249	3	ANTAGONIST
HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
PILOCARPINE	Muscarinic acetylcholine receptor M3 agonist	CHRM3	CHEMBL245	Urinary incontinence	HP:0000020	1	AGONIST
PILOCARPINE	Muscarinic acetylcholine receptor M1 agonist	CHRM1	CHEMBL216	Urinary incontinence	HP:0000020	1	AGONIST
PILOCARPINE	Muscarinic acetylcholine receptor M1 agonist	CHRM1	CHEMBL216	glaucoma	EFO:0000516	4	AGONIST
PILOCARPINE	Muscarinic acetylcholine receptor M3 agonist	CHRM3	CHEMBL245	glaucoma	EFO:0000516	4	AGONIST
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	carcinoma	EFO:0000313	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gliosarcoma	EFO:1001465	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	large cell lung carcinoma	EFO:0003050	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bladder carcinoma	EFO:0000292	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	malignant peritoneal mesothelioma	EFO:0005567	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	brain neoplasm	EFO:0003833	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bronchoalveolar adenocarcinoma	EFO:0000308	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	hepatocellular carcinoma	EFO:0000182	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	sarcoma	EFO:0000691	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	anaplastic astrocytoma	EFO:0002499	1	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell lung carcinoma	EFO:0000708	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	endometrial neoplasm	EFO:0004230	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal carcinoma	EFO:0002916	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	Meningioma	Orphanet:2495	1	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate carcinoma	EFO:0001663	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	melanoma	EFO:0000756	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	mesothelioma	EFO:0000588	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	Familial adenomatous polyposis	Orphanet:733	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	rectum cancer	EFO:1000657	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	cervical carcinoma	EFO:0001061	1	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	renal carcinoma	EFO:0002890	2	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	3	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	oligoastrocytoma	EFO:0000630	1	INHIBITOR
ERLOTINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	thyroid carcinoma	EFO:0002892	1	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lymphoma	EFO:0000574	1	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bladder carcinoma	EFO:0000292	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gliosarcoma	EFO:1001465	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	thyroid carcinoma	EFO:0002892	1	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	male breast carcinoma	EFO:0006861	3	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate carcinoma	EFO:0001663	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gliosarcoma	EFO:1001465	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	bladder carcinoma	EFO:0000292	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	endometrial carcinoma	EFO:1001512	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	endometrial carcinoma	EFO:1001512	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	1	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	4	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	4	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	lymphoma	EFO:0000574	1	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	central nervous system cancer	EFO:0000326	1	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast neoplasm	EFO:0003869	4	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	4	INHIBITOR
LAPATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	prostate carcinoma	EFO:0001663	2	INHIBITOR
LAPATINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	male breast carcinoma	EFO:0006861	3	INHIBITOR
RAF-265	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	metastatic melanoma	EFO:0002617	2	INHIBITOR
RAF-265	Serine/threonine-protein kinase B-raf inhibitor	BRAF	CHEMBL5145	metastatic melanoma	EFO:0002617	2	INHIBITOR
SSR180711	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	CHRNA7	CHEMBL2492	Alzheimers disease	EFO:0000249	2	PARTIAL AGONIST
OC000459	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	atopic eczema	EFO:0000274	2	ANTAGONIST
OC000459	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	allergic rhinitis	EFO:0005854	2	ANTAGONIST
OC000459	G protein-coupled receptor 44 antagonist	PTGDR2	CHEMBL5071	asthma	EFO:0000270	2	ANTAGONIST
OTENABANT	Cannabinoid CB1 receptor antagonist	CNR1	CHEMBL218	obesity	EFO:0001073	3	ANTAGONIST
MILCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Thymoma	EFO:1000581	2	INHIBITOR
MILCICLIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	carcinoma	EFO:0000313	2	INHIBITOR
MILCICLIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	carcinoma	EFO:0000313	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	carcinoma	EFO:0000313	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 1 inhibitor	CDK1	CHEMBL308	Thymoma	EFO:1000581	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Thymoma	EFO:1000581	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
MILCICLIB	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	carcinoma	EFO:0000313	2	INHIBITOR
MILCICLIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	Thymoma	EFO:1000581	2	INHIBITOR
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	primary biliary cirrhosis	EFO:1001486	4	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Hepatitis, Alcoholic	EFO:1001345	2	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	liver disease	EFO:0001421	1	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	biliary liver cirrhosis	EFO:0004267	4	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	Familial partial lipodystrophy	Orphanet:98306	2	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	diarrhea	HP:0002014	2	AGONIST
OBETICHOLIC ACID	Bile acid receptor FXR agonist	NR1H4	CHEMBL2047	obesity	EFO:0001073	1	AGONIST
PERPHENAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	cocaine dependence	EFO:0002610	2	ANTAGONIST
PERPHENAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
KX2-391	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	lymphoma	EFO:0000574	1	INHIBITOR
KX2-391	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	prostate carcinoma	EFO:0001663	2	INHIBITOR
KX2-391	Tyrosine-protein kinase SRC inhibitor	SRC	CHEMBL267	acute myeloid leukemia	EFO:0000222	1	INHIBITOR
AZILSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	type II diabetes mellitus	EFO:0001360	3	ANTAGONIST
AZILSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	diabetes mellitus	EFO:0000400	2	ANTAGONIST
AZILSARTAN	Type-1 angiotensin II receptor antagonist	AGTR1	CHEMBL227	hypertension	EFO:0000537	3	ANTAGONIST
MOTESANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	breast carcinoma	EFO:0000305	1	INHIBITOR
MOTESANIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
MOTESANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
MOTESANIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute myeloblastic leukemia with maturation	EFO:0003028	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	Olfactory Neuroblastoma	EFO:1000407	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	endometrial carcinoma	EFO:1001512	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	bile duct carcinoma	EFO:0005540	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	prostate carcinoma	EFO:0001663	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	melanoma	EFO:0000756	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Olfactory Neuroblastoma	EFO:1000407	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	T-cell acute lymphoblastic leukemia	EFO:0000209	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	bile duct carcinoma	EFO:0005540	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute myeloblastic leukemia with maturation	EFO:0003028	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute megakaryoblastic leukaemia	EFO:0003025	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	prostate carcinoma	EFO:0001663	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	gastric carcinoma	EFO:0000178	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	anal neoplasm	EFO:0003835	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	endometrial carcinoma	EFO:1001512	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	basal cell carcinoma	EFO:0004193	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute myeloblastic leukemia with maturation	EFO:0003028	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Olfactory Neuroblastoma	EFO:1000407	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	germ cell tumor	EFO:0000514	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	paranasal sinus neoplasm	EFO:0003866	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute myelomonocytic leukemia	EFO:0000223	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	verrucous carcinoma	EFO:0007535	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	T-cell acute lymphoblastic leukemia	EFO:0000209	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute myeloblastic leukemia with maturation	EFO:0003028	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	gastric carcinoma	EFO:0000178	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	leukemia	EFO:0000565	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	basal cell carcinoma	EFO:0004193	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	paranasal sinus neoplasm	EFO:0003866	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	cervical carcinoma	EFO:0001061	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute myelomonocytic leukemia	EFO:0000223	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	germ cell tumor	EFO:0000514	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute megakaryoblastic leukaemia	EFO:0003025	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	bile duct carcinoma	EFO:0005540	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute myeloblastic leukemia without maturation	EFO:0003027	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	renal carcinoma	EFO:0002890	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	ovarian carcinoma	EFO:0001075	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	renal carcinoma	EFO:0002890	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	melanoma	EFO:0000756	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	basal cell carcinoma	EFO:0004193	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	melanoma	EFO:0000756	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	endometrial carcinoma	EFO:1001512	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute myeloblastic leukemia without maturation	EFO:0003027	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	gastric carcinoma	EFO:0000178	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute megakaryoblastic leukaemia	EFO:0003025	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute myeloblastic leukemia with maturation	EFO:0003028	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	endometrial carcinoma	EFO:1001512	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	rectum cancer	EFO:1000657	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	ovarian carcinoma	EFO:0001075	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	Olfactory Neuroblastoma	EFO:1000407	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	T-cell acute lymphoblastic leukemia	EFO:0000209	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	T-cell acute lymphoblastic leukemia	EFO:0000209	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	cervical carcinoma	EFO:0001061	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	anal neoplasm	EFO:0003835	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute myelomonocytic leukemia	EFO:0000223	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	germ cell tumor	EFO:0000514	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	ovarian carcinoma	EFO:0001075	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	melanoma	EFO:0000756	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute myelomonocytic leukemia	EFO:0000223	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	prostate carcinoma	EFO:0001663	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	acute myeloblastic leukemia without maturation	EFO:0003027	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	myelodysplastic syndrome	EFO:0000198	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	acute myeloblastic leukemia without maturation	EFO:0003027	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	rectum cancer	EFO:1000657	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	anal neoplasm	EFO:0003835	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	verrucous carcinoma	EFO:0007535	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	germ cell tumor	EFO:0000514	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	leukemia	EFO:0000565	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	esophageal carcinoma	EFO:0002916	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	endometrial carcinoma	EFO:1001512	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	paranasal sinus neoplasm	EFO:0003866	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute monocytic leukemia	EFO:0000221	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	leukemia	EFO:0000565	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	rectum cancer	EFO:1000657	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	T-cell acute lymphoblastic leukemia	EFO:0000209	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	germ cell tumor	EFO:0000514	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	renal carcinoma	EFO:0002890	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute myelomonocytic leukemia	EFO:0000223	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	prostate adenocarcinoma	EFO:0000673	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	renal carcinoma	EFO:0002890	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	leukemia	EFO:0000565	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	basal cell carcinoma	EFO:0004193	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	prostate carcinoma	EFO:0001663	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	leukemia	EFO:0000565	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	cervical carcinoma	EFO:0001061	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	melanoma	EFO:0000756	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	renal carcinoma	EFO:0002890	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	Olfactory Neuroblastoma	EFO:1000407	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	lymphoma	EFO:0000574	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	verrucous carcinoma	EFO:0007535	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	prostate carcinoma	EFO:0001663	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	anal neoplasm	EFO:0003835	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	acute megakaryoblastic leukaemia	EFO:0003025	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	basal cell carcinoma	EFO:0004193	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	paranasal sinus neoplasm	EFO:0003866	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	paranasal sinus neoplasm	EFO:0003866	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	rectum cancer	EFO:1000657	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	salivary gland neoplasm	EFO:0003826	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	verrucous carcinoma	EFO:0007535	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	cervical carcinoma	EFO:0001061	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	verrucous carcinoma	EFO:0007535	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	colorectal adenocarcinoma	EFO:0000365	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	anal neoplasm	EFO:0003835	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	acute megakaryoblastic leukaemia	EFO:0003025	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	gallbladder neoplasm	EFO:0004606	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	ovarian carcinoma	EFO:0001075	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	lymphoma	EFO:0000574	2	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	acute myeloblastic leukemia without maturation	EFO:0003027	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 6 inhibitor	CDK6	CHEMBL2508	bile duct carcinoma	EFO:0005540	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	lymphoma	EFO:0000574	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	cervical carcinoma	EFO:0001061	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	lymphoma	EFO:0000574	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	rectum cancer	EFO:1000657	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	ovarian carcinoma	EFO:0001075	2	INHIBITOR
UCN-01	Cyclin-dependent kinase 2 inhibitor	CDK2	CHEMBL301	gastric carcinoma	EFO:0000178	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	myeloproliferative disorder	EFO:0004251	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	lymphoma	EFO:0000574	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	Gastrointestinal stromal tumor	Orphanet:44890	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	gastric carcinoma	EFO:0000178	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	breast carcinoma	EFO:0000305	1	INHIBITOR
UCN-01	Serine/threonine-protein kinase Chk1 inhibitor	CHEK1	CHEMBL4630	bile duct carcinoma	EFO:0005540	1	INHIBITOR
UCN-01	3-phosphoinositide dependent protein kinase-1 inhibitor	PDPK1	CHEMBL2534	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
UCN-01	Cyclin-dependent kinase 4 inhibitor	CDK4	CHEMBL331	Fallopian Tube Carcinoma	EFO:1000251	2	INHIBITOR
BMS-754807	Insulin-like growth factor I receptor inhibitor	IGF1R	CHEMBL1957	breast carcinoma	EFO:0000305	2	INHIBITOR
BMS-754807	Insulin receptor inhibitor	INSR	CHEMBL1981	breast carcinoma	EFO:0000305	2	INHIBITOR
QUIZARTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
QUIZARTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
QUIZARTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	1	INHIBITOR
QUIZARTINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
QUIZARTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	leukemia	EFO:0000565	1	INHIBITOR
QUIZARTINIB	Macrophage colony stimulating factor receptor inhibitor	CSF1R	CHEMBL1844	leukemia	EFO:0000565	1	INHIBITOR
QUIZARTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
QUIZARTINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	leukemia	EFO:0000565	1	INHIBITOR
ENALAPRILAT	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	3	INHIBITOR
ENALAPRILAT	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	dilated cardiomyopathy	EFO:0000407	3	INHIBITOR
ENALAPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	intracerebral hemorrhage	EFO:0005669	2	INHIBITOR
ENALAPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	Proteinuria	HP:0000093	3	INHIBITOR
ENALAPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	2	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myeloid sarcoma	EFO:1001052	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	multiple myeloma	EFO:0001378	2	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Granulocytic Sarcoma	EFO:1000286	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	relapsing-remitting multiple sclerosis	EFO:0003929	2	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	multiple sclerosis	EFO:0003885	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	breast carcinoma	EFO:0000305	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	diffuse large B-cell lymphoma	EFO:0000403	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	neoplasm of mature B-cells	EFO:0000096	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	prostate carcinoma	EFO:0001663	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	pain	EFO:0003843	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	ovarian carcinoma	EFO:0001075	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoma	EFO:0000574	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	chronic progressive multiple sclerosis	EFO:0003840	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	leukemia	EFO:0000565	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	chronic lymphocytic leukemia	EFO:0000095	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	acute promyelocytic leukemia	EFO:0000224	3	INHIBITOR
MITOXANTRONE	DNA topoisomerase II alpha inhibitor	TOP2A	CHEMBL1806	lymphoid leukemia	EFO:0004289	2	INHIBITOR
AEE-788	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AEE-788	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AEE-788	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AEE-788	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	central nervous system cancer	EFO:0000326	1	INHIBITOR
AEE-788	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	1	INHIBITOR
AEE-788	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
AEE-788	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	central nervous system cancer	EFO:0000326	1	INHIBITOR
AEE-788	Vascular endothelial growth factor receptor 1 inhibitor	FLT1	CHEMBL1868	central nervous system cancer	EFO:0000326	1	INHIBITOR
DOPAMINE	Beta-1 adrenergic receptor agonist	ADRB1	CHEMBL213	Parkinson's disease	EFO:0002508	3	AGONIST
CARMEGLIPTIN	Dipeptidyl peptidase IV inhibitor	DPP4	CHEMBL284	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
IMIGLITAZAR	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	diabetes mellitus	EFO:0000400	3	AGONIST
IMIGLITAZAR	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	diabetes mellitus	EFO:0000400	3	AGONIST
DERENOFYLLINE	Adenosine A1 receptor antagonist	ADORA1	CHEMBL226	congestive heart failure	EFO:0000373	2	ANTAGONIST
GEDATOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	endometrial neoplasm	EFO:0004230	2	INHIBITOR
GEDATOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
GEDATOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
GEDATOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
GEDATOLISIB	Serine/threonine-protein kinase mTOR inhibitor	MTOR	CHEMBL2842	breast carcinoma	EFO:0000305	1	INHIBITOR
ATRELEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	coronary artery disease	EFO:0000378	2	INHIBITOR
ATRELEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	acute coronary syndrome	EFO:0005672	2	INHIBITOR
ATRELEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	atherosclerosis	EFO:0003914	2	INHIBITOR
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	pancreatic carcinoma	EFO:0002618	1	AGONIST
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	non-small cell lung carcinoma	EFO:0003060	2	AGONIST
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	chronic kidney disease	EFO:0003884	2	AGONIST
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Oral leukoplakia	HP:0002745	2	AGONIST
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	amyotrophic lateral sclerosis	EFO:0000253	1	AGONIST
PIOGLITAZONE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	type II diabetes mellitus	EFO:0001360	4	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	obstructive sleep apnea	EFO:0003918	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	bone fracture	EFO:0003931	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	breast carcinoma	EFO:0000305	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	idiopathic pulmonary fibrosis	EFO:0000768	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	1	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pulpitis	EFO:1001139	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	Otitis media	EFO:0004992	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	adenoma	EFO:0000232	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pulpitis	EFO:1001139	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	hypotension	EFO:0005251	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	morbid obesity	EFO:0001074	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pancreatic carcinoma	EFO:0002618	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	hypospadias	EFO:0004209	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	subarachnoid hemorrhage	EFO:0000713	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	asthma	EFO:0000270	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	irritable bowel syndrome	EFO:0000555	2	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	obesity	EFO:0001073	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	gastric carcinoma	EFO:0000178	3	AGONIST
FENTANYL	Mu opioid receptor agonist	OPRM1	CHEMBL233	neuropathic pain	EFO:0005762	3	AGONIST
PRIDOPIDINE	Dopamine D2 receptor modulator	DRD2	CHEMBL217	Huntington disease	Orphanet:399	3	MODULATOR
NELOTANSERIN	Serotonin 2a (5-HT2a) receptor inverse agonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	2	INVERSE AGONIST
NELOTANSERIN	Serotonin 2a (5-HT2a) receptor inverse agonist	HTR2A	CHEMBL224	Lewy body dementia	EFO:0006792	2	INVERSE AGONIST
CUDC-101	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CUDC-101	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	breast carcinoma	EFO:0000305	1	INHIBITOR
CUDC-101	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	1	INHIBITOR
CUDC-101	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
CUDC-101	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
CUDC-101	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	1	INHIBITOR
CUDC-101	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	head and neck malignant neoplasia	EFO:0006859	1	INHIBITOR
CUDC-101	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
CUDC-101	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	1	INHIBITOR
CUDC-101	Receptor protein-tyrosine kinase erbB-2 inhibitor	ERBB2	CHEMBL1824	gastric carcinoma	EFO:0000178	1	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	chronic childhood arthritis	EFO:0002609	3	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	systemic lupus erythematosus	EFO:0002690	1	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	ankylosing spondylitis	EFO:0003898	3	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	4	INHIBITOR
MELOXICAM	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Tuberculosis	Orphanet:3389	3	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	anaplastic large cell lymphoma	EFO:0003032	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	neuroblastoma	EFO:0000621	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	adenocarcinoma	EFO:0000228	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	colorectal carcinoma	EFO:1001951	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	breast carcinoma	EFO:0000305	1	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	breast carcinoma	EFO:0000305	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	gastric carcinoma	EFO:0000178	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	neuroblastoma	EFO:0000621	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	papillary renal cell carcinoma	EFO:0000640	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	prostate carcinoma	EFO:0001663	1	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	glioblastoma multiforme	EFO:0000519	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	squamous cell carcinoma	EFO:0000707	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	adenocarcinoma	EFO:0000228	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	colorectal carcinoma	EFO:1001951	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	prostate carcinoma	EFO:0001663	1	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	gastric carcinoma	EFO:0000178	2	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	lung carcinoma	EFO:0001071	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	lung carcinoma	EFO:0001071	1	INHIBITOR
CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	ALK	CHEMBL4247	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	MET	CHEMBL3717	non-small cell lung carcinoma	EFO:0003060	4	INHIBITOR
ZAFIRLUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	obstructive lung disease	HP:0006536	4	ANTAGONIST
ZAFIRLUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	breast carcinoma	EFO:0000305	2	ANTAGONIST
ZAFIRLUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	asthma	EFO:0000270	4	ANTAGONIST
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	primary myelofibrosis	EFO:0002430	1	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	primary myelofibrosis	EFO:0002430	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	primary myelofibrosis	EFO:0002430	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	psoriasis	EFO:0000676	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	primary myelofibrosis	EFO:0002430	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	polycythemia vera	EFO:0002429	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	multiple myeloma	EFO:0001378	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	primary myelofibrosis	EFO:0002430	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	2	INHIBITOR
LESTAURTINIB	Neurotrophic tyrosine kinase receptor type 2 inhibitor	NTRK2	CHEMBL4898	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	NT-3 growth factor receptor inhibitor	NTRK3	CHEMBL5608	neuroblastoma	EFO:0000621	1	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	essential thrombocythemia	EFO:0000479	2	INHIBITOR
LESTAURTINIB	Nerve growth factor receptor Trk-A inhibitor	NTRK1	CHEMBL2815	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase receptor RET inhibitor	RET	CHEMBL2041	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	prostate carcinoma	EFO:0001663	2	INHIBITOR
LESTAURTINIB	Tyrosine-protein kinase JAK2 inhibitor	JAK2	CHEMBL2971	primary myelofibrosis	EFO:0002430	1	INHIBITOR
DP001	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoporosis	EFO:0003882	2	AGONIST
DP001	Vitamin D receptor agonist	VDR	CHEMBL1977	postmenopausal osteoporosis	EFO:0003854	1	AGONIST
DP001	Vitamin D receptor agonist	VDR	CHEMBL1977	secondary hyperparathyroidism	EFO:1001173	2	AGONIST
OLODATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
OLODATEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	emphysema	EFO:0000464	4	AGONIST
MEPERIDINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	hypotension	EFO:0005251	2	AGONIST
MEPERIDINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	2	AGONIST
PELITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colonic neoplasm	EFO:0004288	2	INHIBITOR
PELITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal neoplasm	EFO:0004142	2	INHIBITOR
PELITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	rectum cancer	EFO:1000657	2	INHIBITOR
PELITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mast-cell leukemia	EFO:0007359	4	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	mast-cell leukemia	EFO:0007359	4	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	leukemia	EFO:0000565	3	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	liver disease	EFO:0001421	1	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	liver disease	EFO:0001421	1	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	acute myeloid leukemia	EFO:0000222	4	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	rectum cancer	EFO:1000657	1	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	rectum cancer	EFO:1000657	1	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	leukemia	EFO:0000565	3	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	abnormality of blood and blood-forming tissues	HP:0001871	2	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	acute myeloid leukemia	EFO:0000222	4	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	liver disease	EFO:0001421	1	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	leukemia	EFO:0000565	3	INHIBITOR
MIDOSTAURIN	Tyrosine-protein kinase receptor FLT3 inhibitor	FLT3	CHEMBL1974	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
MIDOSTAURIN	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	4	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	rectum cancer	EFO:1000657	1	INHIBITOR
MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	KDR	CHEMBL279	mast-cell leukemia	EFO:0007359	4	INHIBITOR
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	cocaine dependence	EFO:0002610	2	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	central nervous system cancer	EFO:0000326	3	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	multiple sclerosis	EFO:0003885	2	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	metamphetamine dependence	EFO:0004701	2	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	central nervous system cancer	EFO:0000326	3	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	stroke	EFO:0000712	2	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	opioid dependence	EFO:0005611	2	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	opioid dependence	EFO:0005611	2	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
DEXTROAMPHETAMINE	Dopamine transporter releasing agent	SLC6A3	CHEMBL238	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	stroke	EFO:0000712	2	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	2	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	narcolepsy with cataplexy	EFO:0000614	4	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	metamphetamine dependence	EFO:0004701	2	RELEASING AGENT
DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	SLC6A2	CHEMBL222	multiple sclerosis	EFO:0003885	2	RELEASING AGENT
TEZOSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	heart failure	EFO:0003144	3	ANTAGONIST
TEZOSENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	pulmonary hypertension	EFO:0001361	2	ANTAGONIST
TEZOSENTAN	Endothelin receptor ET-B antagonist	EDNRB	CHEMBL1785	pulmonary hypertension	EFO:0001361	2	ANTAGONIST
TEZOSENTAN	Endothelin receptor ET-B antagonist	EDNRB	CHEMBL1785	heart failure	EFO:0003144	3	ANTAGONIST
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	colorectal neoplasm	EFO:0004142	3	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	Fish-eye disease	Orphanet:79292	1	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	4	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatoid arthritis	EFO:0000685	4	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	4	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
ETODOLAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	muscular disease	EFO:0002970	3	INHIBITOR
AMITRIPTYLINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Pruritus	HP:0000989	2	INHIBITOR
AMITRIPTYLINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Pruritus	HP:0000989	2	INHIBITOR
PROPAFENONE	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	heart failure	EFO:0003144	3	ANTAGONIST
PROPAFENONE	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	atrial fibrillation	EFO:0000275	3	ANTAGONIST
PROPAFENONE	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	atrial fibrillation	EFO:0000275	3	ANTAGONIST
PROPAFENONE	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	heart failure	EFO:0003144	3	ANTAGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	1	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetic retinopathy	EFO:0003770	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinal vein occlusion	EFO:1001157	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	newborn respiratory distress syndrome	EFO:1000644	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	glaucoma	EFO:0000516	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	carpal tunnel syndrome	EFO:0004143	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tendinopathy	EFO:1001434	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	obstructive lung disease	HP:0006536	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sciatica	HP:0011868	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Cough	HP:0012735	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute respiratory distress syndrome	EFO:1000637	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchiolitis	HP:0011950	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	skin disease	EFO:0000701	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Eczema	HP:0000964	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	premature birth	EFO:0003917	3	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal obstruction	HP:0001742	4	AGONIST
BETAMETHASONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	adenoma	EFO:0000232	1	AGONIST
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	heart failure	EFO:0003144	3	BLOCKER
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	ventricular tachycardia	EFO:0005306	4	BLOCKER
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	atrial fibrillation	EFO:0000275	3	BLOCKER
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	ventricular fibrillation	EFO:0004287	4	BLOCKER
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	Chagas cardiomyopathy	EFO:0005529	3	BLOCKER
AMIODARONE	HERG blocker	KCNH2	CHEMBL240	AL amyloidosis	Orphanet:85443	2	BLOCKER
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	heart disease	EFO:0003777	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myelodysplastic syndrome	EFO:0000198	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	meningeal tuberculosis	EFO:1000039	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	fibrosis	EFO:0006890	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Gastrointestinal stromal tumor	Orphanet:44890	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vestibular neuronitis	EFO:0007537	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	subacute thyroiditis	EFO:1001194	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic kidney disease	EFO:0003884	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	idiopathic pulmonary fibrosis	EFO:0000768	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hemophilia A	Orphanet:98878	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neuroblastoma	EFO:0000621	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	breast carcinoma	EFO:0000305	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thymus neoplasm	EFO:0002626	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypercalcemia	HP:0003072	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple sclerosis	EFO:0003885	1	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neuropathy	EFO:0004149	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Myasthenia gravis	EFO:0004991	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	metastatic prostate cancer	EFO:0000196	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Langerhans Cell Histiocytosis	EFO:1000318	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pain	EFO:0003843	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	optic neuritis	EFO:0007405	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	relapsing-remitting multiple sclerosis	EFO:0003929	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	temporal arteritis	EFO:1001209	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute myeloid leukemia	EFO:0000222	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	central nervous system cancer	EFO:0000326	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemangioma	EFO:1000635	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Lymphoma, AIDS-Related	EFO:1001365	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	congestive heart failure	EFO:0000373	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ulcerative colitis	EFO:0000729	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic childhood arthritis	EFO:0002609	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic conjunctivitis	EFO:0007141	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Cystic fibrosis	Orphanet:586	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	kidney disease	EFO:0003086	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	urticaria	EFO:0005531	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	focal segmental glomerulosclerosis	EFO:0004236	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sarcoidosis	Orphanet:797	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate adenocarcinoma	EFO:0000673	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	contact dermatitis	EFO:0005319	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	heart failure	EFO:0003144	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sympathetic ophthalmia	EFO:1001205	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	frozen shoulder	EFO:1000941	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	eosinophilic pneumonia	EFO:0007257	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	T-cell acute lymphoblastic leukemia	EFO:0000209	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neoplasm of mature B-cells	EFO:0000096	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lung carcinoma	EFO:0001071	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	amyotrophic lateral sclerosis	EFO:0000253	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	juvenile dermatomyositis	EFO:0000557	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hepatitis C infection	EFO:0003047	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diffuse large B-cell lymphoma	EFO:0000403	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hepatocellular carcinoma	EFO:0000182	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sarcoma	EFO:0000691	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cardiomyopathy	EFO:0000318	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Duchenne muscular dystrophy	Orphanet:98896	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	primary myelofibrosis	EFO:0002430	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Autoimmune Hepatitis	EFO:0005676	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	trichinosis	EFO:0007520	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Giant Lymph Node Hyperplasia	EFO:1001332	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	nephrotic syndrome	EFO:0004255	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	uveitis	EFO:1001231	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sickle cell anemia	Orphanet:232	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	arthritis	EFO:0005856	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myeloproliferative disorder	EFO:0004251	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	mycosis fungoides	EFO:1001051	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	iritis	EFO:1000997	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Mantle cell lymphoma	EFO:1001469	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hemolytic anemia	EFO:0005558	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sciatica	HP:0011868	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	hearing loss	EFO:0004238	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atopic eczema	EFO:0000274	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	renal carcinoma	EFO:0002890	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	angioimmunoblastic T-cell lymphoma	EFO:0000255	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergic rhinitis	EFO:0005854	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Stevens-Johnson syndrome	EFO:0004276	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary sarcoidosis	DOID:13406	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hodgkins lymphoma	EFO:0000183	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	berylliosis	EFO:0007168	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pemphigus vulgaris	EFO:0004719	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	essential thrombocythemia	EFO:0000479	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Graves ophthalmopathy	EFO:1001466	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	allergy	EFO:0003785	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Glucose intolerance	HP:0000833	1	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Tenosynovitis	EFO:1001435	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lupus nephritis	EFO:0005761	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic lymphocytic leukemia	EFO:0000095	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polycythemia vera	EFO:0002429	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	IGA glomerulonephritis	EFO:0004194	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-Hodgkins lymphoma	EFO:0005952	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sensorineural hearing loss	EFO:1001176	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Fanconi anemia	Orphanet:84	1	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Blackfan-Diamond anemia	Orphanet:124	1	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	gout	EFO:0004274	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hepatitis, Alcoholic	EFO:1001345	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	membranous glomerulonephritis	EFO:0004254	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Wegener's granulomatosis	EFO:0005297	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriatic arthritis	EFO:0003778	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	HIV infection	EFO:0000764	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pulmonary tuberculosis	EFO:1000049	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Henoch-Schoenlein purpura	EFO:1000965	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seborrheic dermatitis	EFO:1000764	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	cholesterol embolism	EFO:0005801	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatomyositis	EFO:0000398	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lung disease	EFO:0003818	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ankylosing spondylitis	EFO:0003898	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hypereosinophilic syndrome	EFO:1001467	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	unspecified peripheral T-cell lymphoma	EFO:0000211	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sinusitis	EFO:0007486	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune disease	EFO:0005140	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoid leukemia	EFO:0004289	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Burkitts lymphoma	EFO:0000309	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	psoriasis	EFO:0000676	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polymyositis	EFO:0003063	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	erythema multiforme	EFO:1000694	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Churg-Strauss syndrome	EFO:0007208	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	pneumonia	EFO:0003106	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Anemia, Hemolytic, Autoimmune	EFO:1001264	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lichen planus	EFO:1000726	2	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	deafness	EFO:0001063	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Orphanet:90794	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Alzheimers disease	EFO:0000249	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	dermatitis herpetiformis	EFO:1000684	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	4	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Rhinitis, Allergic, Perennial	EFO:1001417	3	AGONIST
PREDNISONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	seasonal allergic rhinitis	EFO:0003956	4	AGONIST
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Parkinson's disease	EFO:0002508	3	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	pain	EFO:0003843	2	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	fibromyalgia	EFO:0005687	1	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Spinal cord injury	EFO:1001919	2	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Parkinson's disease	EFO:0002508	3	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	breast carcinoma	EFO:0000305	2	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	2	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	breast carcinoma	EFO:0000305	2	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	prostate carcinoma	EFO:0001663	3	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	dementia	HP:0000726	3	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	prostate carcinoma	EFO:0001663	3	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	fibromyalgia	EFO:0005687	1	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	Alzheimers disease	EFO:0000249	1	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	cocaine dependence	EFO:0002610	2	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	dementia	HP:0000726	3	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Alzheimers disease	EFO:0000249	1	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	neuropathic pain	EFO:0005762	2	INHIBITOR
VENLAFAXINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	neuropathic pain	EFO:0005762	2	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	pain	EFO:0003843	2	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Spinal cord injury	EFO:1001919	2	INHIBITOR
VENLAFAXINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
AZELASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	vasomotor rhinitis	EFO:0007533	4	ANTAGONIST
AZELASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	4	ANTAGONIST
AZELASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic conjunctivitis	EFO:0007141	4	ANTAGONIST
AZELASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	4	ANTAGONIST
AZELASTINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
ATOMOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	metamphetamine dependence	EFO:0004701	1	INHIBITOR
ATOMOXETINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Alzheimers disease	EFO:0000249	2	INHIBITOR
ACEBUTOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
PROMETHAZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	migraine with aura	EFO:0005295	3	ANTAGONIST
PROMETHAZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	migraine without aura	EFO:0005296	3	ANTAGONIST
PROMETHAZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	insomnia	EFO:0004698	3	ANTAGONIST
PROMETHAZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	1	ANTAGONIST
PROMETHAZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	hyperemesis gravidarum	EFO:1000971	3	ANTAGONIST
BISOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hypertension	EFO:0000537	4	ANTAGONIST
BISOPROLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
NADOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	asthma	EFO:0000270	2	ANTAGONIST
NADOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	asthma	EFO:0000270	2	ANTAGONIST
NADOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	hemangioma	EFO:1000635	3	ANTAGONIST
NADOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	hemangioma	EFO:1000635	3	ANTAGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoma	EFO:0000574	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Spinal cord injury	EFO:1001919	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hantavirus infectious disease	EFO:0007295	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Graves ophthalmopathy	EFO:1001466	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	melanoma	EFO:0000756	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Friedreich ataxia	Orphanet:95	0	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Wegener's granulomatosis	EFO:0005297	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Hepatitis, Alcoholic	EFO:1001345	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	spondyloarthropathy	EFO:0000706	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sudden cardiac arrest	EFO:0004278	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	myelodysplastic syndrome	EFO:0000198	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	non-Hodgkins lymphoma	EFO:0005952	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lupus nephritis	EFO:0005761	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Burkitts lymphoma	EFO:0000309	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	heart disease	EFO:0003777	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anterior ischemic optic neuropathy	EFO:1000809	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	atherosclerosis	EFO:0003914	1	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	ankylosing spondylitis	EFO:0003898	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	IGA glomerulonephritis	EFO:0004194	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Crohn's disease	EFO:0000384	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Fanconi anemia	Orphanet:84	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Nasal Cavity Polyp	EFO:1000391	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	kidney disease	EFO:0003086	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	juvenile dermatomyositis	EFO:0000557	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	appendicitis	EFO:0007149	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	noise-induced hearing loss	EFO:1001254	1	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bell's palsy	EFO:0007167	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	amyotrophic lateral sclerosis	EFO:0000253	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Primary hemophagocytic lymphohistiocytosis	Orphanet:158038	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	polyp	EFO:0000662	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Lymphoma, AIDS-Related	EFO:1001365	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	prostate carcinoma	EFO:0001663	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	neuromyelitis optica	EFO:0004256	1	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	aplastic anemia	HP:0001915	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	carpal tunnel syndrome	EFO:0004143	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic kidney disease	EFO:0003884	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	autoimmune thrombocytopenic purpura	EFO:0007160	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic lupus erythematosus	EFO:0002690	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute graft vs. host disease	EFO:0004599	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic progressive multiple sclerosis	EFO:0003840	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diffuse large B-cell lymphoma	EFO:0000403	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	22q11.2 deletion syndrome	Orphanet:567	1	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	chronic lymphocytic leukemia	EFO:0000095	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	lymphoid neoplasm	EFO:0001642	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Dysphagia	HP:0002015	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	metastatic prostate cancer	EFO:0000196	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	urinary tract infection	EFO:0003103	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	sinusitis	EFO:0007486	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	vestibular neuronitis	EFO:0007537	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	rheumatoid arthritis	EFO:0000685	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Familial lipoprotein lipase deficiency	Orphanet:309015	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	angioimmunoblastic T-cell lymphoma	EFO:0000255	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acne	EFO:0003894	4	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Sickle cell anemia	Orphanet:232	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Henoch-Schoenlein purpura	EFO:1000965	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Meniere disease	EFO:0006862	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Bronchopulmonary dysplasia	Orphanet:70589	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	abdominal pain	HP:0002027	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	thrombocytopenia	HP:0001873	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Plantar Fasciitis	EFO:1001909	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	membranous glomerulonephritis	EFO:0004254	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	unspecified peripheral T-cell lymphoma	EFO:0000211	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	osteoarthritis	EFO:0002506	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple sclerosis	EFO:0003885	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	multiple myeloma	EFO:0001378	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	relapsing-remitting multiple sclerosis	EFO:0003929	3	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	systemic scleroderma	EFO:0000717	2	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Ovarian hyperstimulation syndrome	Orphanet:64739	1	AGONIST
METHYLPREDNISOLONE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute respiratory distress syndrome	EFO:1000637	3	AGONIST
METHADONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	HIV infection	EFO:0000764	1	AGONIST
METHADONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	scoliosis	EFO:0004273	2	AGONIST
FLECAINIDE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	pain	EFO:0003843	2	BLOCKER
FLECAINIDE	Sodium channel protein type V alpha subunit blocker	SCN5A	CHEMBL1980	atrial fibrillation	EFO:0000275	3	BLOCKER
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	drug dependence	EFO:0003890	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	nutritional disorder	EFO:0001069	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	nutritional disorder	EFO:0001069	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	alcohol dependence	EFO:0003829	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	alcohol dependence	EFO:0003829	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	breast carcinoma	EFO:0000305	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	cocaine dependence	EFO:0002610	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	heroin dependence	EFO:0004240	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	pancreatic carcinoma	EFO:0002618	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	drug dependence	EFO:0003890	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	obstructive sleep apnea	EFO:0003918	1	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	fibromyalgia	EFO:0005687	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	breast carcinoma	EFO:0000305	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	obstructive sleep apnea	EFO:0003918	1	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	pancreatic carcinoma	EFO:0002618	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	heroin dependence	EFO:0004240	3	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	fibromyalgia	EFO:0005687	2	ANTAGONIST
MIRTAZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	cocaine dependence	EFO:0002610	2	ANTAGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	diabetic neuropathy	EFO:1000783	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	Parkinson's disease	EFO:0002508	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	sinusitis	EFO:0007486	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis, knee	EFO:0004616	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	restless legs syndrome	EFO:0004270	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	kidney stone	EFO:0003845	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	neuropathic pain	EFO:0005762	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis	EFO:0002506	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis, knee	EFO:0004616	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	2	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	colorectal carcinoma	EFO:1001951	1	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	joint disease	EFO:1000999	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	Pruritus	HP:0000989	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis, hip	EFO:1000786	3	AGONIST
OXYCODONE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	4	AGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Headache	HP:0002315	3	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	pain	EFO:0003843	1	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	melanoma	EFO:0000756	1	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Nausea	HP:0002018	2	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	aphthous ulcer	EFO:0003938	2	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	1	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	breast carcinoma	EFO:0000305	2	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	orthostatic hypotension	EFO:0005252	1	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	diabetic neuropathy	EFO:1000783	2	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	renal carcinoma	EFO:0002890	2	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	migraine disorder	EFO:0003821	3	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	1	ANTAGONIST
DIPHENHYDRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	rectum cancer	EFO:1000657	1	ANTAGONIST
CYCLOBENZAPRINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	migraine disorder	EFO:0003821	3	ANTAGONIST
CYCLOBENZAPRINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	cerebral palsy	EFO:1000632	4	ANTAGONIST
CYCLOBENZAPRINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	migraine disorder	EFO:0003821	3	ANTAGONIST
CYCLOBENZAPRINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	cerebral palsy	EFO:1000632	4	ANTAGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	obesity	EFO:0001073	2	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	coronary artery disease	EFO:0000378	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	multiple myeloma	EFO:0001378	2	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	sclerosing cholangitis	EFO:0004268	1	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Abnormality of lipid metabolism	HP:0003119	4	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	metabolic disease	EFO:0000589	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	HIV-1 infection	EFO:0000180	2	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hypertriglyceridemia	EFO:0004211	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	type II diabetes mellitus	EFO:0001360	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	metabolic syndrome	EFO:0000195	2	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	primary biliary cirrhosis	EFO:1001486	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hyperlipoproteinemia type 3	Orphanet:412	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	alcohol dependence	EFO:0003829	2	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	hypercholesterolemia	HP:0003124	4	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	diabetic retinopathy	EFO:0003770	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Combined hyperlipidemia	Orphanet:79211	3	AGONIST
FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	hyperlipidemia	EFO:0003774	3	AGONIST
CLOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	myocardial infarction	EFO:0000612	3	AGONIST
CLOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	coronary artery disease	EFO:0000378	3	AGONIST
CLOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Myocardial Ischemia	EFO:1001375	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	hemorrhage	MP:0001914	2	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Neural tube defect	Orphanet:3388	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Cystic fibrosis	Orphanet:586	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	rheumatoid arthritis	EFO:0000685	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	hepatitis C infection	EFO:0003047	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Turner syndrome	Orphanet:881	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	osteopenia	HP:0000938	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	hidradenitis suppurativa	EFO:1000710	2	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	osteoporosis	EFO:0003882	2	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	Chronic Hepatitis C infection	EFO:0004220	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	chronic lymphocytic leukemia	EFO:0000095	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	type II diabetes mellitus	EFO:0001360	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	infection	EFO:0000544	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	HIV infection	EFO:0000764	1	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	acne	EFO:0003894	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	polycystic ovary syndrome	EFO:0000660	3	AGONIST
ETHINYL ESTRADIOL	Estrogen receptor alpha agonist	ESR1	CHEMBL206	endometrial neoplasm	EFO:0004230	2	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis, knee	EFO:0004616	2	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	Pruritus	HP:0000989	3	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	opioid dependence	EFO:0005611	1	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pulmonary hypertension	EFO:0001361	2	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	pain	EFO:0003843	3	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	myocardial infarction	EFO:0000612	2	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	obstructive sleep apnea	EFO:0003918	3	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	neonatal abstinence syndrome	EFO:0005799	2	AGONIST
MORPHINE	Mu opioid receptor agonist	OPRM1	CHEMBL233	osteoarthritis	EFO:0002506	2	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	berylliosis	EFO:0007168	1	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Crohn's disease	EFO:0000384	3	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	berylliosis	EFO:0007168	1	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	proctitis	EFO:0005628	3	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	colitis	EFO:0003872	2	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	colorectal carcinoma	EFO:1001951	2	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	ulcerative colitis	EFO:0000729	3	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	irritable bowel syndrome	EFO:0000555	3	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	irritable bowel syndrome	EFO:0000555	3	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	collagenous colitis	EFO:1001293	3	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	Lynch syndrome	Orphanet:144	2	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	nutritional disorder	EFO:0001069	1	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	ulcerative colitis	EFO:0000729	3	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	nutritional disorder	EFO:0001069	1	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	colorectal adenoma	EFO:0005406	2	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	collagenous colitis	EFO:1001293	3	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	colorectal adenoma	EFO:0005406	2	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	Lynch syndrome	Orphanet:144	2	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	proctitis	EFO:0005628	3	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	diverticulitis	EFO:1001460	3	AGONIST
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	Crohn's disease	EFO:0000384	3	INHIBITOR
MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	diverticulitis	EFO:1001460	3	INHIBITOR
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	colorectal carcinoma	EFO:1001951	2	AGONIST
MESALAMINE	Peroxisome proliferator-activated receptor gamma agonist	PPARG	CHEMBL235	colitis	EFO:0003872	2	AGONIST
SERATRODAST	Thromboxane A2 receptor antagonist	TBXA2R	CHEMBL2069	obstructive lung disease	HP:0006536	0	ANTAGONIST
CHLORPROMAZINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	neonatal abstinence syndrome	EFO:0005799	3	ANTAGONIST
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	benign prostatic hyperplasia	EFO:0000284	4	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	retinopathy	EFO:0003839	2	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	acne	EFO:0003894	2	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	prostate carcinoma	EFO:0001663	2	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	androgenetic alopecia	EFO:0004191	4	INHIBITOR
FINASTERIDE	Steroid 5-alpha-reductase 2 inhibitor	SRD5A2	CHEMBL1856	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	lung disease	EFO:0003818	1	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Familial dysautonomia	Orphanet:1764	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	congestive heart failure	EFO:0000373	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Congenital myasthenic syndromes	Orphanet:590	1	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	diabetes mellitus	EFO:0000400	1	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	acute respiratory distress syndrome	EFO:1000637	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	allergy	EFO:0003785	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	pulmonary edema	EFO:1001134	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	obstructive lung disease	HP:0006536	4	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	4	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	memory impairment	EFO:0001072	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	chronic obstructive pulmonary disease	EFO:0000341	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	idiopathic pulmonary fibrosis	EFO:0000768	1	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Lymphangioleiomyomatosis	Orphanet:538	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Glycogen storage disease due to acid maltase deficiency	Orphanet:365	1	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Spinal cord injury	EFO:1001919	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	pulmonary hypertension	EFO:0001361	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	Bronchiolitis	HP:0011950	2	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	seasonal allergic rhinitis	EFO:0003956	3	AGONIST
ALBUTEROL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	alcohol dependence	EFO:0003829	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	lymphoid neoplasm	EFO:0001642	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	body weight gain	EFO:0004566	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	HIV infection	EFO:0000764	1	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	lymphoid neoplasm	EFO:0001642	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	HIV infection	EFO:0000764	1	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	breast carcinoma	EFO:0000305	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	insulin resistance	EFO:0002614	2	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Huntington disease	Orphanet:399	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insulin resistance	EFO:0002614	2	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	Huntington disease	Orphanet:399	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	body weight gain	EFO:0004566	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	amyotrophic lateral sclerosis	EFO:0000253	2	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	diabetes mellitus	EFO:0000400	2	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	alcohol dependence	EFO:0003829	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	breast carcinoma	EFO:0000305	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	drug-Induced dyskinesia	EFO:1000904	1	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	post operative nausea and vomiting	EFO:0004888	2	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	post operative nausea and vomiting	EFO:0004888	2	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	drug-Induced dyskinesia	EFO:1000904	1	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Chemotherapy-induced nausea and vomiting	EFO:0006911	3	ANTAGONIST
OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	diabetes mellitus	EFO:0000400	2	ANTAGONIST
OLANZAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	amyotrophic lateral sclerosis	EFO:0000253	2	ANTAGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	HIV-1 infection	EFO:0000180	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	hemorrhage	MP:0001914	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	primary ovarian insufficiency	EFO:0004266	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	renal carcinoma	EFO:0002890	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	Alzheimers disease	EFO:0000249	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	sleep apnea	EFO:0003877	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	systemic lupus erythematosus	EFO:0002690	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	prostate adenocarcinoma	EFO:0000673	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	Menorrhagia	HP:0000132	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	endometriosis	EFO:0001065	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	pain	EFO:0003843	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	infertility	EFO:0000545	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	osteoporosis	EFO:0003882	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	heart disease	EFO:0003777	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	renal cell carcinoma	EFO:0000681	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	Turner syndrome	Orphanet:881	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	endometrial neoplasm	EFO:0004230	2	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	coronary heart disease	EFO:0001645	3	AGONIST
MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	PGR	CHEMBL208	HIV infection	EFO:0000764	2	AGONIST
DESIPRAMINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
FLUPHENAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
FLUPHENAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	psoriasis	EFO:0000676	2	ANTAGONIST
FLUPHENAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	psoriasis	EFO:0000676	2	ANTAGONIST
PROCHLORPERAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	Headache	HP:0002315	3	ANTAGONIST
PROCHLORPERAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	migraine disorder	EFO:0003821	3	ANTAGONIST
PROCHLORPERAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	Nausea and vomiting	HP:0002017	2	ANTAGONIST
PROCHLORPERAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	breast carcinoma	EFO:0000305	3	ANTAGONIST
PROCHLORPERAZINE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	Nausea	HP:0002018	3	ANTAGONIST
VOLINANSERIN	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	insomnia	EFO:0004698	3	ANTAGONIST
NANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	nutritional disorder	EFO:0001069	2	AGONIST
NANDROLONE	Androgen Receptor agonist	AR	CHEMBL1871	HIV wasting syndrome	EFO:0007312	1	AGONIST
ESMOLOL	Beta-1 adrenergic receptor antagonist	ADRB1	CHEMBL213	diabetic foot	EFO:1001459	1	ANTAGONIST
ESMOLOL	Beta-2 adrenergic receptor antagonist	ADRB2	CHEMBL210	diabetic foot	EFO:1001459	1	ANTAGONIST
METAPROTERENOL	Beta-2 adrenergic receptor agonist	ADRB2	CHEMBL210	asthma	EFO:0000270	4	AGONIST
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	interstitial lung disease	EFO:0004244	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Raynaud disease	EFO:1001145	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Sickle cell anemia	Orphanet:232	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	systemic scleroderma	EFO:0000717	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	congestive heart failure	EFO:0000373	1	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	erectile dysfunction	EFO:0004234	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	vascular dementia	EFO:0004718	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	hypertension	EFO:0000537	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	benign prostatic hyperplasia	EFO:0000284	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Muscular dystrophy	Orphanet:98473	0	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Duchenne muscular dystrophy	Orphanet:98896	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	pulmonary hypertension	EFO:0001361	3	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	Cushing syndrome	EFO:0003099	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	gastroparesis	EFO:1000948	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	obesity	EFO:0001073	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	head and neck squamous cell carcinoma	EFO:0000181	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	stroke	EFO:0000712	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	multiple myeloma	EFO:0001378	2	INHIBITOR
TADALAFIL	Phosphodiesterase 5A inhibitor	PDE5A	CHEMBL1827	upper aerodigestive tract neoplasm	EFO:0004284	0	INHIBITOR
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	asthma	EFO:0000270	4	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	allergic rhinitis	EFO:0005854	4	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	bronchiolitis obliterans	EFO:0007183	2	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	Bronchiolitis	HP:0011950	3	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	asthma	EFO:0000270	4	ANTAGONIST
MONTELUKAST	Cysteinyl leukotriene receptor 1 antagonist	CYSLTR1	CHEMBL1798	seasonal allergic rhinitis	EFO:0003956	4	ANTAGONIST
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	opioid dependence	EFO:0005611	1	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	opioid dependence	EFO:0005611	1	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	metamphetamine dependence	EFO:0004701	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	post-operative sign or symptom	EFO:0005323	1	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	cocaine dependence	EFO:0002610	2	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	cocaine dependence	EFO:0002610	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	lymphoid neoplasm	EFO:0001642	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Parkinson's disease	EFO:0002508	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	prostate carcinoma	EFO:0001663	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Alzheimers disease	EFO:0000249	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	drug dependence	EFO:0003890	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Parkinson's disease	EFO:0002508	2	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Alzheimers disease	EFO:0000249	3	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	chronic progressive multiple sclerosis	EFO:0003840	1	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	relapsing-remitting multiple sclerosis	EFO:0003929	1	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	Sickle cell anemia	Orphanet:232	3	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	relapsing-remitting multiple sclerosis	EFO:0003929	1	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	metamphetamine dependence	EFO:0004701	2	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	chronic progressive multiple sclerosis	EFO:0003840	1	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	multiple sclerosis	EFO:0003885	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Sickle cell anemia	Orphanet:232	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	prostate carcinoma	EFO:0001663	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	dementia	HP:0000726	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	dementia	HP:0000726	3	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	nicotine dependence	EFO:0003768	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	orthostatic hypotension	EFO:0005252	1	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	brain neoplasm	EFO:0003833	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	lymphoid neoplasm	EFO:0001642	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	multiple sclerosis	EFO:0003885	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	breast carcinoma	EFO:0000305	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	drug dependence	EFO:0003890	2	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	brain neoplasm	EFO:0003833	3	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	orthostatic hypotension	EFO:0005252	1	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	nicotine dependence	EFO:0003768	2	INHIBITOR
METHYLPHENIDATE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	post-operative sign or symptom	EFO:0005323	1	INHIBITOR
METHYLPHENIDATE	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	breast carcinoma	EFO:0000305	2	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	cerebrovascular disorder	EFO:0003763	3	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	brain infarction	EFO:0004277	3	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	pain	EFO:0003843	1	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	coronary artery disease	EFO:0000378	3	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	intermittent vascular claudication	EFO:0003876	2	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	stroke	EFO:0000712	2	INHIBITOR
CILOSTAZOL	Phosphodiesterase 3A inhibitor	PDE3A	CHEMBL241	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
SERTRALINE	Serotonin transporter inhibitor	SLC6A4	CHEMBL228	mental retardation	EFO:0003847	2	INHIBITOR
RALOXIFENE	Estrogen receptor beta modulator	ESR2	CHEMBL242	prostate adenocarcinoma	EFO:0000673	2	MODULATOR
RALOXIFENE	Estrogen receptor beta modulator	ESR2	CHEMBL242	breast carcinoma	EFO:0000305	2	MODULATOR
BROMPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	inflammation	MP:0001845	3	ANTAGONIST
BROMPHENIRAMINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Cough	HP:0012735	3	ANTAGONIST
VICRIVIROC	C-C chemokine receptor type 5 antagonist	CCR5	CHEMBL274	HIV infection	EFO:0000764	2	ANTAGONIST
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	pain	EFO:0003843	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	HIV infection	EFO:0000764	0	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	ovarian carcinoma	EFO:0001075	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	endometrial neoplasm	EFO:0004230	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	Duchenne muscular dystrophy	Orphanet:98896	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	amyotrophic lateral sclerosis	EFO:0000253	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	Hereditary hemorrhagic telangiectasia	Orphanet:774	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	Chronic Hepatitis C infection	EFO:0004220	1	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	hemorrhage	MP:0001914	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	bladder tumor	EFO:0000294	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	osteosarcoma	EFO:0000637	1	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	carcinoma	EFO:0000313	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	breast carcinoma	EFO:0000305	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	ductal adenocarcinoma	EFO:0000430	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	cervical adenocarcinoma	EFO:0001416	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	bladder carcinoma	EFO:0000292	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	endometrial carcinoma	EFO:1001512	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	hepatocellular carcinoma	EFO:0000182	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	male breast carcinoma	EFO:0006861	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	breast neoplasm	EFO:0003869	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	cutaneous melanoma	EFO:0000389	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	fibrosis	EFO:0006890	2	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	prostate carcinoma	EFO:0001663	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	infertility	EFO:0000545	3	MODULATOR
TAMOXIFEN	Estrogen receptor alpha modulator	ESR1	CHEMBL206	central nervous system cancer	EFO:0000326	2	MODULATOR
EFLORNITHINE	Ornithine decarboxylase inhibitor	ODC1	CHEMBL1869	Familial adenomatous polyposis	Orphanet:733	3	INHIBITOR
LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	neuropathic pain	EFO:0005762	2	ANTAGONIST
LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	asthma	EFO:0000270	1	ANTAGONIST
LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	nicotine dependence	EFO:0003768	1	ANTAGONIST
LOXAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	asthma	EFO:0000270	1	ANTAGONIST
LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	migraine disorder	EFO:0003821	2	ANTAGONIST
LOXAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	chronic obstructive pulmonary disease	EFO:0000341	1	ANTAGONIST
LOXAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	neuropathic pain	EFO:0005762	2	ANTAGONIST
LOXAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	migraine disorder	EFO:0003821	2	ANTAGONIST
LOXAPINE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	nicotine dependence	EFO:0003768	1	ANTAGONIST
SULFINPYRAZONE	Solute carrier family 22 member 12 inhibitor	SLC22A12	CHEMBL6120	gout	EFO:0004274	4	INHIBITOR
BENAZEPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	Fish-eye disease	Orphanet:79292	1	INHIBITOR
BENAZEPRIL	Angiotensin-converting enzyme inhibitor	ACE	CHEMBL1808	hypertension	EFO:0000537	4	INHIBITOR
LOPERAMIDE	Mu opioid receptor agonist	OPRM1	CHEMBL233	diarrhea	HP:0002014	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	fibroma	EFO:0002424	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	Crohn's disease	EFO:0000384	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate adenocarcinoma	EFO:0000673	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	myelodysplastic syndrome	EFO:0000198	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	metastatic melanoma	EFO:0002617	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	mouth neoplasm	EFO:0003868	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	central nervous system cancer	EFO:0000326	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast neoplasm	EFO:0003869	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	basal cell carcinoma	EFO:0004193	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	Hypocalcemia	HP:0002901	4	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	prostate carcinoma	EFO:0001663	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	breast carcinoma	EFO:0000305	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	type I diabetes mellitus	EFO:0001359	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	cholangiocarcinoma	EFO:0005221	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	sepsis	HP:0100806	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	psoriasis	EFO:0000676	4	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	hypertension	EFO:0000537	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	systemic lupus erythematosus	EFO:0002690	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	diabetic nephropathy	EFO:0000401	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	non-small cell lung carcinoma	EFO:0003060	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	postmenopausal osteoporosis	EFO:0003854	1	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	pancreatic carcinoma	EFO:0002618	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	atopic eczema	EFO:0000274	2	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	osteoporosis	EFO:0003882	3	AGONIST
CALCITRIOL	Vitamin D receptor agonist	VDR	CHEMBL1977	Osteopetrosis	Orphanet:2781	3	AGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Tourette syndrome	EFO:0004895	2	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	Tourette syndrome	EFO:0004895	2	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	cocaine dependence	EFO:0002610	2	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	Tourette syndrome	EFO:0004895	2	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	metamphetamine dependence	EFO:0004701	2	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	metamphetamine dependence	EFO:0004701	2	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	diabetes mellitus	EFO:0000400	2	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	cocaine dependence	EFO:0002610	2	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	drug-Induced dyskinesia	EFO:1000904	1	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	drug-Induced dyskinesia	EFO:1000904	1	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	diabetes mellitus	EFO:0000400	2	ANTAGONIST
RISPERIDONE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	metamphetamine dependence	EFO:0004701	2	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	diabetes mellitus	EFO:0000400	2	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	drug-Induced dyskinesia	EFO:1000904	1	ANTAGONIST
RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	Fish-eye disease	Orphanet:79292	1	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
RISPERIDONE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	cocaine dependence	EFO:0002610	2	ANTAGONIST
METOCLOPRAMIDE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
METOCLOPRAMIDE	Serotonin 3a (5-HT3a) receptor antagonist	HTR3A	CHEMBL1899	post operative nausea and vomiting	EFO:0004888	4	ANTAGONIST
METOCLOPRAMIDE	Serotonin 4 (5-HT4) receptor agonist	HTR4	CHEMBL1875	post operative nausea and vomiting	EFO:0004888	4	AGONIST
VALDECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pain	EFO:0003843	3	INHIBITOR
VALDECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	osteoarthritis	EFO:0002506	3	INHIBITOR
VALDECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pancreatitis	EFO:0000278	2	INHIBITOR
VALDECOXIB	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
ALENDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	postmenopausal osteoporosis	EFO:0003854	4	INHIBITOR
ALENDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteitis deformans	EFO:0004261	4	INHIBITOR
ALENDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteoporosis	EFO:0003882	4	INHIBITOR
ALENDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	breast carcinoma	EFO:0000305	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	femoral neck fracture	EFO:1001792	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Von Willebrand disease	Orphanet:903	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	placenta accreta	EFO:0007440	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	scoliosis	EFO:0004273	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	gastrointestinal hemorrhage	HP:0002239	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	joint disease	EFO:1000999	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	hemorrhage	MP:0001914	4	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	thrombocytopenia	HP:0001873	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Hereditary hemorrhagic telangiectasia	Orphanet:774	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	upper aerodigestive tract neoplasm	EFO:0004284	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	intracerebral hemorrhage	EFO:0005669	2	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Hereditary angioedema	Orphanet:91378	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	lymphoid neoplasm	EFO:0001642	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	uterine fibroid	EFO:0000731	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	hip fracture	EFO:0003964	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	adolescent idiopathic scoliosis	EFO:0005423	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	coronary artery disease	EFO:0000378	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Menorrhagia	HP:0000132	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	subarachnoid hemorrhage	EFO:0000713	2	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	bone fracture	EFO:0003931	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	Abdominal Aortic Aneurysm	EFO:0004214	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	osteoarthritis	EFO:0002506	3	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	bladder carcinoma	EFO:0000292	2	INHIBITOR
TRANEXAMIC ACID	Plasminogen inhibitor	PLG	CHEMBL1801	placenta praevia	EFO:0007442	3	INHIBITOR
RASAGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	multiple system atrophy	EFO:1001050	2	INHIBITOR
RASAGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	Parkinson's disease	EFO:0002508	4	INHIBITOR
BUPROPION	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	obesity	EFO:0001073	2	INHIBITOR
BUPROPION	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	nicotine dependence	EFO:0003768	3	INHIBITOR
BUPROPION	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	lung carcinoma	EFO:0001071	3	INHIBITOR
BUPROPION	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	obesity	EFO:0001073	2	INHIBITOR
BUPROPION	Dopamine transporter inhibitor	SLC6A3	CHEMBL238	nicotine dependence	EFO:0003768	3	INHIBITOR
BUPROPION	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	lung carcinoma	EFO:0001071	3	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	Tourette syndrome	EFO:0004895	1	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	alcohol dependence	EFO:0003829	2	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	complex partial epilepsy	EFO:1000877	4	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	epilepsy	EFO:0000474	4	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	West syndrome	Orphanet:3451	4	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	metamphetamine dependence	EFO:0004701	2	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	Tuberous sclerosis	Orphanet:805	2	INHIBITOR
VIGABATRIN	Gamma-amino-N-butyrate transaminase inhibitor	ABAT	CHEMBL2044	cocaine dependence	EFO:0002610	2	INHIBITOR
HYDROXYZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Pruritus	HP:0000989	4	ANTAGONIST
HYDROXYZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	skin disease	EFO:0000701	4	ANTAGONIST
HYDROXYZINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	urticaria	EFO:0005531	4	ANTAGONIST
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	gout	EFO:0004274	4	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	infection	EFO:0000544	3	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	cellulitis	EFO:0003035	2	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	avian influenza	EFO:0005222	1	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	systolic heart failure	EFO:1001207	2	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	type II diabetes mellitus	EFO:0001360	1	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	systolic heart failure	EFO:1001207	2	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	type II diabetes mellitus	EFO:0001360	1	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	cellulitis	EFO:0003035	2	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	infection	EFO:0000544	3	INHIBITOR
PROBENECID	Solute carrier family 22 member 6 inhibitor	SLC22A6	CHEMBL1641347	obesity	EFO:0001073	3	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	gout	EFO:0004274	4	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	avian influenza	EFO:0005222	1	INHIBITOR
PROBENECID	Solute carrier family 22 member 8 inhibitor	SLC22A8	CHEMBL1641348	obesity	EFO:0001073	3	INHIBITOR
ORPHENADRINE	Norepinephrine transporter inhibitor	SLC6A2	CHEMBL222	Parkinson's disease	EFO:0002508	4	INHIBITOR
ORPHENADRINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Parkinson's disease	EFO:0002508	4	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	melanoma	EFO:0000756	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	squamous cell carcinoma	EFO:0000707	2	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	Peptic ulcer	HP:0004398	4	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	papillary thyroid carcinoma	EFO:0000641	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	colorectal carcinoma	EFO:1001951	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastroesophageal reflux disease	EFO:0003948	4	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	HIV infection	EFO:0000764	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	movement disorder	EFO:0004280	2	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	psoriasis	EFO:0000676	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	multiple myeloma	EFO:0001378	2	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	fibrosis	EFO:0006890	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	non-small cell lung carcinoma	EFO:0003060	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	HIV-1 infection	EFO:0000180	1	ANTAGONIST
FAMOTIDINE	Histamine H2 receptor antagonist	HRH2	CHEMBL1941	gastrointestinal hemorrhage	HP:0002239	3	ANTAGONIST
RIZATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine disorder	EFO:0003821	4	AGONIST
RIZATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine without aura	EFO:0005296	3	AGONIST
RIZATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine disorder	EFO:0003821	4	AGONIST
RIZATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine without aura	EFO:0005296	3	AGONIST
RIZATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	HTR1B	CHEMBL1898	migraine with aura	EFO:0005295	3	AGONIST
RIZATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	HTR1D	CHEMBL1983	migraine with aura	EFO:0005295	3	AGONIST
CHLORPROTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	HTR2A	CHEMBL224	dementia	HP:0000726	3	ANTAGONIST
CHLORPROTHIXENE	Dopamine D2 receptor antagonist	DRD2	CHEMBL217	dementia	HP:0000726	3	ANTAGONIST
CHLORPROTHIXENE	Dopamine D3 receptor antagonist	DRD3	CHEMBL234	dementia	HP:0000726	3	ANTAGONIST
CHLORPROTHIXENE	Serotonin 2c (5-HT2c) receptor antagonist	HTR2C	CHEMBL225	dementia	HP:0000726	3	ANTAGONIST
FEXOFENADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
FEXOFENADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
FEXOFENADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	3	ANTAGONIST
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal neoplasm	EFO:0004142	3	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal adenocarcinoma	EFO:0000365	3	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	cholangiocarcinoma	EFO:0005221	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	gastric carcinoma	EFO:0000178	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	esophageal carcinoma	EFO:0002916	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	intrahepatic cholangiocarcinoma	EFO:1001961	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
FLOXURIDINE	Thymidylate synthase inhibitor	TYMS	CHEMBL1952	colorectal carcinoma	EFO:1001951	3	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	diabetic retinopathy	EFO:0003770	3	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	diabetic neuropathy	EFO:1000783	2	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	diabetes mellitus	EFO:0000400	2	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	type I diabetes mellitus	EFO:0001359	3	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	type II diabetes mellitus	EFO:0001360	2	INHIBITOR
RUBOXISTAURIN	Protein kinase C beta inhibitor	PRKCB	CHEMBL3045	heart failure	EFO:0003144	1	INHIBITOR
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	prostate carcinoma	EFO:0001663	3	ANTAGONIST
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	peritoneal neoplasm	EFO:1001100	2	ANTAGONIST
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	central nervous system cancer	EFO:0000326	1	ANTAGONIST
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	Fallopian Tube Carcinoma	EFO:1000251	2	ANTAGONIST
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	renal carcinoma	EFO:0002890	2	ANTAGONIST
ATRASENTAN	Endothelin receptor ET-A antagonist	EDNRA	CHEMBL252	ovarian carcinoma	EFO:0001075	2	ANTAGONIST
RISEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	leukemia	EFO:0000565	3	INHIBITOR
RISEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	lymphoma	EFO:0000574	3	INHIBITOR
RISEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteoporosis	EFO:0003882	3	INHIBITOR
RISEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Osteogenesis imperfecta	Orphanet:666	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	sarcoma	EFO:0000691	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Osteogenesis imperfecta	Orphanet:666	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	plasmacytoma	EFO:0006738	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	cervical carcinoma	EFO:0001061	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	reflex sympathetic dystrophy	EFO:1001147	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	breast neoplasm	EFO:0003869	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Spinal cord injury	EFO:1001919	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	renal carcinoma	EFO:0002890	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	breast carcinoma	EFO:0000305	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Ewing sarcoma	EFO:0000174	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	pain	EFO:0003843	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteonecrosis	EFO:0004259	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	chronic myelogenous leukemia	EFO:0000339	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Sickle cell anemia	Orphanet:232	1	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Beta-thalassemia	Orphanet:848	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	multiple myeloma	EFO:0001378	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	Hutchinson-Gilford progeria syndrome	Orphanet:740	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	renal cell carcinoma	EFO:0000681	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	chondrosarcoma	EFO:0000333	1	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	neuroblastoma	EFO:0000621	1	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteopenia	HP:0000938	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	urogenital neoplasm	EFO:0003863	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteosarcoma	EFO:0000637	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	mesothelioma	EFO:0000588	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	primary myelofibrosis	EFO:0002430	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteoporosis	EFO:0003882	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	non-Hodgkins lymphoma	EFO:0005952	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	cervical adenocarcinoma	EFO:0001416	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	nasopharyngeal neoplasm	EFO:0004252	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	lung carcinoma	EFO:0001071	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	postmenopausal osteoporosis	EFO:0003854	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	prostate carcinoma	EFO:0001663	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	bone fracture	EFO:0003931	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	ductal carcinoma in situ	EFO:0000432	2	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	prostate adenocarcinoma	EFO:0000673	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteitis deformans	EFO:0004261	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	metastatic prostate cancer	EFO:0000196	3	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	bone disease	EFO:0004260	4	INHIBITOR
ZOLEDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	adenocarcinoma	EFO:0000228	1	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	Sickle cell anemia	Orphanet:232	1	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	nicotine dependence	EFO:0003768	1	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	acne	EFO:0003894	2	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	inflammation	MP:0001845	0	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	chronic obstructive pulmonary disease	EFO:0000341	3	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	asthma	EFO:0000270	4	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	lung carcinoma	EFO:0001071	2	INHIBITOR
ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	ALOX5	CHEMBL215	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	coronary heart disease	EFO:0001645	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	internal carotid artery stenosis	EFO:0002615	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	Myocardial Ischemia	EFO:1001375	3	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	coronary artery disease	EFO:0000378	3	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	ovarian carcinoma	EFO:0001075	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	rheumatoid arthritis	EFO:0000685	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	Recurrent thrombophlebitis	HP:0004419	4	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	HIV infection	EFO:0000764	1	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	Sickle cell anemia	Orphanet:232	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	hypertension	EFO:0000537	1	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
DIPYRIDAMOLE	Equilibrative nucleoside transporter 1 inhibitor	SLC29A1	CHEMBL1997	heart disease	EFO:0003777	2	INHIBITOR
ACECLOFENAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	pulpitis	EFO:1001139	2	INHIBITOR
ACECLOFENAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	arthralgia	HP:0002829	4	INHIBITOR
ACECLOFENAC	Cyclooxygenase-2 inhibitor	PTGS2	CHEMBL230	rheumatic disease	EFO:0005755	4	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	metastatic prostate cancer	EFO:0000196	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	bladder carcinoma	EFO:0000292	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	hepatocellular carcinoma	EFO:0000182	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	renal carcinoma	EFO:0002890	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck malignant neoplasia	EFO:0006859	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	neuroblastoma	EFO:0000621	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	sarcoma	EFO:0000691	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	mesothelioma	EFO:0000588	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell lung carcinoma	EFO:0000708	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	upper aerodigestive tract neoplasm	EFO:0004284	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	nasopharyngeal neoplasm	EFO:0004252	1	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	lung carcinoma	EFO:0001071	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	skin neoplasm	EFO:0004198	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	colorectal carcinoma	EFO:1001951	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	prostate carcinoma	EFO:0001663	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	esophageal carcinoma	EFO:0002916	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	renal cell carcinoma	EFO:0000681	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	stomach neoplasm	EFO:0003897	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	male breast carcinoma	EFO:0006861	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	non-small cell lung carcinoma	EFO:0003060	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast carcinoma	EFO:0000305	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	head and neck squamous cell carcinoma	EFO:0000181	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gliosarcoma	EFO:1001465	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	gastric carcinoma	EFO:0000178	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	germ cell tumor	EFO:0000514	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	salivary gland neoplasm	EFO:0003826	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	urethral neoplasm	EFO:0003846	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	breast neoplasm	EFO:0003869	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	uterine neoplasm	EFO:0003859	2	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	squamous cell carcinoma	EFO:0000707	3	INHIBITOR
GEFITINIB	Epidermal growth factor receptor erbB1 inhibitor	EGFR	CHEMBL203	central nervous system cancer	EFO:0000326	2	INHIBITOR
ALCLOFENAC	Cyclooxygenase-1 inhibitor	PTGS1	CHEMBL221	rheumatic disease	EFO:0005755	4	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	uterine neoplasm	EFO:0003859	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	fibrosarcoma	EFO:0002087	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Pulmonary venoocclusive disease	Orphanet:31837	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colorectal carcinoma	EFO:1001951	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	ovarian carcinoma	EFO:0001075	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate carcinoma	EFO:0001663	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lung carcinoma	EFO:0001071	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chondrosarcoma	EFO:0000333	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colorectal carcinoma	EFO:1001951	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	systemic scleroderma	EFO:0000717	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	leukemia	EFO:0000565	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Hypereosinophilic syndrome	EFO:1001467	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	polycythemia vera	EFO:0002429	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	colon carcinoma	EFO:1001950	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	localised scleroderma	EFO:1001361	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lymphoid leukemia	EFO:0004289	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	uterine neoplasm	EFO:0003859	1	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	leukemia	EFO:0000565	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Merkel cell skin cancer	EFO:1001471	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	central nervous system cancer	EFO:0000326	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	fibrosarcoma	EFO:0002087	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	cutaneous melanoma	EFO:0000389	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	melanoma	EFO:0000756	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	ovarian carcinoma	EFO:0001075	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	thyroid carcinoma	EFO:0002892	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	asthma	EFO:0000270	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	plexiform neurofibroma	EFO:0000658	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lymphoma	EFO:0000574	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	malignant peripheral nerve sheath tumor	EFO:0000760	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Pulmonary venoocclusive disease	Orphanet:31837	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	asthma	EFO:0000270	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	breast carcinoma	EFO:0000305	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	fibrosarcoma	EFO:0002087	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	scleroderma	EFO:1001993	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	scleroderma	EFO:1001993	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	colon carcinoma	EFO:1001950	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	male breast carcinoma	EFO:0006861	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	synovial sarcoma	EFO:0001376	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	breast carcinoma	EFO:0000305	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	small cell lung carcinoma	EFO:0000702	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	localised scleroderma	EFO:1001361	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	male breast carcinoma	EFO:0006861	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	gastric carcinoma	EFO:0000178	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	melanoma	EFO:0000756	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	primary myelofibrosis	EFO:0002430	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	carcinoma	EFO:0000313	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Dermatofibrosarcoma protuberans	Orphanet:31112	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoma	EFO:0000574	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	gliosarcoma	EFO:1001465	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	thyroid carcinoma	EFO:0002892	1	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	mesothelioma	EFO:0000588	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lymphoma	EFO:0000574	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Lymphangioleiomyomatosis	Orphanet:538	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	cutaneous melanoma	EFO:0000389	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lymphoid leukemia	EFO:0004289	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	scleroderma	EFO:1001993	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	sarcoma	EFO:0000691	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	sarcoma	EFO:0000691	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	colorectal carcinoma	EFO:1001951	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	carcinoma	EFO:0000313	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	synovial sarcoma	EFO:0001376	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Gastrointestinal stromal tumor	Orphanet:44890	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Dermatofibrosarcoma protuberans	Orphanet:31112	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	malignant peripheral nerve sheath tumor	EFO:0000760	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	polycythemia vera	EFO:0002429	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	colon carcinoma	EFO:1001950	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Hypereosinophilic syndrome	EFO:1001467	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	chondrosarcoma	EFO:0000333	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	renal carcinoma	EFO:0002890	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Merkel cell skin cancer	EFO:1001471	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	lymphoid leukemia	EFO:0004289	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	central nervous system cancer	EFO:0000326	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chondrosarcoma	EFO:0000333	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	renal carcinoma	EFO:0002890	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	melanoma	EFO:0000756	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	sarcoma	EFO:0000691	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Lymphangioleiomyomatosis	Orphanet:538	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Pulmonary venoocclusive disease	Orphanet:31837	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	primary myelofibrosis	EFO:0002430	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	leukemia	EFO:0000565	3	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	gastric adenocarcinoma	EFO:0000503	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	idiopathic pulmonary fibrosis	EFO:0000768	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Lymphangioleiomyomatosis	Orphanet:538	1	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gastric carcinoma	EFO:0000178	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	synovial sarcoma	EFO:0001376	1	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	pulmonary hypertension	EFO:0001361	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	prostate carcinoma	EFO:0001663	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	lung carcinoma	EFO:0001071	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	chronic myelogenous leukemia	EFO:0000339	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	systemic scleroderma	EFO:0000717	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute myeloid leukemia	EFO:0000222	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	glioblastoma multiforme	EFO:0000519	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	systemic scleroderma	EFO:0000717	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	asthma	EFO:0000270	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	head and neck malignant neoplasia	EFO:0006859	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	central nervous system cancer	EFO:0000326	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	Dermatofibrosarcoma protuberans	Orphanet:31112	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	ovarian carcinoma	EFO:0001075	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	prostate carcinoma	EFO:0001663	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gliosarcoma	EFO:1001465	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	pulmonary hypertension	EFO:0001361	3	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	renal carcinoma	EFO:0002890	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	pulmonary hypertension	EFO:0001361	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	lung carcinoma	EFO:0001071	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	cutaneous melanoma	EFO:0000389	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	gastric carcinoma	EFO:0000178	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	malignant peripheral nerve sheath tumor	EFO:0000760	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	gliosarcoma	EFO:1001465	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	plexiform neurofibroma	EFO:0000658	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Neurofibromatosis type 1	Orphanet:636	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	pancreatic carcinoma	EFO:0002618	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	plexiform neurofibroma	EFO:0000658	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	mesothelioma	EFO:0000588	2	INHIBITOR
IMATINIB	Tyrosine-protein kinase ABL inhibitor	ABL1	CHEMBL1862	mesothelioma	EFO:0000588	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	uterine neoplasm	EFO:0003859	1	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	thyroid carcinoma	EFO:0002892	1	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	primary myelofibrosis	EFO:0002430	1	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	carcinoma	EFO:0000313	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Merkel cell skin cancer	EFO:1001471	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	localised scleroderma	EFO:1001361	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	polycythemia vera	EFO:0002429	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute graft vs. host disease	EFO:0004599	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	acute lymphoblastic leukemia	EFO:0000220	3	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	breast carcinoma	EFO:0000305	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	type I diabetes mellitus	EFO:0001359	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	peritoneal neoplasm	EFO:1001100	2	INHIBITOR
IMATINIB	Stem cell growth factor receptor inhibitor	KIT	CHEMBL1936	male breast carcinoma	EFO:0006861	2	INHIBITOR
IMATINIB	Platelet-derived growth factor receptor beta inhibitor	PDGFRB	CHEMBL1913	Hypereosinophilic syndrome	EFO:1001467	2	INHIBITOR
ENTACAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	metamphetamine dependence	EFO:0004701	0	INHIBITOR
ENTACAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	obesity	EFO:0001073	1	INHIBITOR
ENTACAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	epilepsy	EFO:0000474	1	INHIBITOR
ENTACAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	Parkinson's disease	EFO:0002508	4	INHIBITOR
ENTACAPONE	Catechol O-methyltransferase inhibitor	COMT	CHEMBL2023	cocaine dependence	EFO:0002610	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	cocaine dependence	EFO:0002610	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	parasitic infection	EFO:0001067	4	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	metastatic melanoma	EFO:0002617	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	melanoma	EFO:0000756	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	alcohol dependence	EFO:0003829	4	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	metamphetamine dependence	EFO:0004701	1	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	HIV infection	EFO:0000764	1	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	prostate carcinoma	EFO:0001663	1	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	opioid dependence	EFO:0005611	2	INHIBITOR
DISULFIRAM	Aldehyde dehydrogenase inhibitor	ALDH2	CHEMBL1935	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
CARBACHOL	Muscarinic acetylcholine receptor M3 agonist	CHRM3	CHEMBL245	glaucoma	EFO:0000516	4	AGONIST
SELEGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	nicotine dependence	EFO:0003768	2	INHIBITOR
SELEGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	marijuana dependence	EFO:0004218	2	INHIBITOR
SELEGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	Parkinson's disease	EFO:0002508	4	INHIBITOR
SELEGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	Alzheimers disease	EFO:0000249	1	INHIBITOR
SELEGILINE	Monoamine oxidase B inhibitor	MAOB	CHEMBL2039	cocaine dependence	EFO:0002610	3	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	HIV infection	EFO:0000764	1	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	central nervous system cancer	EFO:0000326	3	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	prostate carcinoma	EFO:0001663	2	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	lupus nephritis	EFO:0005761	3	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	Myasthenia gravis	EFO:0004991	3	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	bullous pemphigoid	EFO:0007187	2	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	melanoma	EFO:0000756	1	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	multiple sclerosis	EFO:0003885	4	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	rheumatoid arthritis	EFO:0000685	3	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	uveitis	EFO:1001231	2	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	Henoch-Schoenlein purpura	EFO:1000965	2	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	systemic lupus erythematosus	EFO:0002690	2	INHIBITOR
TERIFLUNOMIDE	Dihydroorotate dehydrogenase inhibitor	DHODH	CHEMBL1966	multiple myeloma	EFO:0001378	1	INHIBITOR
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	septic shock	EFO:0006834	3	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diffuse large B-cell lymphoma	EFO:0000403	2	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	Burkitts lymphoma	EFO:0000309	2	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	asthma	EFO:0000270	4	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	acute lymphoblastic leukemia	EFO:0000220	2	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	leukemia	EFO:0000565	2	AGONIST
HYDROCORTISONE HEMISUCCINATE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	anaplastic large cell lymphoma	EFO:0003032	2	AGONIST
METHACHOLINE	Muscarinic acetylcholine receptor M3 agonist	CHRM3	CHEMBL245	asthma	EFO:0000270	3	AGONIST
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Niemann-Pick disease	EFO:1001380	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Sickle cell anemia	Orphanet:232	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	HIV infection	EFO:0000764	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	HIV infection	EFO:0000764	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Niemann-Pick disease	EFO:1001380	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	central nervous system cancer	EFO:0000326	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	prostate carcinoma	EFO:0001663	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	anal neoplasm	EFO:0003835	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	bladder carcinoma	EFO:0000292	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	renal cell carcinoma	EFO:0000681	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	anal neoplasm	EFO:0003835	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Juvenile Myelomonocytic Leukemia	EFO:1000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	ovarian neoplasm	EFO:0003893	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	leukemia	EFO:0000565	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	lymphoid leukemia	EFO:0004289	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	anal neoplasm	EFO:0003835	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	anal neoplasm	EFO:0003835	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	MALT lymphoma	EFO:0000191	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	ovarian neoplasm	EFO:0003893	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Alzheimers disease	EFO:0000249	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Sezary's disease	EFO:1000785	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	renal cell carcinoma	EFO:0000681	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Cutaneous T-cell lymphoma	EFO:0002913	4	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	sarcoma	EFO:0000691	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	brain disease	EFO:0005774	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	gastric carcinoma	EFO:0000178	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Crohn's disease	EFO:0000384	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	sarcoma	EFO:0000691	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	bladder carcinoma	EFO:0000292	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	lymphoma	EFO:0000574	3	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	sarcoma	EFO:0000691	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	ovarian neoplasm	EFO:0003893	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	lymphoid leukemia	EFO:0004289	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	marginal zone B-cell lymphoma	EFO:1000630	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	breast neoplasm	EFO:0003869	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	gliosarcoma	EFO:1001465	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	gastric carcinoma	EFO:0000178	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	malignant pleural mesothelioma	EFO:0000770	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	ovarian carcinoma	EFO:0001075	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	sarcoma	EFO:0000691	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	mycosis fungoides	EFO:1001051	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	HIV infection	EFO:0000764	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	primitive neuroectodermal tumor	EFO:0005235	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Crohn's disease	EFO:0000384	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	neuroblastoma	EFO:0000621	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Juvenile Myelomonocytic Leukemia	EFO:1000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	clear cell renal carcinoma	EFO:0000349	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	male breast carcinoma	EFO:0006861	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	central nervous system cancer	EFO:0000326	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Juvenile Myelomonocytic Leukemia	EFO:1000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	ovarian carcinoma	EFO:0001075	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	multiple myeloma	EFO:0001378	3	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	verrucous carcinoma	EFO:0007535	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	melanoma	EFO:0000756	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	gastric carcinoma	EFO:0000178	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	malignant pleural mesothelioma	EFO:0000770	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	primitive neuroectodermal tumor	EFO:0005235	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	HIV-1 infection	EFO:0000180	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	oligoastrocytoma	EFO:0000630	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	lymphoma	EFO:0000574	3	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	HIV-1 infection	EFO:0000180	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	melanoma	EFO:0000756	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	marginal zone B-cell lymphoma	EFO:1000630	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	brain disease	EFO:0005774	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Cutaneous T-cell lymphoma	EFO:0002913	4	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	spinal cord neoplasm	EFO:0003828	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	mycosis fungoides	EFO:1001051	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	breast carcinoma	EFO:0000305	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	anaplastic oligodendroglioma	EFO:0002501	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Alzheimers disease	EFO:0000249	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	bladder carcinoma	EFO:0000292	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	breast neoplasm	EFO:0003869	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	central nervous system cancer	EFO:0000326	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Niemann-Pick disease	EFO:1001380	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	neuroblastoma	EFO:0000621	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	verrucous carcinoma	EFO:0007535	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Sezary's disease	EFO:1000785	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	lymphoma	EFO:0000574	3	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	oligoastrocytoma	EFO:0000630	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	breast carcinoma	EFO:0000305	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	melanoma	EFO:0000756	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Cutaneous T-cell lymphoma	EFO:0002913	4	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Cutaneous T-cell lymphoma	EFO:0002913	4	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	medulloblastoma	EFO:0002939	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	gliosarcoma	EFO:1001465	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	prostate adenocarcinoma	EFO:0000673	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	leukemia	EFO:0000565	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	malignant pleural mesothelioma	EFO:0000770	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	neuroblastoma	EFO:0000621	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	multiple myeloma	EFO:0001378	3	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	multiple myeloma	EFO:0001378	3	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Niemann-Pick disease	EFO:1001380	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	male breast carcinoma	EFO:0006861	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	HIV infection	EFO:0000764	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	marginal zone B-cell lymphoma	EFO:1000630	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Alzheimers disease	EFO:0000249	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	mycosis fungoides	EFO:1001051	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Crohn's disease	EFO:0000384	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	male breast carcinoma	EFO:0006861	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	male breast carcinoma	EFO:0006861	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Sezary's disease	EFO:1000785	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	precursor T-cell lymphoblastic leukemia-lymphoma	EFO:1001830	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	medulloblastoma	EFO:0002939	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	primitive neuroectodermal tumor	EFO:0005235	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	breast carcinoma	EFO:0000305	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	esophageal carcinoma	EFO:0002916	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	mycosis fungoides	EFO:1001051	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	medulloblastoma	EFO:0002939	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	HIV-1 infection	EFO:0000180	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	hepatocellular carcinoma	EFO:0000182	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	lymphoid leukemia	EFO:0004289	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	lymphoid leukemia	EFO:0004289	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	colorectal carcinoma	EFO:1001951	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	marginal zone B-cell lymphoma	EFO:1000630	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	anaplastic astrocytoma	EFO:0002499	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	neoplasm of mature B-cells	EFO:0000096	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	chronic lymphocytic leukemia	EFO:0000095	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	oligoastrocytoma	EFO:0000630	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	ovarian carcinoma	EFO:0001075	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Juvenile Myelomonocytic Leukemia	EFO:1000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	medulloblastoma	EFO:0002939	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	breast neoplasm	EFO:0003869	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	unspecified peripheral T-cell lymphoma	EFO:0000211	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	prostate carcinoma	EFO:0001663	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	lymphoma	EFO:0000574	3	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Sezary's disease	EFO:1000785	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	gastric carcinoma	EFO:0000178	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Alzheimers disease	EFO:0000249	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	prostate carcinoma	EFO:0001663	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	neuroblastoma	EFO:0000621	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	breast neoplasm	EFO:0003869	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	spinal cord neoplasm	EFO:0003828	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Hodgkins lymphoma	EFO:0000183	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	malignant pleural mesothelioma	EFO:0000770	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	chronic myelogenous leukemia	EFO:0000339	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	acute lymphoblastic leukemia	EFO:0000220	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	prostate carcinoma	EFO:0001663	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	leukemia	EFO:0000565	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	multiple myeloma	EFO:0001378	3	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	breast carcinoma	EFO:0000305	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	gliosarcoma	EFO:1001465	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	MALT lymphoma	EFO:0000191	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	spinal cord neoplasm	EFO:0003828	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	small cell lung carcinoma	EFO:0000702	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	primitive neuroectodermal tumor	EFO:0005235	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Sickle cell anemia	Orphanet:232	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	leukemia	EFO:0000565	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	ovarian carcinoma	EFO:0001075	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	non-small cell lung carcinoma	EFO:0003060	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	spinal cord neoplasm	EFO:0003828	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	myelodysplastic syndrome	EFO:0000198	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	central nervous system cancer	EFO:0000326	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	Mantle cell lymphoma	EFO:1001469	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	glioblastoma multiforme	EFO:0000519	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	melanoma	EFO:0000756	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	renal cell carcinoma	EFO:0000681	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	HIV-1 infection	EFO:0000180	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	ureteral neoplasm	EFO:0003844	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	pancreatic carcinoma	EFO:0002618	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	MALT lymphoma	EFO:0000191	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	bladder carcinoma	EFO:0000292	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	head and neck squamous cell carcinoma	EFO:0000181	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	Sickle cell anemia	Orphanet:232	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	diffuse large B-cell lymphoma	EFO:0000403	1	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Sickle cell anemia	Orphanet:232	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	gliosarcoma	EFO:1001465	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	ovarian neoplasm	EFO:0003893	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	oligoastrocytoma	EFO:0000630	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	verrucous carcinoma	EFO:0007535	1	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	brain disease	EFO:0005774	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	acute myeloid leukemia	EFO:0000222	3	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	non-Hodgkins lymphoma	EFO:0005952	2	INHIBITOR
VORINOSTAT	Histone deacetylase 2 inhibitor	HDAC2	CHEMBL1937	Burkitts lymphoma	EFO:0000309	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Malignant epithelial tumor of ovary	Orphanet:398934	2	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	verrucous carcinoma	EFO:0007535	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	soft tissue sarcoma	EFO:1001968	2	INHIBITOR
VORINOSTAT	Histone deacetylase 1 inhibitor	HDAC1	CHEMBL325	renal cell carcinoma	EFO:0000681	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	acute promyelocytic leukemia	EFO:0000224	1	INHIBITOR
VORINOSTAT	Histone deacetylase 3 inhibitor	HDAC3	CHEMBL1829	Crohn's disease	EFO:0000384	1	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	MALT lymphoma	EFO:0000191	2	INHIBITOR
VORINOSTAT	Histone deacetylase 6 inhibitor	HDAC6	CHEMBL1865	brain disease	EFO:0005774	2	INHIBITOR
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	hypercholesterolemia	HP:0003124	3	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Hypertriglyceridemia	EFO:0004211	3	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	alcohol dependence	EFO:0003829	2	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	diabetic retinopathy	EFO:0003770	2	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Disorder of lipid metabolism	Orphanet:309005	3	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	Combined hyperlipidemia	Orphanet:79211	3	AGONIST
FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	PPARA	CHEMBL239	medulloblastoma	EFO:0002939	2	AGONIST
FLUOCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	retinopathy	EFO:0003839	2	AGONIST
FLUOCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	uveitis	EFO:1001231	2	AGONIST
FLUOCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	age-related macular degeneration	EFO:0001365	2	AGONIST
FLUOCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	diabetic retinopathy	EFO:0003770	3	AGONIST
FLUOCINOLONE ACETONIDE	Glucocorticoid receptor agonist	NR3C1	CHEMBL2034	posterior uveitis	EFO:1001119	2	AGONIST
AZD-7624	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	inflammation	MP:0001845	1	INHIBITOR
AZD-7624	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	asthma	EFO:0000270	2	INHIBITOR
AZD-7624	MAP kinase p38 alpha inhibitor	MAPK14	CHEMBL260	chronic obstructive pulmonary disease	EFO:0000341	2	INHIBITOR
IBANDRONIC ACID	Farnesyl diphosphate synthase inhibitor	FDPS	CHEMBL1782	osteoporosis	EFO:0003882	4	INHIBITOR
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	asthma	EFO:0000270	3	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergy	EFO:0003785	4	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	breast carcinoma	EFO:0000305	2	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	urticaria	EFO:0005531	2	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	Rhinitis, Allergic, Perennial	EFO:1001417	3	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	lymphoma	EFO:0000574	0	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	seasonal allergic rhinitis	EFO:0003956	3	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	atopic eczema	EFO:0000274	1	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	multiple sclerosis	EFO:0003885	1	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	pain	EFO:0003843	2	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	rheumatoid arthritis	EFO:0000685	1	ANTAGONIST
LORATADINE	Histamine H1 receptor antagonist	HRH1	CHEMBL231	allergic rhinitis	EFO:0005854	3	ANTAGONIST
